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Abstract 
FGF signalling is pivotal in early vertebrate development and is involved in cell 
movements, germ layer induction and organogenesis.  There is also evidence of an 
important role of FGF signalling in the specification and patterning of posterior 
neural tissues.   Transcriptional targets of FGF signalling during germ layer 
specification have been identified recently by previous lab members.  However, less 
is known about FGF targets active during neural development.  
The aim of this project was to investigate proximal downstream targets of FGF 
signalling in the context of early neural development by using drug-inducible forms 
of Xenopus FGF receptors, iFGFRs 1-4.  The effect of iFGFR 1-4 induction in 
Xenopus laevis during gastrulation was initially investigated through analysis of a 
microarray dataset. This, and investigation of phenotypes of embryos expressing 
iFGFRs, found that each iFGFR had distinct effects upon the Xenopus 
transcriptome and embryonic development.   
An RNA-seq based screen was performed to investigate proximal changes to 
the Xenopus laevis transcriptome in the context of neural development, as a result 
of iFGFR1 or iFGFR4 activation during a period of early neural specification.  After 
filtering the data, 188 genes were found to be affected by iFGFR1 and 274 genes 
affected by iFGFR4.  As well as genes known to regulate posterior neural 
development, a number of genes regulating laterality, cell cycle and anterior neural 
development were also identified as being regulated by both receptors.  Functional 
characterisation of a few novel FGF targets identified from the microarray and/or 
RNA-seq screens was performed using genome editing approaches. TALEN-
mediated knockout of one of these targets, Nek6, was shown to affect the 
expression of mesodermal and neuroectodermal genes, as well as affecting FGF 
signalling itself.  This work shows that FGFR1 and FGFR4 have distinct signalling 
outputs during neural development, but cooperate to specify and pattern the 
developing Xenopus CNS. 
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1 General Introduction 
 
1.1 Introduction 
The focus of this project is to identify and characterise FGF signalling targets during 
Xenopus neural development.  FGFs are important signalling molecules and 
essential for a range of diverse processes in development including mesoderm and 
neural induction, patterning in neural and limb tissues, somitogenesis, myogenesis 
and left/right asymmetry (Slack et al. 1987; Lamb & Harland 1995; del Corral et al. 
2003; Niswander et al. 1993; Dubrulle et al. 2001; Fisher et al. 2002; Meyers & 
Martin 1999).  After embryonic life, FGF signalling is important for regulating cell 
proliferation, differentiation and survival in the adult, so it is not surprising that 
abnormal FGF signalling during development is implicated in many disorders 
including the skeletal abnormalities achondroplasia and Apert syndrome,  and 
cancer (Webster & Donoghue 1997; Turner & Grose 2010).   
1.2 FGF Ligands 
1.2.1 FGF ligands are organised into subfamilies 
FGFs were discovered when they were isolated from the bovine brain and found to 
have mitogenic properties when added to cultured fibroblasts (Gospodarowicz 
1975).  FGFs have since been found to be well conserved throughout evolution as 
orthologues can be found in all metazoans (Böttcher & Niehrs 2005). Two FGF 
orthologues have been identified in Caenorhabditis elegans – Egl17 and Let756. 
The ascidian Ciona intestinalis, which is studied as a model of an ancestral 
chordate, has 6 FGF-like genes.  This suggests numerous duplication events 
occurred during early metazoan evolution after the divergence of protostomes and 
deuterosomes (Itoh & Ornitz 2008).  These Ciona FGFs are known as FGF4-like, 
FGF5-like, FGF8-like, FGF9-like, FGF10-like and FGF 13-like, indicating that the 
precursors of these subfamilies were present in the chordate lineage ancestral to 
modern vertebrates (Itoh & Ornitz 2004; Itoh & Ornitz 2011).   
17 
22 FGF ligands have been identified in higher vertebrates and are functionally 
divided into three groups – paracrine, endocrine and intracrine.  The evolutionary 
progression of the mammalian FGFs was proposed as follows: FGFs derived from 
FGF5, 8 and 10-like conserved their secreted signalling sequence and heparin-
binding sites and became paracrine FGFs.  FGF9 subfamily FGFs also arose in this 
way but also evolved an uncleaved bipartite signal sequence.   There is no 
ancestral gene of the endocrine FGF15/19 family in Ciona, but it is thought that 
these arose from FGF4 by local gene duplication in vertebrate evolution (Itoh & 
Ornitz 2011). Two further genome duplications during vertebrate evolution resulted 
in families of FGF ligands with three or four members (Itoh & Ornitz 2004).  
Therefore, the FGF family has undergone considerable expansion during evolution 
from simple metazoan to vertebrate. 
On the basis of Itoh and Ornitz’s (2008) phylogenetic analyses, human and mouse 
FGFs have been organised into the families as outlined in Table 1.1.   However, 
after studying the location of FGF genes within the genome rather than just 
phylogenetic analysis, there is a slightly different interpretation of grouping the FGFs 
into 6 subfamilies shown in Table 1.2.  This is based upon the analysis of gene loci 
on chromosomes that is thought to indicate more precise evolutionary relationships 
(Itoh & Ornitz 2008).    
 
Table 1.1 – Phylogenetic-based grouping of FGF ligands 
FGF subfamily Ligands Receptor Preference 
FGF1 
FGF1, FGF2 (aka 
bFGF) 
Fgf1 activates all FGFRs, 
FGF2 – FGFR1c, 3c>2c, 1b, 4 
FGF4 FGF4 (aka eFGF),5,6 FGFR1c, 2c>3c, 4 
FGF7 FGF3,7,10,22 FGFR2b>1b 
FGF8 FGF8, 17*, 18* FGFR3c>4>1c 
FGF9 FGF9,FGF16,FGF20 FGFR3c>2c>1c, 3b>>4 
FGF19 – 
Hormone class 
FGF15/19†, FGF21, 
FGF23** 
Hormone class, weakly activate 
FGFR1c, 2c,3c, 4 
FGF11 - iFGFs FGF11,12,13,14 No known activity 
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Table 1.2 – Gene location based grouping of FGF ligands 
 
 
Table 1.1 and 1.2 *FGFs 17 and 18 have not been identified in Xenopus.  ** FGF23 is 
duplicated in Xenopus † FGF15 has not been identified in humans or Xenopus and are likely 
orthologues.  FGF19 has not been identified in mice/rats.  Adapted from (Zhang et al. 2006; 
Pownall & Isaacs 2010) 
The FGF ligands have varying affinities to each FGFR and receptor variants.  FGF1 
is the only ligand that interacts with all four FGFRs, and the other ligands are less 
promiscuous (Zhang et al. 2006).  The binding properties of FGF ligands tend to 
group within families.  For example FGF8 family members only bind FGFRc 
subforms and FGFR4, and FGF7 family members only bind FGFR1/2b.   
There are some small differences between the Xenopus and the mammalian FGF 
repertoire listed in Table 1.1. Recently Lea et al (2009) identified and annotated the 
Xenopus tropicalis orthologues of human and mouse FGF genes.  19 out of the 22 
mammalian FGFs were found in Xenopus.  They found that synteny was largely 
conserved and upon phylogenetic analysis, the tropicalis FGF ligands group into the 
same subfamilies as mouse and human.  However, orthologues for FGF21, FGF18 
and FGF17 were not found in Xenopus in areas expected to contain them based on 
synteny. This was partially due to the poor quality of the frog genome in the regions 
expected to contain those FGFs.  Interestingly, there are two paralogues of FGF23 
present next to each other, meaning that this gene must have undergone a 
duplication event during Xenopus evolution.  Nevertheless, FGFs have been 
remarkably conserved throughout vertebrate evolution, making Xenopus a viable 
organism in which to study FGF signalling and apply it to mammalian systems.   
FGF 
subfamily 
Ligands 
1 FGF1, FGF2 (aka bFGF), 5 
2 FGF3,4 (aka eFGF),6, 15/19, 21, 23** 
3 FGF 7,10,22 
4 FGF8, 17*, 18* 
5 FGF9, 16, 20 
6 FGF11, 12, 13, 14 
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1.2.2 Structure of FGF ligands  
1.2.2.1 Paracrine FGFs 
The paracrine FGFs 3-8, 10, 15/19, 17, 18, 21, 22 are secreted proteins with 
cleavable amino terminal signal peptides for transport through the secretory 
pathway (Ornitz & Itoh 2001).  FGFs 9, 16 and 20 are also secreted proteins but in 
place of the cleavable regions have an uncleavable bipartite signal sequence 
(Revest 2000).  FGF1 and 2 do not have identifiable signalling sequences but 
nevertheless are secreted (Itoh & Ornitz 2008).  FGFs 1-9 range in size from 150-
260 amino acids and have a conserved core region of 120 amino acids.  These core 
regions have between 30 and 70% sequence identity (Ornitz & Itoh 2001; Itoh & 
Ornitz 2004).  FGF10-22 range from 160-250 amino acid residues and again have a 
conserved 120 amino acid core (Itoh & Ornitz 2004).  The core homology domain of 
FGF ligand folds into a globular trefoil.  Paracrine FGFs have a regular trefoil 
domain of 12 β-strands in contrast to the endocrine FGFs which have an atypical 
trefoil domain lacking the β11 strand (Mohammadi et al. 2005; Goetz et al. 2007).  
Paracrine FGFs are secreted proteins that contain binding sites for 
glycosaminoglycans such as heparan sulphate as well as FGF receptors.  Ligands, 
heparan sulphate chains  and the FGFR bind each other in a 2:2:2 configuration on 
the cell surface to activate FGF signalling (Figure 1.1) (Mohammadi et al. 1997).   
1.2.2.2 Intracrine FGFs 
The FGF11 subfamily – FGF11-14 – comprises the intracrine FGFs. They are also 
secreted proteins and contain a nuclear localisation signal, but are unable to bind 
FGFRs. On this basis it has been debated whether they should be considered ‘true’ 
FGFs and so are sometimes referred to as FGF homologous factors (FHFs).  FHFs 
interact with intracellular domains of voltage gated sodium channels as well as the 
neuronal MAPK scaffold protein Islet-brain-2. Their only known role is to regulate 
neuronal excitability (Itoh & Ornitz 2011).  FGF12-/- FGF14-/- double-knockout mice 
suffer from severe ataxia and their neurons fire much less readily, with higher 
voltage thresholds than wild types due to altered sodium channel physiology 
(Goldfarb et al. 2007).  
1.2.2.3 Endocrine FGFs 
The FGF19 family is known as the hormone class of FGFs and act in an endocrine 
manner.  Instead of binding to heparan sulphate they use Klotho as a co-receptor to 
increase affinity between ligand and receptor  (Goetz et al. 2007).  Hormonal FGFs 
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are not expressed early during development and mainly function in the adult 
organism to control metabolism.  Examples include FGF19 involved in bile acid 
metabolism, FGF23 necessary for vitamin D metabolism and FGF21 required for 
correct carbohydrate and lipid metabolism (Inagaki et al. 2005; Shimada et al. 2004; 
Kharitonenkov et al. 2005).   
1.2.3 Regulation of FGF ligands 
FGFs can be regulated by heparin sulphate binding, N-terminal alternative splicing, 
homeodimerisation and proteolytic cleavage (Goetz & Mohammadi 2013).  FGF9 
and its family member FGF20 are unique among the FGFs as they can reversibly 
homodimerise which buries their receptor binding sites – thereby providing a means 
of auto-inhibition of signalling (Plotnikov et al. 2001).  Proteolytic cleavage of the N-
terminus of FGF23 has been shown to occur in vitro.  The truncated FGF23 can no 
longer bind to the FGFR or Klotho,  providing another mode of autoinhibition (Goetz 
& Mohammadi 2013).  Members of the FGF8 subfamily can be alternatively spliced.  
In the chick, FGF8 is alternatively spliced into an FGF8a and FGF8b form.   FGF8b 
induces the MAPK pathway to a much greater extent than FGF8a.  Ectopic 
expression of FGF8a in the chick neural plate caused posterior transformation of the 
presumptive diencephalon to mesencephalon.  In contrast, ectopic expression of 
FGF8b changed the fate of the mesencephalon to cerebellum, thus more severely 
posteriorising the developing brain (Sato et al. 2001).  This result was also seen in 
the mouse model, suggesting the regulation and balance of FGF8 splicing is 
required for correct mesencephalon and hindbrain development (Liu et al. 2003).   
1.2.4 Heparan Sulphate Proteoglycans 
Heparan Sulphate Proteoglycans (HSPGs) are located in the plasma membrane 
and are required as cofactors for a number of signalling pathways including FGF.  
Heparan sulphates consist of repeating disaccharide units composed of a N-uronic 
acid and a derivative of N-glucosamine, the latter of which is variably O-sulphated 
(Esko & Selleck 2002).  The stability of paracrine FGF ligands bound to FGF 
receptor and thereby the ability of this complex to signal depends on the interaction 
of both ligand and receptor with HS chains.  This interaction therefore forms a 
tripartite complex by contacting both the receptor and the ligand simultaneously in a 
2:2:2 ratio (Pellegrini et al. 2000; Schlessinger et al. 2000).   The interaction 
between HSPG and paracrine FGFs enhances ligand stability.  It also sequesters 
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ligands near FGFRs providing a reservoir for ligand storage, in doing so limiting the 
dispersion of ligand signalling (Goetz & Mohammadi, 2013).   
This requirement of HSPGs for FGF signalling has been demonstrated, as prior 
digestion of HSPGs by heparanase inhibits the ability of FGF to induce mesodermal 
genes such as Xbra in Xenopus animal cap explants (Itoh & Sokol 1994).  In vitro, 
the mitogenic property of FGFs is only activated in BaF3 cells transfected with a 
soluble form of FGFR1 when heparan is also present in cell medium (Ornitz et al. 
1992).  There are differences in affinities of FGF ligands for HSPGs which affects 
their signalling.  FGF10 has a greater affinity for HS than its sub-family member 
FGF7.  When these FGFs emanate from a source, the varying affinities for HS 
result in a short steep gradient of FGF10 and a long shallow gradient of FGF7.  
These different affinities are utilised in the context of branching morphogenesis of 
ureteric gland buds during murine development.   Mutation of Arg178 of FGF10 to 
valine, the corresponding amino acid in FGF7, caused a reduction of FGF10 binding 
to HS.  This caused mutant FGF10 to induce branching rather than elongation of 
epithelial buds (Makarenkova et al. 2009).  
The formation of a tripartite signalling complex is dependent on the pattern of 
sulphation on 2- and 6-O-sulphate groups (Pellegrini et al. 2000).  HS chains 
containing tri-sulphated disaccharide units for example greatly promote FGF2-
FGFR1 interactions (Lundin et al. 2000). Differential signal transduction through 
FGF1 and FGF2 was found to be mediated by oligosaccharide length and 
sulphation pattern in cell culture.  This suggests that as well as being required for 
FGF ligand to receptor binding, HSPGs can also influence the affinities of specific 
ligands to receptors thereby introducing another level of signal modulation (Pye et 
al. 2000).   
These sulphation patterns are partially controlled by the actions of 6-O-sulfatases 
Sulf1 and Sulf2.  The removal of sulphate groups from heparan sulphate (HS) 
changes the nature of the interaction of HS to FGFs and consequently the ability of 
FGF to signal.  Loss of HS sulphation in the Drosophila mutant sulfateless leads to 
defects in the Wg and FGF signalling pathways (Lin & Perrimon 1999; Lin et al. 
1999).  The Drosophila slalom mutant, characterised by unsulphated HSPGs, has 
defects in FGF and Hedgehog signal transduction (Lüders et al. 2003).    This is true 
in Xenopus, as overexpression of Sulf1 mRNA in ectodermal explants prevented 
FGF2 and FGF4-dependent mesoderm induction (Wang et al. 2004).  This was also 
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observed in whole embryos, where ectopic Sulf1 resulted in downregulation of 
dpERK and the mesodermal FGF targets Xbra and MyoD.  Conversely, Sulf1 
morphant embryos exhibited an increase in MAPK signalling and levels of Cdx4, 
suggesting a role for Sulf1 of restricting FGF signalling in the presomitic mesoderm 
(PSM) (Freeman et al. 2008).   
1.2.5 Expression of FGF ligands in the Xenopus embryo 
Lea et al. (2009) performed a comprehensive in situ hybridisation screen using 
probes for all the Xenopus tropicalis FGF ligands to investigate differences in their 
expression patterns. Interesting variations in expression patterns and timings of 
ligand expression, even within FGF ligand families, was discovered.  Even though 
FGF1 and FGF2 are in the same family, they have distinct expression patterns 
within the nervous system.  FGF1 is expressed in the brain whereas FGF2 is 
expressed in the extreme posterior central nervous system (CNS) of the embryo 
and branchial arches.  Other paracrine FGFs family have quite similar expression 
patterns in the head, somites and branchial arches.  The intracrine FGF11 family 
members FGF12 and FGF13 are expressed in the brain, neural tube and somites, 
showing that although they do not activate FGF signalling through FGFRs, they are 
co-expressed in the same places as paracrine FGFs.  The hormonal class FGFs in 
contrast are expressed globally at all stages, lacking distinct expression domains 
(Lea et al. 2009). 
There is also variation between and within ligand families of when FGF ligands are 
expressed during development.  FGF1 and 2 are expressed throughout 
development, whereas other paracrine FGFs such as FGF3 and FGF7 are 
expressed only after the onset of neurulation, and FGF6 after stage 30. FGF8 
expression peaks in gastrulation and neurulation and then levels sharply decrease.  
Intracrine FGFs are only expressed past tailbud stage 30 and endocrine FGFs 19 
and 22 are expressed only for a brief window during neurulation.  
This variety in FGF ligands, their affinities to different FGFRs, as well as spatial and 
temporal regulation of ligand expression during development points towards a very 
complicated and nuanced signalling system. This complexity is further increased as 
there is also variation in FGFRs. 
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1.3 FGF Receptors (FGFRs) 
1.3.1 Structure of FGFRs 
There are four main subtypes of FGFR, FGFR1-4.  FGFRs consist of an 
extracellular domain – containing an amino terminal signal sequence and three 
immunoglobulin-like domains – a single membrane transmembrane spanning 
domain, and an intracellular domain (Figure 1.1).   
 
Figure 1.1 Schematic diagram of a FGFR 
The extracellular domain of the FGFR contains three immunoglobulin-like domains D1-3.  
Between D1 and D2 is an acid box region (AB).  Ligands bind to D2 and D3, shown in blue, 
and dimerise the receptor.  This interaction is stabilised through interaction between the ligand 
and receptor with Heparan sulphate chains in HSPGs in the plasma membrane.  The 
extracellular domain of the FGFR is connected to the intracellular via a single pass 
transmembrane domain (TM).  The intracellular domains contain the juxtamembrane region 
(JM), and two kinase domains (K1 and 2) split by a 14 amino acid interkinase domain (IKD) 
and finally the carboxy terminal tail (CT).  These kinase domains are phosphorylated (Pi) at 
several tyrosine residues to activate the receptor.   
The intracellular domain contains a juxtamembrane domain, a split tyrosine kinase 
domain and a short carboxy terminus (Gong 2014).  The sequence and structural 
homology between FGFR1 and FGFR2-4 varies.  FGFR1 and FGFR2 have a 
relatively high similarity, as they share 72% amino acid identity. The least similarity 
is seen between FGFR1 and FGFR4 with only 55% of the amino acid sequence in 
common. The variability between FGFRs is mainly between extracellular domains, 
although FGFR4 shares 66-73% sequence identity in the first kinase domain 
(Kostrzewa & Müller 1998). Perhaps the greatest difference between extracellular 
domains is due to FGFR1-3 containing 19 exons, whereas FGFR4 contains 18.   
24 
The extracellular domain of the FGFR contains three immunoglobulin-like domains 
designated D1-D3 (also known as Ig1-3).  Between the D1 and D2 domains is a 7-8 
acidic amino acid motif known as the acid box which electrostatically interacts with a 
heparan-binding region within the D2 domain. This prevents HSPG binding to the 
FGFR, and therefore provides a mode of FGFR autoinhibition (Kalinina et al. 2012; 
Eswarakumar et al. 2005).  FGF ligands bind to the D2 and linker region between 
D2 and D3 via a network of hydrogen bonds, which stabilise the interactions 
between ligand, receptor and HS chains contacting both ligand and receptor, 
stabilise the interaction (Goetz & Mohammadi 2013).  The tripartite complex of 
ligand, receptor and HS chain brings the intracellular domains of the FGFR into 
close proximity.  The kinase domains transphosphorylate each other on certain 
tyrosine residues.  Tyrosine residues 463, 583, 585, 653, 654, 730 and 766 are the 
major autophosphorylation sites for FGFR1 in vitro, with Y766 being a binding site 
exclusively for the SH2 domain of PLCγ (Mohammadi et al. 1996).  Mass 
spectrometry analysis showed that 5 tyrosine sites in the catalytic core of the 
FGFR1 kinase domain are phosphorylated in a precise order, with Y653 in the 
activation loop being phosphorylated first. This is sufficient for the subsequent 
autophosphorylation of the other tyrosines; however the second phosphorylation 
event of Y654 increases the signal transduction efficiency of FGFR1 1000-fold.The 
phosphorylated tyrosines are then able to act as docking sites for signalling proteins 
(Furdui et al. 2006).  The signalling proteins are activated by phosphorylation and 
go on to activate other downstream signalling components. 
1.3.2 Alternate splicing of FGFRs produce different variants 
1.3.2.1 FGFRIIIb and FGFRIIIc 
Alternate splicing of the D3 domain through differential usage of exon 8 and 9 
generates different isoforms of FGFR1-3 with distinct ligand binding properties, 
known as IIIb and IIIc isoforms (Zhang et al. 2006).  There is also an IIIa spliceform 
possible when exon 7 is spliced out, but it has no known function (Duan et al. 1992).  
FGFR4, with only one exon encoding the c-terminal region of IgIII, does not have 
this property, and only the IIIb form is translated (Kostrzewa & Müller 1998). IIIb 
forms are generally restricted to epithelial cell lineages and preferentially bind 
ligands secreted from mesenchymal tissues, and the reverse is true for IIIc FGFR 
isoform (Goetz & Mohammadi 2013).  This reciprocal expression creates paracrine 
FGF signalling loops between the epithelium and mesenchyme which are important 
for developmental processes and homeostasis.  For example, during murine lung 
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development FGF9 secreted by the developing lung epithelium stimulates the 
proliferation of the mesenchyme while FGF10 secreted from the mesenchyme 
stimulates budding and branching of the epithelium.  FGF9-null mice not only exhibit 
reduced mesenchyme proliferation in lungs, but also decreased branching of 
airways.  Therefore, bidirectional signalling loops between FGFRIIIb and IIIc 
isoforms are an important developmental mechanism for coordinating the 
development of very complex structures (Colvin et al. 2001).     
1.3.2.2 FGFR VT+ and VT- 
As well as alternative splicing in the extracellular domain of FGFRs, another variant 
of FGFR1-3 excludes a Valine423 and Threonine424 (VT) from the juxtamembrane 
region.  These isoforms are known as FGFR VT- and arise from use of an 
alternative 5’ donor splice site (Gillespie et al. 1995).  The threonine424 is a 
conserved phosphorylation site, and the VT+ but not VT- form can be 
phosphorylated by PKC in vitro suggesting the two isoforms have different signalling 
properties (Gillespie et al. 1995).   
RNase protection analysis in Xenopus blastulae showed the FGFR1 (VT-) is 
restricted to marginal zones, whereas the VT+ form is present in animal, marginal 
and vegetal areas (Paterno et al. 2000).  This lead to the hypothesis that FGFR1 
(VT-)  is particularly important for mesoderm development and indeed, the 
mesodermal marker Xbra was expressed as controls in embryos overexpressing 
FGFR1(VT-) compared to those overexpressing FGFR1(VT+) where Xbra was 
almost non-detectable (Paterno et al. 2000).   In Xenopus, the VT- isoform of 
FGFR1 is expressed at very low levels relative to the VT+ isoform except during the 
mid-blastula transition when it increases in abundance to become the predominant 
form, before returning to basal levels in later developmental stages.  The biological 
significance of this is unclear as overexpression of VT- did not produce a detectable 
phenotype (Paterno et al. 2000).    Later experiments in 293T cells revealed that the 
VT region is required for the binding of FRS2 to the FGFR kinase domain.  FGFR1 
VT- was unable to activate MAPK in mouse embryos suggesting that the inclusion 
of the VT motif in FGFRs is important for controlling the formation of the FRS2-
dependent signalling complex (Burgar et al. 2002).   
1.3.3 Expression of FGFRs in Xenopus 
As with FGF ligands, the four main Xenopus FGFR subtypes are expressed in a 
range of locations and developmental stages in the developing embryo.  RT-PCR 
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using primers against the four receptors in Xenopus showed that FGFR1,2 and 4 
are expressed throughout development, whereas FGFR3 is first detectable at stage 
12 and increased in levels most noticeably after neurulation (Lea et al. 2009).  
During gastrula stages, ISH on sagittal sections through Xenopus embryos showed 
that FGFR1 is distributed over the ectoderm and mesoderm, including the involuting 
leading edge.  FGFR4 however is confined within, and anterior to, the prospective 
midbrain/hindbrain boundary in the neural tube (Yamagishi & Okamoto 2010). 
During Xenopus neurulation, FGFR1 is expressed throughout the embryo and 
FGFR2 throughout the neural plate.  FGFR3 is expressed in the anterior neural 
border (ANB) and the presomitic mesoderm, in contrast to FGFR4 which is 
expressed in a complementary pattern around the ANB, as well as in the somitic 
mesoderm and neural plate.  By tailbud stages though, the expression patterns of 
FGFRs are very similar.  FGFR1, 3 and 4 are expressed strongly in the brain and 
eyes, and FGFR2 is less abundant in these areas. FGFR1 and 2 are expressed in 
the pronephros.  All four receptors are expressed in the neural tube, with FGFR1 
having a burst of strong expression in the posterior extremity of the developing CNS 
(Lea et al. 2009).   
1.3.3.1 FGFRL1 
FGFR-like 1 (FGFRL1) is known as ‘the fifth FGFR’ and is the most recently 
discovered member of the FGF signalling family.  Its extracellular domain displays 
up to 50% amino acid sequence similarity to canonical FGFRs (Steinberg et al. 
2010). Experiments in cell culture showed that these extracellular domains are able 
to bind FGF ligands, in particular FGF2, and bind to heparan. In Xenopus, FGFRL1 
is expressed in the forebrain, midbrain-hindbrain boundary, neural tube, somites 
and branchial arches (Hayashi et al. 2004).  The FGFRL1-null phenotype is 
embryonic lethal in mice, which display craniofacial, heart valve and kidney defects, 
and a hypoplastic diaphragm (Catela et al. 2009).  
The intracellular domain of FGFRL1 lacks the FGFR kinase domain required for 
signal transduction (Trueb et al. 2003).  On this basis it was hypothesised that 
FGFRL1 would interfere with FGF signalling, either by heterodimerising with other 
receptors and forming non-functional FGFR heterodimers or by competing with 
FGFRs for ligands (Steinberg et al. 2010).  Experiments in cell culture showed the 
extracellular domain of FGFRL1 was shed from the membranes of HEK293 cells, 
generating soluble FGF receptors able to scavenge ligands away from canonical 
FGFRs.  Support for FGFRL1 having a detrimental impact on FGF signalling was 
27 
shown in vivo when FGFRL1 mRNA was overexpressed in Xenopus embryos and 
caused developmental defects very similar to those caused by injection of a 
dominant negative form of FGFR1 (dnFGFR1) (Amaya et al. 1991; Steinberg et al. 
2010).  These defects could be partially rescued by injecting FGFR1 mRNA 
(Steinberg et al. 2010).   
1.4 FGF signal Transduction 
1.4.1 FGFRs transduce signalling through MAPK, PLCγ and AKT 
Following ligand-induced dimerisation and activation of the FGFR, a number of 
downstream signalling pathways are activated including mitogen activated protein 
kinase (MAPK), phospholipase C gamma (PLCγ) and rac-alpha serine/threonine-
protein kinase (AKT) as illustrated in Figure 1.2.   
1.4.1.1 MAPK 
An important first step in the MAPK and AKT branches of FGF signalling is the 
association of FGFR substrate 2 (FRS2) to phosphorylated tyrosines on the 
activated FGFR intracellular kinase domains (Kouhara et al. 1997). FRS2 
associates with Grb2, an adaptor protein, which itself associates with Son of 
Sevenless (SOS) (Ong et al. 2000).  SOS is a nucleotide exchange factor which in 
combination with Grb2 activates Ras by catalysing the exchange of GDP to GTP.  
Ras is a GTPase which hydrolyses GTP to GDP, inactivating itself, but it activates 
Raf by an unknown mechanism.  Raf in turn activates by phosphorylation the MAP 
kinase kinase MEK.  MEK then phosphorylates and activates the MAP kinase ERK.  
ERK is a serine/threonine kinase, which is able to phosphorylate and regulate the 
activity of transcription factors, such as ETS, which modulate the transcription of 
FGF target genes.  ETS-domain transcription factors, of which there are 22 types in 
humans, have a winged helix-turn-helix DNA binding domain which allows 
monomeric binding to sequences with a GGA(A/T) motif (Hollenhorst et al. 2011).  
Phosphorylation of ETS proteins by MAPK classes such as ERK, JNK and p38 
changes their transcriptional functions and therefore their affinities to DNA, co-
activator recruitment properties and their subcellular localisation (Selvaraj et al. 
2015).  A number of ETS transcription factors have been found to be targets for 
FGF/MAPK signalling (Willardsen et al. 2014).  Examples of these include Etv1, 
Etv4 and Etv5 which are required to regulate the initiation of neurogenesis in the 
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developing Xenopus retina, and induction of atonal-related proneural bHLH 
transcription factors downstream of MAPK (Willardsen et al. 2014). 
 
Figure 1.2. Schematic diagram of some aspects of FGF signalling 
This is a schematic diagram of FGF signalling based upon figures in Pownall & Isaacs (2010) 
and Dorey & Amaya (2010).  FGFRs dimerise when ligands (blue circles) bind to their 
extracellular domains.  This complex is stabilised by interactions with heparan sulphate chains 
on HSPGs in the cell membrane.  Phosphorylated receptor kinase domains provide docking 
sites for PLCγ, which then localises at the membrane and hydrolyses phosphatidylinositol 4, 5 
diphosphate into IP3 and DAG which provoke a calcium response and activate protein kinase 
C (PKC) respectively.  FRS2 also binds to active FGFRs, and bind to Grb2.  To activate the 
MAPK pathway, Grb2 activates Sos, then Ras, which then phosphorylates and activates 
MAPK kinases, resulting in phosphorylation and activation of ERK/MAPK.  ERK can influence 
gene expression in the nucleus, usually through ETS transcription factors.  Grb2 also interacts 
with the scaffolding protein Gab1, which associates with PI3K, which phosphorylates and 
activates Akt (also known as PKB), which transduces signals to the nucleus via CREB and 
NFκB transcription factors.  The MAPK pathway is negatively regulated by Map kinase 
phosphatases (MKP), Sprys, Dusps, and FGF signalling by Sulf. 
1.4.1.2 PI3K/Akt 
GRB2 also associates with a  scaffolding protein GAB1 to activate the 
phosphoinositide-3 kinase pathway, which in conjunction with the serine/threonine 
kinase Akt (also known as PKB) regulates cell survival and growth in normal 
development (Cheng et al. 1997; Nicholson & Anderson 2002).  FGFRs and other 
receptor tyrosine kinases activate PI-3K, which is recruited to the plasma 
membrane.  Following this, PI-3K phosphorylates phosphatidylinositol-4, 5-
bisphosphate (PIP2) generating phosphatidylinositol-3, 4, 5-trisphosphate (PIP3).  
PIP3 recruits Akt to the plasma membrane and alters its confirmation to allow 
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phosphorylation and activation by phosphoinositide-dependent kinase 1 (PDK1).  
Activated Akt regulates several cellular processes, including cell survival and growth 
(reviewed in Nicholson & Anderson (2002).   
1.4.1.3 PLCγ 
PLCγ pathway activation is different from that of MAPK and Akt as Grb2 is not 
required.  The Src homology region 2 (SH2) domain of PLCγ binds directly to a 
conserved phosphotyrosine residue, Y766 in FGF kinase domains (Mohammadi et 
al. 1991).  PLC then hydrolyses phosphatidylinositol-4, 5-diphosphate to inositol-1, 
4, 5-triphosphate (IP3) and diacylglygerol (DAG).  DAG activates PKC, and IP3 
stimulates intracellular calcium release, which activates CamKII, a 
calcium/calmodulin-dependent protein kinase.  This branch of FGF signalling is 
important for regulation of morphology and cell migration (Dorey & Amaya 2010). 
1.4.2 Regulation of FGF signalling 
As well as regulation of FGF signalling at the level of the receptor through 
modifications of HSPG interactions, there are also numerous negative regulators of 
FGF signalling that act post-translationally to quickly and effectively modulate FGF 
signalling.  Those important for regulating the MAPK pathway, which is the 
predominant pathway active during neural development, are detailed below (Pera & 
Ikeda 2003). 
1.4.2.1 MAPK phosphatases (MKPs) and DUSPs 
The series of phosphorylation events undertaken by the MAP kinase pathway 
culminating in the phosphorylation of ERK are reversible, and there is a balance 
between the actions of kinases and MAPK phosphatases (MKPs) rapidly modulating 
MAPK signal transduction.  MKPs are dual-specificity phosphatases and so 
sometimes known as DUSPs.  There is a well-documented negative feedback loop 
conserved from Drosophila to mammals as FGF signalling is required for 
MKP/DUSP expression (Gómez et al. 2005).  Furthermore, MKPs and DUSPs are 
expressed in overlapping expression domains to FGFs suggesting a close 
functional link (Gómez et al. 2005; Eblaghie et al. 2003).  Some DUSPs, such as 
DUSP6, only dephosphorylate one MAPK kinase, in this case ERK.  This keeps 
ERK from translocating into the nucleus and affecting gene expression (Pownall & 
Isaacs 2010). 
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Application of an FGF4-soaked bead to a chick embryo induced Dusp6 expression 
within 1 hour in the chick embryo, whereas beads soaked in the FGF inhibitor 
SU5402 severely reduced Dusp6 expression. Furthermore, overexpression of 
Dusp6 caused depletion of MAPK signalling, showing that Dusp6 expression is 
dependent on FGF signalling and acts via a negative feedback loop to control FGF 
signalling (Eblaghie et al. 2003).  This is also the case in mice, where targeted 
inactivation of Dusp6 increased levels of phosphorylated ERK (dpERK) and 
embryos displayed penetrant phenotypes including dwarfism and coronal 
craniosyntosis reminiscent of those caused by over-active FGF signalling during 
development (Li et al. 2007).  Dusp1, Dusp5 and Dusp6 were also shown to have a 
requirement of FGF signalling in Xenopus and repress FGF signalling, with Dusp6 
overexpression blocking FGF-mediated mesoderm induction (Branney et al. 2009; 
Umbhauer et al. 1995). 
1.4.2.2 Sproutys (Sprys) 
Spry1 and 2 translocate to the plasma membrane and become phosphorylated on a 
conserved tyrosine after stimulation by growth factors such as FGFs.  They then 
antagonise MAPK signalling.  Therefore, like MKPs, they are dependent on FGF 
activity.  Co-immunoprecipitation experiments in HeLa cells showed Sproutys bind 
to Grb2 and inhibit its recruitment with Sos to FRS2.  Spry4 has also been shown to 
bind to Raf to inhibit the MAPK pathway (Sasaki et al. 2003).  Overexpression of 
Spry1 mRNA in Xenopus blocked activation of ERK in cells treated with FGF2 
protein in Xenopus embryos (Hanafusa et al. 2002).   
FGF signalling also feeds into Spry2 expression by increasing the levels of protein 
phosphatase 2A (PP2A) in vitro.  PP2A binding to Spry2 on certain tyrosine 
residues causes the dephosphorylation of two serine residues in 293T cells.  The 
dephosphorylation results in a conformational change in Spry2, revealing a Grb2-
binding motif, necessary for Spry2’s subsequent inhibitory activity to the FGF 
signalling pathway. Interestingly The PP2A binding site is also competed for by c-
Cbl which likely targets Spry2 for ubiquitin-mediated decay.  Therefore, as well as 
inducing Spry2 expression, FGF activation is also needed for Spry2’s negative 
feedback function (Olsen et al. 2006).   
1.4.2.3 Spreds 
Two Spreds, Spred1 and Spred2 have been identified in Xenopus.  Spreds are 
membrane associated proteins that like other negative FGF regulators are 
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expressed in very similar expression patterns to FGFs in the mouse, chick, rat and 
frog (Bundschu et al. 2007).  Spred1 and 2 inhibit the MAPK pathway via 
association with Raf.  Raf is able to associate with Ras in this complex, but these 
kinases cannot be phosphorylated and activated by FGFRs in this state, thus 
inhibiting the MAPK pathway (Wakioka et al. 2001).  Overexpression of Spred1 and 
2 in Xenopus causes a loss of ERK activity and as a result, a loss of mesoderm 
specification (Sivak et al. 2005).  
1.4.2.4 Sef 
In the zebrafish, mouse, chick and rat, Similar Expression to FGF (SEF) is 
expressed in many sites overlapping with FGFs, hence its name (Grothe et al. 
2008).     SEF encodes a type 1 transmembrane protein.  It has similarities with 
FGFR structurally as its extracellular domain contains an Ig-like segments and its 
intracellular domain contains tyrosine phosphorylation sites.  SEF was first identified 
in zebrafish and found to be positively regulated by FGF, however ectopic SEF 
expression specifically inhibited FGF – therefore SEF is another example of an FGF 
negative feedback antagonist (Tsang et al. 2002; Grothe et al. 2008).    It is thought 
that SEF interacts with the FGFR itself at the plasma membrane and prevents 
receptor tyrosine phosphorylation and thus downstream signalling in vitro. In 
zebrafish SEF was found to directly associate with FGFR1, but its exact methods of  
FGF and inhibition remain unclear (Kovalenko et al. 2003; Ren et al. 2007). 
1.4.2.5 FLRT3 
The transmembrane protein FLRT3 is an example of an FGF signal modulator that 
functions in a positive feedback loop with FGF signalling.  It is co-expressed with 
FGFs.  Overexpression of FLRT3 in Xenopus caused posteriorisation of the embryo 
resembling embryos injected with FGFR1 or Ras mRNA (Böttcher et al. 2004).  In 
the context of neural development, BMP signalling was shown to inhibit expression 
of FLRT3.  Injection of a FLRT3 morpholino into the anterior neural tissue Xenopus 
embryo resulted in expansion of anterior neural markers Otx2 and FoxG1, and 
decreased the expression of more posterior markers En2 and Krox20 (Cho et al. 
2013).  
1.4.3 Conclusion 
FGF signalling is a very complicated process, with many different signalling outputs 
possible through variable ligand:receptor interactions, and activation of multiple 
downstream signalling pathways.  FGF signalling is rapidly regulated post-
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translationally through the action of kinases and phosphatases, as well as 
modification of HSPGs.  The variety of these responses are very important to 
safeguard against aberrant cellular behaviour such as uncontrolled proliferation or 
differentiation that could lead towards pathologies or cell death.  In the embryo, FGF 
signalling is also important for numerous developmental processes, including 
mesoderm induction, neural induction and patterning. 
1.5 Mesoderm Induction 
In the classic Spemann Mangold experiments, cells from a region in the dorsal 
blastopore lip of one newt embryo was transplanted to a ventral region of another 
embryo.  Although the graft cells themselves gave rise to an ectopic neural tube, the 
surrounding cells formed a complete secondary axis, including mesodermal tissue.  
Another early experiment by Peter Nieukwoop involved taking animal cap explants 
from newt embryos, which would ordinarily become surface ectoderm, and 
combining them with explants from the vegetal endodermal region.  This resulted in 
the spontaneous formation of mesodermal cells formed from the conversion of the 
ectodermal cells to a mesodermal fate, suggesting that during early development, 
the endoderm signals to the overlying marginal zone cells, specifying them as 
mesodermal (reviewed in Pownall & Isaacs, (2010)).   
The signal responsible for this induction was hypothesised to be FGFs, as they 
were the first purified proteins shown to mimic endogenous mesoderm-inducing 
signals.  Slack et al. (1987), found that the addition of FGF2 protein to animal cap 
explants caused the induction of mesodermal tissues, with lower concentrations of 
FGF2 inducing mesoderm characteristic of the ventral vegetal region (Slack et al. 
1987).  This was also found by Kimelman and Kirschner, (1987) who showed that 
FGF2 was expressed in the Xenopus laevis oocyte, as well as throughout early 
embryonic development (Kimelman & Kirschner 1987).  In addition to FGF2, FGF4 
was shown by Isaacs et al. (1992) to be an inducer of mesoderm, as Xenopus 
animal cap explants cultured with FGF4 developed a central core of muscle tissue 
surrounded by mesenchyme (Isaacs et al. 1992).  FGF4 was later found to be 
necessary for the activation and maintenance of the mesodermal marker gene Xbra, 
with Xbra activating FGF4 expression itself in a positive feedback loop (Figure 1.3) 
(Isaacs et al. 1994; Fletcher & Harland 2008). Evidence that FGF signalling was 
required for mesoderm induction came after the first injections into Xenopus laevis 
embryo with a dominant negative form of FGFR1, dnFGFR1.   Embryos expressing 
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dnFGFR1 displayed a loss of mesodermal tissue (Amaya et al. 1991).  These 
embryos showed a loss of Xbra expression, and a lack of muscle differentiation and 
somitogenesis (Amaya et al. 1993).  As well as the requirement for FGF signalling 
for Xbra activation, intact FGF signalling was shown to be required for activation of 
MyoD (Fisher et al. 2002). 
 
 
Figure 1.3 – Schematic diagram showing signalling during Xenopus mesoderm induction 
This is a schematic diagram of a late blastula Xenopus embryo (from (Nieukwoop and Faber, 
1994)), with the dorsal region to the right and ventral to the left.  Activation of Xnrs, VegT and 
Vg1 in the vegetal endoderm region (yellow) converts ectodermal cells in the marginal zone 
region of the animal pole (red) to mesoderm.  These can be divided broadly into ventrovegetal 
signals (VV, arrowed) and dorsovegetal signals (DV, arrowed).  FGF signals in the marginal 
zone (red) are activated by VV signals.  FGF4 activates and maintains the expression of the 
mesodermal marker Xbra, and also activates BMP antagonists in the presumptive Organiser 
region (blue). 
FGFs are not localised at the vegetal pole during blastula stages and are instead 
present in a characteristic band around the marginal zone where the mesoderm will 
eventually be specified. This means they are probably not the primary inducers of 
mesoderm, although they are required for its maintenance and propagation.  Such 
vegetally-located factors have been identified as TGFβ family members, Nodal-
related Xnr1, Xnr2 and Xnr4 as well as Vg1 and the T-box transcription factor VegT, 
the downstream signalling of which are often activated by the commercially-
available ligand Activin (Figure 1.3) (Pownall & Isaacs 2010).  The action of Activin 
is therefore routinely used to activate mesodermal tissues in Xenopus, particularly 
when added to animal caps.  However, experiments on Activin-treated explants 
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expressing dnFGFR1 or a dominant negative form of Ras found that a loss of FGF 
signalling inhibited the ability of Activin to induce the mesodermal markers Xbra, 
Mix1 and Not-b and Actc1 (LaBonne & Whitman 1994).  Some genes, such as the 
organiser gene Goosecoid and Lhx1 were also diminished in dnFGFR1 and activin 
caps, however to a lesser extent, suggesting that some genes have a higher 
requirement for FGFs than others (Cornell & Kimelman 1994).  This idea was 
expanded by other groups, who found that at low doses, VegT induced Xbra in 
Xenopus embryos, but a higher dose is needed to induce the its endodermal target  
Sox17.  However, when FGF signalling was inhibited by the addition of SU5402 the 
expansion of Xbra was not seen, suggesting that intact FGF signalling is required 
for the action of VegT.  Sox17 levels however, were unchanged upon SU5402 
treatment.  Therefore FGF is required for the activation of Xbra by VegT, but is not 
responsible for all of its mesoderm-inducing effects and thus contributes to different 
kinds of mesoderm (Fletcher & Harland 2008).  FGF4 has been shown to be a direct 
target of Activin (Fisher et al. 2002).  Therefore, Nodal signalling from the vegetal 
pole of a blastula staged Xenopus embryo activates FGF4 and FGF8 in the 
marginal zone.  FGFs then activate mesodermal genes such as Xbra and MyoD to 
specify and maintain a mesodermal fate (Fletcher & Harland 2008; Pownall & 
Isaacs 2010).   
However, there is evidence to suggest that the FGF/Xbra feed-forward loop does 
not exist in other organisms, or may not be the sole mesoderm-inducing pathway in 
Xenopus.  As well as FGF, Xbra is also a direct target of zygotic Wnt signalling in 
Xenopus.  However, Wnt signalling may not be sufficient for Xbra expression as 
addition of FGF2 protein can bypass the requirement of intact Wnt signalling for 
Xbra expression upon Wnt inhibition (Vonica & Gumbiner 2002).  In mouse 
embryos, the knockout phenotype for the Wnt transcription factors, Lef1 and Tcf1 
has a very similar somitic phenotype to loss of brachyury, suggesting a functional 
link between Brachyury and Wnts in higher vertebrates (Galceran et al. 1999).  In 
zebrafish, there are two Xbra orthologues - Ntl and bra.  Loss-of-function 
experiments by Martin and Kimelman, (2009) using morpholinos against Ntl and Bra 
show that Fgf8 expression is unchanged in paraxial mesoderm, whereas Wnt3 and 
Wnt8 gene expression was reduced.  Conversely, overexpression of Ntl caused 
upregulation of Wnt8.  Furthermore, a dominant-negative construct of Tcf1 caused 
loss of both Ntl and bra in fish embryos, suggesting that in this organism, it is a 
feed-forward loop between bra/Ntl and Wnt signalling that is predominantly required 
for mesoderm induction and maintenance (Martin & Kimelman 2009).  Therefore, 
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Wnt signalling may also be required with FGF signalling to induce and maintain the 
mesoderm. 
A microarray-based screen of genes affected by FGF signalling during mesoderm 
induction was undertaken by Branney et al. (2009).  This found 67 genes positively 
regulated, and 16 genes negatively regulated by FGF signalling at this time.  Key 
findings were that negative regulators of the MAPK signalling pathway such as 
Spry2, Dusp5 and Mkp1 were downregulated, indicating multiple negative feedback 
loops operational during mesoderm induction to regulate FGF signalling output.  
Also, pluripotency genes such as Lin28 and FoxD3 were upregulated by FGFs.  
Importantly, during this period of mesodermal specification FGFs signalling was 
shown to be also active in the dorsal mesoderm activating Chordin, Noggin and 
Goosecoid in the Spemann’s Organiser region.  These genes encode BMP 
antagonists which are required for neural induction (Branney et al. 2009; Fletcher & 
Harland 2008).   
1.6 Neural Induction 
Neural induction is the process by which pluripotent cells in the early embryo 
receive particular signals that instruct them to adopt a neural fate.  It is thought that 
this induction happens in the early gastrula, as birth of primary motor neurons and 
sensory neurons rapidly rises during gastrulation in Xenopus (Lamborghini 1980; 
Schlosser et al. 2002). 
1.6.1 The Spemann Organiser 
Neural induction has been extensively researched ever since the famous 
embryological experiments of Spemann and Mangold in 1923.  The transplantation 
of cells from above the dorsal blastopore lip to the ventral side of another embryo 
resulted in antero-posterior axis duplication and the formation of an ectopic second 
head where the embryo would otherwise have formed epidermis.  Cells surrounding 
the transplanted graft became axial mesoderm and neural tube (reviewed in 
Hemmati-Brivanlou & Melton 1997). Therefore cells from this region are not only 
following signalling pathways to become neural in nature, but are capable of 
signalling to surrounding cells to follow the same developmental program.  There 
has since been decades of research into what exactly the nature of these signals 
are. 
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1.6.2 BMP inhibition causes neural induction by a default 
mechanism 
It was hypothesised based on Spemann and Mangold's observations that cells of 
Spemann's organiser must secrete molecules to surrounding tissues to induce 
neural differentiation.  This was supported by early work in using Xenopus 
ectodermal explants.  If explants were dissociated for 5 hours, cells spontaneously 
differentiated into neural cells in the absence of any other treatment (Godsave & 
Slack 1989; Grunz & Tacke 1989).   However, if these dissociated cells were 
allowed to re-aggregate within a period of 5 hours, epidermal differentiation would 
take place (Grunz & Tacke 1989).  These experiments suggested that it was the 
cessation of signalling events between cells that induced a neural fate rather than a 
positive transforming substance that actively converted epidermal signals to neural.   
Whilst screening for secondary axis inducers, Smith and Harland (1992) isolated 
Noggin which was secreted from the Organiser.  Noggin mRNA injected into ventral 
cells of UV-irradiated Xenopus embryos, partially rescuing the loss of body axes 
(Smith & Harland 1992).  Furthermore, Noggin overexpression in the direct-
developing frog Eleutherodactylus coqui was sufficient to induce a secondary axis 
(Fang et al. 2000).  Another molecule secreted from the Organiser – Chordin – was 
identified as a BMP4 antagonist and caused ectopic neural induction (Sasai et al. 
1995).  BMPs are part of the TGFβ family of signalling molecules, expressed 
ventrally and are required for epidermal differentiation.  Both Noggin and Chordin 
bind BMP ligands extracellularly and prevent ligand association to BMP receptors, 
thus are BMP antagonists (Piccolo et al. 1996; Zimmerman et al. 1996).  Therefore 
it was hypothesised that inhibition of the BMP signalling pathway in prospective 
neuroectoderm pushed cells surrounding the organiser to a neural fate.  Repression 
of the BMP pathway by injection of mRNA coding cleavage mutants of BMP7 and 
BMP4 into naïve Xenopus ectodermal explants caused spontaneous expression of 
the neural tissue marker NCAM (Hawley et al. 1995).    The presence of a dominant 
negative mutant of another member of the of the TGFβ signalling pathway Activin, 
or its antagonist Follistatin, both potently neuralised ectodermal explants (Hemmati-
Brivanlou & Melton 1994).  Furthermore, it was found in whole embryos triple 
knockdown of Chordin, Noggin and Follistatin caused complete ablation of the 
neural plate in Xenopus embryos, with a concurrent expansion of posterior and 
ventral fates (Khokha et al. 2005).  Taking all this evidence together lead to the 
postulation of a 'default' model for neural induction - unless told otherwise, the 
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default inhibition of the BMP signalling pathway is necessary and sufficient for 
complete neural induction  (Hemmati-Brivanlou & Melton 1997).   
1.6.3  Problems with the default model 
However, later experiments in amniotes and mammals challenged the default 
model.  In chick embryos, blocking BMP signalling via electroporation of the BMP 
signalling inhibitor Smad6 was not sufficient to induce the pan-neural marker Sox3 
in epiblasts.  Furthermore, injection of Smad6 mRNA into the ventral A4 blastomere 
of a Xenopus embryo also failed to induce the neural markers Sox3 and NCAM, 
even though epidermal markers were not induced  (Delaune et al. 2005; Linker & 
Stern 2004).  These findings could be explained through Smad6 not adequately 
suppressing the BMP pathway, since in Khokha et al, (2005) only a triple 
knockdown of BMP antagonists was sufficient to stop neural induction in Xenopus 
(Khokha et al. 2005).  Therefore, a more potent BMP inhibitor based on a dominant 
negative Smad5 in fish (Smad5-sbn), which forms a non-functional complex with 
Smad1/5 & 8, was used.  Overexpression of Smad5-sbn in ventral epidermis was 
capable of inducing neural marker genes autonomously, however this induction 
required the maintenance of FGF signalling (Linker & Stern 2004). 
Further research in the chick showed that, unlike in Xenopus, over-expression of 
BMP4 in the prospective neural plate at any stage of development did not prevent 
neural development, and ectopic expression of Chordin or Noggin  could not induce 
an ectopic neural plate (Streit et al. 1998). Also in the chick, BMP4 overexpression 
caused inhibition of the neural marker Sox2 but not its upstream activator Sox3.  
Sox3  was therefore still able to influence neural induction - so BMP inhibition could 
be a later incomplete influence on neural induction and preceded by something else 
(Linker & Stern 2004).  In mammals, mice lacking Noggin, Chordin or both of these 
still form a nervous system where all but the anterior-most structures are present 
(McMahon et al. 1998; Bachiller et al. 2000; Belo et al. 2000; Mukhopadhyay et al. 
2001)   Taken together, these experiments suggest that although BMP inhibition is 
necessary for neural induction, it is not sufficient and other factors must be required 
for complete neural induction.  
1.6.4 FGF as a neural inducer in combination with BMP signalling 
As alluded to by Linker and Stern (2004), research occurring in parallel in Xenopus 
and other model organisms pointed towards FGF signalling playing an important 
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role in neural induction.  In ascidians, FGF signalling is the endogenous neural 
inducer, showing that there is a precedent in evolutionary history for FGF to be 
involved in neural induction – FGFs 8/16/20 induce neural tissue in the ectoderm via 
synergy with maternal response factors Ets1/2 and GATA (Bertrand et al. 2003).  As 
with higher vertebrates, it is the MAPK pathway that is required for the acquisition of 
neural fates in otherwise epidermal cells, which further points to an evolutionary 
requirement for this pathway (Hudson et al., 2003).  FGFs are expressed strongly in 
the posterior mesoderm – as are secreted BMP inhibitors – and so are present at 
the correct time and place to participate in neural induction.  The addition of FGF2 
to Xenopus ectodermal explants caused induction of posterior neural markers such 
as HoxB9 independent of its role in mesoderm induction (Lamb & Harland 1995)  In 
the chick, blocking FGF signalling activity using the FGFR1 inhibitor drug SU5402 
inhibited the induction of Sox2 and Sox3 by Hensen's node (a homologous structure 
to Spemann's organiser) (Streit et al. 2000; Kuroda et al. 2005).  However, FGF 
cannot be sufficient for neural induction because after addition of the FGF inhibitor 
drug SU5402, nodes still lengthen and express Chordin (Streit et al. 2000).  In 
animal caps, it is only through a combination of FGF signalling and Noggin 
expression that the full range of anterior and posterior neural markers is expressed  
(Lamb & Harland 1995).   
One way FGF can work through BMP inhibition is by mutual antagonism between 
FGF3 and BMP4/7.  As FGF3 expression rises in the chick epiblast, BMP4 and 7 
levels fall and are thereby restricted to areas fated to be epidermis  (Wilson et al. 
2000).  Overexpression of FGF3 causes ectopic Chordin expression at the expense 
of BMP4 (Kudoh et al. 2004).  This restriction of BMPs through FGF antagonism is 
also seen in the zebrafish, independent of the actions of Chordin and Noggin 
(Fürthauer et al. 2004).   Furthermore, FGF signals are required for Noggin and 
Chordin expression, thus there a BMP antagonist/FGF feed forward loop to further 
promote neural induction (Branney et al. 2009; Delaune et al. 2005; Fletcher & 
Harland 2008).  The ways in which FGF signalling affects the expression of 
proneural genes by itself or through interaction with the BMP or Wnt pathway is 
shown in Figure 1.4. 
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Figure 1.4 – Interaction of FGFs and other pathways to promote neural gene expression 
This is a schematic diagram based upon those in Pownall & Isaacs (2010).  1)FGF activates 
some neural genes directly, such as Dazap2, Zic3 and Htra1 (Roche et al. 2009; Marchal et al. 
2009; Hou et al. 2007).  FGF also activates the BMP antagonists Noggin and Chordin which 
are required for anterior neural induction (2)  (Kudoh et al. 2004; Branney et al. 2009).   3) Wnt 
and FGF cooperate to activate some posterior neural genes, such as Cdx4 (Keenan et al. 
2006), and  Akt is thought to activate Wnt signalling by phosphorylating and inactivating GSKβ 
(4) (Hashimoto et al. 2002).  5) BMP signalling inhibits the expression of neural FGF targets.  
6) active ERK phosphorylates BMP effector Smad1/5/8 sequestering it in the cytoplasm 
(Fuentealba et al. 2007; Kuroda et al. 2005) and also directly represses the activation of  
BMP2/7 ligands (7) (Fürthauer et al. 2004). This prevents BMP signal-mediated activation of 
epidermal genes (8).  MAPK also primes GSK3 which marks Smad1 for ubiquitination (9) 
(Pera et al. 2014).   
A site of convergence for FGF and BMP signalling is Smad1 (Kretzschmar et al. 
1997; Pera & Ikeda 2003).  When phosphorylated through BMP signalling, Smad1 
translocates to the nucleus and activates BMP target genes.  However, the FGF 
MAPK effector dpERK can phosphorylate the linker region of Smad1 at four 
conserved MAPK (PXS[PO3]P) sites (Fuentealba et al. 2007; Kuroda et al. 2005).  
This sequesters Smad1 in the cytoplasm, inhibiting activation of BMP target genes.  
The MEK inhibitor U0126 normally blocks neural differentiation in dissociated 
Xenopus explants.  However, when a linker mutant Smad1 (LM-smad1) lacking 
MAPK binding sites is expressed in the explants, Sox2 and NCAM expression is lost 
and instead epidermal cytokeratin, is upregulated (Kuroda et al. 2005). 
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Therefore, although not sufficient, FGFs are necessary for neural induction.  This is 
partially through their negative effects on BMP signalling which complement the 
BMP inhibition by BMP antagonists that is the essence of the default model. 
1.6.5  FGFs work independently of BMPs 
As well as inducing neural tissue through the direct or indirect inhibition of BMP 
signalling, FGFs have also been shown to promote a neural fate independent of 
BMP antagonism (Figure 1.4).  Using a combination of the FGFR1 inhibitor SU5402 
and/or knockdown of BMP antagonists showed that posterior neural markers are 
more susceptible to depletion upon FGF inhibition, whereas BMP activity was more 
likely to affect anterior neural tissue  (Wills et al. 2010).  The injection of dominant 
negative FGFR1 mRNA into Xenopus did not prevent Noggin inducing the most 
anterior neural structures, however more posterior tissues such as the hindbrain 
and spinal cord were compromised (Ribisi et al. 2000).   This splitting up of neural 
induction into anterior control by BMP antagonism and posterior induction by FGF 
activity is important for patterning the early nervous system and will be discussed 
later.  Other research shows that FGF signalling targets overlap with BMP 
antagonist targets spatially and temporally but work independently.  Work on early 
neural targets Zic1, Zic3 and FoxD5a in Xenopus showed that Zic3 and FoxD5a are 
FGF targets, whereas Zic1 is an immediate-early target of BMP inhibition (Marchal 
et al. 2009).  Morphants of both Zic1 and Zic3, although regulated by different 
signalling pathways, showed that both of these genes were required for neural fate 
acquisition, and therefore cooperation as well as separate signalling between the 
BMP and FGF targets are needed for correct progression through the neural 
program (Marchal et al. 2009).  In the chick a similar result was found after a 
differential screen searching for genes induced by a Hensen's Node graft. One 
novel gene encoding an uncharacterised protein, Asterix, is dependent on FGF 
signalling for activation.  FGFs can synergise with BMP signalling to activate the 
uncharacterised gene Obelix but is neither necessary nor sufficient for induction of 
the neural plate marker TrkC  (Pinho et al. 2011).  Other research has suggested 
that some early onset genes require a mixture of both FGFs and BMPs (Rogers et 
al. 2011).  Therefore, FGFs are required for the acquisition of neural fate, 
particularly posterior neural fate.  FGFs work independently or in cooperation with 
BMP antagonists to induce the full neural program of anterior and posterior neural 
markers. 
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1.6.6  Other Pathways as well as FGF signalling have roles in 
neural induction 
Various research groups have found that signalling pathways other than BMP and 
FGF have important roles in neural induction.   Wnt signalling is important for neural 
induction, as injection of Wnt1 mRNA opposite the future Spemann Organiser in 
Xenopus embryos caused axial duplication and the formation of secondary head-
like structures (McMahon & Moon 1989).  As well as BMP antagonists, Wnt 
antagonists such as Cerberus and Dkk are also secreted from the Organiser. Co-
injection of both Wnt and BMP inhibitors is more likely to induce forebrain compared 
to injection of BMP inhibitors alone (Niehrs & Feld 1999).  Like FGFs, canonical Wnt 
signalling is mutually antagonistic to BMP4 expression and so can restrict BMP4 
signalling to the anterior of the embryo (Baker et al. 1999).  Insulin-like growth factor 
(IGF) signalling also phosphorylates the linker region of Smad1, thereby repressing 
BMP signalling, and injection of a dominant negative IGFR blocks neural induction 
by Chordin (Pera & Ikeda 2003).  Finally, Hedgehog signalling can induce anterior 
neural markers in explants (Lai et al. 1995).  This may be because a common target 
of Hh and Wnt, Suppression of Fused (Sufu) induces expansion of the epidermis at 
the expense of neural plate tissue  in Xenopus (Min et al. 2011). 
To summarise, FGF plays a pivotal role in neural induction by both contributing to 
BMP pathway repression and also by independently activating genes required for 
the onset of neural development. FGF manipulation has a larger influence on 
posterior neural development relative to anterior, and this is important for patterning 
the early CNS.  Lastly, there is still much unknown about the roles and importance 
of other signalling pathways involved in neural induction, either in concert with or 
independent of FGFs.  Induction of the complete neural program is probably much 
more complicated than the original default model would suggest. 
1.7 Neural Patterning 
As well as being important for neural induction, FGF signalling is also required for 
the patterning of neural tissue.  FGF signalling emanating from the posterior of the 
embryo creates a gradient which patterns the spinal cord and posterior hindbrain 
along the antero-posterior axis. 
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1.7.1 FGF signalling promotes a posterior neural fate 
In 1954, Nieuwkoop and Nigtevecht articulated an ‘activation-transformation’ model 
for antero-posterior patterning of the CNS.  This proposed that the first patterning 
step is the activation of anterior neural fate with the specification of the forebrain.  
The next patterning step involves a ‘transforming’ signal, which converts some of 
the forebrain primordia into more posterior fates (Nieuwkoop & Nigtevecht 1954).  
The existence of this transforming signal was realised when folds of competent 
ectoderm were grafted to different locations along the antero-posterior axis of the 
Xenopus embryo.  These graft cells took on the characteristics of the surrounding 
areas suggesting that both activation and transformation of cell fate had taken place 
in these explants.  The activation transformation model has since been modified to 
describe an activation step generating a transient ‘pre-neural state’. The 
transformation step requires signals to maintain an anterior neural fate for some 
stem cells, but for a sub-population of these cells caudalisation signals act to 
transform them into a more posterior fate (Stern 2001).   
One of the candidates for the transformation signal was identified as FGFs, and 
FGFs were found to be necessary for both inducing neural development but they 
are also required for caudalising and patterning neural tissue.  Xenopus prospective 
forebrain explants cultured with FGF2 caused them to become more posterior in 
character and express hindbrain and spinal cord markers (Cox & Hemmati-
Brivanlou 1995).  Conversely, upon transplantation of dnFGFR1-expressing cells to 
a zebrafish embryo to the dorsal neuroectoderm, it was observed that the dnFGFR1 
cells incorporated themselves into more anterior neural structures as development 
progressed (Kudoh et al. 2004).  In Xenopus embryos, overexpression of FGF4 
caused expansion of posterior neural tissue at the expense of anterior structures, 
whereas inhibition of FGF signalling caused posterior truncations and anteriorisation 
of the embryo  (Pownall et al. 1996; Monsoro-Burq et al. 2003).  This suggests that 
FGF signalling is required for specification of posterior neural fates, and conveys 
positional information along the antero-posterior body axis.  
1.7.2 FGF signalling patterns the Antero-Posterior Axis through 
the regulation of Cdx and Hox genes 
1.7.2.1 Evolution of Cdx and Hox genes 
Cdx genes are part of the parahox family, which also includes the genes Gsx and 
Pdx/Xlox.  The Parahox genes reside in a single genomic locus, unlike their 
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evolutionary sister family the Hox family.    Parahox and Hox genes have a common 
60 amino acid DNA-binding motif – the homeodomain – and act as transcription 
factors.  There are two distinct classes of homeodomain in animals – ANTP and 
PRD – as well as more divergent classes LIM, POU SINE and TALE.  The ANTP 
class is split into NK-like genes and the Hox/Parahox group.  The Hox and Parahox 
gene families arose from a single Protohox gene cluster during the divergence of 
Cnidarians and bilatarian clades (Chourrout et al. 2006; Garcia-Fernàndez 2005).  
During vertebrate evolution, the Hox gene cluster underwent a series of duplications 
producing a number of sub-families and map to several chromosomes, however the 
Parahox cluster occupies a single genomic locus (Holland & Takahashi 2005).     
There are three Cdx genes, Cdx1, 2 and 4 in mouse and Xenopus which have been 
well conserved throughout evolution.  Most vertebrates have 39 Hox genes, 
organised into four separate chromosomal clusters A-D.  Each subfamily contains 
13 paralogues (Lappin et al. 2006).  Hox family members have several unique 
properties.  They display spatial collinearity as the 5’ to 3’ chromosomal 
arrangement of each Hox gene on its cluster corresponds to its expression pattern 
from posterior to anterior along the antero-posterior axis of the embryo.  Secondly 
Hox genes display temporal collinearity as 3’ Hox genes are activated earliest in 
development and more 5’ genes activated successively afterwards (Montavon & 
Soshnikova 2014). 
1.7.2.2 Cdx genes posteriorise the embryo and activate posterior Hox genes 
FGFs regulate Hox genes in part through their regulation of Cdx genes (Pownall et 
al. 1996).  Cdx genes were identified first as the caudal gene in Drosophila, and are 
required for normal posterior development and patterning (Mlodzik & Gehring 1987).  
Overexpression of FGF4 in Xenopus embryos caused an anterior expansion of 
Cdx4 and HoxA7 expression domains, which was sufficient to cause development 
of posterior structures at the expense of the head (Isaacs et al. 1994; Pownall et al. 
1996).  On this basis, it was suggested that the pattern of Hox genes is regulated by 
the Cdx family expressed in posterior nascent tissues of the three germ layers in a 
posterior to anterior gradient (Isaacs et al. 1998; Bel-Vialar et al. 2002).   
Evidence for this has been shown in a number of experiments in zebrafish.  
Zebrafish embryos homozygous for the autosomal recessive mutant kugelig are 
characterised by their tail defects as well as aberrant antero-posterior patterning 
(Davidson et al. 2003). This was found to be due to a mutation in Cdx4, and could 
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be rescued by Cdx4 mRNA injection which restored the expression of HoxA7, 
HoxB7 and HoxB9 (Davidson et al. 2003). Later work by the same group involved 
injection of morpholinos for Cdx1 into heterozygous zebrafish Cdx4+/- embryos. 
This did not produce additional morphological defects relative to Cdx4-/- embryos, 
but doubly deficient Cdx1-MO/Cdx4-/- embryos displayed very severe posterior 
defects. This suggested that both Cdx1 and Cdx4 are required for correct posterior 
development, but act in a partially redundant fashion. This was supported by their 
individual and combinatorial effects upon Hox gene expression. Cdx1 morphants 
and morphant/Cdx4+/- embryos both displayed shortened HoxB7 and HoxB9 
expression domains which was even more severe in double mutants (Davidson & 
Zon 2006).  Individual and combined knockdowns of Cdx1, Cdx2 and Cdx4 in 
Xenopus caused severe posterior truncations and a reduction in 5’ Hox gene 
expression (Faas & Isaacs 2009).  Conversely inactivation of Cdx1 and Cdx2 via 
homologous recombination in the mouse caused anterior homeotic transformations 
– that is, vertebra 7 resembled the more anterior vertebra 6 – and this corresponded 
to a reduction and posterior shift in Hox gene expression domain (Subramanian et 
al. 1995).   
The posterior to anterior gradient of FGF and Cdx activity is sharpened by the decay 
of Cdx transcripts anteriorly as the embryo lengthens and grows which also defines 
Hox gene expression (Gaunt et al. 2003; Gaunt et al. 2005).  This gradient is also 
opposed by a gradient of retinoic acid (RA) signalling, which is required for the 
specification of more 3’ Hox genes in the hindbrain (del Corral et al. 2003).  A 
mutually repressive relationship between Cdx activity and the anteriorising activity of 
retinoid signalling in the spinal cord has been demonstrated.   Whereas Cdx4 
directly activates posterior HoxC6, HoxA7, HoxB7 and HoxB9 in a dose-dependent 
manner, it inhibits the expression of more anterior HoxB1 or HoxB3 (Isaacs et al. 
1998).  In zebrafish, Cdx1 or Cdx4 morphant zebrafish embryos were found to 
exhibit ectopic expression of hindbrain marker Krox20 and hindbrain neurons more 
posteriorly than control embryos (Shimizu et al. 2006).  As a result of this posterior 
expansion of hindbrain-fate,   posterior-most tissue was responsive to RA treatment, 
which did not affect the fate of posterior neural tissue (Shimizu et al. 2006; Skromne 
et al. 2007). Therefore, Cdx genes promote a posterior neural fate, whilst also 
restricting the size of the hindbrain.   
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1.7.2.3 Hox genes pattern the hindbrain and spinal cord 
Hox genes are activated and regulated within the elongating neural plate in regions 
overlapping the domains of the neural progenitors around the node in the chick and 
mouse.  It has been shown that early Wnt signalling is crucial in the initial 
specification of prospective hindbrain and spinal cord progenitors, which is later 
refined by retinoid and FGF signals in the ventral neural tube (Liu et al. 2001; Dasen 
et al. 2003; Nordström et al. 2006).    Although Hox genes, regulated by Cdx genes 
pattern all three germ layers, the role of Hox genes in specifying the neuroectoderm 
will be discussed below.   
1.7.2.4 Hindbrain development and Patterning 
The hindbrain or rhombocephalon consists of the cerebellum, pons and medulla and 
these oversee vital functions (Pownall & Isaacs 2010).  During neurulation, the 
prospective hindbrain is divided into seven regions called rhombomeres.  
Rhombomeres are composed of discrete cell groups displaying heterochronic 
patterns of neurogenesis, which give rise to motor or sensory neurons depending on 
their position along the dorsoventral axis (Clarke & Lumsden 1993).  At first the fate 
of each rhombomere is plastic, but after the onset of Hox gene expression cells are 
committed and do not mix.  Hox1-4 are expressed in the hindbrain and spinal cord, 
and Hox4-13 in the spinal cord only (Nolte & Krumlauf 2000).  HoxA2 is the first and 
most anterior Hox gene expressed in the hindbrain, and is expressed in R2.  HoxA2 
and HoxB3 are expressed in R3, thus each rhombomere contains a certain 
combination of Hox genes (Trumpel et al. 2009).  Other anterior Hox genes such as 
HoxB1, HoxA4, HoxB4 and HoxD4 are regulated by retinoid signalling and contain 
retinoic response elements in their promoters. For example, HoxB1 is restricted to 
R4 through early induction by RA and later repression in R3 and R4 from the RA 
degradation enzyme Cyp26A1 (Sirbu et al. 2005).   
Although FGF signalling does not activate anterior-most Hox genes in the rostral 
hindbrain, low FGF activity activates Hox genes indirectly in the caudal hindbrain.  
In zebrafish, the first rhombomere to appear is R4, and it expresses FGF3 and 
FGF8.  Mis-expression of FGF3 and/or FGF8 causes the transformation of tissue to 
R5/R6 fate and ectopic expression of the R5 marker Krox20, showing that FGF 
signalling is needed in an organiser capacity in R4 (Maves et al. 2002). The R5 fate 
is also regulated by FGF’s activation of the R3 and R5 marker gene Krox20 (Marín 
& Charnay 2000).  In mice, Krox20 inhibits the more anterior HoxB1 normally 
expressed in R1 and R2 to help specify R3 (Barrow et al. 2000).  Krox20 expression 
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in R5 is also dependent on the transcription factor Mafb, as in Mafb mutants it is 
restricted to R3 only (Manzanares et al. 1999).  Mafb is also activated by FGFs and 
mouse Mafb mutants lack recognisable R5 and R6 (Maves et al. 2002; Giudicelli et 
al. 2003). Therefore, the actions of Krox20 and Mafb, mediated by FGF signalling 
are essential for correct caudal hindbrain development. 
1.7.2.5 Development and patterning of the spinal cord 
Spinal cord motor neurons (MNs) derive from progenitor cells located at a constant 
point along the dorso-ventral axis along the neural tube.  Neurons are organised 
into columns in the CNS, and Hox genes specify their identification and connectivity.  
MNs acquire their distinct columnar identity depending on their position along the 
antero-posterior axis of the spinal cord (Dasen et al. 2003). 
In the chick, the first step for spinal cord emergence has been proposed to be 
caudalisation of cells exhibiting forebrain characteristics through exposure to FGF 
signals from the primitive streak and the paraxial mesoderm (Jessell 2000).  The 
posterior to anterior gradient of FGF signalling activates Hox genes at the anterior 3’ 
of a cluster at very low levels of FGF, whereas those at the 5’ end are activated at a 
much higher concentration and after exposure for a greater length of time (Dubrulle 
& Pourquié 2004).    
This graded FGF signal induces the expression of 5’ Hox genes at the brachial, 
thoracic and lumbar levels of the spinal cord in their correct order along the antero-
posterior axis (Bel-Vialar et al. 2002).  This is seen in vitro – explants taken at the 
thoracic level of chick embryos were cultured with beads soaked with FGF8.  As the 
concentration of FGF was increased, progressively more 5’ Hox genes were 
activated in cells around the bead (Liu et al. 2001).  Dasen et al. (2003) studied 
HoxC genes further in vivo.  HoxC6 expression in chick MNs was shown to be 
confined to brachial levels, whereas HoxC9 is expressed more posteriorly at the 
thoracic level.  In ovo electroporation of FGF8 to brachial areas lead to the 
disappearance of HoxC6 and ectopic anterior expression of HoxC9, indicating a 
switch from a brachial to thoracic fate.  HoxA9 and HoxC9 expression domains were 
also expanded rostrally and neurons did not express Raldh2, suggesting an 
antagonistic relationship between RA pathway members and FGFs caudally (Dasen 
et al. 2003). 
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1.7.3 Opposing RA and FGF signals control neural differentiation 
1.7.3.1 Retinoic acid signalling patterns more anterior neural differentiation 
Retinoic acid and its metabolic products are required for patterning in the hindbrain 
and rostral spinal cord by regulating the expression of 3’ Hox genes.  Thoracic-level 
chick embryo explants cultured with retinoic acid receptor (RXR) inhibitor LG100815 
caused a loss of HoxC5 expression, and explants cultured with RA did not express 
HoxC6-10 (Liu et al. 2001).  Therefore, retinoid signalling promotes an anterior but 
not posterior neural fate.  RA has also been shown to anteriorise caudal neural plate 
explants in the chick and impose a caudal character to hindbrain cells and rostral 
character to spinal cord cells – untreated cells expressed a combination of HoxB4, 
HoxB8 and HoxB9, reminiscent of the caudal spinal cord.  However, treatment with 
RA blocked the expression of HoxB9, resulting in cells reminiscent of the rostral 
spinal cord (Nordström et al. 2006).  Other work showed that RA treatment could 
not affect posterior Hox genes, as treatment of chick embryos with RA lead to 
anteriorisation of HoxB1-5 expression domains but did not affect the expression 
pattern of the posterior HoxB6-9, suggesting a posterior limit to retinoid signal 
responsiveness (Bel-Vialar et al. 2002).   
1.7.3.2 FGF signalling promotes proliferation of neural progenitors, whereas RA 
promotes neuronal differentiation 
In the chick, FGF activity in the posterior of the embryo maintains a proliferating 
pool of neural stem cells. As the embryo extends in an antero-posterior direction, 
the front of this gradient moves posteriorly.  As the stem cells leave the influence of 
the FGFs in the ‘stem zone’ lateral inhibition causes a salt-and-pepper pattern of 
differentiating neural cells – therefore there is an inverse rostro-caudal gradient of 
neuronal differentiation (Akai et al. 2005; del Corral et al. 2002).  Combinations of 
genes expressed outside of FGF-influenced areas, such as NeuroD and Ngn1, 
induce neurogenesis (Figure 1.5) (del Corral et al. 2003).  Blocking FGFR function 
in the stem zone causes precocious movement of these cells out of the stem zone 
and into the spinal cord (Diez del Corral et al. 2003).  The gradient of FGF 
proliferative activity is sharpened by a complimentary gradient of RA, which is 
required for neuronal differentiation and expression of key ventral neural patterning 
genes (Diez del Corral et al. 2003).  Thus, FGF and retinoid signalling mutually 
antagonise each other to control the onset of neural differentiation.  
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Figure 1.5 – Opposing gradient of FGF and RA pattern the neural tube 
A schematic diagram of the presomitic mesoderm and the neural tube during neural 
development.  In the posterior, FGF signalling in the stem zone promotes proliferation of 
neural progenitors.  FGFs with Wnts activate Cdx genes, which activate 5’ Hox genes.  FGF 
signalling also activates Krox20 which inhibits 3’ Hox genes.  Raldh in the somitic and 
presomitic mesoderm produces retinoic acid (RA), which mutually antagonizes FGF signalling 
and its targets.  The RA degradation enzyme Cyp26A1 is activated by RA in a negative 
feedback loop, as well as by FGF signalling.  RA signalling activates more 3’ Hox genes and 
promotes differentiation of neural progenitors after they leave the stem zone into motor or 
sensory neurons depending on the combinations of Hox genes expressed in each cell.  
Neuron-specific markers such as NeuroD, Ngn1 and Ngn2 are then expressed. 
Specifically, it was found that FGF8 inhibits the RA synthesis enzyme Raldh2 (del 
Corral et al. 2003).    FGF also activates Cyp26A1, an enzyme that triggers RA 
degradation. Cyp26A1 is expressed in complementary patterns to RA and sharpens 
the gradient of RA at both anterior and posterior ends, resulting in a two tailed RA 
gradient that is highest at the midbrain-hindbrain boundary (Pera et al. 2014). 
To summarize, a gradient of FGF signalling emanating from the posterior of the 
embryo activates Cdx and Hox genes caudally to pattern the posterior neural tube 
which later gives rise to the posterior hindbrain and spinal cord.  The FGF gradient 
is opposed by an anterior gradient of RA, which sets the anterior limits of FGF’s 
influence and specifies more anterior Hox genes.  As the embryo grows, cells 
leaving the proliferative zone of FGF signalling are exposed to higher 
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concentrations of RA, which pushes them to differentiate into neurons based upon 
the combination of Hox genes they express. 
1.7.4 FGFs also promote a posterior neural fate through other 
means, and cooperate with posterior Wnts 
1.7.4.1 Htra1 and Dazap2  
FGFs also promote posterior neural development through the regulation of other 
patterning genes.   Htra1 is a serine protease that is known to modulate IGF 
signalling and bind to members of the TGFβ family.  Hou et al. (2007) showed Htra1 
also modulates FGF signals and transduces them over long range.  Ectopic 
expression of Htra1 lead to secondary tail formation and appearance of ectopic 
neurons over the whole epidermis.  Anterior neural markers such as Otx2 and 
Krox20 were downregulated whilst the posterior Cdx4 was upregulated.   Long 
range transduction of FGF signals through Htr1a was shown by combining FGF4-
injected ectodermal explants with Htr1a-injected explants.  Explants injected with 
Htra1 only did not extend as much as FGF4-injected caps, however combination 
explants extended on both sides and induced Xbra despite no cell mixing.  
Therefore genes such as Htra1 may be important for expanding the range of FGF 
influence (Hou et al. 2007).  FGF also works to pattern the posterior via a feed-
forward loop with its target Dazap2 which is required for patterning the spinal cord. 
When Dazap2 was overexpressed in Xenopus through mRNA injection, anterior 
neural markers such as Otx2 and Pax6 were reduced. On the other hand, HoxB9 
expression was expanded anteriorly even in the presence of the antimorphic Cdx4 
construct Cdx4-EnR and in the presence of a dominant negative form of Wnt8. 
Therefore Dazap2 regulates Hox gene expression independent of Cdx and other 
pathways  (Roche et al. 2009).   
1.7.4.2 Wnt signalling promotes posterior neural patterning 
Wnts also have an important role to play in antero-posterior neural patterning, and 
cooperate with FGFs to induce and pattern the posterior neural tube (Figure 1.5). 
Wnt3a and Wnt8 are expressed dorsally in a posterior to anterior gradient, 
overlapping with FGFs (Kiecker & Niehrs 2001).  Wnt1, Wnt3a and Wnt8 are 
expressed in the CNS and their expression domains overlap in the forebrain, 
midbrain and hindbrain (Wolda et al. 1993; McGrew et al. 1997).  The requirement 
for Wnt signalling for neural development was shown when disruption of Wnt1 
expression in the murine brain caused severe deformities in the midbrain and 
cerebellum (Thomas & Capecchi 1990).  Wnt signalling also patterns the posterior 
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CNS.  In Xenopus, ectodermal explants overexpressing either Wnt8 or Wnt3 mRNA 
were fused with albino animal caps which acted as a ‘Wnt acceptor’.  Without the 
presence of Noggin no neural marker gene expression was observed, and so Wnts 
are not sufficient for neural induction.  However a double in situ against the 
hindbrain marker Krox20 and the midbrain marker En2 showed that these genes 
were induced in the acceptor explants and maintained their correct antero-posterior 
patterning – in other words a result which would be expected if both genes’ 
expression required a Wnt concentration gradient (Kiecker & Niehrs 2001).   
Similar to FGF signalling, Wnt signalling also promotes proliferation of neural 
progenitors in the posterior ‘stem zone’ (Figure 1.5). Overactivation of Wnt signalling 
induced by lithium chloride treatment on chick embryos caused a reduction in the 
primary neural marker NeuroD, which is essential for the differentiation of neural 
cells (Olivera-Martinez & Storey 2007).  
1.7.4.3 Cooperation between Wnt and FGF signalling 
Ectopic Wnt3a expression in neuralised animal caps was found to repress the 
anterior neural markers Hesx1 and Otx2 whilst causing an upregulation of the 
midbrain and hindbrain markers En2 and Krox20.  dnFGFR1 alone could not 
repress Hesx1 and Otx2, and Wnt3a could not repress Hesx1 and Otx2 when co-
expressing dnFGFR1, unlike Wnt3a-injected controls. This suggests that the ability 
of Wnt to inhibit anterior neural genes is dependent on active FGF signalling 
(McGrew et al. 1997). An example of this was shown in the chick, where FGF8 was 
found to be essential for maintaining the expression of Wnt8c, which like FGFs, 
inhibited neuronal differentiation when overexpressed (Olivera-Martinez & Storey 
2007).   
Although in some cases Wnt signalling is dependent on FGF signalling, both 
signalling pathways cooperate in some aspects of neural development.  Even with 
normal levels of FGF signalling, expression of dominant negative Wnt8a (dnWnt8a) 
in chick embryos caused loss of midbrain and hindbrain markers (Kiecker & Niehrs 
2001; McGrew et al. 1997).  Secondly, Wnts and FGFs cooperate to activate Cdx 
genes.  Overexpression of Frzb – an antagonist of Wnt1, 3a and 8, and dnFGFR1 in 
animal caps has an additive effect on the inhibition of Cdx4.  However, although it 
was shown that MAPK signalling was imperative for FGF’s actions to activate Cdx4, 
Frzb does not downregulate dpERK and so Wnt must activate Cdx4 via MAPK 
independent means (Keenan et al. 2006).    
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Therefore, in both neural induction and in patterning, Wnt signalling is required in 
conjunction with FGF signalling to specify and pattern the posterior CNS and 
repress anterior fates. 
1.8 Anterior neural patterning with FGFs 
1.8.1 FGF signalling in the anterior prospective CNS 
As well as inducing and patterning the posterior CNS, FGF signalling is active in the 
telencephalon and around the midbrain hindbrain boundary (MHB).  This is most 
easily visualised by looking at the distribution of dpERK by whole-mount 
immunostaining which shows bursts of active FGF activity in the future MHB regions 
and in the extreme anterior of the neural plate which borders the non-neural 
ectoderm, known as the anterior neural border (ANB) (Figure 1.6A). Although in the 
forebrain FGF signalling does not take centre stage, in both the ANB and the MHB 
FGF8 displays organiser activity and acts as a morphogen to pattern the 
prospective anterior neural plate. 
1.8.2 FGF signalling at the Isthmic Organiser (IsO) 
The Isthmus is a constriction located at the midbrain-hindbrain boundary (MHB).  To 
its anterior is the mesencephalon which will eventually give rise to the tectum. To its 
posterior is the hindbrain, composed of rhombomeres 1-7 (Figure 1.6).  
Rhombomere 1, the closest structure posterior to the MHB, gives rise to the 
cerebellum (Sato et al. 2004).   
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Figure 1.6 – FGF signalling in the forebrain 
Figure 1.5A is a dorsal view of a Xenopus laevis embryo at neurula stage 17 immunostained 
with an antibody against diphospho-ERK (ERK).  The anterior is facing.  DpERK is present in 
the anterior neural border (ANB), telencephalon (Tel), and midbrain-hindbrain boundary 
(MHB), as well as in the posterior of the embryo.  Figure1.5B is a schematic diagram of the 
developing brain.  Areas of FGF signalling are in blue – around the telencephalon, and at the 
MHB.  The forebrain is divided into the telencephalon and diencephalon.  The hindbrain is 
composed of rhombomeres (R1-4 of 7 shown here).  FGF8 emanating out of the IsO in the 
MHB patterns the rhombomeres and the mesencephalon.  It is though that Sulf activity in the 
mesencephalon provides an asymmetric gradient of FGF8 either side of the MHB, conveying 
extra positional information to cells.      
The Isthmus has been well documented to have an organiser function, and is known 
as the Isthmic Organiser (IsO). Signals emanating from the IsO pattern surrounding 
tissues in a dose-dependent manner.  This was first shown in chick embryos by 
grafting the MHB to the posterior forebrain.  This produced an ectopic midbrain that 
was a mirror image to the existing midbrain (Martinez et al. 1991).  Further work in 
the chick found that implantation of an FGF8-soaked bead next to the diencephalon 
caused surrounding tissue to mimic the more posterior area around the IsO, and 
become mesencephalic or cerebellar in character (Martinez et al. 1999; Crossley et 
al. 1996).  Therefore, FGF8 was proposed to act as a morphogen secreted out of 
the Isthmic Organiser (IsO) which is required for correct patterning of the 
surrounding developing brain tissue.   
FGF8 knockout mice and FGF8 knockdown frogs fail to gastrulate, and so the loss 
of midbrain and cerebellum could be not due to just signalling defects in the IsO.  To 
circumvent this, Chi et al. (2003) made a conditional FGF8 hypomorphic mouse, 
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where mutant FGF8 was expressed only in the prospective brain.  As a result, 
hypomorphs displayed deletions of mesencephalon/hindbrain derivatives as well as 
loss of Wnt1, Gbx2 and FGF17/18 expression in the IsO region (Chi et al. 2003).  
Conversely, mis-expression of FGF8b by electroporation in ovo posteriorised the 
developing mesencephalon so it differentiated into the cerebellum instead (Sato, 
Araki, & Nakamura, 2001).  Therefore, FGF8 is required for correct midbrain and 
hindbrain development as well as other genes co-expressed in the region.   
Work in other labs around the same time identified a cross-repressive relationship 
between the transcription factors Otx2 and Gbx2 as being required for correct 
placement of the MHB, with FGF8 expression at the interface (Broccoli et al. 1999).  
Otx2 is expressed in the anterior neural tube and its caudal boundary stops sharply 
with the MHB/IsO.  Ectopic expression of Otx2 by knocking it into the En1 locus 
caused a reduction in size of the cerebellum.  This also caused a posterior shift in 
Fgf8 expression and the posterior marker Gbx2, showing the caudal limit of Otx2 is 
important for positioning the Isthmic organiser (Broccoli et al. 1999).  Fgf8 in turn 
also has an influence on Otx2 expression, as ectopic FGF8 via electroporation 
repressed Otx2 and induced Gbx2 more caudally than normal in the 
mesencephalon and caudal diencephalon.  Therefore, FGF8 exhibits organiser 
activity in the IsO, and although Otx2 and Gbx2 are required for its positioning, 
FGF8 has an important role in patterning the IsO and promoting a cerebellar fate.  
This is clearly illustrated in the ace zebrafish mutant, which has a mutation in its 
FGF8 gene which renders it non-functional – these fish lack a cerebellum, 
telencephalic midline structures and the IsO (Reifers et al. 1998; Shanmugalingam 
et al. 2000). 
More recent experiments showed that tissues surrounding the IsO respond to FGF 
activity in a graded manner – at a low level FGF activity specifies the 
mesencephalon and a much higher level is needed to specify rhombomere 1 
(Basson et al. 2008).  Genes close to the IsO have a higher threshold for FGF 
activation, such as EphA, than those in more anterior midbrain such as the EphA 
receptor (Chen et al. 2009).  However, there is an ongoing question of how is a cell 
to know based upon its proximity to the IsO whether it is anterior or posterior to the 
MHB.  This could be because of asymmetrical placement and activities of FGF 
signalling modulators either side of the IsO.  The gradient of FGF8 across the IsO 
requires the presence of HSPGs (Chen et al. 2009; Pye et al. 2000).  Sulf1 and 
Sulf2 are sulphatases which remove 6-O-Sulfate groups and destabilise the 
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tripartite FGF complex, thus inhibiting FGF signalling.  There is a stripe of Sulf2 in 
the posterior mesencephalon, which would therefore dampen the FGF8 signal 
anterior to the IsO compared to the same distance posterior of the IsO 
(Winterbottom & Pownall 2009).  Therefore at the highest doses of FGF8, only 
rhombomere1 will be specified and the slight inhibition of FGF signalling by Sulf2 
anteriorly will result in formation of posterior midbrain. The negative regulator of 
MAPK signalling, Sprouty2 is also present around the MHB.  When Sprouty2 is 
electroporated into rhombomere1, it rostralises the rhombomere into the 
mesencephalon, supporting the idea of a slightly lower FGF signal being required to 
form mesencephalon (Suzuki-Hirano et al. 2005). 
1.8.3 FGF signalling at the ANB 
In zebrafish and frog embryos, the ANB is first visible at late gastrula as a smile-
shaped structure located at the interface between the anterior-most region of the 
neural plate, and the adjacent non-neural ectoderm (Figure 1.6A). The anterior 
neural ectoderm used to be thought to play a passive role during neural 
development, however this changed when Houart et al., (1998) ablated populations 
of these anterior ectodermal cells in zebrafish embryos. This ablation firstly caused 
damage to the prechordal plate – the precursor to the neural plate – as its marker 
goosecoid was lost. In later development ablation caused a high level of apoptosis 
in anterior neural regions. Closer examination of gene expression as a result of 
ablation of the ANB revealed that anterior dorsal forebrain markers Emx and Dlx2 
were absent, whereas the diencephalic Sonic hedgehog (Shh) expression domain 
was expanded. This suggested that the ANB was in fact critical for initial forebrain 
patterning and for the survival cells contributing to the telencephalon (Houart et al. 
1998). 
Earlier research in the rat identified a forkhead transcription factor FoxG1 (also 
known as BF-1) that was restricted to the rostral neural tube and later in 
development, the telencephalon (Tao & Lai 1992).  FoxG1-null mouse mutants died 
at birth with severe reduction in forebrain structures caused by a lack of proliferation 
in telencephalon progenitor cells (Xuan et al. 1995). To study the regulation of 
FoxG1, Shimamura & Rubenstein (1997) cultured neural plates dissected from 
mouse embryos, with or without ANB cells attached.  In explants cultured without 
the ANB, FoxG1 expression was not activated, unlike explants retaining ANB cells. 
This suggested that factors secreted from the ANB are required for FoxG1 
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expression.  FGF8 expressed in the anterior forebrain proved to be such a factor, as 
in neural plate explants without the ANB, the placement of an FGF8-soaked bead 
underneath the anterior of the neural plate potently activated FoxG1 expression 
(Shimamura & Rubenstein 1997).    
As the loss of the ANB caused expression of Shh in the diencephalon, effectively 
posteriorising the developing brain, it was hypothesised that as in the IsO FGF 
signalling in the ANB acts as a morphogen to pattern the surrounding neural 
structures (Eagleson & Dempewolf 2002).  Indeed, ectopic FGF8 expression 
caused by placing an FGF-soaked bead implanted into the ANB in Xenopus 
embryos caused posteriorisation of FoxG1 expression (Eagleson & Dempewolf 
2002).  As well as activating FoxG1, Fgf8 was also shown to be activated by FoxG1 
itself so appears to be part of a positive feedback loop required for early forebrain 
specification (Eagleson & Dempewolf 2002).  FoxG1-/- mice showed a decrease in 
rostral expression of FGF8, which with an increase in BMP signalling caused 
premature differentiation of neurons, depleting the progenitor pool and thus limiting 
the growth of the telencephalon, therefore intact signalling between FGF8 and 
FoxG1 is imperative for correct temporal and spatial development of the forebrain 
(Martynoga et al. 2005).  This is also seen in zebrafish, FGF8-mutant fish display 
defects in commissural axon pathfinding and telencephalon patterning 
(Shanmugalingam et al. 2000).   It was argued that the reason these animals still 
developed remnants of the telencephalon was that either FGF signalling was not 
sufficient for FoxG1 activation and forebrain development, or functional 
compensation was occurring by other FGFs (Paek et al. 2009).  Therefore Paek et 
al., (2009) abolished FGF activity in the telencephalon by raising conditional triple-
knockout FGFR1, FGFR2 and FGFR3 mice (FGFR4 is not expressed in the ANB).  
These embryos completely lacked the telencephalon and as well as not expressing 
FoxG1, also did not express other telencephalic markers such as Dlx2 and Emx1 
(Paek et al. 2009).   This shows that FGF expression in the ANB is absolutely 
required for FoxG1 activation and maintenance, and to pattern the telencephalon. 
Another way FGF signalling contributes to anterior neural development is through 
regulation of the GPCR lysophosphatidic acid receptor 6 (LPAR6), which has been 
identified as being positively regulated by FGFs (Branney et al. 2009; Geach et al. 
2014).  Knockdown of Lpar6 and its upstream LPA-synthesising enzyme Enpp2 in 
Xenopus neurula embryos caused a loss of telencephalic markers FoxG1 and 
Emx1, whereas midbrain and hindbrain markers were unaffected.  Lpar6 morphants 
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displayed anterior forebrain truncations that were worsened when FGF signalling 
was inhibited with SU5402.  During this PhD, I had the opportunity to contribute 
towards Geach et al. (2014), and showed by ISH and immunostaining that as well 
as being FGF targets, knockdown of Lpar6 and Enpp2 caused a severe reduction of 
Fgf8 expression and dpERK levels in the ANB and MHB.  This suggested that as 
well as being induced by FGF signalling, Enpp2 and Lpar6 also affect FGF 
signalling through FGF8, and this relationship between FGFs and Lpar6 is required 
for correct forebrain patterning and development (Geach et al. 2014).  The paper is 
included in Appendix 8.2. 
As well as FGFs, Sonic Hedgehog also plays an important role in ventral 
telencephalon development.  Shh is also known to be required for FoxG1 
expression and ventral telencephalic genes (Hébert & Fishell 2008).  This is 
because FGF negatively regulates Gli3, the negative regulator of the Shh pathway.  
It is this repression that would otherwise prevent FoxG1 from being activated (Rash 
& Grove 2007).  Shh works upstream of FGF as in the murine Shh-/- mutant there is 
no FGF expression in the telencephalon and because levels of Gli3 rise, ventral cell 
types are lost (reviewed in Hébert & Fishell 2008).  Therefore, the effects of FGF 
signalling upon telencephalon could be said to be primarily due to its regulation by 
Shh.   However, Shh also depends on FGF signalling to form the ventral 
telencephalon. 
1.8.4 Conclusions     
Therefore, as well as being important for posterior neural specification and 
patterning, FGF signalling also has a patterning role in more anterior regions of the 
CNS - the rhombomeres, MHB and ANB - by acting as a morphogen.  Although 
insufficient by itself to specify the anterior of the embryo, crosstalk with other 
pathways, such as Wnt, RA and Shh ensures proper development of the forebrain.  
The repressive influence from posterior FGF upon more anterior Hox genes as well 
as the requirement for FGF signalling to actively pattern areas around the MHB and 
ANB points to complicated relationship between FGF and other signalling events to 
specify the full neural program. 
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1.9 Summary 
FGF signalling is required for many processes during embryonic development, but 
this project will focus on its role in neural development.  FGF signalling has 
previously been shown to be required for neural induction and patterning in addition 
to BMP inhibition.  FGF signalling is known mainly for specifying the posterior CNS, 
but roles for FGF signalling in the anterior CNS are also emerging.  Although the 
effect of FGF signalling upon activating Hox genes and eventually posterior neural 
tissue has been investigated, the proximal FGF targets that contribute towards 
neural development and other related processes have not been thoroughly 
investigated before.  Furthermore, it is still not clear how signalling activated by 
individual FGFRs influence neural development.  Therefore this project aims to 
investigate FGF signalling during neural development through use of inducible 
FGFRs (iFGFRs) derived from FGFR1-4.  Changes to the Xenopus transcriptome 
as a result of FGF induction during neural development will be investigated, and 
proximal FGF targets found as a result characterised further. 
1.10 Core Aims of this project 
The main hypothesis for this investigation was that activation of iFGFRs during a 
period of early neural specification would affect expression of genes involved in the 
development and specification of the CNS.  It was also hypothesised that there 
would be differences in signalling outputs between the different iFGFRs.  The core 
aims of this project that would test these hypotheses were: 
1. To characterise and optimise the use of inducible FGF receptors (iFGFRs) 
as a means of temporarily and spatially controlling FGF signalling during 
neural development in Xenopus embryos. 
2. To investigate the effects of iFGFR activation upon the Xenopus 
transcriptome during neural development by a) analysing a previous 
microarray dataset and b) performing an RNA seq experiment to find 
proximal neural targets.   
3. To identify proximal neural FGF targets and characterise them further 
through knockdown and/or overexpression.   
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2  Materials and Methods 
 
2.1 Embryological Methods 
2.1.1 In Vitro Fertilisation of Xenopus tropicalis embryos 
Xenopus tropicalis females were primed by subcutaneous injection of 10 units of 
Human Chorionic Gonadotrophin [HCG; Chorulon: Intervet] 24-72 hours prior to the 
required onset of laying.   On the day of laying, females were injected with 100 units 
of HCG and placed in a darkened 27°C incubator for three hours.  Eggs were 
transferred to Leibovitz’s L-15 [Gibco] + 10% foetal calf serum [Invitrogen]-coated 
55mm dishes [VWR international] fertilised with crushed male Xenopus tropicalis 
testes suspended in 1ml L-15 + 10% heat treated foetal calf serum.  Half an hour 
after fertilisation embryos were dejellied by placing them in a solution of 3% L-
cysteine [Sigma] in MRS/9 (Modified Ringers solution) and washing in MRS/9 
(Ubbels et al. 1983).  Before and during microinjection eggs were cultured in 3% 
Ficoll solution [Sigma] in MRS/9 pH 7.8.  Before the onset of gastrulation embryos 
were transferred to MRS/20 and cultured in 1% agarose-coated 55mm dishes.  
Embryos were staged according to Nieuwkoop and Faber. 
2.1.2 In Vitro Fertilisation of Xenopus laevis embryos 
Xenopus laevis females were primed by subcutaneous injection of 50 units of HCG 
24 hours- 2 weeks before laying.  14 hours before laying, females were injected with 
between 180-250 units of HCG to induce egg laying, and placed in a darkened 
incubator at 20°C overnight.  Eggs were fertilised with crushed male Xenopus laevis 
testes suspended in water.  Half an hour after fertilisation embryos were dejellied by 
placing them in a solution of 2.5% cysteine hydrochloride monohydrate [Sigma] in 
water, pH 7.8.   Embryos were cultured in Normal Amphibian Medium  (NAM/10) 
(Slack & Forman 1980).  Before and during microinjection eggs were cultured in 5% 
Ficoll solution in NAM/3.  Before the onset of gastrulation embryos were transferred 
to NAM/10.  Embryos were staged according to Nieuwkoop and Faber. 
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2.1.3 Microinjection 
Xenopus embryos were microinjected using a Harvard Apparatus PLI-100 gas 
injector.  To target mRNA to the whole embryo, mRNA was injected into one or both 
blastomeres in the animal hemisphere at the 1-2 cell stage.  To target mRNA to 
neural tissue, mRNA was injected into one or both dorsal animal blastomeres at the 
8-cell stage.  For morpholino injections, morpholinos [Genetools] were warmed to 
65°C for 10 minutes before use, centrifuged for 2 minutes at 13000 rpm and kept at 
room temperature during microinjection.  Xenopus laevis embryos were injected 
with a total of 4.2-9.6nl mRNA/morpholino per cell and Xenopus tropicalis embryos 
were injected with a total of 2.3-4.2nl mRNA/morpholino per cell at appropriate 
concentrations.    
2.1.4 Injection of iFGFR mRNA and receptor induction with 
AP20187 
Unless otherwise stated, embryos were injected with 20pg iFGFR mRNA at the 2-
cell stage.  For whole embryo experiments, Xenopus laevis embryos were cultured 
until stage 10.5 and placed in a 1µM solution of AP20187 [Clontech] in NAM/10 until 
neural specification stages.  For targeted injections, embryos were coinjected into 
both dorsal animal blastomeres at the 8-cell stage with 10pg iFGFR1 and GFP if 
required, and treated with AP20187 as before.  For animal cap experiments, 
embryos were co-injected with 20 pg iFGFR and 50pg Noggin mRNA into the 
animal pole at the 1-2 cell stage.  Embryos were cultured until Stage 8 before 
transferring to a solution of NAM/2 and dissecting out ectodermal explants.  Animal 
caps were cultured in NAM/2 until stage 10.5 and transferred to a 1µM solution of 
AP20187 in NAM/2 for 3 hours.  Embryos were snap frozen or fixed at the required 
stage. 
2.1.5 Imaging and manipulation 
Embryos were imaged using a Fluorescent Leica MZFLIII microscope and SPOT 
Advance v4.0.9 software Diagnostic Instruments Inc.  Images were optimised using 
Adobe Photoshop CS3.  Figures were made using CorelDRAW Graphics Suite x6. 
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2.2 Cellular and Molecular Biological 
Methods 
2.2.1 Agarose gel electrophoresis 
6x loading buffer (New England Biolabs) was added to samples to be run on an 
agarose gel.  0.8-2% agarose [Melfords Biolaboratories Inc.] in TAE was heated to 
make a molten gel and set in gel moulds.  Samples were loaded on gels alongside 
5µl Log2 DNA ladder (New England Biolabs).  Gels were placed in an 
electrophoresis tank and run at 180V.   
2.2.2 Quantification of nucleic acids 
DNA/RNA was quantified using the Nanodrop 2000 or Nanodrop 8000 [Thermo 
Scientific].  This also enabled the 260/280 and 260/230 absorption ratios to be 
found to assess nucleic acid purity.   
2.2.3 Transformation of plasmids 
1µl plasmid DNA was added to 50µl DH5ɑ competent cells [Invitrogen] and kept on 
ice for 30 minutes.  Table 2.1 shows plasmids used for making sense RNA for 
microinjection with the restriction enzyme and polymerase required to make sense 
mRNA.   
Table 2.1.  Plasmids used for microinjection in this project 
Construct Vector 
Enzyme to 
linearise 
Promoter for 
Sense 
iFGFR1 VT+ CS2+ NotI SP6 
iFGFR1 VT- CS2+ NotI SP6 
iFGFR2 CS2+ NotI SP6 
iFGFR3 CS2+ NotI SP6 
iFGFR4 CS2+ NotI SP6 
Cas9 CS2+ NotI SP6 
dnFGFR1 Sp64t EcoRI SP6 
Nuclear GFP  CS2+ NotI SP6 
Nek6  CS2+ NotI SP6 
Nek6 TALEN Left CS2+ NotI SP6 
Nek6 TALEN Right CS2+ NotI SP6 
Noggin Sp64t EcoRI SP6 
Samples were heatshocked at 42°C for 90 seconds and placed back on ice for 2 
minutes.  800µl Luria Broth (LB) warmed to 37°C was added to the heatshocked 
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sample and the sample agitated for 1 hour at 37°C.  1/10 of this was plated onto 
LB/agar plates containing 100µg/ml ampicillin (SLS) and then the remaining sample 
spun down at 7.2 rpm.  Most of the supernatant was removed and the total cell 
pellet plated onto LB/agar with ampicillin plates.  Colonies were left to grow on 
plates overnight at 37°C.  
2.2.4 Minipreps 
Colonies from transformations were added to 5ml LB with 100µg/ml Ampicillin and 
agitated at 37°C overnight.  Cultures were pelleted at 8000rpm at room temperature 
and purified with the Qiagen Miniprep Spin Kit.  Minipreps were stored at -20°C. 
2.2.5 Cloning strategies 
2.2.5.1 Genes cloned for this project 
Table 2.2 shows the PCR primers used to amplify the coding DNA sequence (CDS) 
of a gene which was then T-cloned and linearised to make an antisense probe for in 
situ hybridisation  
Table 2.2 PCR primers and conditions for each gene cloned for In situ hybridisation 
Gene Forward Primer 
5'→3' 
Reverse Primer 
5'→3' 
Insert 
Size 
(bases) 
Vector Linearised 
with  
Promoter 
for 
antisense 
Dynll1 ATTTATTTCTACC
TGGGTCAGGTA 
TCAGCACAACAG
GTTTTCAGTCCT 
206 pGEM XhoI T7 
Dynll2 GAGAGAGAATTC
ACCATGGCTGAC
AGAAAGGCTGTTA
T 
CTCTCCTCGAGTT
ATAAAGCATTTAC
ATTTT 
549 pGEM ApaI SP6 
FoxA4 
partial 
CDS 
GATGTTTCCACAG
TAACAACAAGC 
AGAGTCCAATAG
GAGCCTTTACCT 
455 pGEM NsiI T7 
FoxN4 AGAAGAGAATTCA
CCATGGTAGACA
GTGACATCTCTGC
TATAA 
TCTTCTCTCGAGT
TAAAGCAAAGCAA
TAGGCTTGGT 
1521 pGEM NcoI SP6 
Hmx3 AGAAGAGAATTCA
CCATGGAGAGAT
ACCTGAGCAGCT
CAGAGA 
TCTCTCCTCGAGT
CACAACAAACATT
TATTTAACAA 
1363 pGEM SphI SP6 
Lefty GAGAGAGAATTC
ACCATGGGTGTC
ACTACCAAATCTT
T 
TCTCTCCTCGAGT
CATATGATAGCGA
TATTGTCCA 
1104 pGEM ApaI SP6 
Nek6 
5' UTR 
CCGGGACCTAGC
GAGGACAACTCT 
GCCCTCGTGCTG
GTATTCCTGCCC 
450 pGEM SpeI T7 
Rax ATGCACCTGCAC
AGCCCTTCCCTG 
TTACCAAGGCTTG
CCAATAAACTG 
969 pGEM NsiI T7 
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2.2.5.2 PCR amplification of fragments to be cloned 
Xenopus laevis cDNA was used with the primers in Table 2.2 to amplify the region 
of interest.  The PCR reaction consisted of 50µl 2x PCR mastermix [Fermentas], 2µl 
Forwards and Reverse Primer [Sigma], 5µl cDNA and 35µl H2O: 
PCR was then conducted following these conditions: 
Initial melting 95°C 5 minutes 
35 cycles of … 95°C 30s 
 
55°C* 30s 
  72°C 60s/kb 
Final extension 72°C 10 minutes 
 
*This temperature changed depending on the lower Tm value provided by Sigma. 
The PCR product was loaded on a 0.8% agarose gel and run at 120V for 1 hour.  
The band was extracted from the gel and purified using a Qiagen Gel Extraction kit.   
2.2.5.3 T-cloning 
1µl purified PCR products were mixed with 2.5µl 2x ligation buffer, 0.5µl pGEM 
vector, 0.5µl H2O and 0.5µl T4 ligase and left at room temperature for 1 hour.  They 
were then transformed into DH5α cells as in Section 2.2.3.   
2.2.5.4 PCR screening of colonies 
Colony PCR was undertaken to determine how many DH5α colonies contained 
pGEM with incorporated inserts.  Colonies were dispersed using 2µl molecular 
grade H2O.  1µl was added to a PCR reaction and 1µl streaked onto a LB/agar + 
Ampicillin plate.  10µl 2x PCR master mix, 1µl SP6 primer [Sigma], 1µl T7 [Sigma], 
2µl colony dispersed in H2O and 5µl H2O was mixed per reaction. 
The PCR conditions were as follows: 
Initial melting 95°C 5 minutes 
30 cycles of … 95°C 30s 
 
60°C* 30s 
  72°C 60s/kb 
Final extension 72°C 10 minutes 
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The reaction was run on an agarose gel to confirm that a product had been inserted 
into the vector.  Colonies on the patch plate corresponding to those that had taken 
up the insert were cultured in LB broth overnight and miniprepped as in Section 
2.2.4. 
2.2.5.5 Subcloning Nek6 into CS2 
Full length Xenopus tropicalis Nek6 was obtained from Source Bioscience in the 
pExpress vector.  The Nek6 gene was excised by cutting the plasmid with EcoRI as 
described. Simultaneously, 2µg CS2 vector was also linearised using EcoRI.  CS2 
was also dephosphorylated to reduce religation by adding 1µl Calf Intestinal alkaline 
phosphatase (CiP) [New England Biolabs] directly to the linearization reaction and 
heat inactivated at 65°C for 40 minutes. The fragments were run on a gel and the 
correct sized bands were excised and purified as mentioned in Section 2.2.5.2.  The 
linearised vector and excised gene were mixed in a 1:3 molar ratio and ligated using 
T4 ligase. Transformation and purification of the ligated product was performed as 
already described.  Purified CS2+ plasmids containing Nek6 were sequenced in the 
Technology Facility with the Applied Biosystems 3130XL sequencer to determine 
the orientation and identity of the insert.  Correctly subcloned Nek6 was processed 
for mRNA synthesis as described in Section 2.2.7. 
2.2.5.6 Sequencing of plasmid DNA 
Unless otherwise stated, plasmid DNA was sequenced on an Applied Biosystems 
3130XL Sanger sequencing machine in York Technology Facility. 
2.2.6 Linearising plasmid DNA 
Per reaction, 1-5µg plasmid, 10µl 10x Surecut Buffer [Roche], 5µl Restriction 
Enzyme and H2O to 100µl was mixed.  The reaction was incubated at 37°C for 90 
minutes. Table 2.3 shows plasmids in addition to those in Table 2.1 and Table 2.2 
from lab stocks that were linearised to make in situ probes.  
To check the plasmid was cut to completion, 10µl was run on a 1% agarose gel.  To 
clean up the digest, an equal volume of phenol:chloroform [Sigma] was added, 
vortexed and centrifuged for 5 minutes at 13000 rpm.  The aqueous phase was 
added to 1/10 volume sodium acetate [Sigma] and 2V 100% Ethanol [Fisher] and 
precipitated at -20°C for 1 hour.   
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Table 2.3.  Plasmids from lab stocks linearised for in situ probes 
Gene Vector Linearised with: 
Promoter 
for 
Antisense Source 
Cdx4 CS2+ EcoRI T3 
(Illes et al. 
2009) 
En2 pBluescript KS+ XbaI T3 Isaacs Lab 
HoxA7 pGEM BamHI SP6 Isaacs Lab 
Krox20 pGEM4 EcoRI T7 Isaacs Lab 
MyoD Cs2+ BamHI SP6 
(Harvey 
1991) 
Sox3 Bluescript SK+ EcoRI T7 
Grainger 
Lab 
Sox17 CS107 EcoRI T7 Tgas004n06 
N-tubulin pBluescriptII KS+ BAMHI T3 
Papalopulu 
lab 
Xbra pSP64T ClaI T7 
(Conlon et 
al. 1996) 
The precipitate was pelleted in a 4°C centrifuge at 13000 rpm for 20 minutes.  The 
pellet was washed with 70% ethanol, vacuum dried and resuspended in 50µl H2O.   
2.2.7 In vitro transcription of mRNA for microinjection 
Reactions were set up at room temperature as follows using Fisher Megascript kits.  
Per reaction, 4.5µl H2O, 2µl 50mM ATP, 2µl 50mM CTP, 2µl 50mM UTP, 2µl 5mM 
GTP, 2.5µl 40mM mGTP cap [Fisher Scientific], 2µl 10x transcription buffer and 2µl 
enzyme were mixed.  GTP was added at a lower concentration to increase the 
likelihood of mGTP cap being incorporated.   Reactions were incubated at 37°C for 
at least 4 hours.  DNase1 [Promega] was added to destroy the template and the 
reaction incubated for 20 minutes at 37°C.  An equal volume of phenol:chloroform 
was added, the reaction vortexed, centrifuged at 13000 rpm for 5 minutes and the 
aqueous phase transferred to a new tube.  An equal volume of chloroform was 
added, the reaction vortexed, centrifuged at 13000 rpm for 5 minutes and the 
aqueous phase transferred to a new tube.  An equal volume of isopropanol was 
added and the reaction left to precipitate at -20°C for 30 minutes.  The reaction was 
centrifuged for 20 minutes at 13000rpm, 4°C.  The pellet was washed with 70% ice 
cold ethanol and dried before resuspending in 20µl H2O.  The concentration of 
mRNA was quantified using the nanodrop and mRNA divided into 2µl aliquots at a 
concentration of 200ng/µl.   
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2.2.8 Transcription of DiG-labelled RNA for in situ hybridisation 
Per reaction, 15µl 5x Transcription Buffer [NEB], 2.5µl 10x DiG dNTP mix 
[Invitrogen], 5µl Dithiothreitol (DTT) [Invitrogen], 2µl RNasin [Promega], 4µl DNA 
polymerase [Promega], 2µl DNA template and 44µl H2O were mixed. 
The reaction was incubated at 37°C for 4 hours.  1µl of DNase1 was added and the 
reaction incubated for 20 minutes at 37°C.  37.5µl H2O, 75 µl 3M ammonium 
acetate [Sigma], 1.5 µl Glycoblue [Ambion] and 468µl 100% ethanol were added to 
precipitate DiG-RNA and the reaction incubated on dry ice for 1 hour.  Reactions 
were centrifuged at 13000 rpm at 4°C for 20 minutes.  The pellet was washed with 
70% Ethanol and dessicated before resuspension in 30 µl H2O. The presence of 
probe was checked on an agarose gel.   
On some probes, particularly those longer than 800bp, their ability to effectively 
penetrate tissues was improved by hydrolysis.  An equal volume of 80mM NaHCO3 
[Sigma] plus 60mM Na2CO3 [Sigma] was added to RNA probes resuspended in 
H2O.  The amount of time samples were left to hydrolyse at 60°C was determined 
by the formula:   
                                        
                                  
 
1/9 volume 3M sodium acetate was added with 2 volumes of 100% ethanol and left 
to precipitate at -80°C for 10 minutes before centrifugation at 13000 for 15 minutes 
at 4°C.  The pellet was washed with 95% ethanol, and the pellet desiccated and 
resuspended in H2O.  Probes were stored at -80°C until required. 
2.2.9 In situ hybridisation 
Embryos were previously fixed at the appropriate stage in MEMFA (10% MEM salts 
[1M MOPS [Sigma], 20mM EGTA [Fisher Scientific], 10mM MgSO4 [Fisher 
Scientific] in dH2O], 10% formalin [10% Formaldehyde [Sigma] in dH2O] for one 
hour and transferred to 100% methanol.  Embryos were rehydrated in progressively 
weaker solutions of methanol in Phospho-buffered Saline (PBS) plus 1% Tween-20 
[Fisher Scientific] (PBST) and then permeabilised with Proteinase K [Roche] at 
10µg/ml (Xenopus laevis) or 6 µg/ml (Xenopus tropicalis) for roughly 1 minute per 
stage and the reaction quenched with 0.1M Triethanolamine pH 7.8 [Sigma] and 1% 
acetic anhydride [Sigma].  After washing in PBST embryos were re-fixed in 10% 
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formalin in PBST.  After washing in PBST embryos were equilibriated in 1ml PBST 
with a 250µl hybridisation buffer (50% Formamide [Applied Biosystems], 5x SSC 
[Promega], 100µg/ml Heparin [Sigma], 1x Denhardt’s solution [VWR International], 
0.1% Tween 20, 0.1% CHAPS [Sigma] and 10mM EDTA [Sigma]).  Embryos were 
then blocked in hybridisation buffer containing 1mg/ml total yeast RNA sodium salts 
[ICN Biomedical] at 60°C for 2 hours.  The in situ probe was brought to 80°C for 3 
minutes and then added to hybridisation buffer at 60°C containing 1mg/ml total 
yeast RNA.  This probe solution replaced the hybridisation buffer and embryos were 
incubated at 60°C overnight.  After washing in hybridisation buffer embryos were 
washed three times in 2X SSC with 0.1% Tween-20 at 60°C.  If required, embryos 
were treated with 2µl RNaseA [VWR international] in 2x SSC plus 0.1% Tween 20 
at 37°C for 30 minutes.   Embryos were then washed three times in 0.2X SSC in 
0.1% Tween 20 at 60°C. Embryos were moved to RT and washed with maleic acid 
buffer (100mM Maleic Acid [Sigma], 150mM NaCl and 0.1% Tween) (MABT) for 2x 
15 minutes  before being blocked in 2% BMB [Roche] + 2% heat-treated lamb 
serum [Fisher Scientific] in MAB for 2 hours.  This was replaced with fresh solution 
containing 1/2000 dilution of affinity purified sheep anti-digoxygenin antibody 
coupled to AP [Roche] and samples left at 4°C overnight.  The antibody was 
removed by washing with MABT and then the pH was equilibriated for BM purple by 
washing in alkaline phosphatase buffer (100mM NaCl, 100mM Tris [Invitrogen], 
50mM MgCl2 [Sigma] in dH2O) and then replacing with BM purple.  Once staining 
had developed by the required amount, embryos were washed in PBST, fixed 
overnight in 10% formalin and bleached in 5% H2O2 in PBST.   
2.2.10 Extraction of total RNA 
5 Xenopus laevis embryos, 10 Xenopus tropicalis embryos or 15 animal cap 
explants were homogenised in 1ml Trizol [Invitrogen].  All centrifugation steps were 
carried out at 13000 rpm at 4°C unless otherwise stated.  Samples were left at RT 
for 5 minutes then centrifuged for 10 minutes at 13000rpm at 4°C.  To the 
supernatant, 200µl chloroform was added, the sample vortexed and left at room 
temperature for 5 minutes.  The samples were centrifuged for 10 minutes at 
13000rpm, 4°C and the aqueous RNA phase added to a new tube.  An equal 
volume of chloroform [Sigma] was added and the previous step repeated.  The 
aqueous phase from this was added to 500µl isopropanol [VWR International] and 
left to precipitate at -20°C for 30 minutes.  The precipitate was pelleted by 
centrifugation at 13000 rpm for 15 minutes and washed washed with ice-cold 70% 
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ethanol.   The pellet was resuspended in 50µl H2O and 60 µl of a 9/10 LiCl [Sigma]: 
1/10 EDTA mix and precipitated at -80°C overnight.  Samples were then centrifuged 
for 40 minutes at 13000rpm, and the pellet washed twice with ice cold 70% ethanol.  
RNA was dried and resuspended in 20µl water.  RNA was quantified using the 
Nanodrop 2000.   
2.2.11 cDNA first strand synthesis 
1µg of RNA was mixed with 1µl OligodT 12-18 primer [Invitrogen], 1µl 10mM dNTPs 
[Invitrogen] and H2O to a total volume of 13µl. 
This was incubated at 65°C for 5 minutes to denature and secondary RNA 
structures.  After cooling on ice for 2 minutes 4µl First strand buffer [Invitrogen] and 
2µl DTT [Invitrogen] were added per reaction and incubated at 42°C for 2 minutes.  
1µl Supercript II reverse transcriptase [Invitrogen] was then added to each reaction 
and placed at 42°C for one hour and then 70°C for 15 minutes to terminate the 
reaction.  cDNA was stored at -20°C until required. 
2.2.11.1 L8 PCR 
To ensure cDNA could be amplified, a PCR was performed for the housekeeping 
gene L8.  Per reaction, 10µl 2x PCR master mix, 1µl 10µM L8 Forwards primer 
[Sigma], 1µl 10µM L8 Reverse primer [Sigma], 1µl cDNA and 7µl H2O were mixed. 
The conditions for PCR were as in Section 2.2.5.4: 
Success of the PCR was determined by running the product out on a 1% agarose 
gel. 
2.2.12 Western blots 
5 Xenopus laevis embryos, 10 Xenopus tropicalis embryos or 10+ animal cap 
explants previously snap frozen and stored at -80°C were homogenised in 50µl 
Phosphosafe [Novogen-Merk].  Samples were spun at 13000 rpm, 4°C for 20 
minutes and the supernatant added to a fresh tube with 2x sample buffer.  Samples 
were heated at 95°C for 10 minutes to denature protein.  Samples were then run on 
a 12% polyacrylamide gel at 120V alongside a protein ladder [Thermo Scientific] 
and then transferred onto an Immobilon Millipore membrane [Fisher Scientific] at 
100V for 1 hour.  The membrane was blocked in a solution of 5% Marvel Milk in 
PBS for 1 hour, and incubated overnight at 4°C in primary antibody (see Table 2.4).  
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The membrane was washed in PBS and the incubated overnight in secondary 
antibody (see Table 2.4).  Protein bands were visualised by adding BM 
Chemiluminescence Western Blotting Substrate (POD) [Roche] to the membrane 
and exposing it to ECL Hyperfilm [Amersham] and developed using an Xograph 
machine.  If required, membranes were stripped by incubating the membrane in 
stripping buffer (for 100ml, 0.3g DTT [Melford Biolaboratories Ltd], 2ml Tris pH 6.8, 
250µl 10% SDS in dH2O) at 55°C for 15 minutes, washing in PBS, reblocking in 5% 
Marvel milk powder in PBS, and treating with antibodies as before.  The 
concentrations of all antibodies used are shown below in Table 2.4. 
Table 2.4 Dilutions of all antibodies used 
Primary Dilution Secondary Dilution 
dpERK 1 in 4000 anti mouse 1 in 4000 
FLAG 1 in 5000 
anti rabbit light 
chain 
1 in 
40000 
GAPDH 1 in 5000 anti mouse 1 in 5000 
HA 1 in 2000 anti mouse 1 in 4000 
pSmad1/5/8 1 in 1000 anti rabbit 1 in 2000 
tERK 1 in 500000 anti rabbit 1 in 8000 
    2.2.13 Immunostaining for dpERK 
Embryos to be immunostained were fixed at the appropriate stage in MEMFA for 
one hour and transferred to 100% Methanol [Fisher Scientific].  Embryos were 
rehydrated in progressively more dilute solutions of Methanol in PBS.  A potassium 
dichromate (K2Cr2O7) solution in 5% acetic acid (for 250ml, 7.35g K2Cr2O7 [Sigma] 
and 12.5ml Acetic acid [Sigma]) was added to embryos for 40 minutes.  After 
washing in PBS, embryos were permeablised and bleached for 45 minutes in 5% 
H2O2 [Sigma] in PBS.  After again washing in PBS, embryos were blocked once in 
BBT (1% BSA [Invitrogen], 0.1% Triton X-100 [SLS] in PBS) for 2x 1 hour and then 
in BBT + 5% horse serum [VectorLab] for a further hour.  Embryos were incubated 
overnight at 4°C in 1/10000 dilution of anti dpERK antibody [raised in mouse, 
Sigma].  The embryos were then washed 4x 1 hour in BBT, blocked in BBT + 5% 
horse serum and this replaced with BBT+5% horse serum containing horse anti-
mouse igG-AP conjugated secondary antibody [VectorLab] overnight at 4°C, at a 
concentration of 1/1000.  Embryos were washed in BBT for one hour and then PBS 
for 4 hours.  dpERK localisation was visualised upon the addition of BM purple 
(Roche).  When the colour had developed to the desired level, embryos were fixed 
and stored in 10% formalin in PBS. 
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2.3 RT-qPCR 
2.3.1 Primers used 
Primers for RT-qPCR were designed using the Primer3plus online tool.  Primers 
were selected that had a 60°C Tm, amplified between 80 and 120 bp of cDNA and 
did not have a high propensity to form primer dimers or bind to other genes.  
Primers are listed in Table 2.5. 
Table 2.5 – RT-qPCR primers 
Gene Forwards 5'→3' Reverse 5'→3' 
ATP6V03 TGCAAACTCTCTGACGCAAA AGCCAGCAGCTAGACCACTC 
Chmp1 AGAAAGTGTCTGCTGTCATGGA GGGGTGGTTAGTGTCATTGC 
Cited2 GCAAACAGCCCAACAGAGTAA GGAAGAAAGGTTCTGTGTCCA 
Cyclin1B ACTTCCTCAGACGGGCTTC GAAGGCTTGATGTGGACCAT 
Dynll1 TGCTACTCAGGCACTGGAGA AATTCCTTCCCACAATGCAA 
Dynll2 TAATGCACTGATGGCTGAAG CCAGGCAACTAAACAGAAGTCA 
Egr1 GGAGGGAGCTGAGCAATTC CTGGTTGGCATAGCTGGATT 
FoxA4 ACCTCAACTGTGGACCCCTA GGCCCTGGTAAGCCATTACT 
FoxN4 TGATGCCCTTGATCCAAGCA GGCACCTAATGTGTCCAGACT 
H3F3A ACTGGAGGGGTGAAGAAACC TGCGAATCAGAAGCTCAGTG 
Hesx1 AGACAAGAAGATGGATGTGGCT GGGATTTGCCAAAAGGTGCC 
Hmx3  CCGGGCTGGTGGTATTCTTA CAGACACTGGAGATGTGGGG 
Ift172 CTGCAAAAGCATGGAAAAGAG GTAATTGAGCCGCCGTAAAC 
Krt12 GCAGCCTTCAGAGTTTGGAA CCATATCGGCCATCTGTTTC  
Lefty AAGAGATCACTGCCCAGCTT GGACTCCATTCCAAAAACCA 
Lmbrd2 TGTGGGCACTCTGTTAGCC GGTGCAGGAGTCACAGCAT 
Med9 GGATGAAGCAGTCGAAGAGG AGCTCGTTCAGCTCCTGGTA 
MyoD AACTGCTCCGATGGCATGAT TGGGCTGTCACTGTAGAAGC 
Nek6 CCTGTTTTCCCTGTGTCAGAA    CTTTGGTCTGGGTCTGGGTA 
Oct-60 TGCCATCTCCAGTAGAGCAG TGGCAAACTCTTCCATCTCC 
ODC AAAGCTTGTTCTACGCATAGCAACT AGGGTGGCACCAAATTTCAC 
Poc5 TTCCAGAGTGTTCAGCAACG GAGAACGCTTCCAAACCTGA 
Ras-dva ACTTGGTGCCTACTGCTTGG TCTCATCCACCAGTGCTTCTG 
Rax GAGATTCATCCCCAACAGGA CACTCGCTTGAGGTCTTTCC 
Slc12a3 TGAAGGGACCAGAAAAAGCA AAGTGGAGGTTTGCCACAGT 
Snx10 TCGACAAAAGCTTCAGAGCA TCTTGCAATCCACGGACAC 
Sprouty2 GGTGGTTGCAGACCGAATA TTTCCACAATCCTCACACATTA 
Tuba1a GTGAGACAGGAGCTGGGAAG GAGTTGCTCAGGGTGGAAAA 
Xbra TACGGTTCTGCTGGACTTTG GGAACCCATTCTCCATTCAC 
Zeb2 TCCATGCTTCTTGTCCCTTT ATGGACTCGGCTCTGTGAAT 
Zfp36L1 TATCTCTTTCGCCCCATGTC CTGGAACTGCTCAGGTAGCC 
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The RT-qPCR mastermix was, per reaction, 12.5µl Power SYBR™ mastermix [Life 
Technologies], 2µl Primers, 5.5µl H2O and 5µl cDNA.  Three technical replicates 
were loaded onto a 96 well plate and run on an Applied Biosystems 7300 PCR 
machine and results analysed using Applied Biosystems 7300 series software.  
2.3.2 Primer Optimisation  
Before use in a Relative Expression assay, primers were optimised by performing 
Absolute quantification qPCR using standard serial 1/10 dilutions of cDNA, thus 
creating a standard curve, to ensure primers were efficient and had a linear dynamic 
range.  Thermal cycling conditions were as follows: 
Stage Temperature Time 
1 50°C 2 mins 
2 95°C 10 mins 
3. 40 cycles of.. 95°C 15s 
 
60°C 1 min 
4. Dissociation stage 95°C 15s 
 
60°C 20s 
 
95°C 15s 
 
Primers were discarded that gave an R2 value of less than 0.98 or had unevenly 
spaced Ct values between cDNA dilutions.  A dissociation curve was also 
conducted and primers that formed non-specific products and dimers discarded.  
Water controls for each primer set were also analysed to ensure absence of any 
amplified product.   
2.3.3 Relative quantification qPCR 
After optimisation, relative quantification RT-qPCR was performed. Thermal cycling 
conditions were as follows:  
Stage Temperature Time 
1 50°C 2 mins 
2 95°C 10 mins 
3.  40 cycles of.. 95°C 15s 
 
60°C 1 min 
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Ct values were normalised against those of the housekeeping gene ODC for each 
condition.  The Ct threshold was chosen automatically by the software.  Average Rq 
values for each gene and condition were compared using Applied Biosystems 
software to find the relative expression fold change between control and test 
samples.  Results were exported to an Excel.csv file for further analysis. 
2.3.3.1 Graphical representation and statistical analyses of RT-qPCR results 
Column graphs for RT-qPCR data were made in Microsoft Excel 2007.  Error bars 
were added following calculation of Standard Error from the mean.  Where 
appropriate (at least three biological replicates performed), a student’s 2 tailed T 
test was performed using SPSS software to compare the mean Ct values for each 
technical replicate.  Data were shown to be normal, but P-values accounting for the 
equality of variances not assumed chosen due to the low number of values tested.  
2.4 Microarray methodology 
The following were carried out by other members of the Isaacs lab: 
2.4.1 Sample preparation 
Xenopus laevis embryos were injected with 20pg of iFGFR1, iFGFR2, iFGFR3 or 
iFGFR4 mRNA at the 2-cell stage, and cultured until the onset of gastrulation.  
1.25µm AP20187 was added to culture medium and embryos cultured throughout 
gastrulation until stage 13 at 22°C.  10 embryos per condition (induced and 
uninduced per receptor) were processed for total RNA isolation as previously 
described.  The quality of RNA was tested using an Agilent 2100 Bioanalyzer.   
2.4.2 Preparation of cRNA and chip hybridisation 
The Affymetrix GeneChip one-cycle target labelling kit [Affymetrix] was used 
according to manufacturer’s instructions, to process 2mg total RNA to cRNA.  
Resultant biotinylated cRNA was fragmented to 35-200bp lengths at 94°C in 
fragmentation buffer [Affymetrix].  The biotin-labelled fragments were hybridised to 
GeneChipH Xenopus laevis Genome Array for 16h at 45°C.  The arrays were 
washed, stained and scanned using the Affymetrix Model 450 Fluidics station and 
Affymetrix Model 3000 scanner. 
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2.4.3 Microarray data processing  
Processing of the raw microarray data was performed using Affymetrix GCOS 1.2 
software.  Probe cell intensities were calculated and summarised for the respective 
probe sets using the MAS5 algorithm.   
Data were then imported into BRB ArrayTools software.  Spot filters had a threshold 
minimum value of the spot intensity was below 5.  The array was normalised using 
the median over the entire array.  Genes with more than 50% data missing/filtered 
out were excluded. 
Subsequent data analyses were performed by myself: 
Genes were excluded which had <1.5-fold expression change upon iFGFR 
induction.  Scatterplots were generated using the ‘Phenotypes Averages’ tool.   
Gene lists were generated by comparing iFGFR uninduced to iFGFR induced 
expression values for each receptor.  Target gene annotation was performed using 
existing Affymetrix Gene array annotation and BLAST searching of target 
sequences using Genbank databases. 
2.5 RNA-seq 
2.5.1 Experiment setup 
Xenopus laevis embryos were co-injected with 50pg Noggin and 20pg iFGFR1 or 
iFGFR4 mRNA at the 2 cell stage and cultured to stage 8.  Animal cap explants 
were taken and cultured in NAM/2 overnight at 12°C.  At stage 10.5, injected animal 
caps were induced with AP20187 for three hours at 22°C and then snap frozen. 
2.5.1.1 Quality control of experiment 
Whole stage matched controls were also induced at stage 10.5 and collected three 
hours later for western blot analysis for dpERK and pSmad1/5/8.  Some sibling 
embryos only injected with 50pg Noggin were raised to tailbud to ensure a 
ventralisation phenotype as in Smith & Harland, (1992), and iFGFR-injected siblings 
raised to check a typical FGF-overexpression phenotype resulted.  Western blot 
analysis was also performed on sibling embryos to confirm upregulation of dpERK 
in induced samples. 
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2.5.2 Extraction of total RNA 
As described in Section 2.2.9, RNA was extracted from 20 neuralised animal cap 
explants.  RNA integrity was measured by Lesley Gilbert on a Bioanalyser in the 
Technology Facility.  Samples were sent on dry ice to the University of Liverpool 
Centre for Genomic Research (CGR) and processed further for RNA-seq.   
2.5.3 Processing of samples for RNA-seq by the CGR, University 
Liverpool 
Samples were treated with Ribo-Zero rRNA Removal Kit [Illumina].  Samples were 
then fragmented using light restriction enzymes to lengths of 100-150 bp.  A PhiX 
spike-in control was used for all samples.  Samples were sequenced on an Illumina 
HiSeq 2500.  ~110 million paired reads were obtained for iFGFR1 Uninduced, ~80 
million for iFGFR1 Induced, ~90 million for iFGFR4 Uninduced, and ~85 million 
reads iFGFR4 Induced.  
The mean read length for all samples before trimming was 100bp.  The raw Fastq 
files were then trimmed for the presence of Illumina adapter sequences using 
Cutadapt version 1.2.1, with option –O 3, so that 3’ end of any reads matching the 
adapter sequence for >3bp were trimmed.  Reads were further trimmed using Sickle 
version 1.200 with a minimum window score of 20.  Reads shorter than 10bp after 
trimming were also removed.  The mean read lengths after trimming were 82-96bp 
for all samples.  
2.5.4 Data Processing by Toby Hodges 
Initial analysis of raw data was performed by Toby Hodges from York Technology 
facility.   
The reference transcripts used for mapping are contained 
in XENLA_2013may.longest_cdna_annot.fa.gz, obtained from the May 2013 
('Mayball') release from http://daudin.icmb.utexas.edu/pub/annot/.  Transcripts were 
indexed ready for mapping using BWA-MEM (http://bio-bwa.sourceforge.net/) (Li & 
Durbin 2009).  Reads were downloaded from CGR Liverpool and mapped against 
the reference transcript sequencing by BWA-MEM using the following script: 
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bwa mem -M -t20 <referenceSeqs.fasta> <sample_read1.fastq.gz> 
<sample_read2.fastq.gz> | samtools view -Sb - \  
 > <sample_XENLAmay2013_MEM.bam> 
 
The –M flag was used to mark secondary alignments.  The transcript collection was 
of low quality in places, and so a cautious approach for counting mapped reads was 
employed.  The BAM alignment produced from was further filtered as below, and 
secondary alignments and unpaired reads filtered out. 
samtools sort <sample_XENLAmay2013_MEM.bam> 
<sample_XENLAmay2013_MEM_sorted>  
samtools view -bF256 <sample_XENLAmay2013_MEM_sorted.bam> | samtools 
view -bf2 - \  
 > <sample_XENLAmay2013_MEM_sorted_mappedPairs.bam>  
   
Counts of reads per fragment mapping to each transcript were obtained by using 
SAMtools idxstats software (http://samtools.sourceforge.net/) (Li et al. 2009).  
Reads were normalised to FPKM values using the python script FPKMcalculator.py, 
and fold-change differences between iFGFR uninduced and induced samples 
filtered and returned using the python script FPKMfoldChange.py. 
2.5.5 Further Data Processing 
Subsequent threshold adjustment and genelist compiling as well as further data 
analysis was performed by myself in Microsoft Excel.  Venn Diagrams were 
constructed using a tool on the University of Gent’s Bioinformatics Evolutionary 
Genomics website (http://bioinformatics.psb.ugent.be/webtools/Venn/).  Scatterplots 
were plotted using SPSS.  Ontological analyses were performed using 
Network2Canvas (http://www.maayanlab.net/N2C/) (Tan et al. 2013), and 
PANTHER (http://pantherdb.org/) (Mi et al. 2013). 
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2.6 CRISPR and TALEN-related protocols 
2.6.1 Design of Nek6 TALEN 
The target region of the Nek6 TALEN was in the first coding exon of the Xenopus 
tropicalis gene.  The CS2+ TALEN plasmids were made by Jared Cartwright in the 
Technology Facility.  The Left TALEN was composed of 19 bases, separated from 
the Right TALEN by a 16 base spacer region.  For immunodetection, a Flag and HA 
tag were added to the Left and Right TALENs respectively.  Plasmids were 
linearised with NotI enzyme and mRNA synthesised with SP6 as described in 
Section 2.2.7. 
2.6.1.1 Microinjection of TALENs 
1ng Left and 1ng Right TALENs were coinjected into Xenopus laevis or Xenopus 
tropicalis at the 1 cell stage. 
2.6.2 Design of CRISPRs 
2.6.2.1 Design and synthesis of template 
A target sequence to incorporate into a guide strand was designed using the online 
tool E-Crisp (Heigwer et al. 2014).  The target site was picked in a coding exon of 
the Xenopus tropicalis gene as close to the 5’ start site of the gene as possible 
satisfying the restraint of containing the sequence 5’-G-n19-nGG-3’.  Guide strand 
templates are made with replicating overlapping primers by PCR.  An 
oligonucleotide fragment that acts as a 5’ primer was designed incorporating the 
custom sequence guide stand for each CRISPR: 
TAATACGACTCACTATAGnnnnnnnnnnnnnnnnnnnGTTTTAGAGCTAGAAATAGC
AAG.  The T7 promoter is in bold and the sgRNA target in italics as in (Nakayama et 
al. 2013).  The rest of the primer is complimentary to the common 3’ primer: 
AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTT
TAACTTGCTATTTCTAGCTCTAAAAC which contains a recognition motif for Cas9.   
5’ Primers used are detailed in Table 2.6 below: 
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Table 2.6 – sgRNA 5’ primer sequences 
Gene 5' guide strand sequence 
Cited2 
TAATACGACTCACTATAGTCAGTTGAGCCCCTTGATTGTTTTAGAGCTAGAA
ATAGCAAG 
Snx10 
TAATACGACTCACTATAGTTTTCTCTTCCTCTTCCGCGTTTTAGAGCTAGAA
ATAGCAAG 
Zswim4 
TAATACGACTCACTATAGCCCTCGGTTAAAGGGAACCGTTTTAGAGCTAGA
AATAGCAAG 
 
The PCR reaction to make sgRNA template was composed of 10µl 5x High Fidelity 
buffer [New England Biolabs], 1µl 10mM dNTPs, 5µl 10µM sgRNA primer [Sigma], 
5µl 10µM common reverse primer [Sigma], 0.5µl Phusion High Fidelity polymerase 
[New England Biolabs] and 21µl H2O.  
PCR conditions were as follows: 
Initial melting 98°C 30s 
30 cycles of … 98°C 10s 
 
60°C 30s 
  72°C 15s 
Final extension 72°C 10 minutes 
 
Templates were stored at -20°C. 
2.6.2.2 Synthesis of guide strand mRNA 
Components from the T7 Megashortscript kit [Invitrogen] were composed of 1µl 10x 
Reaction buffer, 1µl 75mM ATP solution, 1µl 75mM GTP solution, 1µl 75mM GTP 
solution, 1µl 75mM UTP solution, 2µl Template, 1µl T7 enzyme and 2µl H2O per 
reaction.   Reactions were incubated for 4 hours at 37°C: 
DNase treatment and a phenol chloroform cleanup was performed as previously 
described as in Section 2.2.7.  Wild type Cas9 template was used to synthesise 
mRNA as previously described.  mRNA was stored at -80°C. 
2.6.2.3 Microinjection of CRISPR mRNA 
600pg CRISPR sgRNA was co-injected with 2.2ng of Cas9 mRNA into Xenopus 
tropicalis embryos at the 1 cell stage. 
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2.6.3 Extraction of genomic DNA from CRISPR/TALEN-injected 
embryos 
Embryos injected with a CRISPR or TALEN were grown to at least stage 30 and 
transferred individually to PCR tubes.  Lysis buffer was prepared containing 1M Tris 
pH 7.5, 5M NaCl, 0.5M EDTA, 10% SDS in dH2O and filter sterilised.  250mg/ml 
Proteinase K and 5% w/v Chelex 100 resin [BioRad] were added to lysis buffer just 
before use, and 100µl of this added to embryos.  Using a PCR machine, embryos 
were heated to 55°C for 1 hour and then 95°C for 15 minutes.  Samples were then 
centrifuged at RT at 13000 rpm for 10 minutes and stored at -20°C. 
2.6.4 PCR amplification and T-cloning of target region 
Primers were chosen to span a <600bp region of genomic DNA around the 
TALEN/CRISPR target site.  The PCR reaction mix was composed of 15µl 2x PCR 
master mix, 1µl 10µM Forwards Primer, 1µl 10µM Reverse primer 0.5µl gDNA and 
12.5µl H2O. 
The PCR fragment was run on an agarose gel, the band cut out and the DNA 
extracted using a Qiagen PCR clean up kit.  The purified product was then 
transformed into DH5α cells, and then a number of colonies per embryo picked, T-
cloned, screened and purified and as described in Section 2.2.3- 2.2.5.    
2.6.5 Sequencing of CRISPR/TALEN target region amplicons 
Purified pGEM plasmids containing amplified CRISPR/TALEN target regions were 
mixed with pGEM M13 Forwards primer (ACGACGTTGTAAAACGAC ) [Sigma] and 
sent to GATC Biotech AG.  Results were analysed using Seqman software 
[DNASTAR]. 
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3  Microarray-based analysis 
of FGF targets in whole 
embryos 
 
3.1 Introduction 
3.1.1 Inducible FGFRs (iFGFRs)  
Receptor tyrosine kinases (RTKs), which include FGFRs, rely on ligand-induced 
dimerisation of inactive receptor monomers to activate downstream signalling 
(reviewed in Pownall & Isaacs 2010).  This property of FGFRs has been exploited in 
conjunction with dimerisation agents to allow synthesis of inducible FGF receptors.  
The agents are based upon the 1:1 interaction between FKBP12 and its ligand 
FK506, also known as Tacrolimus. FK506 is a natural immunosuppressant used for 
treatment of organ transplant patients (Tanaka et al. 1987). FKBP12 molecules do 
not normally form dimers, however the fusion of two FK506 compounds provides a 
surface for dimerisation of two molecules of FKBP12 (Spencer et al. 1993).  To 
minimise the interaction of FK506 with endogenous FKBPs, a synthetic variant – 
AP20187 – was synthesised which only binds to a variant of FKBP12 with a F36V 
mutation (FKBPv) (Clackson et al. 1998; Yang et al. 2000).  FKBPv domains can be 
fused to genes of interest such as RTKs, and the addition of AP20187 used to 
induce dimerisation and activation of the protein when required.  An inducible form 
of FGFR1, iFGFR1 was first used by Welm and colleagues to stimulate mammary 
tumour progression in a murine model (Welm et al. 2002).  A schematic diagram of 
its structure is shown in Figure 3.1. 
The iFGFR1 construct consists of the kinase domain of FGFR1 (amino acids 365-
822) fused at the C-terminus to a myristoylation sequence, which targets it to the 
cell membrane.    The N-terminus of the kinase domain is fused to an FKBPv 
domain. An HA tag is fused to the other end of the FKBPv domain to enable 
immunodetection of the translated iFGFR protein.  Plasmids encoding the inactive 
iFGFR monomers can be transfected into cell culture, or mRNA injected into 
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Xenopus embryos at cleavage stages.  When required, AP20187 is added directly 
to Xenopus culture medium and diffuses through the vitelline membrane into the 
embryo.  This brings the kinase domains of the inactive monomers into close 
enough proximity to cause transphosphorylation of tyrosine residues, thus activating 
the receptor and downstream signalling.  The iFGFR does not have an extracellular 
domain.  Therefore induction of the iFGFR is not FGF ligand-dependent. 
 
Figure 3.1 Schematic diagram of iFGFRs compared to endogenous FGFRs 
A) is a schematic diagram of a wild type FGFR.  FGF ligands bind to extracellular Ig-like 
domains.  Receptor monomers are drawn into close proximity, and transphosphorylation of the 
kinase domains (red) activate downstream FGF signalling pathways.  B)  shows an iFGFR 
tethered to the cell membrane by a myristoylation domain.  AP20187 added to culture medium 
binds to the FKBPv domain, bringing the kinase domains as in A).  The HA tag tethered to the 
FKBPv domain enables immunodetection of the construct. 
 
A further advantage of this system in Xenopus is that by using fate maps of the 
early cleavage stage embryos, specific tissues can be targeted with iFGFRs (Moody 
1987).  For example, by injecting iFGFRs into the two dorsal animal blastomeres at 
the 8-cell stage, iFGFRs can be confined only to prospective neural tissues.    
iFGFR1 was first used  in Xenopus by this lab.  iFGFR1 was shown to robustly 
activate the MAPK pathway, as well as induce expression of known FGF target 
genes Cdx4 and HoxA7 in neural tissue past the stage where it would be normally 
competent to respond to FGF signalling (Pownall et al. 2003).  As well as iFGFR1, 
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iFGFRs based upon the intracellular domains of FGFR2, FGFR3 and FGFR4 – as 
well as another isoform of iFGFR1 lacking a valine and threonine in the 
transmembrane region (iFGFR1 VT-) – have also been constructed.  These were 
used for an investigative microarray experiment to assess FGF activity during 
gastrulation. 
3.1.2 A microarray experiment using iFGFRs 
Previously, other members the lab performed a single run of a microarray using 
iFGFR1, iFGFR2, iFGFR3 and iFGFR4.   The aim of this experiment was to 
investigate how constitutive FGF induction, from the onset of gastrulation to the 
beginning of neuralation, affected the global Xenopus transcriptome.   
A core aim of this project was to identify proximal FGF neural targets by RNA-seq. 
As the embryos used in this microarray screen express iFGFRs throughout the 
embryo and the induction period is long, FGF targets found are not necessarily 
proximal neural targets.  Nevertheless data from this experiment are useful 
experiment in their own right to investigate the effects upon the Xenopus 
transcriptome of global FGF induction during the post-mesodermal period of 
development.  Furthermore, findings from this data could form a foundation for 
further experiments. 
3.1.3 Aims of this chapter 
 To identify sets of genes upregulated or downregulated by each iFGFR. 
 To assess overlaps of these genelists to gain an insight into the differences in 
signalling output between different FGFRs. 
 To validate the dataset by confirming upregulation of known FGF targets found 
in the microarray.  This will also provide a means of obtaining positive controls 
for application to optimising a more complicated RNA-seq experiment. 
 
3.2 Results 
3.2.1 Experimental methodology 
The injection conditions used were as in Pownall et al., (2003). 20pg of each iFGFR 
mRNA was injected bilaterally into Xenopus laevis embryos at the 2-cell stage and 
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cultured until stage 10.  Whole embryos were then treated with 1.25µM AP20187 
between stage 10 and 13 – about 5 hours at 22°C.  A single experiment was then 
processed for microarray. Embryos injected with each receptor and treated with 
AP20187 were compared to injected, but untreated control embryos.   
3.2.2 iFGFRs1-4 affect the expression of many genes 
The microarray dataset was analysed using BRB Arraytools.  Firstly, raw log2 gene 
expression values of induced embryos injected with iFGFRs were compared to 
uninduced control embryos and the ratios displayed in the scatterplots in Figure 
3.2A.  Most genes fall along y=x (marked in yellow) as they are not affected by 
changes in FGF expression.  Those points falling to the left of the green line 
correspond to genes showing a >1.5-fold upregulation and those to the right of the 
red line correspond to genes showing a >1.5-fold downregulation following iFGFR 
activation.  The scatterplots show all four receptors activate many genes.  iFGFR1 
and 2 points lie over a wider area compared to iFGFR3 and 4, showing that iFGFR1 
and 2 have a stronger effect upon gene expression in terms of number and also 
expression fold change at this point in development.  
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Figure 3.2 Microarray data analysis 
A) shows scatterplots for each FGFR tested in the microarray.  The log2 expression value for 
each gene is plotted as a ratio between whole embryos injected with iFGFR and induced with 
AP20187 (iFGFR I) between stages 10 and 13 and untreated controls (iFGFR U).  Most points 
lie across y=x, coloured yellow.  Points to the left of the green line represent genes 
upregulated >1.5-fold by iFGFR and points to the right of the red line represent >1.5-fold 
downregulated genes.  B shows genes with expression fold changes over 1.5x sorted by 
receptor into a Venn diagram.   
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Table 3.1 Genes commonly regulated by iFGFRs as found by microarray 
Overlapping Categories 
Number of 
genes Genes 
iFGFR1 iFGFR2 iFGFR3 iFGFR4 8 cnfn capn8 fam115a xepsin Unknown MGC115642 irg1  TA-2 
iFGFR1 iFGFR2 iFGFR3 6 plscr1 MGC68910 junb otog sbk1 foxa4   
iFGFR1 iFGFR2 iFGFR4 7 cd81 wnt3a kremen2 slc3a2 LOC100127277 G protein receptor ubp1 
iFGFR1 iFGFR3 iFGFR4 2 Rexp44 mRNA Cico01 mRNA 
   
  
iFGFR1 iFGFR2 148 
lefty syt1 pitx2 tfap2a pdgfa nipal4 vill 
kcnc3 elf1 rab27a lmo2 MGC53311 gdf3 LOC398134 
fut1 MGC85058 sat1 foxi1 b3gnt1 fam3d rab25 
mst1 dnajb14 hal.1 ehd4 gata3 hoxa10 itln1 
tob1 wnt8a hoxc6 amd1 gprc5c c4orf31 LOC443682 
agr3 slc1a5 foxd4l1.1 U8 snoRNA cmahp   sulfotransferase MGC80993 
hoxc10 stard4 tmem45b tpbg eppk1 gbx2.2 t 
ido1 aldh1l1 tcf12 rax atp1b2 nuak2 gata2 
LOC496380 LOC397753 arl5b fa2h eps8l1 pfkfb3 menf.1 
xk81a1 rasl11b cldn4L2 agr2 LOC398232 pitx1 mpc2 
ventx2.2 LOC100158288 znf750 hoxa7 gdpd1 slc19a3 ccno 
MGC68521 tfap2b grhl3 hexokinase -2 pou2f1 prr5 MGC68655 
esrra hoxd3 liph MGC78986 tmem169 kit ca2 
fezf2 LOC100037100 tspan1 LOC100037144 kiaa1324l mmp14 glo1 
dynll1 LOC100158277 hesx1 hoxa3 sgsm3 sytl2 traf4b 
cdx4 MGC82269 MGC52875 ventx3.2 bcat1 dusp6 cfd 
dvl3 LOC494641 capn9 EIG121L hoxc8 MGC80142 fzd4 
loc398404 anxa9 Ras dva egr1 MGC81684 foxd5b gmpr2 
LOC443659 anxa2 six3 tmcc1 LOC100337617 crx LOC495248 
nek6 wnt11b fam3a LOC100487499 MGC131003 kitlg cdx1 
slc25a24 spry2 ca12 zfp729 LOC398437 grhl1 mtus1 
iFGFR1 iFGFR3 4 sox13 TA-2 LOC503673 gdf1 
  
  
iFGFR1 iFGFR4 
9 atp12a MGC53823 mmp3 foxn4 lgals9  Cd81 sytl1 
  tnnc2 cml des.1 
   
  
iFGFR2 iFGFR3 5 ptafr MGC82544 MGC52622 socs3 txn 
 
  
iFGFR2 iFGFR4 5 laptm4a krt16 eps8l3 rasd1   paqr5 
 
  
iFGFR3 iFGFR4 1 muc19-like             
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To assess the overlap of genes affected by each receptor and to gain an insight into 
how FGF signalling output varies between the four receptors, genes more than 1.5-
fold up or downregulated by each receptor were compiled into lists.  Full genelists 
separated into up-and downregulated genes are in Supplementary Tables 1-8.  
Affymetrix Probe IDs for each gene were entered into a Venn Diagram maker from 
the University of Gent.  The resultant Venn Diagram is shown in Figure 3.2B, and 
genes in overlapping regions displayed in Table 3.1.  A breakdown of all 
overlapping and non-overlapping genes can be found in Supplementary Table 9.  
Only 8 genes are affected by all four receptors.  Two of these, irg and TA-2 can be 
disregarded as they are likely to be stress-response genes; they are found 
upregulated by dnFGFR1/4a in Branney et al., (2009).    iFGFR1 and iFGFR2 share 
a relatively high number (148) genes in common compared to iFGFR3 and iFGFR4, 
which only share 1 gene in common.  Furthermore, there are only 9 genes that are 
common between iFGFR1 and iFGFR4.  These include the forkhead box 
transcription factor FoxN4, and cd81 which encodes a tetraspanin integral 
membrane protein (Maecker et al. 1997).  These are repressed by both receptors. 
Tnnc2 which encodes troponin C (skeletal muscle) is differentially regulated by 
iFGFR1 and iFGFR4 (Takayama et al. 2008; Vassylyev et al. 1998).  Overall 
however, these data show that iFGFRs have very different signalling outputs and 
can therefore provide an insight into how different FGFRs individually regulate 
development. 
3.2.2.1 Genelists 
Supplementary Tables 1-8 show the genes affected by each receptor, ranked by 
expression fold change.  Using BRB Arraytool’s confidence filtering thresholds and 
a requirement for genes to show a gene expression change of at least 1.5x, 151 
genes were upregulated and 293 genes downregulated by iFGFR1, 160 genes 
upregulated and 161 genes downregulated by iFGFR2, 39 genes upregulated and 
20 downregulated by iFGFR3 and 36 genes upregulated and 33 downregulated by 
iFGFR4.  
Many genes listed in the genelists are already known to be FGF targets.  Firstly, 
members of the MAPK pathway are found in the upregulated genelists as expected, 
as induced iFGFR1 and iFGFR2 upregulate the MAPK modulators Dusp6 and 
Sprouty2 (reviewed in Pownall & Isaacs 2010) (Table 3.2) .  Ras GTPase is a 
critical link between RTKs such as FGFRs and the rest of the MAPK pathway 
(McKay & Morrison 2007).  All four receptors upregulate Ras-related genes. 
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Rasl11b, which is not currently known as an FGF target but is involved in TGFβ 
signalling, is upregulated by iFGFR1 and iFGFR2 induction as is RasD1, member of 
the Ras superfamily involved in MAPK signalling  (Pézeron et al. 2008; Liu et al. 
2014).  iFGFR3 upregulated Ras and Rassf6, an oncogene which binds activated 
Ras (Allen et al. 2007). Lastly, iFGFR4 upregulated RasD1.   
FGFs induce the expression of Cdx genes which in turn activate posteriorly 
expressed 5' Hox to pattern the posterior neural tube.  Indeed, iFGFR1 and 2 both 
upregulated Cdx1 and 4, and combined upregulated HoxA3, A7, A10, B7, C10 and 
D3 more than 1.5-fold.  Other neural genes affected included the rostrally-
expressed transcription factors Dlx2 and 3 as well as forkhead transcription factor 
FoxD5 known to regulate neural ectodermal fate and neural differentiation (Luo et 
al. 2007; Yan et al. 2009).   
Members of other signalling pathways were also affected by induced iFGFRs, 
particularly the Wnt signalling pathway which is known to cooperate with FGF to 
pattern posterior tissue (reviewed in Garnett et al. 2012).  Genes found known to be 
affected by alternative signalling pathways are shown in Table 3.2.  Wnt3a, 8a, 5b, 
11b were upregulated by iFGFR1 activation and negative Wnt regulators Kremen 
and Prickle1 upregulated by iFGFR2 activation.  iFGFR4 did not activate as many 
Wnt signalling components compared to iFGFR1 and iFGFR2, but did upregulate 
Wnt3a and Kremen.  iFGFR1 and iFGFR2 also downregulated the expression of 
Frizzled receptor Fzd4 and Wnt effector Dvl3.  iFGFR1 downregulated the 
expression of Ctnnb1, also known as β-catenin.  Other Wnt signalling genes 
affected were Cdh1 and Cdh2, Sfrp2 and Pcdh10, all downregulated by iFGFR1,  
Only iFGFR3 did not affect the Wnt pathway.  The Sonic hedgehog (Shh) pathway 
was also represented as iFGFR2 upregulated Shh itself, as well as Btrc, and 
downregulated Smo.  iFGFR1 upregulated the Shh receptor Ptch2.  The cellular RA 
pathway binding protein Crabp2 was upregulated by iFGFR1, but RA receptors 
RXR and retinoic acid receptor responder1 (Rarres1) were downregulated by 
iFGFR2.  TGFβ-related genes included Junb, which with iFGFR1 and iFGFR2, was 
the only gene in this list upregulated by iFGFR3.  iFGFR3 downregulated the TGFβ-
related factor Gdf1.    
Table 3.2 Components of other signalling pathways regulated by iFGFRs 
Pathway Gene Summary/Reference iFGFR 
FGF RASL11B Small GTPase iFGFR1, iFGFR2 
SPRY2 MAPK antagonist iFGFR1, iFGFR2 
DUSP6 MAPK phosphatase iFGFR1, iFGFR2 
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RASD1 Small GTPase iFGFR2, iFGFR4 
RAS-DVA Small GTPase iFGFR1, iFGFR2 
RASSF10 Small GTPase iFGFR1 
RAS MAPK small GTPase iFGFR3 
RASFF6 Small GTPase iFGFR3 
WNT WNT3A Wnt ligand iFGFR1, iFGFR2, iFGFR4 
  KREMEN2 Wnt antagonist receptor iFGFR1, iFGFR2, iFGFR4 
 
WNT11B Wnt ligand iFGFR1, iFGFR2 
  WNT8A Wnt ligand iFGFR1, iFGFR2 
  
XBRA 
Transcription factor (Vonica & 
Gumbiner 2002) iFGFR1, iFGFR2 
  DVL3 Wnt signal transduction iFGFR1, iFGFR2 
  FZD4 Wnt receptor iFGFR1, iFGFR2 
  WNT5A Wnt ligand iFGFR1 
  WNT5B Wnt ligand iFGFR1 
  
CDH1 
Cadherin, negative Wnt regulator 
(Colli et al. 2013) iFGFR1 
  
CDH2 
Cadherin, negative Wnt regulator 
(Revollo et al. 2015) iFGFR1 
  
SFRP2 
Frz-related protein (Ladher et al. 
2000) iFGFR1 
  PCDH10 Protocadherin (Zhao et al. 2014) iFGFR1 
  CTNNB1 Wnt signal transduction iFGFR1 
  PRICKLE1 Wnt antagonist receptor iFGFR1 
  WNT3 Wnt ligand iFGFR2 
  
BTRC 
Ubiqutin protein ligase (Su et al. 
2008) iFGFR2 
  FZD7 Wnt receptor iFGFR2 
TGFβ 
JUNB 
Transcriptional activator 
(Busnadiego et al. 2013) iFGFR1, iFGFR2, iFGFR3 
  LEFTY Nodal effector iFGFR1, iFGFR2 
  GDF3 TGFβ-related growth factor iFGFR1, iFGFR2 
  RASL11b GTPase iFGFR1, iFGFR2 
  GDF1 TGFβ-related growth factor iFGFR1, iFGFR3 
  BMP7.2 BMP ligand iFGFR1 
  
JUND 
Transcriptional activator (Lee et 
al. 2012) iFGFR2 
Sonic 
Hedgehog PTCH2 Shh receptor iFGFR1 
  
BTRC 
Ubiqutin protein ligase (Su et al. 
2008) iFGFR2 
  SHH Shh ligand iFGFR2 
  SMO Shh signal transduction iFGFR2 
RA 
GPRC5C 
G protein receptor (Robbins et al. 
2000) iFGFR1, iFGFR2 
  CRABP2 RA-binding protein iFGFR1 
  RXRB RA receptor iFGFR2 
  RARRES1 RA receptor responder iFGFR2 
Colours refer to Upregulated by iFGFR and Downregulated by iFGFR.  Gene functions were 
found using Xenbase – if the pathway-related function was not listed under gene function, 
literature searches were conducted and references are shown. 
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Therefore, all four of the iFGFRs affect the expression of genes active in the other 
major signal transduction pathways during this period of development.  Of the genes 
listed in Table 3.2, iFGFR1 and iFGFR2 affect the majority, either on their own or in 
combination with each other.  iFGFR3 and iFGFR4 may have roles in regulation of 
the TGFβ and Wnt signalling pathways respectively, and iFGFR2 affected the most 
genes in the Shh and RA pathways. 
Groups of genes involved in certain developmental processes were also 
represented in the genelists.  Among downregulated genes were those involved 
with eye development.  The eye markers and transcription factors Rax and Pax6 
was downregulated by iFGFR1 and 2.  Genes involved in Left/Right development 
were also represented.  Nodal interactants Lefty and Pitx1 and 2, essential for 
breaking left/right symmetry are upregulated and downregulated by both iFGFR1 
and 2 respectively.  Other genes involved in Nodal/TGFβ signalling are FoxI1 and 
Menf.1 downregulated by iFGFR1 and iFGFR2 (Kumano & Smith 2002; Zhang & 
Klymkowsky 2007).  Traf4, a zinc finger protein with signalling transduction through 
both Nodal and BMP pathways, was positively regulated by iFGFR2 (Kalkan et al. 
2009) .  In keeping with FGF's role in inhibiting BMP signalling in the neuroectoderm 
which would otherwise specify epidermis, epidermal genes such as the transcription 
factor Grhl1, 2 and 3 expressed in non-neural ectoderm, and ANB and epidermal 
marker keratin, are downregulated by iFGFR1 and iFGFR2 and interestingly, 
upregulated by iFGFR4. 
Interesting novel putative FGF targets genes include Dynein light chain 1 Dynll1 and 
Never in mitosis kinase Nek6 upregulated by both iFGFR1 and iFGFR2.  Nek6, as 
part of a complex with Nek7 and Nek9 has been shown be activated through 
binding of Dynll1 (Regué et al. 2011).  One of the largest changes to gene 
expression by iFGFR1 and iFGFR2 was that of Tspan1, an integral membrane 
protein.  A link between Tspan1 and FGF signalling has not been yet made, but 
Tspan1 has been shown to be negatively regulated by BMP signalling and required 
for primary neurogenesis (Yamamoto et al. 2007). 
These data show that in addition to FGF being involved in neural induction and 
patterning, it also influences the activity of other signalling pathways and 
developmental processes.   
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3.2.3 iFGFRs reproducibly upregulate known FGF targets in 
whole embryos and in a neural context 
Some genes in the dataset were picked to be investigated further by RT-qPCR.  
This was done partially to validate the microarray dataset.  Another reason was to 
ascertain if iFGFRs could reproducibly affect gene expression as only one repeat of 
the microarray experiment was performed. An aim was to ascertain whether the 
experimental conditions could be refined to target iFGFRs to the CNS to affect gene 
expression.  Finally, they would provide a number of positive controls for the RNA-
seq experiment.  Egr1, Sprouty2 and Leftyb were chosen to validate the microarray 
dataset as they have known connections to FGF signalling.     
Early growth response 1 (Egr1) is a zinc finger transcription factor previously shown 
in an enriched cDNA library screen to be a target of the FGF target Xbra as well 
being a direct FGF target in gastrula-staged embryos (Saka et al. 2000; Branney et 
al. 2009).  It was upregulated 3.81-fold by iFGFR1.  Sprouty2  is a well known 
negative regulator of the MAPK pathway and was upregulated 1.91-fold by iFGFR1 
(Hanafusa et al. 2002; Sivak et al. 2005).  The Left/Right determination factor 
Leftyb, upregulated 2.41-fold by iFGFR1, is part of the Nodal signalling cascade 
which is responsible for breaking left/right symmetry in the early embryo.  The 
murine Lefty1 and 2 genes seem to correspond to Leftyb and a in Xenopus laevis 
after comparing sequences, and these give a virtually identical protein product (data 
not shown). There is a single Lefty gene in Xenopus tropicalis.  Therefore Leftyb will 
be hereafter referred to as Lefty.   
3.2.3.1 RT-qPCR confirms Egr1 and Sprouty2 are positively regulated by iFGFR1 
in whole embryos 
Using the same experimental conditions as those used in the microarray-based 
analysis, RT-qPCR was performed to confirm the upregulation of Egr1 and 
Sprouty2.  In addition to inducing embryos injected with 20pg iFGFR1 from stage 
10.5 to 13, some embryos were also induced until stages 15 and 17 to investigate 
whether the effects on downstream gene expression caused by iFGFR1 change 
over time.  To provide a complementary experiment, embryos injected with 1ng 
dnFGFR1 were also collected and subjected to RT-qPCR at the same time points.  
This dosage of dnFGFR1 caused similar gastrulation defects and anteriorisation of 
Xenopus laevis embryos as those described in Amaya et al. (1991) and a decrease 
in dpERK levels by western blot analysis (data not shown).  RT-qPCR results are 
shown in Figure 3.3.  Expression levels for all RT-qPCR results were normalised to 
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the housekeeping gene ornithine decarboxylase (ODC).  For iFGFR experiments 
fold-expression changes are displayed relative to uninduced controls and for 
dnFGFR1-injected embryos, uninjected controls. 
Figure 3.3A shows that at all time points tested, induced iFGFR1 caused 
upregulation of both Egr1 and Sprouty2, however this ceased to be significant for 
the longest induction period, from stage 10.5 to 17.  The mean fold expression 
changes for the stage 10.5 to 13-induced embryos were 3-fold for Sprouty2 and 
3.61-fold for Egr1. This is slightly higher than the values found in the microarray.   A 
corresponding significant reduction in levels of Sprouty2 and Egr1 was seen in 
dnFGFR1-expressing embryos.  This was significant at all stages, suggesting that 
dnFGFR1’s effects on FGF targets are longer lasting than those of iFGFR1.   There 
was no appreciable difference in gene levels between uninjected and uninduced 
iFGFR1-injected embryos.   
3.2.3.2 Egr1, Sprouty2 and Lefty are upregulated by iFGFR1 in neuralised 
ectodermal explants 
As these results confirmed those found in the microarray, RT-qPCR was conducted 
upon neuralised animal cap explants injected with iFGFR1 to see whether iFGFR1 
could influence the expression of Egr1, Sprouty2 and Lefty in a neural context.  
Embryos were co-injected with 20pg iFGFR1 and 50pg Noggin mRNA at the 2-cell 
stage and explants dissected at late blastula stage 8.  An induction time period of 3 
hours at 22°C from stage 10.5 was chosen, as Xenopus Refseq and RNase 
protection analysis data suggest this is the time period taken for targets of FGF 
signalling such as MyoD and HoxA7 to be activated after immediate early targets of 
FGF such as Xbra and Cdx4 (Keenan et al. 2006; Tan et al. 2013).  Expression of 
Noggin mRNA only or iFGFR1+Noggin alone did not affect the expression of the 
three genes.  Co-injected induced explants showed significant upregulation of Lefty, 
Sprouty and Egr1.  To see if these responses were the same when iFGFR1 was 
induced at a later stage, the experiment was repeated but explants treated with 
AP20187 at stage 12 – late gastrula.  This resulted in an even greater upregulation 
of all three genes relative to uninduced explants (Figure 3.3B,ii).  Therefore, as well 
as replicating the findings in the microarray, iFGFR1 upregulates Egr1, Sprouty2 
and Lefty in a neuralised explants, suggesting these genes are also neural FGF 
targets.  The difference in expression changes between early and later periods of 
iFGFR1 induction for Lefty, Sprouty2 and Egr1 suggests the response of genes to 
iFGFRs may change over time. 
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Figure 3.3 RT-qPCR for Lefty, Sprouty2 and Egr1 
A)Shows RT-qPCR results for the genes Sprouty2 (i and ii) and Egr1 (iii and iv). i) and iii) 
show embryos injected with 20pg iFGFR1 and treated with AP20187 between stages 10.5 and 
13, 15 or 17.  ii) and iv) are from embryos injected with 1ng dnFGFR1 and collected at stage 
13, 15 or 17.  Error bars represent SE from three biological replicates.  Asterisks represent 
statistical significance of normalised Ct values below p=0.05.    Ct values were normalised 
against those of the housekeeping gene ODC and fold expression changes normalised 
against uninduced iFGFR1-injected embryos, which have a fold change of 1. 
B)Shows RT-qPCR results for genes Sprouty2, Egr1 and Lefty in neuralised animal cap 
explants.  Explants were injected with 50pg Noggin and 20pg iFGFR1 and treated with 
AP20187 from i) stage 10.5 for three hours or ii) stage 12 for 3 hours.  i) Error bars represent 
SE from three biological replicates. Asterisks represent statistical significance of normalised Ct 
values below p=0.05.  ii) Shows mean expression fold change from technical replicates.  Ct 
values were normalised against those of the housekeeping gene ODC and fold expression 
changes normalised against co-injected uninduced explants which have a fold change of 1. 
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3.2.3.3 iFGFR1 expands the expression domains of Cdx4 and HoxA7 
The known FGF targets Cdx4 and HoxA7 were also found in the microarray to be 
positively regulated by iFGFR1.  10pg iFGFR1 was injected bilaterally into Xenopus 
laevis embryos into the two dorsal animal blastomeres at the 8-cell stage.  Embryos 
were cultured until stage 10.5 and treated with AP20187 for 3 hours at 22°C. They 
were processed for ISH using antisense DiG-tagged probes against Cdx4 and 
HoxA7.  Cdx4 is expressed in a ring around the closing blastopore, strongest 
ventrally.  Figure 3.4 shows that iFGFR1 induction in prospective neural tissue 
expands the Cdx4 domain both dorsally above the closing blastopore (Figure 3.4 B, 
compare with A, arrowed), and anteriorly (Figure 3.4B', compared to A, line).  
HoxA7 expression is present as a crescent ventrally underneath the closing 
blastopore and is extended dorsally in some iFGFR1 induced embryos as shown by 
the dotted lines in (Figure 3.4D compared to C).   
 
Figure 3.4.  iFGFR1 targeted to prospective neural tissue expands the expression domains 
of Cdx4 and HoxA7. 
Embryos were injected bilaterally with 10pg iGFR1 into two dorsal animal blastomeres at the 
8-cell stage and processed for ISH.  B shows an expansion of the Cdx4 (N=9) expression 
domain dorsally as shown by the arrow to compare to the control in A.  A’ and B’ are side 
views of A and B. The anterior expansion of the Cdx4 expression domain is shown by a black 
line.  D shows the HoxA7 (N=9) expression domain expanded dorsally relative to C, the 
control.  Percentages show embryos resembling the representative image. 
Therefore, as well as predictably affecting expression levels of known iFGFR1-
upreglated genes found in microarray by RT-qPCR, the expression domains of 
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other FGF target genes Cdx4 and HoxA7 were expanded when iFGFR1 was 
induced in the prospective CNS. 
3.3 Discussion 
3.3.1 A microarray screen shows iFGFRs profoundly affect the 
Xenopus transcriptome 
A dataset from a preliminary microarray performed by previous lab members was 
analysed which investigated transcriptomic changes that occurred as a result of 
iFGFR1, iFGFR2, iFGFR3 or iFGFR4 induction in whole embryos throughout 
gastrulation.    iFGFR1 and 2 affected the levels of many genes ≥1.5-fold, whereas 
iFGFR3 and iFGFR4 generally affected fewer genes to a lesser extent.  iFGFR1 
and iFGFR2 signalling outputs were the most similar to each other, suggesting that 
at during this point in development the output of these receptors is fairly similar 
relative to the other receptors.  However, 220 genes were still unique to the iFGFR1 
genelist and 96 genes unique to the iFGFR2 genelist suggesting that these 
receptors must nevertheless have unique roles in development.  iFGFR3 and 4 
commonly regulate comparatively very few genes with the other receptors and each 
other.  This suggests that at this point in development, FGFRs1-4 indeed have 
different signalling outputs, and so iFGFRs are therefore a useful tool for assessing 
differences in FGFR signalling outputs.  This finding was not found in Branney et al, 
(2009) who used dnFGFR1 and dnFGFR4a to investigate the FGF-dependent 
transcriptome during blastula stages – in this paper the two receptors had an almost 
identical expression profile.  The authors postulated that this may be due to 
promiscuous heterodimerisation of dnFGFR causing non-specific receptor effects 
upon gene expression (Ueno et al. 1992; Branney et al. 2009).  Therefore, to study 
individual FGFR signalling outputs, iFGFRs are a better tool to use than dnFGFRs. 
It would be interesting to use iFGFRs at earlier stages to see how they compared 
and contrasted with those of Branney et al. (2009).   
3.3.2 There is crosstalk between FGF signalling and other 
pathways  
Many genes in the genelists have known links to FGF signalling, or are members of 
pathways that interact with FGFs.  MAPK effectors such as DUSPs and Ras family 
members were well represented in the data, as were Cdx and Hox genes which are 
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well documented targets of FGF signalling in patterning the posterior neural tube 
(reviewed in Montavon & Soshnikova 2014).   
3.3.2.1 Wnt and RA signalling 
 A significant number (19) of Wnt signalling pathway components, including Wnt 
ligands and receptors, were found in iFGFR1,2 and iFGFR4 genelists.  FGF and 
Wnt signalling pathways are known to cooperate closely during neural development 
in the patterning of the posterior neural tube, in part by regulating Cdx gene 
expression (Keenan et al. 2006; Shimizu et al. 2006).  Furthermore, Wnt signalling 
has been reported to be active in the transition zone between opposing FGF and 
RA gradients during posterior neural patterning and neuron differentiation.  In the 
chick, FGF signalling promotes Wnt8c expression which is maintained even as cells 
leave the posterior influence of FGF signalling.  Wnt8c was then found to act similar 
to FGFs by inhibiting neuronal differentiation, although unlike FGF signalling this 
does not seem to be through repression of retinoid signalling (Olivera-Martinez & 
Storey 2007).  Crabp2, which encodes a retinoic acid binding protein, found here 
upregulated by iFGFR1 was previously found to be a target of Wnt signalling as well 
as RA, and so was hypothesised to work at the interface of RA and Wnt signalling 
during antero-posterior embryonic patterning in Xenopus (Janssens et al. 2010).  
Crabp2 could therefore be an important point of regulation during development and 
patterning of the posterior CNS where RA, Wnt and FGF signals meet. The RA 
receptor RxrB and Rarres, a RA receptor responder were both downregulated by 
iFGFR2, indicating a possible role of FGFR2 in negative regulation of the retinoid 
signalling. 
3.3.2.2 Sonic Hedgehog signalling 
Shh was upregulated by iFGFR2, as was its receptor Ptch2 by iFGFR1.  Its 
negative regulator Smo was downregulated by iFGFR2.  Shh signalling  is required 
for forebrain development as Shh activates FoxG1 expression (Hébert & Fishell 
2008).  FGF signalling encourages this event as it negatively regulates Gli3, the 
negative regulator of the Shh pathway (Rash & Grove 2007).  Shh is also required 
for dorso-ventral patterning in the neural tube, where FGF signalling acts to 
maintain cells in an immature state by repressing neuronal differentiation in general, 
as well as Shh-activated class 1 and 2 proteins oppose dorso-ventral patterning 
(Diez del Corral et al. 2002; Diez del Corral et al. 2003; Briscoe & Novitch 2008).  
Therefore there is a precedent for crosstalk between FGF and hedgehog signalling 
during neural development. 
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3.3.2.3 Nodal Left/Right asymmetry cascade  
There are also many genes represented that are involved in processes other than 
neural induction and patterning, such as those involved in left/right asymmetry.  
Lefty, Pitx1 and Pitx2 are all members of the Nodal signalling cascade, which 
breaks left/right symmetry early in development. 
The breaking of left/right asymmetry in early embryonic development is an essential 
event for correct organ placement. Aberrations in this process can cause bilateral 
symmetry, isomerism – duplicated left/right sided identity – random organ 
placement (heterotaxia) or situs inversus totalis, where the whole L/R axis is 
inverted (Ramsdell & Yost 1998).  Polarised cilia are required to provide a left-wards 
flow across the posterior-most roof of the archenteron –the gastrocoel roof plate 
(GRP) – in Xenopus, Kuppfer’s vesicle (KV) in zebrafish, and the node in mammals 
to break left/right symmetry (Schweickert et al. 2007; Nonaka et al. 1998).  It is 
thought that this flow either carries vesicles containing morphogens to the left-hand 
side of the embryo or sensory cilia also in the node/GRP sense fluid movement and 
convert this into an asymmetric calcium signal (Okada et al. 2005; McGrath et al. 
2003; Nonaka et al. 1998). Leftwards flow connects to changes in gene expression 
by causing the Nodal inhibitor Coco to be downregulated in the left lateral plate 
mesoderm only, which lifts repression of the TGFβ family member Nodal signalling 
asymmetrically (Schweickert et al. 2010). Nodal activates a cascade of gene 
expression in part by activating another TGFβ-related gene Lefty, which restricts 
Nodal protein to the left lateral plate mesoderm where the Nodal effector Pitx1 is 
also expressed (Ramsdell & Yost 1998).  Manipulation of Lefty, Pitx1/2 or Nodal 
cause laterality defects in Xenopus, such as left cardiac isomerism, reversed gut 
looping and heterotaxia (Schweickert et al. 2012).   
FGF signalling is linked to both cilia development and regulation of the nodal 
cascade (Basu & Brueckner 2009).  Zebrafish FGF8 mutants (also known as ace 
mutants) have been reported to have fewer or shorter cilia in the GRP relative to 
wild-type embryos, impairing leftward flow which consequently caused defects in gut 
looping (Hong & Dawid 2009; Neugebauer et al. 2009).  Other studies in the fish 
showed 30% of ace mutants lacked the KV.  As a result embryos developed 
laterality defects, particularly in the heart.  The brains of these fish were also found 
to contain laterality defects, as Pitx2c expression which is normally on the left-hand 
side of the diencephalon only, was either absent or expressed bilaterally in the 
majority of ace embryos  (Albertson & Yelick 2005).  FGF8-mutant mouse embryos 
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have laterality defects such as random or absent heart looping and right pulmonary 
isomerism/situs inversus of lungs, reminiscent of Lefty-deficient embryos. In these 
embryos Lefty2 expression was also not detected suggesting Lefty expression 
requires FGF signalling (Meyers & Martin 1999).  In the chick, application of a 
Lefty2-soaked bead to the right hand side of the node caused a loss of FGF8 
expression, suggesting Lefty2 represses FGF signalling (Rodríguez Esteban et al. 
1999). A direct link between FGF8 and Lefty downstream has not to my knowledge 
been established, however in the zebrafish, morpholinos against the FGF targets 
Ier2 and Fibp1 in the zebrafish had randomized expression of Lefty (Hong & Dawid 
2009).   
Lefty, Pitx1 and Pitx2 were found by this microarray to be upregulated by iFGFR1 
and/or iFGFR2, suggesting that FGF signalling regulates left/right asymmetry 
through mediation of several genes in the Nodal cascade.  Other genes also 
implicated in Nodal/TGFβ signalling found in the microarray-based screen include 
Foxi1 and Menf.1, downregulated by iFGFR1 and iFGFR2.  Although a connection 
between FoxI1 with FGF has been reported, as FoxI1 morphants prevented FGF-
mediated mesoderm induction, no link to laterality defects have as yet been 
reported (Suri et al. 2005).  Menf.1 has previously been shown to be activated by 
Nodal signalling and negatively regulated by FGF activity in induction of ventral 
mesoderm, however again, no link to left/right asymmetry or laterality defects have 
been reported (Kumano & Smith 2002). 
3.3.3 iFGFRs affect downstream gene expression – validation of 
a preliminary microarray dataset 
Some known FGF targets were picked from the microarray in order to see if iFGFRs 
could reproducibly achieve the same level of effect by RT-qPCR and ISH and also 
to validate the microarray.  Conditions of the microarray were replicated to 
investigate Egr1 and Sprouty2 by RT-qPCR, and also over a longer iFGFR1 
induction period. 
3.3.3.1 RT-qPCR shows that Egr1, Sprouty2 and Lefty are FGF targets in whole 
embryos and in neuralised explants 
Early growth response 1 (Egr1) is a zinc finger transcription factor previously shown 
in an enriched cDNA library screen to be a target of the FGF target Xbra, imperative 
for mesoderm induction and maintenance (Saka et al. 2000). Furthermore, it was 
found in a microarray screen by Branney et al, (2009) to be positively regulated by 
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FGF in gastrula stage Xenopus embryos (Branney et al. 2009). ISH in Xenopus 
embryos showed Egr1 to be expressed in the mesoderm (Saka et al. 2000). 
However, outside of early developmental biology, Egr1 has been implicated in 
neural plasticity and memory through its regulation of neuronal apoptosis (Pignatelli 
et al. 2003). Therefore there is a precedent for it having a role in neural as well as 
mesodermal development.   
Sprouty2 is a MAPK antagonist and required for correct morphogenesis during 
Xenopus gastrulation (Sivak et al. 2005). However there is also evidence to suggest 
that it is has a role in neural development.  In the chick, Sprouty2 transcripts are 
detected in the midbrain and hindbrain regions, as well as specifically in the isthmus 
and rhombomere 1(Chambers & Mason 2000). In the IsO Sprouty2 expression 
overlaps with, and is induced by, FGF8.  Expression of a dominant-negative form of 
Sprouty2 in the chick resulted in an expansion of the FGF8 expression domain and 
an anterior shift in the posterior border of the tectum (Suzuki-Hirano et al. 2005).  
Independent of FGF8, Sprouty2 inhibits neuronal differentiation and survival in a 
negative feedback loop with another growth factor BDNF in primary cultures of 
immature neurons (Gross et al. 2007).  Also, viral vector-mediated disruption of 
endogenous Sprouty2 using dnSpry2 in the dorsal hippocampus of adult rats 
stimulated neurogenesis. These rats also showed behavioural differences to control 
littermates as they were more resilient to stress, whereas those overexpressing wild 
type Spouty2 displayed more anxiety when startled by white noise (Dow et al. 
2015).  It may therefore useful to confirm Egr1 and Sprouty2 as being neural FGF 
targets to give an insight into how aberrances in cell signalling in these pathologies 
originate.  
RT-qPCR results reproduced those found by microarray for Sprouty2 and Egr1. 
These genes were conversely affected by dnFGFR1 and this repression was 
significant for all time periods tested. The iFGFR1 upregulation response was not 
significant over the longest induction period from stage 10.5 to late neurula stage 
17.  Perhaps other FGFRs signalling normally can compensate for constitutively-
active iFGFR1 signalling, whereas the blanket FGFR repression by dnFGFR1 
prevents this.  A greater insight into this result could be provided by using other 
dnFGFRs such as dnFGFR4a, as well as more induction lengths for iFGFR1 to see 
if there is a cut-off point for the influence of iFGFRs on Egr1 and Sprouty2, as well 
as other genes’ expression levels. 
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Lefty, upregulated by iFGFR1 and 2 in the microarray screen was chosen in 
conjunction with Egr1 and Sprouty2 to investigate iFGFR1 upregulation in 
neuralised animal cap explants.  In neuralised animal cap explants, Lefty, Egr1 and 
Sprouty2 were robustly upregulated to a much greater extent relative to whole 
embryos by iFGFR1 in neuralised animal cap explants.  When induced from stage 
12 for 3 hours, the extent of the upregulation was even more pronounced.  It would 
therefore be interesting to investigate and compare the transcriptome when FGF 
signalling is activated during a later period of neural specification.  These results 
suggest that not only are the microarray results reproducible, but those that appear 
to be neural FGF targets based upon present literature are strongly affected in the 
context of neuralised animal cap explants.  This is encouraging as a foundation for 
investigating the whole Xenopus transcriptome in a neural context. 
3.3.3.2 iFGFRs cause ectopic expression of FGF targets HoxA7 and Cdx4  
Some of the microarray results were also validated through ISH with known FGF 
targets HoxA7 and Cdx4.  FGF induction expanded the expression domains of all 
three of these genes.  iFGFR1 expressed throughout the Xenopus embryo has 
already been shown to expand the expression domains of Cdx4 and HoxA7 by ISH 
in whole embryos in Pownall et al. (2003).  Figure 3.4 shows that when injections of 
iFGFR1 were targeted to prospective neural tissue, an expansion of Cdx4 and 
HoxA7 is still seen, albeit to a lesser extent than the whole-embryo induction shown 
in Pownall et al., (2003).  Thus, iFGFRs can be used to investigate gene expression 
in a neural context through targeting iFGFRs to the CNS as well as by using 
neuralised animal cap explants.   
3.3.4 Caveats to the microarray data 
Although the experimental conditions for this microarray certainly produced 
profound effects on downstream gene expression, the methodology was not 
optimised beforehand for iFGFR2-4, and based upon conditions used for iFGFR1 in 
Pownall et al. (2003).  It was also not reported in Pownall et al., (2003) whether the 
optimal drug concentration was used to maximise MAPK activation.  It was also not 
reported if iFGFR induction of the MAPK pathway remained constant during neural 
induction stages to ensure continual activation of FGF signalling.    Furthermore, it 
was unknown how quickly AP20187 was able to diffuse into the embryo to produce 
a detectable increase in dpERK levels.  This is not so important in this experimental 
context where iFGFRs were activated over a long period of time, but it would be 
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beneficial to know if activating the iFGFRs for a short window of time from a defined 
stage – for example, if it took one hour for MAPK signalling to increase from drug 
application, the drug may have to be added pre-emptively to ensure uniform 
iFGFR1 dimerisation over the whole induction period.    
Only one biological repeat of the experiment was undertaken.  Ideally at least three 
biological replicates would have been performed in order to perform statistical 
analyses.  This is not imperative for the initial aims of the analyses performed here; 
to provide an initial insight into iFGFR effects upon the transcriptome and to provide 
positive controls for further experiments to study FGF signalling in the CNS.  
However, these data were interesting in their own right, as putative novel FGF 
targets such as Tspan1 and Hmx3 were revealed and so to take these findings 
forward and to complement the RNA seq data, additional biological repeats would 
be advantageous.  They may eliminate false positives in the data – especially for 
those genes falling on the expression-change thresholds of ≥1.5 fold-expression 
change such as FoxN4 which did not meet significance for fold change by RT-qPCR 
and may be more likely to be false-positives and upregulated/downregulated by 
chance (discussed in Chapter 6). 
3.3.5 Future work 
3.3.5.1 Areas of interest in the microarray dataset to investigate further 
Compared to iFGFR1 and iFGFR2, iFGFR3 did not affect the expression of as 
many genes in the microarray experiment. Although iFGFR3 affected the 
expression of Junb and Gdf1, effectors of TGFβ signalling, Xenbase searches of 
most of the genes in the iFGFR3 genelists did not find many that were linked to FGF 
signalling or neural development.  Searching the genelist for GO terms on 
PANTHER revealed the majority of genes were linked to metabolic processes (data 
not shown) FGFR3 may function in other cellular processes during neural 
specification or may be important for later aspects of neural development, as in 
tailbud embryos it is present in the brain (Lea et al. 2009).  However, it will not be 
investigated further in this project.  More detailed analyses of FGFR3's targets at 
this, and other points in development, and how its effects differ from other receptors 
would be interesting in its own right to investigate at a later date.    
iFGFR1 (VT-) was not included in the microarray-based screen, but iFGFR1 VT- 
was synthesised along with the other receptors.  A comparison between iFGFR1 
VT+ and VT- would be interesting to see how signalling differed, if at all, between 
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these iFGFR1 subtypes, or whether genes are differentially regulated by these two 
receptors. 
3.3.5.2 Investigation of iFGFR signalling in Xenopus neural development 
For this microarray-based screen, iFGFRs were expressed throughout the embryo 
and the iFGFR induction length was long enough for secondary or even tertiary 
targets of FGF signalling to be activated. In order to investigate proximal FGF neural 
targets, iFGFRs would have to be targeted to the CNS, neuralised explants used or 
the CNS isolated from the rest of the embryo.  The former two options have been 
shown in this work to be viable approaches to affect downstream neural FGF 
targets. 
3.3.6 Summary 
This chapter has shown through the analysis of a microarray dataset that 
constitutive activation of the FGF signalling pathway using iFGFRs has a strong 
effect upon the Xenopus transcriptome.  The low overlap between genes affected 
by each iFGFR suggests that each FGFR has a unique role in Xenopus 
development.  Validation of known FGF targets showed that iFGFR1 reproducibly 
affects gene expression both in whole embryos and in a neural context.   
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4  Optimisation of iFGFR 
injection and induction 
 
4.1 Introduction 
4.1.1 Investigating FGF function using Overexpression of Mutant 
FGF receptors 
Reverse genetics are commonly used in biology to investigate the function of a 
gene or signalling pathway, by inhibition or overexpression of the gene of interest, 
and observation of the changes in development that result at the physiological and 
molecular levels.  In Xenopus, mRNA coding for the gene of interest or mutant 
constructs can be microinjected into embryos at cleavage stages to study effects of 
overexpression, or inhibition of genes.   
4.1.1.1 Dominant negative FGFRs (dnFGFRs) 
There are many components to FGF signalling pathways downstream from the 4 
main receptor types, and so repression of any one ligand, receptor, or receptor-
interacting protein is unlikely to result in effective signalling inhibition.  However 
mutant versions of the receptors which act as constitutively active or dominant-
negative receptors have been used successfully in Xenopus to study FGF 
signalling. Dominant negative FGFRs such as dnFGFR1 and dnFGFR4a lack 
cytoplasmic kinase domains.  DnFGFRs expressed in Xenopus embryos dimerise 
with wild type FGFRs when translated.  Without kinase domains, dnFGFR:FGFR 
heterodimers cannot cross-phosphorylate each other and thus cannot function to 
mediate signal transduction (Amaya et al. 1991; Hongo et al. 1999).   
 dnFGFR1 and dnFGFR4 have been used in a number of studies in Xenopus and 
completely block the activation of dpERK in the early stages of development 
(Christen & Slack 1999).  They also have been used to show that FGF is required 
for mesoderm induction through a positive feedback loop between FGF4 and Xbra, 
the formation of mesodermal tissues such as muscle, correct posterior 
development, and morphogenetic movements during gastrulation (Enrique Amaya 
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et al. 1991; Amaya et al. 1993; Isaacs et al. 1994).  DnFGFR1 and 4 have also been 
used in a microarray screen by Branney et al., (2009) to investigate how FGF 
signalling affects the Xenopus transcriptome during mesoderm formation. In this, 
and previous studies, dnFGFR4a was shown to have more drastic effects than 
dnFGFR1, perhaps pointing towards differential roles for the two receptors for 
neural development (Hardcastle et al. 2000; Branney et al. 2009; Hongo et al. 
1999). However, as there was considerable overlap between many of the genes 
affected by the two dnFGFRs in Branney et al, (2009), it could suggest that FGFR1 
and FGFR4 signalling outputs are very similar.  This result may be due to a lack of 
dnFGFR specificity however, as dnFGFR1 has also been shown to inhibit FGFR2 
and 3 as well as FGFR1.  It is likely that this is due to the promiscuous binding of 
dnFGFR1 to other FGF receptors (Ueno et al. 1992).  
4.1.1.2 Constitutive activation of FGF signalling 
Injection of mRNA coding for individual FGF ligands has been used previously to 
investigate the effects upon development of general over-activation of FGF 
signalling in Xenopus.  This of course only gives the effects of a subset of FGF 
signalling events, as many ligand and receptor combinations take place to fine tune 
FGF signalling during development.  There are also synthetic constitutively-active 
forms of FGFRs available.  Ligand-independent synthetic forms of FGFRs have 
been used to study FGFR function during development. An early type of 
constitutively-active FGFR is comprised of intracellular domains of FGFR1 or 
FGFR4 fused to the Drosophila mutant torso protein, which is permanently 
dimerised.  These constitutively-active receptors were used to show that FGFR1 but 
not FGFR4 activity converts naïve ectodermal explant cells into mesoderm with 
activation of the MAPK pathway (Umbhauer et al. 2000).    Constitutively-active 
forms of each FGFR are now available that have been individually expressed in 
zebrafish embryos to investigate ligand:receptor affinities and the effects each 
receptor has upon development. It was found that all four caFGFRs caused 
dorsalisation, brain caudalisation and secondary axis formation (Ota et al. 2009).  
Constitutively-active FGFR1 and FGFR1 VT- have also been made by fusing the 
intracellular kinase domains to the Fc region of human antibody molecule IgG1; this 
permanently dimerises with other Fc molecules via a disulphide bond, rendering the 
FGFR constitutively active.  These receptors showed that the VT- motif of FGFR1-3 
is required for interaction with FRS2 (Burgar et al. 2002).  
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4.1.2 Inducible methods of affecting FGF signalling 
To investigate FGF signalling during neural development, the use of dnFGFRs or 
caFGFRs are problematic as they are translated and act to repress FGF signalling 
from early stages. Changes caused by disruption of FGF signalling during neural 
specification stages could be masked by earlier defects of mesoderm formation and 
gastrulation. Therefore inducible systems that allow timed disruption of FGF 
signalling are more suitable to investigate FGF signalling in a neural context. 
4.1.2.1 Transgenesis 
The use of transgenic frogs expressing dnFGFR1 has previously been reported.  
Kroll & Amaya (1996), studied post-mesodermal FGF signalling by injecting oocytes 
with sperm containing a dnFGFR1 plasmid under control of the simian 
cytomegalovirus promoter.  Unlike dnFGFR1 mRNA injected embryos, transgenic 
embryos expressed dnFGFR1 in a non-mosaic manner only from late blastula 
stages (Kroll & Amaya 1996).  This caused severe posterior truncations and a loss 
of early HoxA7 and HoxB9 expression (Pownall et al. 1998).  Again, as this uses 
dnFGFRs, the problem with receptor specificity still exists.  Furthermore, use of this 
method to induce dnFGFRs from later developmental stages would depend on 
finding suitable regulatory elements to drive expression during the required time 
period (Pownall et al. 2003). 
4.1.2.2 Hormonal methods 
One potential way of achieving inducible changes to protein levels is to fuse a 
protein of interest to a ligand-binding domain of the glucocorticoid receptor. This has 
been used by Kolm & Sive (1995) to study the master regulator of muscle 
development, MyoD in Xenopus laevis. mRNA coding for the gene-of-interest fusion 
protein is injected, translated and kept in an inactive form until application of 
glucocorticoid hormone into culture medium. This releases the protein of interest 
enabling it to activate gene expression in addition to the endogenous protein (Kolm 
& Sive 1995).  Unfortunately, this approach could not be used on secreted proteins 
such as FGFs as glucocorticoid receptor is a nuclear hormone receptor that acts as 
a transcription factor. 
4.1.2.3 Pharmacological methods 
Another approach to manipulate FGF signalling is the use of pharmacological 
agents such as SU5402 and BCI. SU5402 is an ATP-competitive inhibitor of the 
tyrosine kinase activity of FGFR1 and can be added to Xenopus culture medium 
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where it diffuses into the embryo (Mohammadi et al. 1997).  Thus, it is an inducible 
method of FGF pathway inhibition and if added from late blastula stage 9 onwards, 
the negative effects of FGF repression upon gastrulation can be circumvented.  An 
example of this is its use as part of a microarray screen to investigate the effect 
upon the Xenopus transcriptome of inhibiting FGF signalling during a short window 
from stage 10.5 to 11.5 (Chung et al. 2004). A major drawback of SU5402 however 
is that it is not specific to just FGFR1 and also inhibits FGFR3 as well as VEGFR 
and PDGFR signalling (Sun et al. 1999). Similar reagents are not available that are 
specific to the other FGFRs. Therefore SU5402 is unsuitable for investigating the 
individual roles of FGFRs. BCI is another pharmacological agent which can be 
added to culture medium to activate FGF signalling when required. It inhibits the 
dual-specificity phosphatase 6 (Dusp6), thereby alleviating its repressive effects on 
the MAPK pathway when added to culture medium (Molina et al. 2009). Again, 
although suitable for looking at a global increase in FGF signalling output, the use of 
BCI would not enable study of individual FGFRs’ contribution to development.  
4.1.3 iFGFRs allow receptor-specific FGF activation in a spatial 
and temporally controlled manner 
iFGFRs provide a way to induce FGF signalling during discrete windows during 
Xenopus development.  By using Xenopus fate maps, iFGFRs can be targeted to 
prospective neural tissues also giving spatial control of FGF activation.  Thus, 
iFGFRs have advantages over caFGFRs or pharmacological methods in terms of 
temporal and spatial control over FGF signalling.  The availability of different 
versions of iFGFRs corresponding to FGFR1-4 enables investigation into the 
different signalling properties of each receptor during neural development.    
Therefore by using inducible forms of FGFR1-4, a truer separation of iFGFR 
subtype and effect upon the transcriptome during discrete periods of Xenopus 
development can be achieved. 
4.1.4 Aims of this chapter 
The main aim of this study is to identify proximal gene targets of FGF signalling 
during Xenopus neural development using drug inducible FGF receptors.  
Before embarking this objective, it was necessary to optimise the use of iFGFRs 
and this is the subject of this chapter.  The aims of this chapter are therefore: 
 To optimise the injection and activation of iFGFRs in Xenopus embryonic 
development. 
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 To investigate the effects of iFGFRs on FGF signalling and Xenopus 
development. 
 
4.2 Results 
4.2.1 iFGFRs are stably expressed in the developing Xenopus 
embryo 
In order to find FGF signalling targets during Xenopus neural specification and 
development, it must be confirmed that iFGFRs proteins translated from injected 
mRNA are present before, and during neurulation.   
In a previous study, 20pg iFGFR1 mRNA was shown to produce effective amounts 
of inducible protein (Pownall et al. 2003).  Xenopus laevis embryos were therefore 
injected bilaterally with 20pg of iFGFR1.    The embryos were collected for western 
blot analysis at a number of stages from early blastula to the end of neuralation.  
Figure 4.1 is a western blot probed for the HA tag present in the N-terminus of 
iFGFR1.    
 
Figure 4.1 – iFGFRs are stably expressed from early stages  
Western blot showing the level of HA epitope tag in embryos injected with 20pg iFGFR1 
increasing, and being maintained, from blastula stages (NF st.6) to post-neurulation (st. 20).  
The predicted size of iFGFR1 is ~72Kd.  GAPDH was used for a loading control, and is ~37Kd. 
The presence of epitope-tagged iFGFR protein is first detectable at mid-blastula 
stage 8 and increases in abundance throughout gastrulation before plataeuing and 
remaining constant until at least late neurula stage 20.  Therefore for the periods of 
development which this study focuses on – gastrula to neurula – iFGFRs are 
translated and present in the embryo at a stable level.   
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4.2.2 Optimisation of AP20187 dosage required to elicit an FGF-
activation response 
The concentration of AP20187 required to robustly induce FGF signalling whilst not 
being toxic to the embryo was investigated.  In Pownall et al, (2002) 1.2µM of 
AP20187 was routinely used, however it was not determined whether 
concentrations below this would still produce the same level FGF signal activation, 
or if a higher concentration is optimal without causing non-specific effects.  A 
convenient assay for FGF pathway activity is by immunodetection of the active 
diphosphorylated form of the MAPK effector ERK, dpERK.  20pg of iFGFR1 was 
injected bilaterally into Xenopus embryos at the 2-cell stage and AP20187 added for 
two hours from stage 8 by which time iFGFR1 is immunodetectable (Figure 4.1).  
The embryos were processed for western blot analysis.  Figure 4.2 shows that at a 
concentration of 1µM, approximately equivalent to the concentration used in 
Pownall et al, (2002), a strong induction of dpERK was observed relative to sibling 
controls which were injected with iFGFR1 but not treated with AP20187.   
 
Figure 4.2.  1µM of AP20187 is the optimal dosage of AP20187 to activate the MAPK 
pathway. 
Western blot showing levels of dpERK in embryos expressing iFGFR1 and treated with 
varying dosages of AP20187 from stage 8 for 2 hours relative to untreated sibling controls.  
Total ERK (tERK) was used as a loading control.  The predicted weight of ERK is 43 Kd. 
The strength of this induction weakens considerably when the dosage of AP20187 
is reduced from 1µM, suggesting that in order to activate FGF signalling to replicate 
results in Pownall et al (2002), 1µM of drug should be used at least.   
To determine if AP20187 is toxic to embryos at amounts greater than 1µM, and/or 
developmental defects more severe, embryos were injected with 20pg of iFGFR1 
and cultured to stage 10.5.  AP20187 was added to both the culture medium of 
embryos injected with iFGFR1 and also uninjected sibling embryos at a range of 
concentrations.   Embryos were cultured to tailbud stages before fixing for imaging.   
106 
 
Figure 4.3.  AP20187 can be added to embryos at doses up to 10µM without negatively 
impacting development. 
Uninjected embryos or siblings injected with 20pg iFGFR1 were exposed to AP20187 from 
stage 10.5.  Numbers on treated embryos indicate embryos resembling the representative 
image.   
Figure 4.3 shows that for all concentrations of up to 10µM, induced iFGFR1 causes 
gross morphological defects. The severity of defects do not seem to increase as the 
concentration of AP20187 increases to 10µM suggesting that it is not necessary to 
add more than 1µM of AP20187 to achieve the same morphological effects.  
Secondly, at concentrations of up to 10µM, uninjected embryos develop normally.  
However, increasing the concentration of AP20187 to 50µM killed 100% of both 
uninjected and iFGFR1-expressing embryos.  As this is fifty times the amount 
required to elicit a strong dpERK response, toxicity of AP20187 will not be a cause 
for concern in this investigation.     
4.2.3 AP20187 rapidly diffuses into the embryo 
As the start and endpoint of induction times with AP20187 need to be tightly 
controlled it needed to be determined how rapidly AP20187 can diffuse into the 
embryo and cause a rise in dpERK levels.  If this is too slow, AP20187 would have 
to be added pre-emptively to affect stage-dependent gene expression.   
Xenopus laevis embryos were injected bilaterally with 20pg iFGFR1 and cultured to 
late blastula stage 8 before adding 1µM AP20187 to the culture medium.  Embryos 
were then cultured for different periods of time at 22°C.  Figure 4.4 shows that after 
only 15 minutes exposure to AP20187, a there is a small increase in dpERK in 
iFGFR1 ‘induced’ embryos relative to ‘uninduced’ and uninjected sibling controls. 
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Figure 4.4.  The MAPK pathway is activated within 15 minutes upon the addition of 1µM 
AP20187 
Xenopus laevis embryos were injected with 20pg iFGFR1 and cultured to stage 8 before 
adding 1µM AP20187 to the culture medium.  Embryos were cultured at 22°C and collected at 
various timepoints, and processed for a western blot against dpERK. tERK was used as a 
loading control.  Dotted lines demarcate different experimental repeats. 
iFGFR induction can therefore be timed from the addition of AP20187.  A dpERK 
upregulation is still evident after 18 hours, showing that the dimerised iFGFR and/or 
AP20187 must be stable and continue to activate dpERK until tailbud stages. 
4.2.4 iFGFR induction causes severe defects in development 
Next, the ability of iFGFR1 (VT-), iFGFR2, iFGFR3 and iFGFRF4 to activate the 
MAPK signalling pathway and affect development was investigated. 
20pg of either iFGFR1, iFGFR1 (VT-), iFGFR2, iFGFR3 or iFGFR4 were injected 
bilaterally into Xenopus laevis embryos at the 2-cell stage and AP20187 added at 
stage 10.5.  Embryos were cultured to tailbud stages and fixed for imaging.  Figure 
4.5 shows that uninjected embryos and embryos untreated with AP20187 develop 
normally.  Induction of iFGFR1 and iFGFR2 caused the most severe defects, with 
loss of anterior structures at the expense of an expanded posterior domain, which 
was also deformed.  Thus the embryo could be said to be ‘posteriorised’, a term 
used previously to describe posterior domain enlargements upon FGF over-activity 
in Pownall et al., (2003) and Kudoh et al. (2002).  Embryos also failed to elongate 
relative to controls.  Interestingly, the iFGFR1 (VT-) isoform did not have as severe 
a phenotype as iFGFR1, although embryos exhibited facial defects including 
incomplete eye development.  Embryos expressing iFGFR3 had an expanded 
cement gland and generally under-developed head.  There was often oedema 
ventrally around the developing head and guts.  iFGFR4 also produced milder 
defects compared to iFGFR1 and iFGFR2,  but still had appreciably under-
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developed eyes and head with a failure to elongate.  In some instances, the neural 
tube failed to close anteriorly.     
 
Figure 4.5.  Effect upon phenotype after induction of iFGFRs  
Xenopus laevis embryos were injected with 20pg iFGFR mRNA and cultured to stage 10.5.  
AP20187 was then added and embryos cultured until tailbud stages.  Numbers indicate 
embryos resembling the representative image.  All iFGFRs cause elongation defects and 
problems with anterior development, although to different extents.   
Therefore, iFGFRs posteriorise the embryos as expected, but also that each iFGFR 
has different effects on development, suggesting FGFRs have different 
developmental roles.   
Ectodermal explants taken at blastula stages and treated with FGF2 undergo 
convergent extension from gastrula stages whereas untreated counterparts remain 
spherical (Slack et al. 1987).  In order to investigate the effects of activating 
iFGFR1, iFGFR1 (VT-) iFGFR2, iFGFR3 and iFGFR4 on animal cap explants, 20pg 
of each iFGFR was injected into bilaterally the animal pole of Xenopus laevis 
embryos at the 2-cell stage.  Explants were dissected at stage 8 and transferred to 
culture medium containing AP20187.  When stage-matched controls reached late 
neurula stages, animal caps were fixed for imaging.   
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Figure 4.6.  Activation of iFGFR1 VT+/- and iFGFR2 causes convergent extension of animal 
caps. 
20pg iFGFR mRNA was injected bilaterally into Xenopus laevis embryos at the 2-cell stage.  
Ectodermal explants were taken from embryos at stage 8 and cultured until late neurula.  
Numbers of animal caps resembling the representative image are shown.  N=9-12 caps per 
condition. 
Figure 4.6 shows that animal caps expressing both isoforms of iFGFR1, and 
iFGFR2 elongated in the majority of cases.  iFGFR3 and iFGFR4 however, 
remained spherical and resembled untreated controls suggesting that mesodermal 
tissues that are responsible for elongation in the embryo are not specified in 
induced iFGFR3/4-injected embryos.   
4.2.5 iFGFRs activate the MAPK pathway to varying extents 
4.2.5.1 iFGFR-injected explants exhibit increased MAPK activation 
It was important to check that the phenotypes seen in Figure 4.5 and Figure 4.6 
correlate with activation of the MAPK pathway for all iFGFRs.  20pg iFGFR mRNA 
was injected bilaterally into Xenopus laevis embryos at the 2-cell stage. Ectodermal 
explants were taken at stage 8.  Explants are commonly used in Xenopus 
experiments as their cells are still pluripotent and can be forced down different 
differentiation pathways, as they have not been exposed to signalling events 
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elsewhere in the embryo.  Thus they provide an isolated system in which to study 
signalling away from other signalling pathways in the embryo which could interfere 
with FGF activity.  Explants were added to culture medium containing AP20187 for 
2 hours and processed for western blot analysis. 
 
Figure 4.7 iFGFRs increase dpERK levels 
20pg iFGFRs were injected bilaterally into Xenopus laevis embryos at 2-cell stage.  
Ectodermal explants were taken at stage 8, cultured in the presence of AP20187 for 2 hours, 
and collected for western blot analysis.  Untreated or uninjected explants as well as whole 
stage-matched controls (W.E.) were also analysed.  Western membranes were probed with 
either anti-HA to detect the presence of iFGFR, or dpERK.  tERK was used as a loading 
control.  The iFGFRs’ weight is expected to be between 70 and 100Kd.   
Figure 4.7 shows that compared to untreated or uninjected controls, explants 
expressing one of the five iFGFRs and induced with AP20187 exhibit increased 
levels of dpERK.  This is much more pronounced in iFGFR1, iFGFR1 (VT-) and 
iFGFR2-injected embryos compared to iFGFR3 and iFGFR4.  As levels of HA in 
iFGFR3/4-injected embryos are comparable to the other receptors, it can be 
concluded that their weaker response is not due to a lesser amount of iFGFR 
translated.      
4.2.5.2 iFGFRs cause ectopic MAPK pathway activation 
Next, the effects on the spatial distribution of active dpERK were investigated in 
embryos by immunostaining whole embryos with an antibody against dpERK.  
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Xenopus laevis embryos were injected unilaterally into the animal pole at the 2-cell 
stage with 10pg iFGFR.  Embryos were cultured until stage 10, which is when 
endogenous dpERK is present in a vegetal ring around where the blastopore will 
develop (Figure 4.8), and processed for immunostaining against dpERK. 
 
Figure 4.8 iFGFRs cause ectopic dpERK 
Embryos were unilaterally injected with 10pg iFGFRs and exposed to AP20187 from stage 8 
to stage 10.  Animal views of embryos are shown with a vegetal view of endogenous dpERK 
at stage 10 as a comparison.  Ectopic dpERK can be seen in AP20187-treated embryos on 
the right injected hemisphere only.  Percentages show AP20187-treated embryos resembling 
the representative image.  N values - iFGFR1 VT+ (17/17), iFGFRVT- (15/15), iFGFR2 
(12/15), iFGFR3 (6/9), iFGFR4 (7/9). 
Figure 4.8 shows that all iFGFRs can induce ectopic dpERK on the animal pole of 
injected embryos as shown by blue staining on the injected right hemisphere.  
Uninduced and uninjected embryos did not show ectopic staining.  Again, the level 
and extent of dpERK activation is less in iFGFR3 and iFGFR4-injected embryos 
compared to the other iFGFRs.       
4.2.6 Using iFGFRs to activate FGF signalling in the developing 
CNS 
The principal aim of this investigation was to study the effects of activating FGF 
signalling in neural tissue, which can be achieved for example by targeted injections 
using fate maps, or using neuralised explants.  At the 8-cell stage, only the two 
animal dorsal blastomeres contribute to neural development (Moody 1987).  
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Therefore iFGFRs injected and induced in only these blastomeres would activate 
FGF signalling only in prospective neural tissue, giving spatial as well as temporal 
control of FGF signalling.   Another method commonly used to simulate conditions 
in the developing CNS is to use neuralised ectodermal explants.  At late blastula 
when explants are dissected from the animal pole, their cells are still pluripotent. 
They can therefore be pushed into a neural fate by co-injecting 50pg of the BMP 
antagonist Noggin with iFGFRs into the animal pole (Schulte-Merker & Smith 1995; 
Smith & Harland 1992; Yamagishi & Okamoto 2010). 
4.2.6.1 Targeting iFGFRs to prospective neural tissue 
iFGFR1 and iFGFR4 were chosen to observe the effects of FGF signalling upon 
Xenopus phenotype when expressed solely in the developing CNS. This is because 
induction of iFGFR1 and 4 cause different convergent extension behaviours and 
signalling properties in this work, and when constitutively active in developing 
Xenopus embryos (Umbhauer et al. 2000).  To observe the effect of iFGFR1 and 
iFGFR4 expression solely in the developing CNS, 20pg of either receptor was 
injected bilaterally into the 8-cell stage Xenopus laevis embryos.  Embryos were 
treated with AP20187 from stage 10.5 and fixed at stage 40 for imaging.   
Figure 4.9 shows that activating iFGFRs in prospective neural tissues does not have 
as severe an effect as when iFGFRs are expressed globally.  However both induced 
receptors caused defects in eye development which for each receptor fell into two 
categories. For iFGFR1-induced embryos, retina pigmentation was fainter or the 
whole eye smaller, lacking a defined retina and lens. For iFGFR4-induced embryos, 
the most visibly-affected embryos had eyes missing pigment in parts of the retina 
and/or lens. A smaller number had thinner retinas.   
Following this, immunostaining against dpERK with embryos injected with iFGFR1 
at the 8-cell stage was performed to see if iFGFRs could ectopically activate FGF 
signalling in the developing neural plate.  Embryos were induced for various lengths 
of time from stage 10.5 to see if the strength of MAPK activation remained constant, 
as in Figure 4.4.  The amount of injected iFGFR1 was halved to 10pg. This was 
because in the smaller dorsal animal blastomeres spontaneous dimerisation of 
iFGFR1 occurred in previous experimental repeats using 20pg, leading to ectopic 
dpERK staining in uninduced control embryos (data not shown). GFP was co-
injected as a visual check that injections were targeted to the neural plate (data not 
shown). 
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Figure 4.9 – targeting iFGFRs to prospective neural tissues affects phenotype 
20pg iFGFR1 (N=18) or 20pg iFGFR4 (N=23) were injected bilaterally into dorsal animal 
blastomeres at 8-cell stage and treated with AP20187 at stage 10.5.  Embryos were fixed at 
stage 40.  Induced iFGFR1-injected embryos either had fainter retina pigment (left) or had 
more severe eye defects (right).  IFGFR4-injected embryos had either thinner lenses (left) or 
missing pigment in the retina/lens (right).  Numbers on AP20187-treated embryos refer to 
numbers of AP20187-treated embryos resembling the representative image.   
Figure 4.10 shows after 1 or 2 hours exposure to AP20187, there is a strong ectopic 
dpERK response in the posterior dorsal region of the embryo.  Unexpectedly, given 
the stability and continued upregulation of dpERK in whole embryos after an 18 
hour induction (Figure 4.5) this dpERK response was not maintained after 4 hours 
treatment with AP20187.   
 
Figure 4.10 – targeting iFGFR1 and treating with AP20187 for different periods of time 
10pg iFGFR1 was injected bilaterally into prospective neural blastomeres at the 8 cell stage.  
Embryos were cultured at stage 10.5 and treated with AP20187 for 1 (N=10), 2 (N=7), 4 (N=9) or 6  
(N=8) hours.  dpERK protein is stained blue.  Endogenous dpERK is present ventrally in earlier 
stages (only animal view shown) and in later stages is present in the posterior, midbrain hindbrain 
boundary and apical ectodermal ridge as in 6 hr controls.  Percentages in induced embryos show 
embryos exhibiting ectopic dpERK.  
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After this period dpERK staining was fainter, more diffuse and not concentrated at 
the developing neural plate.  This may be caused by compensation of signalling 
events in the rest of the embryo not expressing iFGFR1.  Partly on this basis, and 
because Xenopus tropicalis RNA-seq and RNase protection analysis data suggests 
that roughly three hours is the time taken for FGF signalling targets such as Cdx4 to 
be activated after onset of FGF activity, a three hour induction time was picked for 
future experiments to ensure activation of proximal targets, but not any subsequent 
negative regulators (Tan et al. 2013; Keenan et al. 2006). 
4.2.6.2 Using neuralised animal cap explants to simulate FGF signalling in neural 
tissues 
A common way of mimicking neural conditions in an isolated system is by using 
neuralised ectodermal explants.  To ascertain that the MAPK pathway is induced 
above normal levels in neuralised animal cap explants by iFGFR1 similar to when 
only iFGFR1 is activated, 50pg of Noggin mRNA was co-injected with 20pg iFGFR1 
bilaterally at the 2-cell stage in Xenopus laevis embryos. Explants were taken at 
mid-blastula stage 8, cultured until whole stage-matched controls reached early 
gastrula stage 10.5 and then treated with AP20187 until stage 15.  Explants were 
then processed for western blot analysis against dpERK and the BMP effectors 
pSmad1/5 and 8. 
 
Figure 4.11 – MAPK activation in iFGFR1-injected neuralised animal caps 
Embryos were injected with 50pgNoggin, iFGFR1 or both Noggin and iFGFR1 and treated with 
AP20187 from stage 10.5 to 15.  Western blots were performed with samples either being 
probed with pSmad 1/5/8 antibody, or dpERK antibody.  Loading controls were GAPDH and 
tERK respectively.  pSmad 1/5/8 has a predicted weight of 58Kd.     
Figure 4.11 shows that Noggin inhibited the BMP pathway, thus neuralising the 
explants. As shown by reduced levels of pSmad1/5/8 in Noggin-injected embryos. 
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dpERK is strongly induced at the same level in explants expressing solely iFGFR1 
or iFGFR1+Noggin.  This shows that FGF signalling can be activated robustly in 
neuralised animal cap explants.   
4.2.7 Conclusions 
Data in this chapter have shown that iFGFRs are translated early in development, 
are induced rapidly in response to addition of AP20187 to culture medium and are 
stable for the duration of gastrulation and neurulation.  All five iFGFRs tested 
activated the MAPK pathway when induced, however not to the same extents.  
There were also differences in morphological phenotypes and convergent extension 
phenotypes in ectodermal explants.  Lastly, iFGFRs have been shown to activate 
FGF signalling when targeted to the CNS, or expressed in neuralised ectodermal 
explants. This provides a good foundation upon which to plan an RNA-seq 
experiment to investigate FGF signalling during neural development. 
4.3 Discussion 
This chapter has shown that iFGFRs are stably expressed in Xenopus embryos, 
and can be activated in whole embryos as well as neuralised animal caps to 
activate MAPK signalling.  Induction of FGF signalling through all iFGFRs tested 
affected normal Xenopus development, with phenotypes reminiscent of FGF over-
expression phenotypes in whole embryos and explants.   
4.3.1 Signalling by iFGFRs cause gross morphological defects  
The five different iFGFRs had varying effects on Xenopus embryo phenotype when 
induced from early gastrula to tailbud.  iFGFR1 and iFGFR2 produced the most 
severe phenotypes, with a complete loss of anterior structures and also posterior 
defects.  These posterior defects were not as severe as those caused by activating 
iFGFRs from stage 8, which disrupted gastrulation (Pownall et al. 2003).  These 
phenotypes resemble those seen in Xenopus laevis embryos microinjected with 
FGF3 and FGF4 mRNA at cleavage stages as well as expressing FGF4 from a 
plasmid – in this case posterior defects were shown to be accompanied by an 
anterior expansion of Cdx4, HoxA7 and HoxB9 expression domains (Lombardo et 
al. 1998; Isaacs et al. 1994; Pownall et al. 1996).  These severe defects were also 
found after iFGFR1 induction by Pownall et al (2003). The eye defects found in 
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embryos with activated iFGFR1 and iFGFR4 in prospective neural structures were 
also found by Lombardo et al, (1998), who placed an FGF4-soaked bead next to the 
developing eye.  Embryos displayed a loss of eye pigment resembling those in 
which was found to be due to a loss of differentiation of  pigmented epithelial cells 
(Lombardo et al. 1998). 
Analysis of developmental defects of embryos over-activating other individual 
FGFRs is sparse in the literature.  Ota et al. (2009) injected constitutively-active 
FGFRs 1-4, (caFGFRs) into zebrafish embryos, as well as the VT- equivalent of 
FGFR2 (FGFR2 VT-).   In this study, the most severe phenotypes occurred with the 
expression of caFGFR1 and caFGFR2, similar to the results in Figure 1.6, with 
injected embryos displaying a complete loss of anterior tissue and eyes.  caFGFR2 
VT- also displayed anterior truncations, but these were not as severe as those from 
caFGFR2, which also follows findings in Figure 1.6 for iFGFR1 and iFGFR1 VT-.   
The presence of these defects in iFGFR1 VT- embryos however, contrast with the 
findings of Paterno et al, who overexpressed the VT- isoform of FGFR1 in Xenopus 
embryos and saw no difference in tadpole phenotype (Paterno et al. 2000).  These 
defects may be due to the fact that Paterno and colleagues overexpressed a ligand-
dependent receptor which may become inactive at some points during development 
due to lack of specific ligands (Paterno et al. 2000).  caFGFR3 and caFGFR4-
expressing zebrafish embryos displayed distinct phenotypes with only slightly 
smaller heads and defective eyes compared to controls, which the authors 
proposed as being due to the lower signalling potential of caFGFR3 and caFGFR4 
than the other caFGFRs, instead of producing distinct effects (Ota et al. 2009).    
The convergent extension behaviour observed in ectodermal explants due to FGF 
over-expression has also been well documented.  Explants either treated with 
FGF2, FGF3 or FGF4 protein, or mRNA coding for these FGFs also displayed 
convergent extension of animal caps to a similar degree to caps expressing 
iFGFR1, iFGFR1 (VT-) and iFGFR2 in Figure 1.7 (Isaacs et al. 1994; Lamb & 
Harland 1995; Lombardo et al. 1998; J. M. Slack et al. 1987).  Overexpression of a 
constitutively active FGFR2 also caused convergent extension of explants (Neilson 
& Friesel 1995).  The result of FGFR3 overexpression has not been reported, but 
injection of iFGFR4 into neuralised explants similarly failed to elicit as great a 
convergent extension response as those expressing iFGFR1 or Noggin alone 
(Yamagishi & Okamoto 2010).   
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These experiments therefore agree with research in the literature into the effects of 
over-activating the FGF signalling pathway during neural development. They also 
provide insight into the different effects each FGFR subtype brings to development. 
4.3.2 iFGFRs activate the MAPK pathway, but to different extents 
Western blot analyses on ectodermal explants expressing iFGFRs, as well as 
immunostaining with whole embryos showed that dpERK is upregulated and 
expressed ectopically after receptor induction (Figures 1.8 and 1.9).  As with the 
findings with phenotype, the dpERK response was most potent in iFGFR1, iFGFR1 
(VT-) and iFGFR2-expressing embryos.  Previous work analysing FGFR2 VT- 
transfected with human BaF3 cells found them to be unable to activate the MAPK 
signalling pathway, based upon the lack of detectable phosphorylated ERK2.  
(Twigg & Burns 1998).   Furthermore, Burgar et al. (2002) found that in 293T cells, 
transfected FGFR1 VT- could not interact with FRS2, a key component of the MAPK 
and PKC pathway.  This contrasts with findings here showing iFGFR1 VT- 
expressing embryos and explants repeatedly displayed dpERK upregulation at 
similar levels to iFGFR1 VT+.  This may reflect differences between wild type 
FGFR1 VT- and iFGFR1 VT-, or could be a cell type specific effect or found only in 
vitro as other interacting partners are present in vivo to activate MAPK.  Further 
work in different cell types and model organisms would be needed to get a better 
insight into these discrepancies.    
iFGFR3 and iFGFR4-expressing embryos also activated the MAPK pathway, but to 
a lesser extent and over a smaller area.  An explanation for this is that only cells 
closest to the injection site inherited the highest amounts of iFGFR3/4 mRNA and 
protein which would activate an amount of dpERK detectable by immunostaining.    
The weaker effect FGFR4 has on the MAPK pathway relative to iFGFR1 has been 
previously documented.  One explanation for this is that FGFR4 kinase domain has 
an inherently weaker autophosphorylation potential and therefore activates 
downstream signalling proportionally less compared to FGFR1 (Yamagishi & 
Okamoto 2010).  Yamigishi and colleagues overexpressed FGFR4 in Xenopus, 
thereby increasing the likelihood that FGFR4 would receive FGF ligands over 
FGFR1.  Interestingly, a posterior shift in anterior neural markers reminiscent of 
when FGFR1 is inhibited was observed, indicating a weaker net FGFR signalling 
output (Yamagishi & Okamoto 2010).   Therefore, the authors concluded that 
118 
competition between FGFRs for ligands, with FGFR4 being a ‘weak FGFR1’, is 
responsible for regulating neural development.  
Other research disagrees with this finding, and concludes that these signalling 
differences are mainly due to cellular context. Although some studies found the 
phosphorylation level of FGFR4 to be weaker than that of FGFR1 in PC12 cells, 
other studies in Xenopus laevis animal caps found that phosphorylation of  the two 
receptors was indistinguishable (Raffioni et al. 1999; Umbhauer et al. 2000).  In 
these explants, FGFR4 was unable to activate the MAPK effector Ras, supporting 
the relative lack of dpERK activation in Figure 1.8 and 1.9. However, FGFR4 did 
activate PLCγ, thereby activating Wnt1 and the midbrain marker En2 (Umbhauer et 
al. 2000).   Therefore the authors postulated the differences in pathways activated 
by the two receptors provided the difference in signalling properties, rather than 
quantitative differences in receptor phosphorylation potential (Umbhauer et al. 
2000). On this basis it would be interesting to perform western blot analysis using 
antibodies against the other branches of FGF signalling such as PLCγ or Akt for 
iFGFR3 and 4-induced embryos.   
The data obtained from the microarray in the previous chapter seem to agree with 
this latter view of different FGFRs having unique signalling outputs – as if iFGFR4 
and 3 are indeed just ‘weaker’ versions of iFGFR1 and iFGFR2, one would expect 
the microarray genelists to be very similar to each other, with iFGFR3 and iFGFR4 
lists activating the same genes as iFGFR1/2 but to a lesser extent.  As discussed in 
the last chapter, very little overlap of genes between the different receptor lists was 
evident, indicating that in this context, different iFGFRs had distinct developmental 
roles and effects upon the Xenopus transcriptome and FGF targets. 
4.3.3 Challenges to the use of iFGFRs 
It would be very hard to account for all FGF ligand/receptor variants and 
combinations to give a comprehensive view of the effects of ectopic FGF activation 
during Xenopus neural development.  As iFGFRs are a ligand-independent system 
without an alternatively-spliced extracellular domain, along with HSPG interactions 
that are responsible for the fine-tuning of signalling output, iFGFRs may be 
considered a simplification of FGF-mediated signalling events during neural 
induction.  Another potential concern with the use of iFGFRs is that the kinase 
domains of the iFGFRs may not introduce enough variability to reproduce the 
induction of a given receptor, as they do not account for regulation by FGF ligands 
119 
or receptor splicing.  However, this simplification from the use of iFGFRs allows 
focus on finding novel targets of each receptor, and this receptor variability is 
adequate enough to meet the aims of the project.  Indeed, the preliminary 
microarray dataset discussed in the last chapter showed there to be a low degree of 
overlap between genes activated or repressed by the four receptors tested, 
suggesting that iFGFRs 1-4 are varied enough to produce unique signalling outputs.   
Also, it is unknown whether iFGFRs are targeted solely to the plasma membrane 
and not to other compartments in the cell such as the nucleus, which FGFR1 has 
been reported to translocate to, which could be another point of difference from wild 
type FGFRs (Stachowiak et al. 2003).  There therefore will inevitably be differences 
between iFGFRs and wild type receptors, but for the scope of this project, these two 
chapters taken together have shown that iFGFRs produce differing and 
measureable effects upon the Xenopus transcriptome and development. 
4.3.4 Further work 
4.3.4.1 Using neuralised animal cap explants to study FGF signalling in neural 
development 
The ability of iFGFR1 to activate downstream neural gene targets and the MAPK 
pathway shown to be robust using neuralised animal caps.  These results could not 
be replicated using whole embryos where iFGFR1 injections were targeted to the 
prospective CNS (data not shown).  This was probably due to activity in the rest of 
the embryo not expressing iFGFRs, such as activity of other signalling pathways, 
regulating and minimising the effects of iFGFR1 induced in only a small proportion 
of the total embryo.  Therefore neuralised animal cap explants are the superior 
method to investigate specifically FGF signalling in neural development.  Another 
approach would be to dissect out prospective neural tissue at neural specification 
stages and conduct RNA-seq upon neural plate tissue.  However, this would be 
tricky due to the dissection of the correct cells at early neurula stages and the fact 
that these would need to be collected soon after dissection.  This is a problem 
because as a response to wounding, the embryo upregulates dpERK for a few 
hours.  With the neuralised explant protocol in this study, the time between taking 
the caps and inducing them is overnight, allowing them to heal and the dpERK 
response to subside (Christen & Slack 1999). Nevertheless, this dissection of neural 
plate methodology has been used successfully in RNA seq screen in Xenopus 
tropicalis seeking to identify targets of the eyefield marker Rax (Fish et al. 2014).     
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4.3.4.2 Length of iFGFR induction 
In order to investigate proximal gene expression the induction time period must be 
kept fairly short as developmental events are rapid in Xenopus.  After longer 
periods, multiple rounds of gene transcription may occur.  Furthermore, secondary 
targets may crosstalk with other signalling pathways or auto-regulate and obfuscate 
the primary FGF targets.  This may have been the case with the loss of ectopic 
dpERK after a 4 hour induction with AP20187, although RT-qPCR experiments to 
see if, as well as Sprouty2, other negative FGF regulators are also upregulated 
would be needed to support this.  This choice is also supported by Xenopus Refseq 
data, and the time taken for Cdx4 to be induced in explants after FGF4 treatment in 
RNase Protection Assays.  These data suggest 3 hours is roughly the time period 
taken for targets of FGF signalling to be activated (Tan et al. 2013; Keenan et al. 
2006). 
4.3.5 Summary 
This chapter has outlined how the microinjection and induction of iFGFRs causes an 
increase in FGF signalling and affects Xenopus development.  Taken with the 
previous chapter, iFGFRs have an effect on downstream gene expression in both 
whole embryos and in neuralised explants.  iFGFR injection has been optimised in 
order to pave the way to an RNA-seq experiment to investigate FGF signalling in 
neural development.  iFGFR1 and iFGFR4, since they have been shown to have 
very different behaviours, will be used in the context of neuralised ectodermal 
explants and this will be described further in the next chapter.  
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5  Investigating the effect of 
iFGFR signalling by RNA-
seq 
 
5.1 Introduction 
5.1.1 Investigating transcriptomes 
Investigating the regulation of gene expression and gene networks is fundamental in 
linking genotypes to phenotypes (Marguerat & Bähler 2010).   Manipulation of 
signalling pathways gives us clues as to how they are regulated and the 
consequences upon development or pathologies when they are abnormally 
regulated.  Developmental processes are often regulated by a small number of 
'master regulators' such as BMPs, Wnts and FGFs.  Understanding the global 
targets of these pathways and how the interact in a developmental context gives 
insight into the many subsidiary processes they feed into.   
5.1.2 Methods of investigating the Xenopus transcriptome 
Microarrays were the predominant technology for transcriptome analysis up until the 
start of the last decade.   Microarrays however, have a number of shortcomings, 
one of which is a high level of background and reduced specificity due to cross-
hybridisation.  Furthermore, compared to sequencing based approaches, 
microarrays have a lower dynamic range -100-200-fold compared to 5 orders of 
magnitude (Wang et al. 2009).  This means that very small or large changes in gene 
expression are difficult to detect.  Compared to RNA-seq, microarrays are inferior at 
distinguishing different splice-variants of a gene as many different isoforms will bind 
to one representative oligo probe.  Lastly, unless expensive tiling arrays are used, 
there is a reliance on existing knowledge of the genome – if a DNA sequence is not 
present on the chip for hybridisation, or is not yet annotated, it will not be detected 
(Marguerat & Bähler 2010; Wang et al. 2009).  In Xenopus laevis, this is becoming 
progressively less of a problem after the recent sequencing and annotation of the 
genome (Karpinka et al. 2014). 
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These problems can be partially overcome by investigating transcription using 
sequence-based means such as RNA-seq and Serial Analysis of Gene Expression 
(SAGE).  SAGE uses 14-20bp sequence tags from the 3’ ends of genes to measure 
and identify gene expression levels (reviewed in Harbers & Carninci, 2005).   The 5’ 
variant of SAGE is called cap analysis of gene expression – CAGE.  SAGE and 
CAGE have the advantage over microarrays of being able to detect different 
transcription start sites and different promoter usages.  It also provides a digital 
readout of gene expression levels, useful for in-depth gene regulation studies.  
However, because only gene termini are counted, splicing events and SNPs are not 
usually detected.  Lastly, SAGE and CAGE are based on Sanger sequencing 
technology, making them relatively expensive (Wang et al. 2009).   
5.1.3 Next generation RNA sequencing using Illumina Technology 
RNA-seq is a high-throughput sequencing approach and since the first published 
experiments in 2008 has dramatically increased in popularity. More cost-effective 
than microarrays and cDNA/EST sequencing described above, it can also identify 
SNPs, novel splice events, non-coding RNA and unknown regions depending on the 
depth of sequencing. Unlike microarrays, there is not a reliance on genomic 
sequence with RNA-seq, although for the purposes of this project it is easier if a well 
annotated genome is available (Wang et al. 2009).  Comparisons between Illumina 
sequencing data and array data shows the results are reproducible across these 
platforms, with RNA-seq allowing easier detection of low-expressed genes, novel 
spliced variants and novel transcripts (Marioni et al. 2008).  Illumina technology was 
chosen for use in this experiment by the Technology Facility based upon the 
sequencing depth it could achieve relative to the in-house Ion Torrent PGM 
sequencer.  
5.1.3.1 RNA-seq methodologies 
A schematic workflow diagram of typical RNA-seq using Illumina technology is 
shown in Figure 5.1 and is reviewed in Nagalakshmi et al. (2010).  Firstly, mRNA is 
isolated from the total RNA extraction, by either rRNA depletion or mRNA 
enrichment to prevent the high proportion of ribosomal RNA skewing results.  The 
mRNA is reverse transcribed into cDNA and then broken into approximately 100bp 
fragments by digestion with DNase 1.  The cDNA library is prepared by ligating 
adaptors onto both ends of the double-stranded fragments enabling pooling of 
samples together.  Quantification is performed at this step to ensure that the library 
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reflects natural conditions as much as possible.  The cDNA is added to a flow cell 
populated by oligos that bind the adaptors on the termini of cDNA fragments.    The 
fragments are extended, and bind to an adjacent surface oligo forming a bridge.  
This enables double stranded replication and amplification of the cDNA, known as 
solid phase bridge amplification.  Reverse strands are cleaved and discarded.  This 
amplification step results in more than 40 million clusters, each containing around 
1000 clonal copies of the original template molecule (Morozova & Marra 2008). 
 
Figure 5.1 – RNA seq workflow 
Total RNA is extracted from cells or tissue.  It is reverse transcribed into cDNA and 
fragmented into roughly 100bp fragments.  After quantification, adaptors are fused to each end 
of the fragments to prepare a library.  The samples are pooled together and their adaptors 
bound to oligos fused to an Illumina flow cell surface.  After amplification, sequencing primers 
are added.  Light emitted when bases are incorporated allows the sequence of the fragments 
to be identified.  The sequences are then aligned to the genome. 
The ends of the fragments are capped to eliminate overhangs, and then sequencing 
primers are added.  All four bases, each fused to a different coloured fluorophore, 
are introduced to the flow cell.  When each is incorporated to the oligo template, a 
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laser excites the fluorophore and the base’s colour is recorded.  The fluorophore is 
cleared, and the next base can then bind.  Therefore the raw sequencing output is 
image records of light emitted by every parallel sequencing reaction across the 
whole chip.   The images are then processed to get numerical values for each base 
– this is an assignment of ‘base call quality’ (Nagalakshmi et al. 2010).  Fragments 
containing too many low-quality base calls are discarded. 
After sequencing, the pooled samples are isolated once more.  The forwards and 
reverse sequences are paired.  This is important, as if the paired reads are much 
more than 100bp apart, this points to non-specific binding so is a point for quality 
control.  The sequences are then aligned to the genome and reads per gene 
converted to Fragments Per Kilobase Of Exon Per Million Fragments Mapped 
(FPKM), a commonly used unit for RNA-seq.  Therefore, both the gene sequence 
and the abundance in each sample can be calculated.  A base resolution profile of 
each gene is formed. 
5.1.4 Aims of this Chapter 
 To undertake an RNA-seq based analysis aimed at identifying genes 
regulated by FGF signalling during neural development  
 To organise the data into genelists and gain an overview by literature 
searches and ontological analyses after initial processing by the University 
of York Technology Facility.  
 To validate the RNA-seq data by RT-qPCR. 
 
5.2 Results 
5.2.1 Experimental Methodology 
The aim of this study was to investigate the role of FGF signalling in a neural 
context, as well as the differences in signalling output between the different FGFRs.  
Ideally, all five iFGFRs would be investigated, but in order to maximise the depth of 
sequencing with the resources available, it was decided to investigate the effects of 
induction of iFGFR1 and iFGFR4 in a single RNA-seq run.  These two receptors 
were chosen as they are known to have different signalling properties, and 
overexpression of constitutively active/dominant negative receptors of both result in 
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abnormal neural development in the fish and frog (Hongo et al. 1999; Ota et al. 
2009). Secondly, the initial iFGFR microarray-based analysis suggested that 
iFGFR1 and iFGFR4 affected very different genes, so would give a wider picture of 
the role of FGF signalling in neural development (see Figure 3.2).  For this reason 
iFGFR2 was not chosen as the microarray showed it to have a relatively similar 
profile to iFGFR1 and so its use may not find represent the full range of FGFR 
effects.  Although interesting for a future investigation, iFGFR1 VT- was not used for 
the same reason.  iFGFR3 in the microarray did not seem to affect many neural 
genes or conventional FGF targets, and so although interesting, it is less of a 
priority to investigate than iFGFR4.  Therefore 4 samples were prepared – 
iFGFR1+Noggin uninduced control, iFGFR1+Noggin induced, iFGFR4+Noggin 
uninduced control and iFGFR4+Noggin induced. 
As shown in the previous chapter, western blot and RT-qPCR analyses on 
neuralised ectodermal explants showed robust activation of dpERK and known FGF 
targets, showing them to be a good system to study neural development.  Use of 
these explants rather than whole embryos enabled investigation of iFGFR induction 
solely in a neural context, away from the interference of signalling processes 
occurring elsewhere in the embryo.  50pg of Noggin was co-injected bilaterally into 
the animal pole of Xenopus laevis embryos at the 2-cell stage with 20pg of either 
iFGFR1 or iFGFR4 mRNA (Figure 5.2).  The embryos were cultured until stage 8, 
and ectodermal explants taken.  These were cultured until stage-matched sibling 
embryos reached stage 10.5.  Half of these explants were then cultured with 
AP20187 to activate FGF signalling for 3 hours at 22°C.  Explants were then 
processed for total RNA extraction.  At least 1µg of RNA per sample was required 
for Illumina RNA seq, and so 20 explants per condition were collected.   
 
Figure 5.2 RNA-seq sample preparation methodology 
Schematic diagram of RNA-seq sample preparation protocol.  Xenopus laevis embryos were 
coinjected with 20pg FGFR1 or 4 and 50pg Noggin at the 2-cell stage, neuralised caps taken, 
and cultured to stage 10.5.  FGF signalling was induced for three hours and then caps snap 
frozen.  RNA extraction was then performed and western blot analysis on sibling caps 
undertaken to ensure upregulation of dpERK. 
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As a quality control check of iFGFR induction and neuralisation, sibling whole 
embryos were cultured further and displayed typical Noggin and FGF-
overexpression phenotypes (data not shown).   
 
Figure 5.3 Western blot check for RNA-seq samples 
10 neuralised animal caps treated with AP20187 from stage 10.5 for 3 hours were processed 
for western blot analysis for dpERK.  tERK was used as a loading control.  dpERK was 
successfully induced compared to untreated controls. 
A western blot for dpERK – shown in Figure 5.3 - was also conducted and showed 
activation of the MAPK pathway was at a comparable level to previous experiments 
in neuralised explants as seen in Chapter 4.  Therefore further quality control of 
collected total RNA was undertaken.   
The quality of the extracted RNA was measured in the University of York 
Technology Facility with an Agilent 2100 Bioanalyzer.  Figure 5.4 shows a 
representative trace.  For RNA-seq, total RNA was required to have an RNA 
integrity number (RIN) of at least 7.  Figure 5.4 shows a representative trace of a 
sample passing these requirements, with a RIN of 7.9.  Absorption is on the y-axis 
against nucleic acid length on the x-axis. The largest absorption peaks correspond 
to the ribosomal subunits, and smaller sized fragments to their left corresponding to 
mRNA.  This is also observed on the virtual gel on the right. 
  
Figure 5.4 Representative total RNA spectra and virtual gel 
The above shows a representative bioanalyzer output spectra of a total RNA sample with a 
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virtual gel image.  This sample had a RIN of 7.9.  The x-axis refers to RNA fragment size, and 
absorbance is on the Y axis.  The major peaks and bands are ribosomal subunits.  Minor 
peaks and lower weight bands show mRNA.  Nt on x axis = nucleotide length, FU on y axis = 
fluorescent units.  
5.2.2 Processing and running of samples 
The workflow of the RNA-seq experiment and the contributions by myself, the 
Centre for Genomic research at the University of Liverpool, and Toby Hodges of the 
University of York technology facility is shown in Figure 5.5.  Further detail is given 
in the Methods section. 
 
Figure 5.5.  Workflow undertaken for RNA-seq. 
Lines on the left hand side of the flow diagram indicate the contribution from myself, Toby 
Hodges from the York Biology Technology Facility and the University of Liverpool Centre for 
Genomics Research. 
After total mRNA was sent to the University of Liverpool, it was processed as 
described in the Chapter introduction and Methods.  Samples were sequenced on 
the Hiseq 2500 machine and between ~80 and ~120 million reads were obtained for 
each sample – far higher than initially predicted.  Fragments were sequenced from 
both ends in order to obtain paired reads.   
Extract total RNA and quality control 
Deplete rRNA 
Fragment RNA 
Construct whole transcriptome library  
Run on Hiseq Machine 
Myself 
University 
of Liverpool 
Decode image output into bases, filter out low quality base score, 
 trim 3’ ends. 
Align to the Mayball Xenopus laevis longest cDNA library 
Convert to FPKM, filter out low reads, find fold changes,  
filter out low fold changes. 
Toby 
Hodges 
Myself 
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The raw RNA-seq output was processed by Toby Hodges of the University of York 
Technology Facility, as outlined in the Methods section.  The trimmed reads were 
then aligned using BWA-MEM (Li & Durbin 2009) software to the Xenopus laevis 
Mayball repository of longest cDNAs, collated by the Marcotte lab (accessible at 
http://daudin.icmb.utexas.edu/ ).  This repository was used as although the Xenopus 
laevis genome has been sequenced, its level of annotation was not sufficient for this 
study.  Counts of reads per fragment mapping to each transcript were obtained by 
using SAMtools software (Li et al. 2009).  Reads per fragment were normalised 
against the length of the transcript to prevent biases towards longer genes to obtain 
FPKM values.  From this, FPKM values for induced samples could be compared 
against uninduced samples for each receptor to find the expression fold change for 
each gene after iFGFR induction.   
5.2.3 Scatterplots show many genes are affected by induction of 
iFGFR1 and iFGFR4 
Raw FPKM values for each gene were tabulated and genes with values of 0 FPKM 
in either or both uninduced control and induced fields eliminated.  To obtain an 
overview of the data, induced log2 FPKM values were plotted against uninduced 
log2 values for each receptor, shown in Figure 5.6.  Predictably, most points align 
along y=x indicating no fold expression change as a result of FGF induction.  
However, many data points for both receptors lie outside of the lines y=x±1, 
indicating that they have a 2-fold or greater expression level change.  This indicates 
that many genes were affected by induction of FGF signalling over the course of this 
experiment.  The uninduced samples, as they are expressing the inactive iFGFRs, 
would not be expected to differ much in terms of gene expression levels.  This is 
seen when plotting iFGFR1 and 4 uninduced values against each other, as far fewer 
points lie outside the lines y=x±1.  However, towards the bottom left of the plot 
where FPKM values are lower, there is a greater amount of noise indicating the 
need to interpret the expression changes of these genes with caution. 
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Figure 5.6.  Scatterplots to show ratio of uninduced to induced log2 FPKM for iFGFR1 and iFGFR4 
iFGFR1 and iFGFR4 uninduced values were also plotted against each other (bottom). Those points in 
the green area (to the left of y=x+1) are >2-fold upregulated by FGF induction, and those in red are (to 
the left of y=x-1) >2-fold downregulated.  The yellow line is y=x.   
Towards the bottom left of the scatterplots are genes with low read counts that may 
be false positives in induced vs. uninduced scatterplots - for instance, they may 
display a 5-fold change in expression but their FPKM change from only 0.01 to 0.05, 
which is unlikely to be biologically relevant.  As only one run of this experiment was 
performed, genes not meeting fairly stringent FPKM thresholds or certain fold 
changes must be filtered out to minimise noise and false positives in the data.   
5.2.4 Initial filtering of the dataset and compilation of genelists. 
The filtering conditions suggested by the Technology Facility were implemented 
upon the dataset.  The first condition was that one or both of the uninduced or 
induced samples for each gene had to have an FPKM of ≥ 30.  Secondly, only 
genes that exhibited an expression change of ≥ 2-fold were included.  Genes were 
then sorted into either up or down-regulated genes for each receptor and ordered by 
the magnitude of expression change.  The genelists are displayed in Supplementary 
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Tables 10-13 and include gene symbols, their source entry from the Mayball longest 
cDNA library, and the region of Xenopus laevis genome to which the entry aligns.   
These genelists show that many genes were affected by FGF induction enough to 
pass these filtering thresholds.  Among the top iFGFR1-upregulated genes in the 
RNA-seq data are FoxA4, Lefty FoxD5/FoxD4L1.1 and Tspan1, all of which were 
found in the microarray analysis described in Chapter 3 to degrees summarised in 
Table 5.1.  Lefty and Sprouty2 were also upregulated in this experiment by 8 and 
19.6-fold respectively, although the FPKM of Sprouty2 was not included in genelists 
as its induced FPKM was 23.9, slightly under the threshold of 30.  Hesx1 was 
similarly downregulated by 3.2 and 7.8-fold by iFGFR1 and iFGFR4 respectively.   
Table 5.1 Comparison of highly-affected genes 
Gene Receptor 
Expression fold change 
Microarray RNA-seq RT-qPCR (if performed) 
Tspan1 iFGFR1 6.47 4.1 - 
Egr1 iFGFR1 3.81 25.9* 11.19 
Lefty iFGFR1 2.41 19.6 19.3 
Sprouty2 iFGFR1 1.91 8* 5.24 
Cdx4 iFGFR1 1.67 FPKM <1 - 
FoxD5/FoxD4L1.1 iFGFR1 1.62 5.18 - 
FoxA4 iFGFR1 1.56 166.51 - 
T/Xbra iFGFR1 1.55 FPKM <1 - 
Hmx3 iFGFR4 -1.63 FPKM <1 - 
FoxN4 iFGFR4 -1.67 FPKM <2 -5 
Hesx1 iFGFR1 -2.18 -3.23 -3.56 
*Genes were between 20-30 FPKM and just under filtering thresholds to be included in 
Genelists. 
Hmx3 and FoxN4, found by microarray and in neuralised animal caps to be 
downregulated by iFGFR4, were not found by RNA-seq to be affected by iFGFR 
induction and their FPKMs were extremely low – ‘induced’ values were 1.7 for Hmx3 
and 1.9 for FoxN4.  Egr1, previously found upregulated by iFGFR1 by RT-qPCR 
and the microarray also did not pass filtering conditions due to low read counts 
(18.5 FPKM).  Therefore inevitably due to filtering conditions, some known targets of 
FGF may be excluded from the genelists above.  The mesodermal genes Cdx4 and 
Xbra (listed as T) were both upregulated in whole embryos in the microarray screen.  
They would not be expected to be present in neuralised caps, and indeed their read 
levels were extremely low in the RNA-seq data.  This was also true of the 
mesodermal MyoD1, which was not affected by iFGFR1 or 4 in the RNA-seq screen 
and was expressed at extremely low levels with an FPKM of <1.  This confirms that 
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these neuralised explants are indeed representative of neural tissue.   However 
there are also genes, such as Hba1 encoding haemoglobin found upregulated by 
RNA-seq that are very unlikely to be truly upregulated by FGF induction in a neural 
context.  Therefore the thresholds picked although rigorous probably do not 
eliminate all ‘noise’ and will inevitably exclude true low-read FGF targets. 
5.2.5 iFGFR1 and iFGFR4 affect the expression of different 
genes 
The preliminary microarray results suggested that iFGFR1 and iFGFR4 modulated 
the expression of different genes. To investigate the extent of redundancy or 
otherwise between the different receptors during early neural specification the 
filtered genelists were compared to observe the extent of overlap between genes 
activated or repressed by each receptor in a Venn Diagram - Figure 5.7. 
 
Figure 5.7 – Venn Diagram of iFGFR1 and iFGFR4 signalling targets 
Genes taken from the genelists in Supplementary tables 10-13 were compared.  Genes lying 
in overlapping regions are listed. 
117 genes were found upregulated and 71 genes found downregulated by iFGFR1, 
and 184 genes upregulated and 90 genes downregulated by iFGFR4 induction.  
Figure 5.7 shows that only a relatively small number of genes were commonly 
upregulated or downregulated by iFGFR1 and iFGFR4.  Interestingly, Crabp2, 
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Zfp36l1, Dynll1, Appl1, Ift172 and Slc12a3 were differentially regulated by the two 
receptors, suggesting although in the main iFGFR1 and iFGFR4 function 
independently, there may be a degree of cooperation and competition between 
them.   
5.2.6 Comparison of RNA-seq genelists with other datasets 
To assess the similarity between these RNA-seq data and the iFGFR microarray 
described in Chapter 3, the Venn Diagram tool was used to identify genes these 
datasets had in common.  In addition to this, two other datasets were compared to 
the RNA-seq and the microarray screens, from Branney et al, (2009) and Chung et 
al, (2004).  The results are shown in Table 5.2. 
Table 5.2 – Overlap of RNA-seq data to other datasets 
Dataset 
Compared 
to… 
Number 
of genes  Overlapping genes 
RNA-seq 
iFGFR 
Microarray 38 
Agr2 Eif1 Krt12 Rax 
Arl5 FoxA4 Loc398207 Snai1 
Arg FoxD4L1.1 Nr6A1 Sox13 
Ccnb1 Gnb3 Nuak2 Spry1 
Crabp2 Hesx1 Patch2 Tmem169 
Crx Insm1 Pkfb3 Tspan1 
DnajB14 Irg1 Pnp Wnt11b 
Dusp5 KIAA124-L Prickle Xepsin 
Dynll1 Kit Ptafr   
Eppk1 Lefty Slc312a3   
Branney et 
al 2009 16 
Admp Frz Noggin Sp5l 
Dusp5 Hes Oct.1 Sprouty1 
FoxA4 Hesx1 Pnp Tspan1 
FoxD4L1.1 Lin28 Prickle Zeb2 
Chung et al 
2004 4 Arl5 Dusp1 FoxB1 Zfp36L1 
iFGFR 
Microarray 
Branney et 
al 2009 17 
Cdx1 FoxD5 Lin28a Spry1 
Cdx4 Gsc Meso05 Spry2 
Egr1 Hesx1 Nog Wnt5 
FoxA4 Irg Prickle Wnt8 
      Xmc 
Chung et al 
2004 5 
Arl5 Cdx4 Gata4 Gdf3 
      Mst1 
 
The microarray dataset, as mentioned previously, represents whole embryos with 
iFGFRs activated over a greater period of time compared to the RNA-seq 
experiment, and so is not strictly looking at proximal neural targets.  However 38 
genes found in the microarray were also found more than 2-fold affected by iFGFR1 
or iFGFR4 in this dataset, lending more support for these genes being FGF targets.  
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In addition there are other genes from the same families if not the exact same gene 
found in both datasets– for example other Dusps, Wnts, Hes, and Fox genes.  
In 2009, Branney et al. investigated the FGF-dependent transcriptome with the use 
of dnFGFRs shortly after the onset of mid-blastula transition in Xenopus tropicalis.  
dnFGFR1 or dnFGFR4-expressing embryos were cultured until stage 10.5 and 
processed for microarray analysis.  67 genes were found to be positively regulated 
and 16 genes negatively regulated by FGF signalling (Branney et al. 2009).  16 
genes found by Branney and colleagues appear in this RNA-seq dataset.  Hesx1 
and Hes1 were found similarly downregulated, whereas Fox4l1.1, FoxA4, Pnp, 
Dusp5, Admp, Noggin, Frz1, Sp5l, Sprouty1 and Prickle1 were found similarly 
positively regulated by FGFR signalling.  Egr1 and Sprouty2 did not pass thresholds 
for RNA-seq but was found upregulated by Branney et al too. However, Otx2, Zeb2 
and Lin28A were found positively regulated by FGF signalling by Branney et al but 
listed as negatively regulated by iFGFR4 in this investigation.  Furthermore, some 
mesodermal genes, for instance Xbra found 19x upregulated by Branney et al., are 
not changed in this study, reinforcing this RNA-seq data as being representative of 
neural as opposed to mesodermal development, although a similar number of 
genes were found shared between Branney et al., and the microarray data.   
Another microarray study investigating FGF signalling targets used SU5402 to 
inhibit FGF signalling in whole Xenopus laevis embryos between stages 10.5 and 
11.5.  38 genes were found to be positively regulated by FGF signalling and 5 
genes negatively regulated by FGF signalling (Chung et al. 2004).  Due to the age 
of Chung et al., 11 genes were classed as unidentified proteins and their accession 
numbers are still only recognised as an unidentified ‘transcribed locus’ or have been 
retired on NCBI.  Upon closer inspection a further 15 genes listed in general terms 
such as ‘reverse transcriptase’ still have no entry on Unigene and Xenbase, and the 
identities of these genes are still unknown.  Of the remaining genes, after 
conversion into modern gene symbols 4 were found in common with the RNA-seq 
dataset – Arl5, FoxB1, Dusp1 and Zfp36l1 – and 5 in common with the iFGFR1/4 
microarray – Arl5, Mst1, Gdf3, Cdx4 and Gata4.  This suggests that these genes 
are important for FGF signalling during development in general rather than in a 
solely neural context. 
These comparisons with other datasets show that as well as novel putative FGF 
targets, the RNA-seq experiment has replicated some of the findings made by other 
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research groups, which lends weight to these overlapping genes being FGF targets 
in a neural context. 
5.2.7 Many genes identified by RNA-seq have roles in neural 
development and/or FGF signalling 
An extensive literature search was conducted on genes up- and downregulated by 
iFGFR1 and iFGFR4.  The aim of this search was to gain an insight into how many 
genes in the dataset were already known to have roles in neural development 
and/or have known links to FGF signalling.   
Firstly, genes were searched for on Xenbase.  On Xenbase, each gene entry 
normally includes its function if known, and a community-submitted ISH image of 
gene expression, although the amount of information available about each gene is 
variable.  When basic information was unavailable, other model organism 
databases were searched such as eMAGE (mouse) and ZFIN (zebrafish) for 
expression data.  Genes which appeared from this preliminary search to be 
expressed in the developing CNS, were involved in neural development, or were 
listed as being involved in other FGF-related processes such as ciliogenesis or the 
cell cycle were investigated more extensively using Pubmed.   This more extensive 
literature search revealed many of these genes to indeed have known links to 
neural development and patterning, as well as often being involved in FGF 
signalling.  The results of this search are tabulated in Table 5.3-4.   
The majority of the upregulated genes investigated were already known to be 
expressed in the CNS.  Several genes or their family members were found affected 
by iFGFRs in the microarray screen.  Furthermore, many genes have published 
links to FGF signalling either directly or indirectly, and in some cases other genes in 
the dataset (in bold).   Genes identified in the microarray screen using iFGFRs 
discussed in Chapter 3 were often members of other major signalling pathways 
including TGF, Wnt, Shh, and RA and targets of these pathways were also 
represented in this RNA-seq data.   Furthermore, patterns emerged such as genes 
involved in ciliogenesis, left/right asymmetry and eye development - processes of 
which FGF signalling is known to be required for.   
This lends support for this dataset being representative of neural genes, and many 
findings are in keeping with what is already known about FGF signalling and targets.   
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Table 5.3 – Selection of genes upregulated by iFGFR1 
Gene 
Fold 
Change Role 
In 
microarray? Expression Summary 
References 
ADMP 5.7 
TGFβ growth 
factor No Dorsal midline 
ADMP is a member of the BMP pathway which has 
ventralising activity.  Required for correct anterior-
posterior neural patterning.  Represses FGF signalling 
in Ciona. 
(Ohta & Satou 
2013; 
Reversade & De 
Robertis 2005)  
ATP6V0C 2.8 
H+ v-ATPase 
subunit No 
Brain neural tube, 
neurons 
Also known as Ductin.  Implicated in early laterality 
through its association with Rab11, and 
pharmacological inhibition causes heterotaxia in 
Xenopus, zebrafish and chick.  Possible link to Snx10 
in regulating ciliogenesis.  Involved in control of 
neuronal excitability.   
(Adams et al. 
2006; 
Vandenberg et 
al. 2013; Chung 
et al. 2010)  
BCL9  2.2 
Transcription 
co-activator No unknown 
Implicated in lens and body axis development.  BCL9 
is part of a complex which, with canonical Wnt 
signalling, activate FGF18 and 20   
(Katoh & Katoh 
2006; Kennedy 
et al. 2010)  
BTG2 4.5 
Anti- 
proliferation 
factor No 
Notochord, 
somitic mesoderm 
Inhibition causes anterior head defects and 
downregulation of neural markers such as EN2 and 
Otx2 and Rax.  Interacts with Ccnb1 and Not-b and 
required for notochord differentiation 
(Sugimoto et al. 
2007; Ryu et al. 
2004)  
CRABP2 2.1 
Retinoic acid 
binding protein Yes CNS 
Involved in retinoid signalling.  Represses 3' Hox 
genes.  RA and FGF pattern the antero posterior 
neural axis 
(Lloret-
Vilaspasa et al. 
2010) 
CREBBP 
2.1 
 
Creb binding 
protein Creb3 CNS (mouse) 
Listed on Xenbase as interacting with BMPs, Chordin, 
Smads, NeuroD, Wnts, Cited2, Zeb2 and FGF8.  It is 
known to be controlled by FGFR1 signalling to 
stimulate cell differentiation 
(Fang et al. 
2005) 
DUSP1 2.1 
MAPK 
phosphatase Dusp6 
Telencephalon 
(mouse) 
MAPK phosphatase, also found upregulated by 
FGFR1 in a previous microarray screen. 
(Branney et al. 
2009) 
DUSP5 10.6 
MAPK 
phosphatase DUSP6 
Anterior CNS, 
branchial arches 
MAPK phosphatase also found upregulated by FGFR1 
in a previous microarray screen. 
(Branney et al. 
2009) 
DYNLL1 2.3 
Microtubule 
motor 
component and 
scaffolding Yes Cilia, neural tube 
Differentially regulated by the two receptors in this 
screen.  Light chain component of motor protein 
dynein, but found to bind to a wide range of complexes 
as a scaffolding protein. Interacts with Nek6 (found in 
(Rapali et al. 
2011; Regué et 
al. 2011; Kim et 
al. 2011; 
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protein microarray) through binding to Nek9 and is required for 
ciliogenesis.  Also an effector of Nde1. 
Goggolidou et 
al. 2014)  
FOXA4 116.5 
Transcription 
factor Yes 
Notochord, 
Spemann's 
organiser 
Also known as Pintallavis. FoxA4 is a notochord 
marker which restricts anterior neural development, 
including the expression of Hesx1 and is required for 
maintenance of the CNS.  
(Murgan et al. 
2014; 
Martynova et al. 
2004)  
FOXB1 6.0 
Transcription 
factor no CNS 
FGF is required for FoxB1-suppression of anterior 
neural structures.  FoxB1 also promotes neural 
induction 
(Takebayashi-
Suzuki et al. 
2011) 
FOXD4L1.2 7.3 
Transcription 
factor Yes Posterior CNS 
Also known as FoxD5A.  Early neural gene regulated 
by FGF and BMP signalling.  Regulates a number of 
neural transcription factors to regulate transition from 
immature neural ectoderm to neural progenitors. 
(Marchal et al. 
2009; Neilson et 
al. 2012)  
HES1 2.9 
Transcription 
factor Hes5.2/6 
Neural plate 
border 
Notch effector. Essential for neural crest proliferation 
downstream of FGFs with Hes2. Interacts with 
Neurogenin.  With Rax and Notch, Hes1 promotes glial 
cell formation at the expense of neuronal fates in the 
rat. 
(Furukawa et al. 
2000; Nichane 
et al. 2008)  
ID3 3.3 
Transcription 
factor No Neural plate 
A known FGF target.  It’s interaction with HES1 is 
essential for neural crest formation.  It is able to 
disrupts a Stat3-FGFR4 complex formation in neural 
crest development 
(Nichane et al. 
2010; Nichane 
et al. 2008)  
IKZF2 15.5 Zinc finger No 
CNS (mouse), 
neurons 
Also known as Helios.  Required for lateral ganglion 
eminence and striatal neuron development. 
(Martín-Ibáñez 
et al. 2012) 
IRX1 2.3 
Transcription 
factor No 
Dorsal midline, 
primary neurons 
Also known as Iroquois.  Required for neural 
patterning, MHB formation, and required for FGF8 
expression in the Isthmic organiser.   
(Glavic et al. 
2002) 
LEFTY 19.6 
Left/right 
asymmetry Yes 
CNS, head, 
paraxial 
mesoderm 
FGFs may interact directly with Lefty and interacts 
indirectly through Fibp1 and Ier2 to mediate left/right 
patterning.  Both Lefty and FGFs are required for 
correct breaking of left/right asymmetry. 
(Rodríguez 
Esteban et al. 
1999; Hong & 
Dawid 2009)  
MXI1 2.6 
Transcription 
factor No Brain 
Mxi1 is essential for neurogenesis and positively 
regulated by the pan -neural marker Sox3 and 
negatively by Notch.  Overexpression of Mxi1 inhibits 
the primary neuron marker N-tubulin 
(Klisch et al. 
2006) 
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NOT-B 8.1 
Transcription 
factor No Notochord 
Required for notochord development and can be 
suppressed by SU5402. 
(Chung et al. 
2004) 
NOTCH3 2.1 
Signal 
transduction No 
Neural ectoderm, 
somites 
FGF known to interact with Notch pathway 
 
 
 
 
(Harada et al. 
1999; Mitsiadis 
et al. 2010; 
Faux et al. 
2001)  
OCT-25 
3.3 
 
Transcription 
factor No Dorsal midline  
Oct25 is a known neuralising factor known to 
upregulate FoxB1. 
(Kole et al. 
2014; 
Takebayashi-
Suzuki et al. 
2011)  
POU3F4 2.8 
Transcription 
factor POU2F2,2F3 neural plate, brain 
A noggin-inducible gene, with neuralising activity.  
Other interactants listed on Xenbase are Cdx2, 4 and 
posterior Hox genes.  It is controlled by RA and FGF 
signalling. 
(Robert-Moreno 
et al. 2010) 
POU4F2 52.2 
transcription 
factor No CNS 
Involved in retinal ganglion cell differentiation.  
Interacts with other Pou family members  
(Li et al. 2014) 
PRICKLE1 2.8 
Wnt negative 
regulator Yes 
Posterior CNS, 
somites FGF are known to interact with Wnts to pattern CNS 
See General 
Intro 
PTCH2 2.5 
Hedgehog 
receptor Yes CNS, somites 
FGF and Hedgehog signalling interact in other 
developmental contexts such as the limb, the anterior 
neural border, neocortical patterning and neural tube 
patterning. 
(Bénazet & 
Zeller 2009; 
Kessaris et al. 
2004; Briscoe & 
Novitch 2008)  
SMURF2 2.0 
Ubiquitin protein 
ligase No Neural plate 
A Member of the TGFβ signalling family, Smurf2 binds 
to inhibitory Smads to mark them for degradation.  
(Inoue & 
Imamura 2008) 
SP5L 4.3 
Transcription 
factor No Posterior CNS 
A known FGF target involved with antero-posterior 
patterning.  Found in a microarray to be downstream of 
FoxD4L1.2.   
(Sun et al. 2006; 
Zhao et al. 
2003)  
SPROUTY1 8.0 
MAPK negative 
regulator Yes 
Branchial arches, 
MHB, tailbud Negative regulator of MAPK pathway 
See general 
introduction 
TSPAN1 4.1 
Tetraspanin 
membrane 
protein Yes 
Posterior CNS, 
cement and 
hatching gland 
Integral membrane protein negatively regulated by 
BMPs also required for gastrulation movements and 
neural differentiation. 
(Yamamoto et 
al. 2007) 
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WNT11B 14.1 
Wnt signalling 
ligand Yes CNS 
FGFs are known to interact with Wnts to pattern the 
CNS 
See General 
Intro 
YY1 2.1 
Transcription 
factor No 
Anterior neural 
tube 
Regulates expression of the neural crest marker Slug.  
Interacts with Ruvbl2 and involved in anterior posterior 
patterning. 
(Morgan et al. 
2004; Kwon & 
Chung 2003)  
ZFP36L1 2.0 
Zinc finger 
protein No 
Pronephros, otic 
vesicle, brain 
Shown to be downstream of ERK and required to 
control lipoprotein receptor mRNA stability 
(Adachi et al. 
2014) 
 
 
Table 5.4 – Selected genes upregulated by iFGFR4 
Gene 
Fold 
change Role 
In 
microarray? Expression  Summary 
References 
CCNB1 3.1 
Cell cycle 
regulator Yes Global Phosphorylated by MAPK. 
(Walsh et al. 
2003) 
CDC6 2.6 Cell cycle No Global 
Cdc6 is involved in the cell cycle, like FGFs, and is 
downregulated by FGF in chondrocytes; repressive 
complexes on the Cdc6 promoter increases upon FGF 
treatment. 
(Kolupaeva & 
Basilico 2012) 
CITED2 2.9 
Transcriptional 
regulator No CNS (mouse) 
Required for breaking left/right asymmetry and part of 
the nodal signalling cascade.  Overexpression induces 
anterior genes such as Otx2 but represses the 
posterior HoxB9 and the eyefield marker Rax. 
(Lopes Floro et 
al. 2011; 
Bamforth et al. 
2004; Yoon et 
al. 2011) 
DUSP22 2.6 
Dual-specificity 
phosphatase 22 DUSP6 Posterior CNS 
Dusp1, Dusp5 and Dusp6 also mentioned in this 
dataset and microarray. 
 
FGFR1OP2 2.2 
FGFR1 
oncogene 
partner No Thymus (mouse) 
Novel gene fused to FGFR1 in 8p11 myeloproliferative 
syndrome, causing its deregulation. 
(Grand et al. 
2004) 
FOPNL 2.2 
FGFR1OP n 
terminal-like No Unknown Involved in ciliogenesis, a centrosome protein  
(Lee & Stearns 
2013) 
FRS3 4.6 Docking protein No 
Anterior CNS, 
somites 
FGF Receptor substrate also required for lens placode 
development. 
(Kim et al. 2015) 
GREM1 2.4 BMP antagonist No CNS, somites Found downregulated in zebrafish fgf8 mutants. 
(Nicoli et al. 
2005) 
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HES2 2.8 
Transcription 
factor 
Hes 
members in 
microarray 
Forebrain, 
hindbrain, retina 
Notch effector.  Interacts with Id3 downstream of FGF 
to specify neural crest progenitors.  Hes1 is also an 
interactant.  Hes2 is expressed in the retina and 
increases glial cell production by repressing 
neurogenesis. 
(Nichane et al. 
2008; Sölter et 
al. 2006)  
HN1 
2.1 
 
Human notch 
paralogue No CNS FGF signalling known to regulate Notch pathway 
(Faux et al. 
2001; Akai et al. 
2005; Mitsiadis 
et al. 2010)  
IFT172 
6.5 
 
Ciliogenesis No Unknown 
Ift172 regulates FGF8 in MHB development.  Positively 
regulated by Mxi1.  When upstream regulator ATMIN 
is depleted, Ift172 and Dynll1 are both downregulated. 
(Gorivodsky et 
al. 2009; Ko et 
al. 2013)  
INSM1 2.3 
Transcription 
factor  No 
CNS, PNS, 
pancreas 
Depletion of Insm1 caused upregulation of FGFR4 in 
cells, and Insm1 also regulates Neurogenin3. 
(Osipovich et al. 
2014) 
ITPKC 2.1 
1D-myo-inositol-
triphosphate 3-
kinase A No Unknown 
 
Part of the inositol triphosphate pathway, a branch of 
FGF signalling 
 
KLF2 3.4 Zinc finger klf17 CNS 
Repression of FGF signalling reduces KLF2 levels in 
vitro 
(Lanner et al. 
2010) 
MARK4 24.3 Ciliogenesis Yes Unknown 
Promotes axoneme extension during ciliogenesis, a 
process FGF is involved with 
(Kuhns et al. 
2013) 
NDE1 
2.1 
 
Scaffolding 
protein No CNS 
Inhibits ciliogenesis which affects cell cycle re-entry. 
Deficiencies cause left-right patterning defects.  MAPK 
modulation by the Nde1- Lis1-Brap complex patterns 
the mammalian CNS.  Influences Dynll1 expression. 
(Kim et al. 2011; 
Lanctot et al. 
2013)  
NEDD9 4.3 Adaptor protein NEDD4-like Unknown 
Retinoic-acid inducible protein.  Regulates neural crest 
cell migration. 
(Aquino et al. 
2009) 
NOGGIN 2.2 BMP antagonist No CNS Well-documented FGF interaction 
(Branney et al. 
2009; Fletcher & 
Harland 2008)  
OCT60 3.1 
Transcription 
factor No Neural plate 
Also known as Pou5F3.3.  Linked to FGF through its 
target Spalt-like 4, which activates Oct60. 
(Young et al. 
2014) 
POC5 2.1 
Centriolar 
protein No 
Spinal cord, 
retina, dorsal root 
Required for the formation of full-length centrioles but 
in mouse is localised to the CNS. 
(Azimzadeh et 
al. 2009) 
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ganglion (mouse) 
RAB21 2.3 Small GTPase 
RAB4 and 
RAB27 Global Member of Ras superfamily. 
 
RASSF3 2.7 
Ras-associating 
protein Yes Global MAPK effector 
 
RND3 2.0 
GTP binding 
protein No Brain, somites 
Required for somitogenesis, and knockdown of FGF8 
causes a posterior shift in Rnd3 expression 
(Goda et al. 
2009) 
SNX10 2.6 Sorting Nexin No Unknown 
A regulator of ciliogenesis and required for correct 
left/right patterning.  Possible functional link to 
Atp6V0C. 
(Chen et al. 
2012) 
TAPT1 2.2 
Transmembrane 
protein No Global (mouse) 
Tapt1 is a downstream effector of HoxC8 and when 
mutated causes homeotic transformations  
(Howell et al. 
2007) 
VANGL2 3.3 
Non canonical 
Wnt signalling 
protein  VANGL1 
Somites, 
notochord 
Interacts with FGF signalling through cadherin and has 
a role in left/right asymmetry.  Also listed as interacting 
with Cdx4, FoxA4, Wnts, Shh, HoxD1, Xbra, and 
Nodal on Xenbase. 
(Nagaoka et al. 
2014; 
Vandenberg et 
al. 2013)  
 
Table 5.5 – Selected genes downregulated by iFGFR1 
Gene 
Fold 
change Role 
In 
microarray? Expression  Summary 
References 
APPL1 -2.6 
Signal 
transduction No Anterior CNS 
An APPL1/Akt signalling complex regulates dendritic 
spine and synapse formation in hippocampal neurons. 
(Majumdar et al. 
2011) 
CIRBP -2.0 
Cytoplasmic 
RNA binding 
protein No CNS, pronephros 
In Xenopus, compared to controls Cirpb morphants 
have a slower cell migration rate, inhibit eFGF and 
activin-induced animal cap elongation and have 
defects in brain development 
(Peng et al. 
2006) 
HES3.1 -2.4 
Transcriptional 
repressor 
Hes family 
members 
also in 
microarray anterior CNS 
Hes1 and Hes3 regulate maintenance of the isthmic 
organizer and development of the mid/hindbrain.  Loss 
of FGF activity or Hes1/Hes3 function results in 
premature differentiation of ventricular zone progenitor 
cells. 
(Hirata et al. 
2001) 
HESX1 -3.2 
Transcription 
Factor Yes Anterior CNS 
Hesx1 controls neural differentiation and patterning of 
the anterior CNS.  Represses Ras-dva, Activates Otx2 
and anterior FGF8.  It is repressed by Hmx3 
(Ermakova et al. 
1999; Tereshina 
et al. 2014; 
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(microarray).  FoxA4 is essential for defining its 
posterior limits. 
Ermakova et al. 
2007; 
Martynova et al. 
2004)  
IFT172 -3.0 Ciliogenesis No Unknown 
Ift172 regulates FGF8 in MHB development.  Positively 
regulated by Mxi1.  When upstream regulator Atmin is 
depleted, Ift172 and Dynll1 are both downregulated.   
(Gorivodsky et 
al. 2009; Ko et 
al. 2013) 
KRT12 -5.3 Keratin Yes Epidermis 
Neural induction represses epidermal genes such as 
keratin  
(Delaune et al. 
2005) 
MDK -2.2 Growth factor No CNS 
Midkine/MDK is a growth factor with neurotrophic and 
neurite outgrowth activities and known to be positively 
regulated by RA.  Found in microarrays similarly 
affected by changes in RA levels with Dusp6, Cdx4, 
Cited2, and Otx2.  
(Hayata et al. 
2009; Arima et 
al. 2005)  
PIN4 -2.0 
Parvulin-like 
peptidyl-prolyl 
cis-trans 
isomerase  No Unknown 
NIMA-interacting.  Closely-related Pin1-mediated 
activation of Runx2 is needed for FGF2’s role in 
osteoblast differentiation, as well as interaction with 
Nek6. 
(Chen et al. 
2006) 
PITPNB -2.8 
Phosphatidylino
sitol transfer 
protein No 
Thymus 
primordium (mice) Part of phosphatidylinositol cascade 
 
PTMA-A -2.7 Ubiquitin ligase No CNS Involved in cell proliferation and differentiation.  
(Donizetti et al. 
2008) 
RUVBL2 -2.3 DNA helicase No CNS 
Interacts with Yy1.   It regulates transcription through 
multiple chromatin remodelling complexes. Essential 
for cilia motility in zebrafish.  
(López-Perrote 
et al. 2014; 
Zhao et al. 
2013) 
SNAI1 -2.8 
Transcriptional 
repressor Yes CNS 
Required for neural crest development.  Loss of 
FGFR1 causes loss of Snai1 expression in mice  
(Ciruna & 
Rossant 2001) 
TUBA1A-B -2.2 alpha tubulin No epidermis Neural induction represses epidermal genes  
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Table 5.6 – Selected genes downregulated by iFGFR4 
Gene 
Fold 
change Role 
In 
microarray? Expression  Summary 
References 
CCND1 -2.6 Cell cycle No CNS 
Wnt target through Frz (microarray) based on the Bcl9 
complex.  Upregulated by FGF2 in vitro. 
(Katoh & Katoh 
2006; Lai et al. 
2011)  
CRABP2 -9.6 
Retinoic acid 
binding protein Yes CNS 
Represses 3' Hox genes.  RA and FGF pattern the 
antero posterior neural axis.  
(Lloret-
Vilaspasa et al. 
2010) 
CRX-A/B -2.0/-2.1 
Transcription 
Factor Yes Anterior CNS 
Implicated in eye development, interacts with Rax, and 
increased in FoxN4 (microarray) mutants.  
Mesodermal Crx is depleted when FGF is inhibited. 
(Giudetti et al. 
2014; Vignali et 
al. 2000; Xiang 
& Li 2013; 
Fletcher & 
Harland 2008)  
CYP26A1 -5.9 RA hydroxylase No CNS 
FGF activates Cyp26A1, an enzyme that triggers RA 
degradation.  It sharpens the RA gradient during 
patterning of the midbrain/hindbrain regions. 
(Rhinn & Dollé 
2012; Shiotsugu 
et al. 2004) 
DYNLL1 -2.5 
Scaffolding 
protein Yes Cilia, neural tube 
Differentially regulated by the two receptors in this 
screen.  Light chain component of motor protein 
dynein, but found to bind to a wide range of complexes 
as a scaffolding protein. Interacts with Nek6 (found in 
microarray) through binding to Nek9 and is required for 
ciliogenesis.  Also an effector of Nde1. 
(Rapali et al. 
2011; Regué et 
al. 2011; Kim et 
al. 2011; 
Goggolidou et 
al. 2014)  
GNB3 -3.1 
G protein b 
subunit Yes MHB, retina 
Involved in eye development, Gnb3 is expressed by 
Islet1-positive cone ON-bipolar cells and by cone 
photoreceptors. 
(Ritchey et al. 
2010) 
HESX1 -7.8 
Transcription 
Factor Yes Anterior CNS 
Hesx1 controls neural differentiation and patterning of 
the anterior CNS Represses Ras-dva, inhibits Otx2 
and FGF8. 
(Ermakova et al. 
1999; Ermakova 
et al. 2007; 
Tereshina et al. 
2014)  
KRT5.7 -3.4 keratin 
Other 
keratins 
present Epidermis 
Neural induction inhibits epidermal genes such as 
keratin  
(Delaune et al. 
2005) 
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LIN28A -3.0 RNA processing No 
Dorsal blastopore 
lip 
Found in previous microarray screen for FGF targets.  
Required for germ layer specification in Xenopus.  A 
loss stops cells responding normally to FGF 
(Branney et al. 
2009; Faas et 
al. 2013)  
NR6A1 -4.7 
Transcription 
Factor Yes CNS 
Also found in screen for RAR target.  Downregulates 
Oct4.  A knockout phenotype failed to close the neural 
tube and had ectopic tail and deformed heads.   
(Barreto et al. 
2003) 
OTX2 -2.9 
Transcription 
Factor No Anterior CNS 
Anterior neural marker repressed and activated by 
FGF8 at various times during neural development.  
Affects the expression of Btg2.  In positive loop with 
Ras-dva and FGF8.  Inhibited by Hesx1 and Cdx4. 
(Liu et al. 2003; 
Tereshina et al. 
2014; Isaacs et 
al. 1998; 
Ermakova et al. 
2007)  
RAX -2.6 
Transcription 
Factor Yes Retina 
An eyefield marker, expression downregulated as 
neuralation proceeds.  Reduced when FGF target 
Lpar6 is knocked down.   
(Giudetti et al. 
2014; Geach et 
al. 2014)  
ROR2 -3.5 Kinase No 
Branchial arches, 
posterior CNS 
 Interacts with Wnt5.  Ror2 receptor mediates Wnt11 
ligand signalling and affects convergence and 
extension movements in zebrafish. 
(Oishi et al. 
2003; Bai et al. 
2014)  
SHISA2 -2.1 ER protein No 
Somites; 
branchial arches 
Shisa2 promotes the maturation of somitic precursors 
and is required for somitogenesis. Wnt and FGFs 
rescue Shisa2 MO defects.  Shisa2 promotes head 
formation through the inhibition of the caudalising 
factors, Wnt and FGF   
(Nagano et al. 
2006; 
Yamamoto et al. 
2005)  
SHROOM3 -2.8 
Actin regulating 
protein No CNS 
Important for morphogenesis during gastrulation and 
neuralation.  Shroom3 induces apical constriction and 
is required for hingepoint formation during neural tube 
closure. Overexpression of Vangl2 inhibits its apical 
restriction. 
(Ossipova et al. 
2015) 
TUBA1A -2.0 Alpha tubulin No Epidermis Neural induction represses epidermal genes  
ZEB2 -18.1 
Transcription 
factor No CNS 
FGFs activate Zeb2 through Churchill, which is 
required for Zeb's expression in neural plate.  
Transcriptional repression during neural induction and 
inhibits Bmp4.  It is required for neural induction and 
depletion causes loss of N-tubulin. 
(Nitta et al. 
2004; van 
Grunsven et al. 
2007)  
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Therefore even though only one biological experiment was undertaken instead of a 
replicated study, the links between the genes in the data, the documented activity of 
many of these genes in the CNS and in connection to FGF signalling and each 
other strengthens the likelihood of this dataset being a true reflection of FGF 
overactivation in a neural context.  
5.2.8 Ontological Analyses 
Ontological analyses were performed to find further functional patterns in putative 
FGF targets during neural development by searching for common gene ontology 
‘GO’ terms.  A range of online programs were tried to achieve this, among them 
DAVID and GOrilla, using the genelists above containing genes with an FPKM of 
≥30 FPKM and fold change of ≥2.  Unfortunately, due to these tools not being 
optimised for Xenopus, only 17% of genes from already small genelists were 
included in the output so no meaningful results were obtained.   
Therefore to increase the size of the dataset for easier statistical enrichment 
analyses, the filtering conditions of the dataset were relaxed slightly - genes from 
the original unfiltered dataset were picked out that had an FPKM of at least 20 for 
either or both uninduced and induced samples, and an expression fold change of 
≥1.5.  Also, the A and B pseudoalleles unique to the tetraploid laevis were merged 
into just one form to increase the likelihood they would be recognised by other 
databases.   
The PANTHER (Protein ANalysis THrough Evolutionary Relationships) 
Classification System was then tried with these new conditions with better results.  
The PANTHER website which has several options for analysing genelists and 
performing enrichment analyses based on a background genelist dataset (the whole 
organism genelist).  The aspect of PANTHER used in this study compare gene 
symbols in the input (one of the four genelists) against a Xenopus background list, 
and performed statistical tests to determine if a GO term, protein or pathway 
component was enriched or depleted based upon an expected value predicted from 
a dataset of a certain size (Table 5.7 and Table 5.8).    
5.2.8.1 Clustering genes by GO term 
Although not of interest to this study, all four of these genelists are enriched highly 
significantly for metabolic genes, showing that FGFs have a role in regulation of 
metabolism as well as neural development.  Cell cycle genes are also enriched in all 
145 
four genelists, although it is most significant in the iFGFR1 downregulated and 
iFGFR4 upregulated genelists, where the P-values were 6.73E-6 and 2.44E-6 
respectively.  An interesting point of difference between the receptor genelists are 
the terms involving development.  The iFGFR1 upregulated genelist was 
significantly enriched for the term ‘developmental process’ and ‘ectoderm 
development’ whereas the iFGFR1 downregulated genelist was depleted for the 
terms ‘mesoderm development’, ‘system development’ and ‘developmental 
process’.  This confirms that FGF signalling is involved in many developmental 
processes, in keeping with known roles of FGF.  However, the ‘iFGFR4 upregulated’ 
GO term output had more in common with ‘iFGFR1 downregulated’ output in this 
respect.  Nervous system, ectodermal, muscle, heart, skeletal system and system-
developmental processes were all present at less than the expected value.  It is not 
surprising that heart, muscle and skeletal developmental processes are not 
enriched in a neuralised animal cap, but the net downregulation of the nervous and 
ectodermal development across the whole datasets is interesting, seeing as this 
experiment is within neuralised explants system.  Plenty of known neural targets 
were picked for the literature analysis in the iFGFR4 upregulated dataset, so it is 
undeniable that iFGFR4 has an important role in neural development and other 
aspects of development at this time, but maybe across the whole dataset there are 
less of these genes present than the expected value and iFGFR4 is more heavily 
involved in other processes.  Common to both downregulated genelists, genes 
implicated in RNA processing, splicing and translation are enriched.  Ribosomal 
metabolism is also enriched – although this needs to be interpreted with caution as 
the rRNA depletion methods used enrich total RNA for mRNA to use in RNA-seq 
may leave variable residual amounts of ribosomal transcripts in the samples. 
According to these analyses components of cell cycle regulation and metabolism 
are both positively and negatively influenced by FGF signalling.  Therefore, although 
there is little overlap between genes appearing in iFGFR1 and iFGFR4 genelists, 
the receptors cooperate to regulate some processes.  Some processes such as 
RNA processing are negatively regulated by both receptors during Xenopus neural 
development.  Developmental processes may be differentially regulated by iFGFR1 
and iFGFR4, suggesting there are also fundamental differences between the long-
term outputs of each receptor. 
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Table 5.7 iFGFR1 GO Term Enrichment 
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Table 5.8 iFGFR4 GO terms Enrichment 
 
5.2.8.2 PANTHER Protein Analysis 
Statistical enrichment analysis was repeated on the same genelist to pick out 
classes of protein associated signalling by iFGFR1 and iFGFR4 (Table 5.9).  As 
with GO term analysis findings, ribosomal proteins were enriched in both 
downregulated lists, as were cell:cell adhesion related proteins.  An interesting point 
of difference between the two receptors was the terms involving transcription 
factors.  The iFGFR1 upregulated lists were enriched for the terms ‘transcription 
factor’, ‘homeobox transcription factor’, ‘helix-loop-helix transcription factor’, ‘KRAB 
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box transcription factor’, ‘basic leucine zipper transcription factor’ and ‘helix-turn-
helix transcription factor’.  The iFGFR1 downregulated list was enriched for ‘HMG 
box transcription factor’ but depleted for ‘zinc finger transcription factor’ and ‘KRAB-
box transcription factor.  As with the GO terms pertaining to developmental 
processes, this pattern was reversed with iFGFR4 genelists with the upregulated 
genelist being significantly depleted for these terms and the downregulated genelist 
enriched for ‘transcription factor’.  Similar to GO terms suggesting transcriptional 
and translational-related genes are enriched in both downregulated genelists, 
downregulated genelists for both receptors were similarly significantly enriched with 
transcription, translation and RNA processing-related protein terms, although the 
significance of this is unclear.  Lastly, defence immunology-related proteins were 
present at significantly less than the expected value in the upregulated lists for both 
receptors, suggesting that stress-response genes were not activated in large 
amounts in response to FGF induction. 
5.2.8.3 PANTHER pathways 
The preliminary microarray dataset contained a lot of genes involved in other 
developmental signalling pathways, particularly Wnts of which FGF signalling is 
known to cooperate with in the patterning of posterior neural tissue (McGrew et al. 
1997; Kudoh et al. 2002; Dyer et al. 2014).  Do iFGFR1 and iFGFR4 also modulate 
the expression of other signalling pathways in neural development?  To answer this 
question, PANTHER pathway enrichment analysis was undertaken using the same 
genelists as for previous PANTHER studies, and the genes involved in each 
pathway listed (Table 5.10).  Indeed, the iFGFR1 upregulated genelist was 
significantly enriched for FGF, Wnt, PI3K and Notch pathway components indicating 
a wide range of crosstalk between FGFR1 and these pathways. The iFGFR4 output 
was very different, and few non-metabolic pathways were found significantly 
enriched.      
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Table 5.9 PANTHER Protein Class Enrichment
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Table 5.10 PANTHER Pathway Enrichment 
 
 
5.2.8.4 Kinase enrichment analysis using Network2Canvas 
Kinase enrichment analysis using Network2Canvas was performed to complement 
the PANTHER pathway analysis, as kinases are often components of cell signalling 
pathways.  Network2canvas is a way of visualising networks within datasets.  
Commonly interacting genes form a ‘node’, and these nodes are visualised in 
Network2Canvas on a toroidal grid, with the brightness of the nodes proportional to 
the strength of connection to its neighbouring nodes.   
Thus, in Network2Canvas kinase enrichment analysis (KEA), nodes are built around 
kinases.  Not all kinases are in the genelists, but if a significant number of 
intersecting genes in the genelists interact with it, it will be listed as a node. This is 
observed with Nek6, found upregulated by iFGFR1 in the preliminary microarray 
and RNA-seq by iFGFR1 but not included in RNA-seq genelists due to low read 
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counts.  In Table 5.11 Nek6 is listed as forming an interactant node with SGK1, 
SMAD4, SMURF2 and NUP98.    Information about other nodes was found by 
looking up their genecard reference on the NCBI database.  Other nodes from 
iFGFR1 listed are the cell cycle-related CDK1, CDK2 and FRK as well as the 
Pi3K/Akt related kinases AKT1 and MTOR.  MAPK1 is listed as well as MAPKAPK2 
and MAPK14, so therefore the FGF pathway effectors are well represented in the 
dataset.   
Table 5.11 Kinase enrichment for iFGFR1-upregulated genes 
Node 
Name P-Value 
Associations 
Intersecting Genes 
CDK2 2.37E-04 Cell Cycle 
AFF1;AKT1S1;ARID1A;BCL9;BRD3;CCNA1;CDC27
;CREBBP;EP300;FNBP4;ID3;MYBL2;POLR2A;PPM
1B;RAP1GAP;RPS3;SF1;SMAD4;SOX11;TSC1;UB
E2E3;ZNF217;SGK1;C1ORF198;FOXK2;MLL2;MTA
2;NUFIP2;NUMA1;NUP153;NUP98;PBRM1;POU2F
1;WHSC2 
AKT1 8.42E-04 FGF-AKT 
AKT1S1;EP300;FLNA;PLXNA1;PTEN;RAC1;TSC1;
YAP1;THRA;CREBBP;KHSRP;PFKFB3;RPS3;SMA
D4;SH3BP4;TTC3;ZFP36L1;CDC25B 
MTOR 1.59E-03 FGF- AKT 
AKT1S1;SGK1;UBR4;CDC42BPB;FLNA;FOXK2;NU
MA1;POLR2A;RC3H1 
NEK6 1.88E-03 
NIMA-
related 
kinase SGK1;SMAD4;SMURF2;NUP98 
GSK3B 3.53E-03 WNT 
AFF1;ARID1A;BCL9;BRD3;CDC25B;CDC27;CNOT
4;CRKL;FLNA;FNBP4;IER3;LRP6;MYBL2;NOTCH1;
PCDH1;POGZ;POLR2A;PTEN;RAP1GAP;RPS3;SF
1;SMAD4;SON;SOX11;SPEN;UBE2E3;WHSC2;ZN
F217;SGK1;MLL2 
CDK1 1.07E-02 Cell cycle 
AKT1S1;C13ORF15;CCNA1;CDC25B;CDC27;CNO
T4;CRKL;DUSP1;FLNA;GADD45G;MLL4;MYBL2;P
CDH1;PIK3C2A;POGZ;POLR2A;POU2F1;RAP1GA
P;SON;SPEN;TSC1;WHSC2;FOXK2;MLL2;NUMA1;
NUP98;PI4KB 
MAPK1 1.37E-02 FGF-MAPK 
CNOT4;DUSP1;DUSP5;IER3;MYBL2;POLR2A;RPS
3;SMAD4;TGIF1;WHSC2;SGK1;CREBBP;SF1;BTG
2;EP300;NUP153;WASF2 
FRK 1.60E-02 Cell cycle RAC1;PTEN 
MAPK14 2.08E-02 FGF-MAPK 
AKT1S1;BCL9;CDC25B;CDC27;DUSP1;FLNA;FNB
P4;IER3;KHSRP;MYBL2;NUP153;NUP98;POLR2A;
SF1;SON;SPEN;TSC1;WHSC2;ZFP36L1;SGK1;BT
G2;MLL2 
TRIO 2.09E-02 
Serine/thre-
onine 
kinase FLNA;RAC1 
RPS6KA
5 3.00E-02 
Ribosomal 
kinase ATF1;CREBBP;EP300;ETV1 
MAPKA
PK2 3.77E-02 FGF-MAPK CDC25B;ETV1;HNRNPA0;ZFP36L1 
PLK4 3.88E-02 Cell cycle FAM46C;SMAD4 
CAMK1 4.22E-02 
Calcium/cal
modulin 
kinase ATF1;EIF4G3;EP300 
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The iFGFR4-based analysis in Table 5.12 also contains FGF-related kinases, such 
as the MAPK components RAF1, BRAF and STK24, the PI3K/AKT pathway kinases 
–AKT1, PIK3CA and BRSK1 as well as the PKC pathway kinase PRKCA.  Cell 
cycle-related kinases feature numerous times, showing again that iFGFR4 is 
important for regulating the cell cycle.  There are also two nodes involved in AMPK 
signalling. 
Table 5.12.  Kinase enrichment for iFGFR4 upregulated genes 
Node 
Name P-Value 
Associations 
Intersecting Genes 
RAF1 3.64E-04 FGF-MAPK 
CDC25A;CFLAR;GNG4;GRB10;HRAS;MRAS;PPP1
CC;PPP2R2B;RAF1;RAP1A;PPP1R12A 
CDK1 1.93E-03 Cell cycle 
C13ORF15;CCNA1;CCNB1;CCNB2;CDC16;CDC20
;CDC25A;CEP55;CRKL;DUSP1;DYNC1LI1;GADD4
5G;GOLGA2;GRB10;HOMEZ;NASP;NDE1;RPA2;S
TMN1;TLE1;TMPO;WEE1;ACLY;APPL1;BRCA2;CA
RHSP1;DNMT1;KIF2C;MCM3;ORC1;PDIA3;PKN2;
POC5;UNG 
MST4 4.01E-03 
Serine/Thre
-onine 
kinase GOLGA2;RAF1;PDCD10 
EPHB6 8.87E-03 
Wnt-Ephrin 
receptor B6 CBL;CRKL;SAT1 
BRAF 9.71E-03 FGF-MAPK HRAS;MRAS;RAF1;RAP1A 
PRKAA1 1.99E-02 AMPK RAF1;CSNK1E;CRY1;PFKFB3;PPP1R3C 
TBK1 2.50E-02 NFκB ATP5A1;AZI2;GAPDH;HSPA5;LDHB;TUBA3C 
PLK1 2.22E-02 Cell cycle 
BRCA2;CCNB1;CEP55;MCM3;TUBG1;WEE1;CDC1
6;CDC6 
AKT1 2.37E-02 FGF- AKT 
APPL1;CHUK;GRB10;PKN2;RAF1;TNFSF11;UXS1;
CARHSP1;CFLAR;DNMT1;PFKFB3;PIKFYVE;RNF
11;WEE1;ZFP36L1;ACLY 
STK25 1.61E-02 
Neuronal 
migration GOLGA2;PDCD10 
PRKCI 2.17E-02 FGF-PKC CHUK;FRS3;GAPDH;HRAS;MARK4 
BUB1B 1.91E-02 Cell cycle BRCA2;CDC16;CDC20 
NUAK1 3.08E-02 AMPK HSPA5;MARK4;NUAK2;PPP1R12A 
STK24 2.87E-02 FGF-MAPK PDCD10;STK24 
BRSK1 3.61E-02 FGF-PI3K WEE1;TUBG1 
PIK3CA 3.81E-02 FGF-PI3K APPL1;HRAS;MRAS 
DAPK1 4.76E-02 Cell cycle DAPK1;BECN1;MCM3 
 
Among the two upregulated genelists, within the cell cycle related kinases, spindle 
and centriole-related kinases Nek6, Bub1B, Plkk are listed, giving a greater insight 
into FGF’s role in the cell cycle function asides from the phosphorylation and 
regulation of cyclin related proteins.   
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5.2.9 RNA seq validation by RT-qPCR 
Some of the findings of the RNA-seq data were validated by other means in order to 
assess how successful the experiment was in identifying genuine FGF targets.  
Several genes from across the dataset were picked that had varied roles and fold 
changes, as well as some which were shown to be commonly or differentially 
regulated between the two receptors.  RT-qPCR was chosen as a way to validate 
the findings of RNA-seq.  Primers against the genes chosen were optimised, and 
then three biological replicates of relative expression RT-qPCR performed using 
neuralised explants treated the same way as for RNA-seq.  The results are shown 
in Figure 5.8.  
Figure 5.8 A and A' show genes predicted to be upregulated by iFGFR1.  FoxA4 is 
extremely positively upregulated by iFGFR1 induction and so is represented on 
different y-axis to the other iFGFR1 upregulated genes, and this is highly significant.  
Atp6V0c, Lmbrd22 and Zfp36l1 are also upregulated as predicted by RNA-seq, 
although not to the same magnitude.   Only Zfp36l1 is significantly upregulated.   
Figure 5.8B shows genes predicted by RNA-seq to be downregulated by iFGFR1.  
The histone component H3f3a was actually found by RT-qPCR to be significantly 
upregulated by iFGFR1, and the transcriptional coactivator Med9 was also slightly 
upregulated, although this was not significant.  These genes may be dynamically 
regulated by iFGFR1, or may not be FGF targets at all. Krt12 however, is 
significantly downregulated, although to a lesser extent (-2.5x) than in the RNA seq 
experiment (-5.1x).  Ift172 and Tuba1A did not appear to change expression levels 
upon FGF signal induction by RT-qPCR.   
Ccnb1, Chmp1A, Cited2, Ift172, Lmbrd2, Oct60, Poc5 and Snx10 were all listed as 
being upregulated by iFGFR4 by RNA-seq.  All of these genes exhibited a small 
upregulation, but there was a high degree of inconsistency between replicates for 
Ccnb11, Lmbrd2 and Oct60 so the levels of these genes were not significantly 
altered. Chmp1a, Cited2, Ift172, Poc5 and Snx10 all showed small but significant 
increases in expression after iFGFR4 induction.  Again, these increases were not as 
large as expected given the RNA-seq fold changes.  Lastly, Rax, Slc12a3, Tuba1a 
and Zeb2 were all listed as being negatively regulated by iFGFR4, and indeed Rax, 
Slc12a3 and Zeb2 indeed significantly downregulated.  Tuba1a was slightly 
downregulated but this was not significant.  
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Figure 5.8.  Validation of selected RNA-seq genes with RT-qPCR.   
Embryos were injected with 20pg iFGFR1 or iFGFR4 as well as 50pg Noggin bilaterally into 2-cell stage Xenopus laevis embryos.  iFGFRs were induced at 22°C for 3 
hours from stage 10.5. Ct values were normalised against those of the housekeeping gene ODC and fold expression changes normalised against uninduced 
iFGFR1/4-injected embryos. Error bars represent SE from three biological replicates.  Asterisks represent statistical significance of normalised Ct values below p=0.05 
found by 2 sample T-tests. A) and A’) show the expression change of genes predicted to be upregulated by iFGFR1.  B) shows expression changes of genes predicted 
to be downregulated by iFGFR1.  C) shows the expression change of genes expected to be upregulated by iFGFR4 and D) shows expression changes of genes 
predicted to be downregulated by iFGFR4. 
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Lmbrd2 and Tuba1a were upregulated or downregulated by both receptors 
respectively.  Lmbrd2 is slightly upregulated by both receptors although this is not 
significant.  Tuba1a on the other hand was unchanged upon iFGFR1 induction and 
slightly, although not significantly, downregulated by iFGFR4.  Ift172 was chosen to 
validate in part as it was listed as differentially regulated by iFGFR1 and iFGFR4.  
These results show that although Ift172 was significantly upregulated by iFGFR4, it 
was not downregulated by iFGFR1. 
5.3 Discussion 
5.3.1 Comparison of Methodology to other Recent Xenopus RNA-
seq experiments 
5.3.1.1 Use of Xenopus laevis 
To date, most RNA-seq experiments performed with Xenopus have utilised 
Xenopus tropicalis.   As Xenopus tropicalis are diploid as opposed to the polyploid 
Xenopus laevis, its genome has been available for longer making it simpler to 
perform transcriptomic studies.  However, recently the Xenopus laevis genome was 
made available as well as numerous cDNA libraries, collected together by the 
Marcotte lab.  Xenopus laevis embryos were used for this study as all experimental 
optimisation took place in Xenopus laevis and due to differences in Xenopus 
tropicalis embryo culture, the experiment was more practical to do routinely in 
Xenopus laevis.   
However there are still challenges with the use of Xenopus laevis.  Firstly, many 
Xenopus laevis genes exist in ‘A’ and ‘B’ forms which arose through genome 
duplication, Kwon. et al (2014), authors of one of the first RNA-seq papers using 
Xenopus laevis, found that only 23-31% of reads mapped to both duplicated genes.  
To assess the effects of how counting these genes affected final results, the authors 
counted only the ‘a’ form, and then only uniquely mapped reads– 68-75% of the 
data, and finally whichever was the ‘best’ target. No significant differences in the 
outcome of analyses was found, and so as comparing isoforms is not a priority for 
this experiment, it is unlikely to be a cause for concern (Kwon et al. 2014).   
Another disadvantage of using Xenopus laevis is that there are still gaps in the 
genome annotation, which affected the choices made by the Technology Facility for 
choosing programs to analyse the raw RNA-seq data.  Tools used to map transcript 
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sequences onto a reference genome can be categorised as ‘splice aware’ and ‘non 
splice aware’ mappers.  Tophat is an example of a splice-aware mapper where 
reads are mapped to the reference genome, and any unmapped reads further 
fragmented and re-aligned to find novel splice sites, a program used by Chiu et al. 
(2014) and Fish et al. (2014) for their RNA-seq studies in Xenopus tropicalis.  
However because of the poor quality of the laevis genome annotation in some 
regions, a ‘non-splice aware’ called BWA-MEM was chosen, invented by Li & Durbin 
(2009). This program maps reads against a reference cDNA database – the 
Xenopus laevis Mayball longest cDNA collection in this case – quickly and efficiently 
as it uses a Burrows-Wheeler transform method taking relatively low computational 
time compared to similar programs (Li & Durbin 2009).The disadvantage for using 
this program is that any novel splice sites may not be detected.  A very similar 
algorithm called Bowtie was recommended for use in laevis studies (Amin et al. 
2014; Kwon et al. 2014) and has also been used for published Tropicalis RNA-seq 
experiments (M. H. Tan et al. 2013; Collart et al. 2014) and as the first priority of this 
RNA seq experiment is to find detect whole genes, this should not be a great 
disadvantage.     
Other important considerations for RNA-seq experimental design are how reads are 
sequenced (single end vs. pair end sequencing) and how they are measured, the 
most common units being FPKM and RPKM – Fragments/Reads per Kilobase of 
transcript per Million mapped reads.  The difference between RPKM and FPKM is 
subtle.  Although in this study, only paired reads were included in mapping, both the 
reads in a pair might not necessarily be mapped if one is of poorer quality. FPKM 
counts one alignment per paired read, whereas RPKM counts individual mapped 
reads - therefore some transcripts could be counted twice and others counted once, 
skewing the data.   In this study paired reads were measured.  Although single end 
sequencing is much quicker to perform, paired end sequencing provides an element 
of quality control, as pairs should align a known distance apart.  Also, by reading 
paired reads instead of single end reads more information about the fragments can 
be gathered such as splice variants and SNPs, their genomic positional information, 
as well as better 3’ end coverage which would be missed using single reads (Fang 
& Cui 2011).    Paired end sequencing has also been used for all recent Xenopus 
RNA-seq papers listed on Xenbase apart from Chiu et al (2014).    
The filtering thresholds used in this study are fairly stringent, but may be viewed as 
slightly arbitrary as some genes known to be affected by iFGFRs did not pass 
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thresholds, and vice versa.  Statistical confidence values based upon replicates 
were used by Tan et al. (2013), Chiu et al. (2014), and Fish et al. (2014) in Xenopus 
tropicalis based RNA-seq and this was the basis of their filtering conditions instead 
of choosing fold changes.  Kwon et al, used a similar 2-fold expression cut-off for 
their single experimental run of RNA-seq, and so there is a precedent for the 
methods used here in the literature (Kwon et al. 2014).   Therefore, these decisions 
taken about how to perform and analyse the RNA-seq data are similar to other 
published methodologies in Xenopus. 
5.3.1.2 Caveats to the experiment 
The main caveat to this methodology was that unfortunately, due to limited time and 
resources, only one biological run of the RNA seq experiment was completed 
instead of the minimum of three needed for most statistical analyses.  Therefore the 
data are more likely to contain false positives which could be eliminated with the use 
of programs such as Cuffdiff that eliminate non-statistically relevant reads.   
It was originally planned to perform a pilot RNA experiment to compare the effects 
of iFGFR1 induction in whole embryos, neuralised animal caps and whole embryos 
where iFGFR1 had been targeted to the prospective CNS.  The methodology 
returning the most neural targets and most closely matching the fold changes for 
genes found in the microarray and by RT-qPCR such as Egr1, Sprouty2 and Lefty 
and other highly regulated genes like FoxA4 would be used for two more biological 
repeats using the other iFGFRs.  This experiment was performed with the in-house 
Ion Torrent PGM sequencer.  Unfortunately, due to the high level of multiplexing 
only ~750000 reads were obtained per experimental condition.  In comparison, of 
the Xenopus RNA-seq experiments detailed above which reported their read 
counts, obtained 20-70 million reads per condition (M. H. Tan et al. 2013; Collart et 
al. 2014).  Therefore, genes such as Egr1, reproducibly found upregulated by RT-
qPCR in whole embryos and animal caps, was not found affected by iFGFR 
induction in any condition and had very low read counts (<1 FPKM).  There were 
also technical issues, possibly stemming from the use of the wrong adaptors during 
library preparation meaning only 30% of total transcripts read were mapped.  
Therefore data from this experiment was not used.   
Due to constraints upon time and resources following this, it was decided to 
outsource samples from a single experiment on an Illumina Hiseq machine to 
maximise sequencing depth – Illumina RNA-seq has been reported to produce 
158 
between 50-200 million reads per lane (Li & Durbin 2009).   It was advised that use 
of the Hi-seq would yield a far higher read count per condition - approximately 45 
million reads if multiplexing four samples.  As it turned out, a far higher read 
count/condition was achieved - approximately 75 million reads.  It would therefore 
have been possible to multiplex more biological repeats on the same run.   
Biological replicates of the dataset could enable relaxation of the cut-off thresholds 
applied here which eliminated genes such as Egr1 and Nek6 significantly 
upregulated by iFGFR1 by RT-qPCR and the preliminary microarray.  And as can 
be seen from the validation results by RT-qPCR, there are some genes in the 
dataset that could not be replicated, and may have been eliminated from the data 
upon replication.  This indicates some noise in the data and underlines the 
importance of careful validation of the dataset.  
5.3.2 Comparison to other datasets looking at FGF-mediated 
effects upon gene expression in Xenopus 
5.3.2.1 Yamigishi and Okamoto, 2010 
iFGFR1 and iFGFR4 have been used and compared functionally before in Xenopus 
by Yamigishi and colleagues, and their conclusions were that the two wild-type 
receptors compete for ligands in order to regulate neural development.  This was 
based upon the finding that overexpression of FGFR1 mRNA in Xenopus embryos 
shifted the MHB marker Pax2 anteriorly; whereas FGFR4 mRNA caused a posterior 
shift similar to when FGF signalling is inhibited, suggesting that when FGFR4 is 
more prevalent, it is more likely to bind to FGF ligands, and the embryo is 
anteriorised due to its ‘weaker’ signalling properties.  However, using ligand-
independent over-activation of FGF signalling using iFGFR1 and iFGFR4 caused an 
anterior Pax2 shift for both receptors.  The authors concluded that the elimination of 
ligands excluded the possibility that differences in downstream signalling caused a 
differential effect in Pax2 positioning.  Therefore one would expect iFGFR4 to affect 
the gene expression in the same way as iFGFR1, but to a lesser extent.  However, 
the ‘anterior’ shift for iFGFR4 was only observed in ~10% of embryos, with ~80% of 
embryos with unchanged Pax6 positioning.  Therefore, maybe iFGFR4 does not 
regulate Pax2, rather than ligand binding being responsible for all shifting effects.    
Ligand binding must have some influence upon Pax2 though, as although iFGFR1 
induction and FGFR1 mRNA produced the same proportions of embryos with 
anteriorised Pax2, the same cannot be said when comparing iFGFR4 induction and 
FGFR4 mRNA.  FGFR4 mRNA caused 60% of embryos to exhibit a posterior shift 
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in Pax2 expression whereas the majority of iFGFR4 had normal Pax2 expression.  
This could be inducible vs. non-inducible effects, but could potentially point to a 
shortcoming of iFGFRs in being a ligand-independent system (Yamagishi & 
Okamoto 2010). 
5.3.2.2 iFGFR Microarray 
Finally, the microarray dataset using iFGFR1 and iFGFR4 discussed in the first 
experimental chapter was compared with this dataset.  This dataset as mentioned 
previously is in the context of whole embryos over a greater period of time and so is 
not strictly looking at proximal neural targets.  However 35 genes found in the 
microarray were also found more than 2-fold affected by iFGFR1 or iFGFR4 in this 
dataset, lending more support for these genes being FGF targets.  In addition there 
are other genes from the same families if not the exact same gene found in both 
datasets– for example other Dusps, Wnts, Hes, and Fox genes.  
5.3.2.3 Branney et al, 2009 and Chung et al 2004 
These datasets have been described in more detail in the results section.  In 
contrast to the findings of this study, only 5 genes in the Branney dataset exhibited 
a greater than 2-fold difference in expression change between each receptor.  
Therefore at this developmental stage, no real differences in signalling output 
between dnFGFR1 and dnFGFR4 were observed.  However, this may be due to the 
lack of specificity of the dnFGFRs (Ueno et al. 1992).  The differences between the 
RNA-seq findings and Branney et al could suggest that the regulation of FGF 
signalling targets may change at different stages of development, although further 
validation would be needed to make this assertion.   
Only four genes, after conversion into modern gene symbols, were found in 
common with the RNA-seq dataset – Arl5, FoxB1, Dusp1 and Zfp36l1 – and 5 in 
common with the iFGFR1/4 microarray – Arl5, Mst1, Gdf3, Cdx4 and Gata4.  This is 
partly due to the ambiguous nature of the genes identified as FGF targets and their 
Ensembl tags being retired on Unigene.  However, the genes in common with RNA-
seq and the microarray-based screen suggests that these genes are important for 
FGF signalling during development in general rather than in a solely neural context. 
These comparisons with other datasets show that as well as novel putative FGF 
targets, the RNA-seq experiment has replicated some of the findings made by other 
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research groups, which lends weight to these overlapping genes being FGF targets 
in a neural context . 
5.3.3 Themes in the RNA seq data 
The extensive literature search found many genes that were already found to be 
linked to FGF signalling.  Examples of commonalities between genes that were 
interesting are discussed below. They show that as well as neural induction and 
patterning, FGF signalling is also important for other developmental processes at 
this time of early neural specification. 
5.3.3.1 The Cell Cycle 
Ontological analyses and literature searches showed cell cycle-related genes to be 
present in both iFGFR1 and iFGFR4 genelists and highly significantly enriched.  
FGF signalling is well known for its roles in the cell cycle and pluripotency – FGFs 
were named after their mitogenic properties, and FGF signalling favours cell 
proliferation over differentiation.      
A nuclear form of FGFR1, nFGFR1, has been implicated in this process, derived 
from newly translated FGFR1 released from the pre-golgi membrane and 
translocated into the nucleus (Terranova et al. 2015).  Translocation of FGFR1 
through the nuclear membrane and accumulation was first shown in vivo in the rat 
brain and shown to be dependent on the transporter importin-B (Stachowiak et al. 
1996; Stachowiak et al. 2003).  Within the nucleus nFGFR1 binds to genes on 
several different chromosomes and so is a general transcriptional regulator and 
stimulates multiple signalling pathways involved in cell growth and differentiation 
(Stachowiak et al. 2003).  nFGFR1 was later shown to be important for glial growth, 
dendritic outgrowth in rat neurons and differentiation of neuronal progenitors 
(reviewed in Stachowiak et al. 2007).  This is in contrast to the ‘anti-differentiation’ 
role of canonical FGFRs.  This may be important to this project as nFGFR1 has 
been shown to directly target many genes during development, including those 
involved in neural development. nFGFR1 binds to promoters of pluripotency genes 
such as Oct4, Klf4 and Myc, as well as sites identified as consensus sequences for 
these pluripotency factors themselves (Terranova et al. 2015).   Oct4 is negatively 
regulated by the nuclear hormone receptor Nr6a1, found in this screen as being 
downregulated by iFGFR4 (Barreto et al. 2003).  As iFGFRs are not transported to 
the nucleus, the use of these will not provide information about genes affected by 
FGF signalling in the nucleus.  This is important to consider when extrapolating the 
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effect upon the transcriptome of iFGFR induction to wild-type FGF signalling 
behaviour, as iFGFRs may not represent the full potential of FGFR signalling 
events. 
Links between FGF signalling and the cell cycle itself have been reported. The 
degradation of the cyclin dependent kinase Cdkn1b in late G1 phase of the cell 
cycle activates CDK2-cyclinE and Cdk20-cyclinA complexes that signal cells to 
enter S phase (Ganoth et al. 2001).  Cks1 mediates this degradation of Cdkn1b.  In 
3T3 cells, FRS2 binds and sequesters Cks1 until FRS2 is phosphorylated by 
FGFR1, releasing Cks1.  Cks1 is then free to bind to the Cdkn1b/Cyclin/Cdk 
complex and target it for ubiquitin-mediation degradation.  This is therefore a way 
FGF stimulates cell proliferation (Zhang et al. 2004).  Another method involves 
phosphorylation of CyclinB (Ccnb1) by ERK.  Entry into mitosis is regulated by the 
activation of the CyclinB/Cdc2 complexes, the formation of which is catalysed in part 
by the enzyme Wee1. This is accompanied by a translocation of the complex into 
the nucleus.  Walsh et al, (2003) showed that in Xenopus oocytes and egg extracts, 
the translocation of CyclinB into the nucleus is caused by its phosphorylation by 
ERK (Walsh et al. 2003).   Cyclin B (Ccnb1) and Wee1 were found upregulated by 
iFGFR4 in this screen, however Wee1 was upregulated 1.8-fold and so did not pass 
the filtering conditions.    In addition, another cyclin, Ccnd1, also required for the 
G1/S transition and upregulated by exposure to FGF2 in murine mesenchymal stem 
cells which caused inhibition of differentiation, was downregulated by iFGFR4 (Lai 
et al. 2011).  Cdc6, part of the pre-replicative complex formed in G1, is essential for 
the proper initiation of chromosomal replication in the S phase (Kim et al. 2015).   It 
has been reported to be repressed by FGFs in chondrocytes, however in this RNA-
seq screen it was upregulated by iFGFR4 (Kolupaeva & Basilico 2012). 
Therefore, as iFGFR4 stands out as affecting the majority of the genes mentioned 
here, it may have a larger role in the cell cycle than the other receptors.  Validation 
by RT-qPCR of more cell cycle genes, as well as use of the other iFGFRs would be 
useful for investigating this further. 
5.3.3.2 Cilia and Left/Right asymmetry related genes 
FGF signalling, as discussed in previous chapters, is required for both ciliogenesis 
and regulation of the nodal cascade, which underpins left/right asymmetry.  Of the 
genes subjected to an in-depth literature search, 11 were found that have published 
connections to ciliogenesis or left/right asymmetry – two processes which are 
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closely connected.  These include Lefty, Vangl2, Cited2, Atp6V0C, Ift172, Snx10, 
Dynll1, Mark4, Fopnl, Nde1 and Ruvbl2.  Targeted deletion of Ift172 in mouse 
embryos die prior to birth with neural tube defects, telencephalic truncations and 
holoprosencephaly, as well as randomization of left/right asymmetry. Mutant 
embryos possessed cilia with very truncated axonemes that containing no visible 
microtubules (Gorivodsky et al. 2009).  Ruvbl2 is essential for cilia motility in 
zebrafish, and mutant embryos contained axonemes with fewer dynein arms. 
Although this caused ciliary disorganisation and loss of function in ciliated kidney 
cells, this was not linked to laterality defects (Zhao et al. 2013).  RPE-1 cells 
transfected with siRNA against Fopnl or Mark4 failed to undergo ciliogenesis (Kuhns 
et al. 2013; Lee & Stearns 2013).  In contrast, zebrafish embryos injected with a 
morpholino against Nde1 contained longer cilia compared to controls, but as cell 
division was inhibited in the KV, embryos still exhibited laterality defects (Kim et al. 
2011).  Injection of a translation blocking morpholino against Snx10 into zebrafish 
embryos caused a loss of cilia and laterality defects, and mechanistically interacts 
with V-ATPases, of which Atp6V0C, the proton pump subunit of H+-V-ATPase, is an 
example (Chen et al. 2012).  Atp6V0C is also implicated in laterality in its own right, 
as it is asymmetrically located in the ventral right blastomere at the 4-cell stage, 
localised to Rab11 (Vandenberg et al. 2013).  Expression of a dominant negative 
Rab11, or pharmacological inhibition of Atp6V0C both cause consistent heterotaxia 
in Xenopus embryos (Vandenberg et al. 2013; Adams et al. 2006).   Xenopus 
Vangl2 has also been linked to left/right asymmetry as 60% of morphants develop 
laterality defects (Vandenberg et al. 2013).  This is thought to be due to Vangl2’s 
role as part of the planar cell polarity pathway, as it is responsible for the polarity of 
cilia in the KV of zebrafish (May-Simera et al. 2010).  Cited2-null mouse embryos 
die before birth and have a range of heart defects, including abnormal heart looping 
and left atrial isomerism.  As Nodal, Lefty and Pitx2 were not expressed in the 
lateral mesoderm in null mutants, this suggested that an aspect of Cited2 activity 
was required for correct left right patterning (Weninger et al. 2005; Bamforth et al. 
2004).   
7 of the 11 genes found were upregulated upon iFGFR4 induction (Cited2, Snx10, 
Vangl2, Mark4, Fopnl, Nde and Ift172) suggesting that FGFR4 has an important role 
in regulating this process as well as FGFR1.  iFGFR1 induction upregulated 4 
(Dynll1, Lefty, Atp6V0c) and downregulated Ift172 and Ruvbl2.  Thus Ift172 was 
differentially regulated between the two receptors, although validation of Ift172 by 
RT-qPCR could not reproduce this downregulation by iFGFR1.  FGF is already 
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known to be required for correct ciliogenesis, but a common view in the literature is 
that this is due to its positive influence on Wnt signalling, as Wnts regulated the 
expression of the early ciliogenesis gene FoxJ1 in zebrafish (Caron et al. 2012).  
The findings of so many of these genes in this RNA-seq data suggest that proximal 
putative FGF targets are directly involved in ciliogenesis and left/right patterning. 
5.3.3.3 Eye development  
A number of genes in the dataset were found to be required for eye development.  
iFGFR4 was listed as downregulating Gnb3, expressed in photoreceptors and 
involved in eye development, as well as the eyefield marker Rax and its interactant 
Crx, also active in cone cells and implicated in eye development (Ritchey et al. 
2010; Giudetti et al. 2014; Vignali et al. 2000).  FGFs and FGFRs are known to be 
expressed in the developing Xenopus eye and are required for initiation of the eye 
developmental program, but not for its maintenance (Atkinson-Leadbeater et al. 
2009; Lea et al. 2009).  Cross sections of Xenopus laevis embryos by Lea et al., 
(2009) showed that only FGFR3 was strongly expressed in the lens.  FGFR1 and 4 
expression was concentrated around the lens and FGFR2 only seemed to be 
expressed in cells on the periphery of the eye.  This suggested that the eye requires 
different combinations of FGFR to develop (Lea et al. 2009). 
Transient inhibition of FGF signalling in Xenopus by adding the FGFR inhibitor 
SU5402 at early but not late neural specification stages disrupted the dorso-ventral 
axis of the developing retina, and caused changes in retinal gene expression (Lupo 
et al. 2005; Atkinson-Leadbeater et al. 2009).  Furthermore, the FGFR effector 
FRS3 – found upregulated by iFGFR4 in this screen – was found to be expressed in 
the anterior CNS and eye, with morphants having defects in lens placode formation.  
Although this could be rescued by wild-type Frs3, a mutant Frs3 lacking the FGFR 
phosphatase SHP2-binding tyrosine residues could not rescue the morphant 
phenotype, further implicating FGF signalling pathways as being necessary for 
correct eye development (Kim et al. 2015).  Pou4F2, found by this RNA-seq to be 
upregulated by iFGFR1, is known to be involved in retinal ganglion differentiation (Li 
et al. 2014).   Also upregulated by iFGFR1, Hes1 has been previously found to push 
retinal progenitor cells into a Müller glial fate at the expense of neural fate in 
Xenopus, and with Rax and Notch1 promotes Müller gliogenesis in retinal progenitor 
cells at the expense of neural (Furukawa et al. 2000).  Finally Xenopus Hes2, found 
upregulated by iFGFR4 in this screen, is expressed in the retina and other sensory 
organ progenitor cells.  When overexpressed it also causes an upregulation of glial 
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cells again by the repression of proneural genes including NeuroD (Sölter et al. 
2006). This suggests therefore that FGFR4 and 1 can act to repress neural genes in 
order to activate eye development.   
5.3.3.4 Anterior CNS 
The Nieukwoop activation-transformation model of neural induction postulates that 
firstly anterior neural tissue is specified, and then caudalising FGF and Wnt signals 
cause posteriorisation of neural fates (Pownall & Isaacs 2010).   FGF is well known 
in the literature for its role in posterior neural development and patterning because 
of its role in activating Cdx and Hox genes.  FGFs also have an antagonistic 
relationship with anterior BMP, and RA pathway genes which promote anterior 
fates.  However, FGF is present in the MHB and the anterior ectodermal border, and 
is required for telencephalon development and as a morphogen in the Isthmic 
Organiser (reviewed in Pownall & Isaacs 2010).  Reflecting this, a number of 
putative FGF targets found in this screen are expressed in the anterior CNS and 
have been previously shown to be required for correct telencephalon and 
diencephalon development.     
The forebrain is specified after Wnt antagonists secreted from the anterior  of the 
developing Xenopus embryo caudalise the anterior neural ectoderm (Niehrs & Feld 
1999).  This anterior decrease in Wnt signalling causes activation of rostral forebrain 
markers FoxG1 and Emx1. The posterior forebrain marker Otx2, found in this 
screen to be downregulated after iFGFR4 induction, and Pax6 are thereby 
repressed in this region, to favour rostral telencephalon development.   
Hesx1, also known as Xanf, activated by the Wnt antagonist Dkk and found by this 
microarray and RNA-seq based screen to be negatively regulated by both iFGFR1 
and iFGFR4, is a transcription factor expressed in the prospective forebrain from 
late gastrula stages (Matsuda & Kondoh 2014).  Overexpression of Hesx1 in 
Xenopus expanded the neural plate as shown by ISH for the pan-neural marker 
NCAM, but suppressed the differentiation of primary neurons (Ermakova et al. 
1999).  Furthermore, ectopic Hesx1 caused anteriorisation of the forebrain, as the 
expression domain of the rostral telencephalic marker FoxG1 expanded into the 
diencephalon.  The posterior forebrain markers Otx2 and Pax6 were repressed, 
leading to the conclusion that the function of Hesx1 is to repress posterior forebrain 
fates and encourage rostral identities (Ermakova et al. 1999).  This is supported by 
later work showing knockdown of Hesx1 in Xenopus using a morpholino caused an 
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expansion of Otx2 and Pax6 anteriorly, as well as ectopic differentiation of retinal 
pigment in the diencephalon normally only fund in posterior forebrain.  Furthermore, 
expression of  FGF8 in the ANB and FoxG1 were diminished (Ermakova et al. 
2007). 
The confinement of Hesx1 expression to the forebrain was shown to be important 
by Martynova et al. (2004), who identified a 14bp region in its promoter which when 
deleted, caused posterior expansion of the Hesx1 expression domain (Martynova et 
al. 2004).  A yeast one hybrid screen using the region as bait identified FoxA4 - 
found in this screen potently upregulated by iFGFR1 - as being responsible with 
XVent2 for delineating the posterior limits of Hesx1.  Therefore, as well as being 
important for development of the antero-posterior axis and notochord, an early burst 
of FoxA4 expression in the organiser region is directly involved in restricting anterior 
neural development (Murgan et al. 2014).  Therefore FGFR1 and 4 signalling has a 
repressive influence on Hesx1 expression from the posterior directly shown by 
these RNA-seq results, and indirectly through iFGFR1’s activation of FoxA4.     
Hesx1 also represses the Ras family member Ras-Dva found in the iFGFR 
microarray discussed in Chapter 3 to be downregulated by iFGFR1 in whole 
embryos.  In the RNA-seq data Ras-dva was found to be upregulated 1.8-fold by 
iFGFR1, (thus not meeting filtering thresholds) but RT-qPCR gave conflicting results 
(data not shown).  Xenopus embryos injected with a morpholino against Ras-Dva 
exhibited defects in head development including reduction of forebrain, inhibition of 
FoxG1 and Otx2, and disruption of FGF8 expression (Tereshina et al. 2006).  Later 
work by the same group revealed that Ras-Dva expression is restricted to non-
neural cells in cement and hatching glands, so this may explain why neuralised 
explants gave conflicting results.  FGF8 secreted by neighbouring cells in this region 
activated Ras-Dva, which in turn induced expression of Otx2.  Otx2 was found to 
then activate Agr-secreted factors including Agr2, which was found by this data as 
being downregulated by iFGFR4 (Tereshina et al. 2014).   
Therefore a positive feedback loop involving FGF8, Ras-Dva, Otx2 and Agr2 – 
which positively affects FGF8 – are found as putative neural FGF targets in the 
RNA-seq data, with a negative input from Hesx1.  According to this data, both 
iFGFR1 and 4 regulate these genes, showing that signalling by both receptors is 
required for this process.   
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5.3.4 Gene Ontology analyses identify further themes in the RNA-
seq data 
The ontological analyses, taken with the patterns that emerged from the dataset 
discussed above suggest that in some instances, although different genes are 
activated by each receptor, they often feed into the same processes.  For example, 
GO terms associated with metabolic processes are significantly enriched in all four 
genelists, as are cell cycle components, particularly with iFGFR4. 
Other developmental processes are differentially regulated by iFGFR1 and iFGFR4 
during neural development based upon these analyses.   PANTHER protein 
analysis suggested that transcription factors are differentially affected by each 
receptor.  FGFR1 induction positively affected transcription factors, and several 
classes were found enriched in the upregulated genelist and conversely depleted in 
genes downregulated by iFGFR1.  Genes upregulated by iFGFR4 however were 
less likely than predicted to be transcription factors.  This gives an insight into the 
‘division of labour’ between the receptors. 
Another point of receptor output difference were terms pertaining to developmental 
processes, which were conspicuously enriched in iFGFR1 upregulated/iFGFR4 
downregulated genelists and depleted in iFGFR4 upregulated /iFGFR1 
downregulated genelists.  It is not surprising that heart and skeletal developmental 
processes are depleted at this stage; however the neurogenesis, ectodermal and 
mesodermal-related terms which are differentially enriched between the two 
receptors may be more biologically relevant.  Further validation and testing of the 
genes picked out as being implicated in these processes would be required to 
confirm this.   
Although the PANTHER pathway analysis did not yield as many significant results, 
the iFGFR1-upregulated genelist was enriched with components from the Notch, 
Wnt and FGF signalling pathways in line with current knowledge about FGF:Wnt 
and FGF:Notch pathway interactions (McGrew et al. 1997; Pera et al. 2014; Faux et 
al. 2001; Akai et al. 2005).  Other signalling pathways did not prominently feature in 
iFGFR4 genelists and so iFGFR4 may not be as involved as iFGFR1 in crosstalk 
with other pathways.  The kinase enrichment analysis provided more information 
and leant support for FGFR4 signalling down other branches of the FGF signalling 
pathways involved in Akt and PKC as found in (Umbhauer et al. 2000).   
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These results and conclusions must be interpreted with caution however, as the 
dataset filtering thresholds had to be relaxed in order to provide enough numbers for 
PANTHER to conduct analyses.  This inevitably incorporated noise into the data 
which could obfuscate the outputs.   Further RNA-seq biological repeats would help 
eliminate some of the noise in the data, which would then enable the inclusion 
thresholds of the RNA to be relaxed, thereby hopefully giving more solid 
conclusions. 
5.3.5 Validation by RT-qPCR does not completely reproduce 
RNA-seq data 
Validation was performed using 17 different genes picked across the dataset.  The 
aim of this was to assess how likely any given gene picked could be independently 
identified as an FGF signalling target, or if for example, genes below 3-fold were not 
predictably regulated, the filtering thresholds could be adjusted accordingly to 
increase the probability that the dataset represented true FGF targets.   
The genes assayed were generally up or downregulated predictably based on the 
dataset but, with the exception of FoxA4, none were regulated to the same extent, 
and only roughly half of these were significant.  There was also no real correlation 
between genes significantly regulated by RT-qPCR and their fold change; Zeb2 for 
example was just significantly regulated by iFGFR4 in RT-qPCR experiments, but 
the most downregulated gene of iFGFR4 found by RNA-seq (-18.1x).  However 
other genes like Poc5 were more highly significantly affected by RT-qPCR but only 
upregulated 2.1 fold by iFGFR1 in RNA-seq.  Therefore adjustment of the RNA-seq 
filtering threshold is unlikely to definitively eliminate false positive/negative FGF 
targets. 
There was a high degree of variation between experimental repeats.  Although all 
clutches of Xenopus embryos were cultured under the same conditions, their 
speeds of development varied. Although good consistency of induction times from 
stage 10.5 was aimed for and embryos kept in the same incubator at 22°C, the 
onset of stage 10.5 is subjective and even small temperature fluctuations change 
the rate of embryo development.  Secondly some of these genes are likely to be 
highly dynamically regulated.  Cell cycle genes such as Ccnb1 and 
transcriptional/translational components such as H3f3a and Med9 are likely to be 
very dynamically regulated, and RNA-seq findings determined by the stage of the 
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cell cycle in which cells happen to be.  This was borne out by their very different 
expression fold changes between biological replicates found by RT-qPCR.   
In addition to RT-qPCR, in situ hybridisation could be employed alongside RT-qPCR 
to see if gene expression domains are changed as a result of iFGFR1/4 induction.  
Furthermore, in addition to injecting iFGFRs, dnFGFR1 could be expressed in 
sibling embryos to see if complementary effects upon gene expression occur, which 
would improve the argument for them being FGF signalling targets.  A number of 
groups such as Collart et al,. (2014) who investigated the Xenopus tropicalis 
transcriptome during MBT, employed Nanostring technology to validate their data, 
which can digitally investigate the relative expression of up to 800 genes at once 
(Collart et al. 2014).  With this dataset, validating a larger set of genes would 
provide a better insight into how reproducibly this data is. 
5.3.6 Further work and conclusions 
It would be interesting to compare and contrast all iFGFRs in the future, particularly 
the VT+ and VT- isoforms of iFGFR1 to give a more global insight into the roles of 
each iFGFR in neural development.  Also, comparing the transcriptome after early 
and late periods of FGF induction would be useful to see how FGFs role in neural 
development changes over time.   
In the RNA-seq genelists there is information that has not been analysed in this 
study, including the many ‘Unknown’ hits, and information relating to the ‘A’ and ‘B’ 
forms of each gene, as well as any non-coding mRNAs that may have been 
sequenced.  Further analysis of A and B forms of each gene, which will be more 
feasible when the laevis genome improves, would be interesting to gain insight into 
gene evolution and function, but is outside the scope of this project.  The ‘B’ form of 
Hes2 in Xenopus laevis for example, is present at a much higher level in the neural 
plate than the ‘A’ form, and the ‘A’ form is a maternal factor whereas the zygotic ‘B’ 
form becomes predominant after MBT, the significance of which is unclear (Murato 
et al. 2007).  In order to analyse the 'unknown' files, the original sequence would 
have to be found.  This proved difficult as the sequence data contributing to the 
Mayball longest cDNA library is no longer available, and the Mayball search engine 
only recognises the gene name, and not the read name attached to each gene.  
Due to time constraints, this was not looked into further although could yield 
interesting results if investigated at a later date.  As there was a high level of 
sequencing depth in this study, it is possible that miRNAs and ncRNAs are present 
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in this data.  To affirm this would require more in-depth data processing and re-
alignment of the sequencing data, and may not yield optimal results as the 
fragmentation and library preparation protocols were optimised for longer fragments 
of RNA.  The protocol for finding smaller RNAs selects RNA fragments of only ~24 
bp and makes libraries of these, which would exclude the longer fragments which 
were used for library preparation in this study (Harding et al. 2014; Hafner et al. 
2008).  Nevertheless, it could be possible to see if miRNAs are present in their 
mature form in the sequenced fragments by aligning them to the Xenopus tropicalis 
collection of known miRNAs on miRBase (www.mirbase.org) to see if there are any 
miRNAs or other short RNAs present before proceeding further.  Lastly, there may 
be different splice variants of genes present in the data, particularly those that 
feature in the genelists more than once.  A disadvantage of using a non splice-
aware read mapper during sequence alignment means that no novel splice 
junctions will be found, but further investigation into this could give an insight into 
how FGF signalling might regulate splicing during neural development, and what 
functional implications this has. 
5.3.7 Summary 
To my knowledge, an in-depth comparison between different FGF receptor 
signalling outputs has not been reported before in Xenopus to study specifically 
neural development.   The RNA-seq data show that the Xenopus laevis 
transcriptome was strongly affected by induction of iFGFR1 and iFGFR4 during 
early neural specification stages. The literature search undertaken and the overlap 
of these findings with other datasets and previous RT-qPCR experiments show that 
these data are in keeping with previously reported roles of FGF signalling during 
neural development. Genes involved in related developmental processes such as 
Left/right asymmetry, anterior neural patterning and eye development are also 
represented in the dataset, as are putative FGF targets that have not been 
investigated in any capacity yet.  Very few genes were commonly regulated by both 
receptors, showing that iFGFR1 and iFGFR4 have very different signalling outputs.  
However, searches in the literature and ontological analyses showed that there are 
similarities as well as differences between the processes and signalling pathways 
modulated by each receptor.  This suggests a level of cooperation as well as 
possibly competition between FGFRs in regulating development.  The aims of the 
chapter have been met, although further biological repeats of the RNA-seq would 
probably improve the confidence of picking FGF targets and downstream analyses.   
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6 Characterisation of novel 
FGF targets 
 
6.1 Introduction 
6.1.1 Inhibition and characterisation of FGF targets  
After analysis and validation of the RNA-seq and microarray datasets, it was 
decided to investigate a number of potentially interesting novel FGF targets in more 
detail.  ISH was used in some instances to ascertain the expression patterns of 
these during Xenopus development.  To gain an insight into FGF target gene 
function, it was decided to make use of recently introduced gene editing technology 
to assess the effects of gene knockout upon Xenopus development.  Nek6 was 
investigated through knockout by employing a TALEN.  Additionally, the effects of 
knockout of three putative neural FGF targets found in the RNA-seq dataset– 
ZSwim4, Snx10 and Cited2 – were investigated by using the CRISPR/Cas9 system.   
6.1.1.1 TALE nucleases - TALENs 
TALE nucleases (TALENs) are, like CRISPRs, very recent technologies that make 
custom knockdowns of genes much simpler and cheaper than morpholinos. TALEs 
are naturally occurring zinc finger proteins derived from the plant pathogenic 
bacteria Xanthomonas. TALEs contain DNA-binding regions composed of a series 
of 33-35 amino acid tandem repeat domains that each recognise a single base pair.  
Each tandem repeat is identical apart from repeat-variable di-residues - RVDs – at 
positions 12 and 13, which recognise each base (Lei et al. 2012; Gaj et al. 2013). 
TALE repeats can be recombined to bind a user-defined DNA sequence of interest 
(Schmid-Burgk et al. 2013).  Custom TALEs fused to endonucleases, (TALENs), 
bind to target sequences and produce double stranded breaks (DSBs) (Miller et al. 
2011).  These DSBs are improperly repaired through non-homologous end joining 
(NHEJ), leading to small inserts or deletions (indels) in the DNA sequence.  These 
cause frameshift mutations in the translated protein (Santiago et al. 2008; Ishibashi 
et al. 2012).   
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Figure 6.1.  TALEN method of action illustrating how they work 
Left and Right TALEN mRNAs are injected into Xenopus embryos, and when translated bind 
to the forward and reverse strands either side of the genomic target region, typically within the 
first coding exons.  Both TALENs contain epitope tags and also nuclear localisation signals 
(NLS).  When both bound, the Fok1 nucleases make a double stranded break (DSB) which is 
improperly repaired.  This introduces indels into the sequence, causing frameshift mutations 
and non-functioning proteins.  
Figure 6.1 is a schematic diagram of how TALENs were used in this study.  mRNA 
coding for a ‘Left’ and ‘Right’ TALEN were injected into Xenopus embryos.  Each 
TALEN half contains a nuclear localisation signal (NLS) and an epitope tag, which in 
this case was Flag (left) and HA (right).  When translated the left and right TALENs 
bind to the genomic DNA around a target site in the first exon of Nek6, with a spacer 
region of 16bp between them.  This region is cleaved by the endonuclease Fok1, 
fused to the TALE region.      
6.1.1.2 CRISPR/ Cas9 genome editing 
The (Clustered Regularly Interspaced Short Palindromic Repeats) CRISPR/Cas9 
genome editing system has recently increased in popularity due to the relative 
speed and ease of making targeted gene alterations.  In bacteria, the CRISPR 
system provides immunity against invading foreign DNA by the activation of 
endonuclease Cas9-directed cleavage (reviewed in Gaj et al. (2013).  This can be 
exploited by designing a guide RNA that is complementary to a portion of a coding 
exon within a gene of interest.  A sequence in preferably the first coding exon is 
172 
chosen that starts with a G - to bind T7 polymerase and initiate transcription- and 
after 19 bases ends with the PAM sequence, NGG, required for Cas9-mediated 
cleavage.  The guide RNA is attached to a ‘seed’ sequence to which the 
endonuclease Cas9 binds (Bassett et al. 2013).  As with TALENs, this break is 
repaired by NHEJs, leading to indels.  Figure 6.2 shows a schematic diagram of 
how CRISPRs were designed in this study, following the PCR method of template 
synthesis by Nakayama et al. (2013).   
 
Figure 6.2.  CRISPR/Cas 9 method of action 
A target site in a gene of interest is picked based on it satisfying the conditions that it starts 
with a G, and 20 bases later is followed by another GG.  This NGG constitutes the 
Protospacer Adjacent Motif (PAM) sequence, which is required for Cas9-mediated DSBs.  
Templates for in vitro transcription are made by PCR amplification of overlapping primers.  The 
5’ primer contains a T7 polymerase binding motif, the target sequence and a stretch that 
overlaps with a common 3’ primer containing the Cas9 endonuclease binding motif.  From this, 
the single synthetic guide RNA (sgRNA) can be transcribed in vitro and co-injected into the 
Xenopus embryo with Cas9 mRNA.  The sgRNA binds to the target sequence, and when 
translated, Cas9 binds to the sgRNA and introduces a DSB upstream of the PAM sequence.  
Incorrect repair of the DSB introduces indels into the gene, causing defective protein 
synthesis. 
Overlapping primers - 5’ primer containing a T7 promoter, the target sequence and 
a sequence complementary to that of a common 3’ primer containing the Cas9 
binding motif – were amplified by PCR to form a template for in vitro transcription 
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containing the guide RNA and seed sequence for Cas9 binding.   Using T7 
polymerase, a synthetic guide RNA (sgRNA) is synthesised in vitro, which when 
injected into the Xenopus embryo, binds to the target sequence.  The co-injected 
Cas9 mRNA when translated binds to the sgRNA and forms a DSB just upstream of 
the PAM sequence (Nakayama et al. 2013).   
6.1.2 Aims of this Chapter 
The aims of this chapter were to begin to analyse in detail the expression and 
function of a number of putative FGF targets identified by the microarray and RNA-
seq based screens. 
6.2 Results  
Investigation of putative FGF targets Hesx1, FoxN4 and 
Hmx3 
As well as the validated FGF targets Egr1, Sprouty2 and Lefty found in datasets 
generated by the microarray-based screen, some putative FGF targets negatively 
regulated by iFGFR1/iFGFR4 were identified. Literature searches and existing 
expression data on Xenbase suggested that Hesx1, FoxN4 and Hmx3 are 
expressed in the anterior CNS.  They were found to be negatively regulated by 
iFGFR1 and/or iFGFR4.  Therefore further investigation of their responses to 
iFGFR1 and 4 in whole embryos and neuralised explants was performed both to 
validate previously unanalysed aspects of the microarray dataset and to ascertain 
whether these genes are targets of FGF signalling in whole embryos and/or in a 
specifically neural context 
Hesx1 and FoxN4 were downregulated by iFGFR1 in the microarray by 1.65 and 
1.67-fold respectively.  iFGFR4 induction decreased the expression levels of FoxN4 
1.58-fold and Hmx3 1.63-fold.  Hesx1, Hmx3 and FoxN4 have been previously 
shown to be expressed in the anterior nervous system (Martynova et al. 2004; 
Bayramov et al. 2004; Schuff et al. 2006).  Hesx1 and Hmx3 have been associated 
previously with FGF signalling, as both positively regulate FGFs, although it is not 
known if they are regulated themselves by FGF signalling (Adamska et al. 2001; 
Tereshina et al. 2014).  There is no known link between FoxN4 and FGFs.  As FGF 
signalling has traditionally been investigated in the context of posterior neural 
development, the investigation of these anterior genes could shed light on the 
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repressive role of FGF signalling upon anterior neural development for iFGFR1 and 
iFGFR4. 
6.2.1 Expression of FoxN4 and Hmx3, downregulated by iFGFR4 
The expression patterns of FoxN4 and Hmx3 were investigated in the Xenopus 
embryo.  The CDS of these genes were cloned into pGem to provide a template for 
the synthesis of antisense DiG-labelled probes for ISH analysis on Xenopus laevis 
at a number of developmental stages.   Results are shown in Figure 6.3. 
 
Figure 6.3.  The expression of putative iFGFR4 targets Hmx3 and FoxN4 in the developing X. 
laevis embryo 
A shows expression of Hmx3 in tailbud stages is present in a dorsal to ventral stripe near the 
head (arrowed).  Hmx3 was not detectable in earlier-staged embryos.   B-D shows FoxN4 
expression.  At mid-neurula, it is present in the developing eye fields (B, anterior view).  At 
stage 25 it is present in the developing retina and hindbrain, C, arrowed.  C’ shows FoxN4 
expression in discrete places in the neural tube when a cross section is cut at the point 
indicated in C.  D is a tailbud embryo (head is damaged) with strong expression in the 
Midbrain (MB), Hindbrain (HB), pronephros (open arrow) and retina.   
 At mid-neurula stages, FoxN4 was present in the developing eye fields (Figure 
6.3B).  At stage 25 it was expressed in the developing eye and hindbrain (Figure 
6.3C).  A transverse cross-section of the head of a stage 25 embryos showed 
FoxN4 to be located in the domain where V2 neurons will be specified in the neural 
tube (Dessaud et al. 2008).  In tailbud embryos FoxN4 expression was strong in the 
midbrain, hindbrain and retina (Figure 6.3D).  Hmx3 was not detectable at earlier 
stages – indeed available Refseq data shows Hmx3 is expressed at low levels 
during neurula stages  and increases in abundance to peak relatively late at Stage 
33 (M. H. Tan et al. 2013).  At tailbud stages, Hmx3 was present in a stripe 
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comprising of (from dorsal to ventral) the anterior otic vesicle, the otic ganglion and 
the anteroventral lateral line placodes, but not visibly in the CNS (Figure 6.3A).   
6.2.2 RT-qPCR validates microarray findings for iFGFR1 targets 
RT-qPCR was firstly performed using primers against the putative iFGFR1 targets 
Hesx1 and FoxN4 in whole Xenopus laevis embryos injected with 20pg iFGFR1 at 
the 2-cell stage, cultured to stage 10.5, and treated with AP20187 until stage 13 to 
replicate the conditions of the microarray.  Fig Figure 6.4Ai shows both genes to be 
downregulated compared to controls - FoxN4 significantly - after iFGFR1 induction 
by degrees similar to that of the microarray.  As a complementary experiment, this 
experiment was repeated with embryos injected with 1ng dnFGFR1 and collected at 
stage 13.  Hesx1 and FoxN4 showed a ~2-fold upregulation in expression, further 
strengthening their role as FGF targets in whole embryos.     
The expression patterns of FoxN4 and Hesx1 were then investigated in neuralised 
animal cap explants induced from stage 10.5 to 13.  Hesx1 was downregulated 
3.57-fold by induced iFGFR1+Noggin-expressing explants, but interestingly 
uninjected controls had a very low relative abundance of Hesx1 compared to 
Noggin-injected explants.  Therefore Noggin may induce Hesx1 expression which is 
in turn repressed in the presence of activated iFGFR1.  The opposite was true of 
FoxN4 which was downregulated in the presence of Noggin, and repressed further 
in induced co-injected explants.  Hesx1 was found by RNA seq to be downregulated 
by both iFGFR1 and iFGFR4 so is likely to be a neural FGF target.  However, 
FoxN4 was present at very low abundances and was not affected by iFGFR1 
induction in this context. 
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Figure 6.4 RT-qPCR experiments involving genes predicted to be downregulated by the microarray by iFGFR1 
Graphs showing RT-qPCR results for the genes FoxN4 and Hesx1.  Whole embryos in Ai) were injected with 20pg iFGFR1 and treated with AP20187 between stages 
10.5 and 13.  Whole embryos in A) ii were injected with dnFGFR1 and collected at stage 13.  Explants co-injected with 50pg Noggin were treated the same in B as in 
Ai).  In Ai) error bars represent SE from three biological replicates.  Asterisks represent statistical significance of normalised Ct values below p=0.05.    In Aii) Error 
bars represent SE from two biological replicates.  B) shows mean fold changes from technical replicates. Ct values were normalised against those of the housekeeping 
gene ODC and fold expression changes normalised against iFGFR1-injected uninduced embryos/explants.  
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6.2.3 Investigating FoxN4 and Hmx3, putative iFGFR4 targets 
RT-qPCR was performed in whole embryos expressing iFGFR4, replicating the 
conditions of the microarray to validate them as iFGFR4 targets (Figure 6.5).   Hmx3 
was significantly downregulated by iFGFR4 induction in whole embryos.  FoxN4 
was also downregulated but this was not significant.   
 
Figure 6.5 – Hmx3 and FoxN4 are negatively regulated by iFGFR4 
These are results of RT-qPCR for the genes Hmx3 and FoxN4.  Embryos were injected 
with 20pg iFGFR4 and treated with AP20187 between stages 10.5 and 13.  Error bars 
represent SE from three biological replicates.  Asterisks represent statistical significance of 
normalised Ct values below p=0.05.    Ct values were normalised against those of the 
housekeeping gene ODC and fold expression changes normalised against uninduced 
iFGFR1-injected embryos. 
6.2.4 RNA-seq confirms Hesx1 as being a neural FGF target 
RNA-seq results showed Hesx1 to be downregulated by iFGFR1 -3.2-fold, and by 
iFGFR4 -7.8-fold in neuralised explants.  This further confirms Hesx1 as a target of 
both iFGFR1 and iFGFR4.  The raw RNA-seq readings showed FoxN4 and Hmx3 to 
be present at very low abundances in neuralised animal caps (FPKM <2), and their 
levels did not change upon either iFGFR1 or iFGFR4 induction, suggesting they 
may not be FGF targets during neural development.  Therefore, the microarray and 
RT-qPCR show all three genes to be negatively regulated by FGF signalling in 
whole embryos, and RNA-seq shows Hesx1 to also be a neural FGF target. 
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Nek6 
6.2.5 NIMA-related Kinase 6 (Nek6) 
Nek6, Nek7 and Nek9 are NIMA-related kinases comprising the NIMA complex 
which is active during mitosis and involved in regulation of the mitotic spindle 
(Quarmby & Mahjoub 2005).  Nek6 was initially chosen to study as it was shown to 
interact with putative FGF target Dynll1 (See Dynll1 section in Appendix) indirectly 
through Nek9. Nek6 is a relatively unstudied protein, and the majority of 
investigations into its functions have taken place in cell culture with its in vivo 
function unexplored.  Nek6 also has no previous reported FGF connection.  In the 
preliminary microarray, Nek6 was upregulated 2.8-fold by iFGFR1 induction and 
2.6-fold by iFGFR2 induction.  By RNA-seq, Nek6 was upregulated by iFGFR1 5-
fold, however low read counts excluded it from genelists. 
6.2.6 The expression pattern of Nek6 in Xenopus 
Xenbase contains automated ISH images of Nek6 of variable quality at a few stages 
of Xenopus development.  Therefore ISH was undertaken with a wider range of 
stages in Xenopus laevis embryos to investigate Nek6 expression during 
development.  The sequence of Xenopus Nek6 protein shares a 94% similarity to 
Nek7 and so therefore, to make an ISH probe specific only to Nek6, the 3’ 
untranslated region was cloned into pGEM.  Nek6 was first detectable at mid-
neurula stages (Figure 6.6A) in the posterior paraxial mesoderm.  By stage 24, it 
was present in the developing somites (Figure 6.6B).  In the tailbud stage embryo, 
Nek6 expression persisted in the somites, branchial arches and also in the posterior 
extremities, which overlaps with FGF expression at this time (Lea et al. 2009).  
Sections along the antero-posterior axis at this stage revealed Nek6 expression in 
the notochord, but not the neural tube - Figure 6.6C,C’ and C’’. Nek6 did not show a 
high level of localised expression in neural tissue.   
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Figure 6.6 Expression of Nek6 
Xenopus laevis embryos were cultured to a range of stages and processed for ISH against a 
probe specific to Nek6.  A) shows Nek6 is first detectable at mid-neurula stage 15 in the dorsal 
paraxial mesoderm.  B shows a stage 24 embryo with Nek6 expression in the developing 
somites (arrowed).  C shows a tailbud stage 30 embryo with Nek6 expression in the branchial 
arches (Ba) and somites, as well as in the posterior-most tip (open arrow).  C’ and C’’ show 
cross sections of embryos with Nek6 in the notochord (Nc arrowed in C) and the surrounding 
posterior ectoderm in C’’ (open arrow).    
6.2.7 RT-qPCR shows Nek6 positively regulated by FGFR1 
To ascertain whether the findings of the microarray could be replicated through 
other means, RT-qPCR was conducted using primers specific to Nek6.  Xenopus 
laevis embryos were injected bilaterally with 20pg iFGFR1 at the 2-cell stage, and 
AP20187 added to culture medium at stage 10.5.  Embryos were collected at stage 
13, and sibling embryos were also collected at stages 15 and 17.  A complementary 
experiment was performed where 1ng dnFGFR1 was injected bilaterally into 
Xenopus laevis embryos at the 2 cell stage and embryos processed for RT-qPCR at 
the same stages as before.  Results from these experiments are shown in Figure 
6.7. During all three induction periods, iFGFR1 induction increased the levels of 
Nek6, and this was significant for embryos induced from stage 10.5 to 15 and from 
stage 10.5 to 17.  Figure 6.7B shows that at all three stages, dnFGFR1 significantly 
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reduced levels of Nek6.  Therefore Nek6 is positively regulated by FGF signalling in 
whole embryos. 
Next, RT-qPCR was performed to see if Nek6 was a target of FGF signalling in  
neuralised ectodermal explants.  In the raw RNA-seq data, Nek6 was shown to be 
upregulated by iFGFR1 5.2-fold, however read counts were not high enough to pass 
filtering thresholds and so it does not appear in the genelists.  iFGFR1 and 50pg 
Noggin mRNA were co-injected bilaterally into Xenopus laevis embryos.  Also, 50pg 
Noggin only was injected into sibling embryos.  At stage 8, ectodermal explants 
were taken and cultured until stage 10.5.  AP20187 was added to induce FGF 
signalling for 3 hours at 22°C.  The presence of Noggin did not have an effect on 
Nek6 expression (Figure 6.7C).  However, relative to uninduced neuralised caps, 
induced iFGFR1 caused a significant 1.7-fold upregulation, suggesting Nek6 is an 
FGF target in a neural context as well as in whole embryos, even though  it is not 
detected at high levels by ISH.
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Figure 6.7 RT-qPCR to investigate iFGFR1 induction on Nek6 
In A, whole Xenopus laevis embryos were injected bilaterally with 20pg iFGFR1 and cultured until stage 10.5.  AP20187 was then added to culture medium and sibling 
embryos cultured at 22°C until stage 13, 15 or 17.  In B, 1ng dnFGFR1 was injected bilaterally into Xenopus laevis embryos and cultured until the same stages as A. In 
C, 20pg iFGFR1 and 50pg Noggin were coinjected bilaterally into Xenopus laevis embryos, ectodermal explants taken at stage 8, and iFGFR1 induced from stage 
10.5 for 3 hours. Ct values were normalised against those of the housekeeping gene ODC and fold expression changes normalised against iFGFR1-injected 
uninduced embryos (A and C) or uninjected controls (B and D).  Error bars represent SE from the mean of three biological replicates.  Asterisks represent statistical 
significance as measured by performing a two-sample T test on normalised Ct values. 
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6.2.8 FGFR inhibition causes loss of Nek6 
To determine if FGF inhibition changed the expression domain of Nek6, Xenopus 
laevis embryos were injected at the 2-cell stage bilaterally with 1ng dnFGFR1 and 
cultured until stage 15.  Samples were then processed for ISH using a Nek6 in situ 
probe.   
 
Figure 6.8 Effect of FGF signal manipulation upon Nek6 expression 
Xenopus laevis embryos were bilaterally 1ng dnFGFR1(N=10)  and cultured until stage 15.  
ISH using a probe against Nek6 CDS was undertaken.  Numbers represent embryos 
resembling the representative images shown.   
In uninjected controls, Nek6 was present in the dorsal paraxial mesoderm and more 
intensely in the posterior (Figure 6.8).  Most sibling embryos injected with1ng 
dnFGFR1 exhibited a partial loss of Nek6 expression.  This may be due in part to 
the gastrulation defects seen in many embryos (Figure 6.8, centre), however 
embryos expressing dnFGFR1 and more successfully completing gastrulation also 
displayed a loss of Nek6 expression (Figure 6.8, right). 
These ISH and RT-qPCR studies as well as the RNA-seq experiment show that 
Nek6 is positively regulated by FGF signalling in whole embryos, and neuralised 
explants.  Therefore, it was decided to investigate the function of Nek6 further. 
6.2.9 Characterisation of Nek6 function by knockout using a 
TALEN 
6.2.9.1 Nek6 TALEN design 
The Nek6 TALEN pair was designed and synthesised by the Technology Facility 
using the first coding exon of Nek6 I provided.  The first coding exon was chosen as 
a target site to maximise the chance that a truncated non-functional protein product 
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would be translated.  Figure 6.9 shows the TALEN-binding region in the first Nek6 
exon, with a 16bp spacer region in between where Fok1 endonuclease produces 
DSBs. 
 
Figure 6.9 Nek6 TALEN design  
A)The first coding exon of Xenopus tropicalis Nek6 was chosen as a TALEN target region.  
The exon is capitalised.  The Left TALEN binds to a 19bp region in red, and the right TALEN 
binds to the region in blue.  The 16bp target spacer region is underlined.  The TALEN RVDs 
are listed below. B)Shows a BLAST alignment of the Xenopus tropicalis and Laevis left and 
right TALEN and target sequences 
The Left and Right TALENs were synthesised and cloned into pCS2+ by the 
Technology Facility, and from this templates and synthetic mRNA was synthesised. 
6.2.9.2 Optimisation of TALEN injection 
Firstly, to determine that both Left and Right TALENs are translated in the Xenopus 
embryo, either 1ng or 2ng Nek6 TALEN mRNA was injected into Xenopus laevis 
embryos at the 1 cell stage and cultured to early neurula stage 14.  They were then 
processed for western blot analysis using antibodies against the Flag epitope within 
the Left TALEN and the HA epitope present within the Right TALEN.   
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Figure 6.10 Western blot showing Nek6 TALEN mRNA is translated into protein 
Xenopus laevis embryos were injected at the 1 cell stage with either 1ng or 2ng of Flag-tagged 
Left TALEN, HA-tagged Right TALEN, or both.  The expected size of each TALEN is 100kDa.  
GAPDH was used as a loading control.     
Figure 6.10 shows that both left and right TALENs are translated into protein at both 
dosages at detectable levels, both when expressed on their own or when co-
injected. 
6.2.10 Nek6 TALEN injection causes major developmental 
defects 
2ng of Nek6 TALEN (co-injection of 1ng Left TALEN+1ng Right TALEN) was 
injected into Xenopus tropicalis and Xenopus laevis embryos at the 1-cell stage to 
maximise the likelihood of all daughter cells inheriting Nek6 TALENs.  Embryos 
injected with 2ng Right TALEN only developed as uninjected controls.  However 
those injected with 2ng Left and Right TALEN exhibited gross developmental 
defects in both species from early stages.  Figure 6.11 shows the phenotype of 
Nek6 TALEN-injected Xenopus laevis embryos throughout development. Xenopus 
tropicalis embryos displayed the same phenotype (not shown).
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Figure 6.11 Development of the Nek6 TALEN phenotype 
2ng Nek6 TALEN – 1ng Left TALEN + 1ng Right TALEN – was injected into Xenopus laevis embryos at the 1 cell stage and embryos fixed and imaged at various 
developmental stages.  Embryos injected with only 2ng Right TALEN developed as uninjected controls.  TALEN injected embryos developed normally until mid-
gastrula, where they failed to complete gastrulation, and then failed to neurulate.  As a result, at stage 41, embryos exhibited anterior and posterior truncations, a 
failure of neural tube closure and a lack of discernible organogenesis.  This effect was reproducible and seen in almost all injected embryos. 
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Embryos injected with both Left and Right TALENS developed as controls until mid-
gastrulation (St 11), when the blastopore failed to close.  This was succeeded by a 
failure to neurulate properly (St16 and 24).  At early tailbud stages, (St 27), surviving 
TALEN-injected embryos had not elongated and displayed an open neural tube, 
with severe posterior and anterior truncations.  At stage 40, control embryos 
displayed typical organogenesis and were able to swim.  However TALEN-injected 
embryos lacked all recognisable organs, head, tails or recognisable antero-
posterior/dorso-ventral axes; although the epidermis was fairly well developed as 
pigment cells formed.  Therefore Nek6 knockout has a profound effect on 
development.   
It was unclear from the ISH experiment whether Nek6 was expressed in the CNS 
and thus could conceivably be involved in neural development, although the 
neuralised animal cap RT-qPCR data do support a role for Nek6 in neural 
development.  Therefore the Nek6 TALEN was targeted to the CNS by injecting 2ng 
bilaterally into the two dorsal animal blastomeres of Xenopus laevis embryos at the 
8-cell stage.  A slight phenotype was seen, namely that the eyes of Nek6 TALEN 
embryos were smaller.  This is depicted in Figure 6.12 as a box plot.  Both eyes of 
17 control embryos injected with just 2ng Right TALEN only, and both eyes of 33 
embryos injected with 2ng both TALENs were photographed under the same 
magnification and their diameter measured in pixels.  The differences in eye size 
were highly significant. Therefore a Nek6 may influence eye development, 
supporting a role for Nek6 in neural development.     
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Figure 6.12 – Embryos with Nek6 TALEN targeted to the developing CNS exhibit a reduction 
in eye size 
Xenopus laevis embryos were injected bilaterally at the 8-cell stage with 2ng of Nek6 Left and 
Right TALEN or just 2ng of the Right TALEN and cultured to stage 40. Each eye on 17 2ng 
Right TALEN only embryos, and 33 2ng TALEN injected embryos was photographed and the 
eye diameter measured in pixels along its widest length (y axis).  Representative images are 
shown on the x axis.  Asterisks represent statistical significance as determined by a 2 sample 
T test. 
6.2.10.1 Nek6 TALEN injection causes movement defects  
In addition to morphological defects, Nek6 TALEN-injected embryos displayed 
aberrant movement phenotypes, similar to those of Dynll1 morphants (See 
Appendix Section 8.1).  From tailbud stages, embryos ‘coast’ around the culture 
dish by beating epidermal cilia on their trunks in order to circulate oxygen – tailbud 
embryos did not move around the culture dish, or waft cellular debris away 
suggesting cilia defects.  Nek6 TALEN embryos failed to do this.  This lack of 
‘coasting’ movement is shown in Movies 1-3 on the Accompanying Material CD.  
Uninjected control embryos (Movie 1) and 2ng Right TALEN control embryos 
(Movie2) coasted normally around the culture dish, however 2ng TALEN-injected 
embryos did not (Movie 3).  Figure 6.13 shows this information in a column chart, 
using the following criteria to categorise embryos based upon movement: embryos 
that moved as wild type, embryos that moved at a slower rate than wild type, those 
that remained stationary but could still waft away cellular debris with beating cilia, 
and those that remained stationary and could not waft away debris. 
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Figure 6.13 Effects of Nek6 TALEN on Embryo movement 
Stage 30 Xenopus laevis embryos injected with 2ng Nek6 TALEN or 2ng Right TALEN only at 
the 1 cell stage were scored based upon their ability to coast around the culture dish and 
whether cellular debris could be wafted away.   
Uninjected embryos and those injected with 2ng of Right TALEN moved normally 
around the culture dish.  However, most embryos injected with 2ng TALEN were 
unable to move around the dish, with around 50% of these unable to waft away 
debris, which could be due to major defects in epidermal cilia.   
6.2.11 Nek6 TALEN causes deletions in genomic Nek6 
sequence 
The next aim was to determine that these phenotypes were due to indels in the 
genomic DNA (gDNA) sequence of the Nek6.  The TALEN was designed against 
the Xenopus tropicalis Nek6, however the sequence targeted is almost identical to 
the Xenopus laevis Nek6.  Both Xenopus laevis and Xenopus tropicalis embryos 
were injected with 2ng Nek6 TALEN mRNA and cultured to stage 30.  gDNA was 
extracted from individual embryos and the genomic target region amplified by PCR 
using primers spanning the target region of the TALEN.  In order to observe 
individual indel events, the PCR products were purified and T-cloned.  Individual 
clones were then cultured and sequenced.  Figure 6.14 shows aligned fragments of 
clones from both species.   
 
189 
A. Xenopus laevis 
 
B. Xenopus tropicalis 
 
Figure 6.14 Nek6 TALEN causes deletions in the Xenopus laevis and tropicalis genomes 
2ng Nek6 TALEN was injected into Xenopus laevis/tropicalis embryos and genomic DNA 
extracted from individual embryos.  The genomic region around the TALEN target region was 
amplified by PCR, and fragments cloned, transformed and sequenced.  The aligned 
sequences are shown above.  In each case, the target sequence is highlighted in yellow with 
the spacer region in the centre.   
In Xenopus laevis 7/10 clones sequenced contained deletions, all of which would 
cause frameshift mutations.  In Xenopus tropicalis, half of the sequenced clones 
contained deletions, two of which would definitely cause frameshift mutations.  
Therefore, the Nek6 TALEN causes mutations in the genome at a fairly high 
frequency in the F0 generation. 
6.2.12 Effect of Nek6 knockout upon gene expression 
6.2.12.1 Nek6 knockout negatively affects mesodermal but not endodermal gene 
expression domains 
The next aim of the investigation into Nek6 function was to find out if Nek6 knockout 
had an effect on endodermal, mesodermal and/or (neur)ectodermal gene 
expression.    Firstly, ISH was performed on Xenopus laevis embryos - injected with 
2ng TALEN at the 1-cell stage and cultured to mid-gastrula (stage 11) - with probes 
against the mesodermal genes Xbra, MyoD, and Cdx4.  In addition, the endodermal 
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marker Sox17b was also utilised to see whether Nek6 knockout affects endoderm 
development. 
 
Figure 6.15 Effect of Nek6 knockdown on mesodermal genes 
Xenopus laevis embryos were injected with 2ng TALEN at the 4-cell stage and cultured to 
stage 11, where they were processed for ISH with probes against the mesodermal Xbra, 
MyoD and Cdx4 as well as the endodermal marker Sox17b.  Expression of mesodermal genes 
around the closing blastopore was lost in TALEN-injected embryos; however Sox17b 
expression was not affected.  Percentages show numbers of embryos resembling the 
representative image.   Xbra n=56, MyoD n=35, Cdx4 n=15 and Sox17b n=16. 
Mesodermal genes are expressed in a ring around the closing blastopore during 
gastrula stages.  The expression of Xbra, MyoD and Cdx4 were partially, or in some 
instances completely lost in embryos injected with Nek6 TALEN compared to 
controls, as shown in Figure 6.15.  In some cases – shown by Xbra here – this loss 
of expression was patchy probably due the mosaicism of cells inheriting Nek6 
TALEN.  Therefore knockout of Nek6 causes a loss of mesodermal gene 
expression.  Conversely, although the expression domain of Sox17b is larger 
because the blastopore failed to close in these embryos, the expression pattern of 
Sox17b did not change.  This indicates that loss of Nek6 affects mesodermal, but 
not endodermal gene expression. 
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6.2.12.2 Nek6 knockout also negatively affects expression of neural markers  
Next, the effect of Nek6 knockdown on genes involved in neural development was 
investigated.  ISH probes for the pan-neural marker Sox3, the eyefield marker Rax, 
the primary neuron marker N-tubulin, the hindbrain marker Krox20 and the MHB 
marker En2 were synthesised.  As Nek6 TALEN caused severe gastrulation defects 
which could mask neural gene expression, Xenopus laevis embryos were injected 
with 2ng Nek6 TALEN into the two dorsal blastomeres at the 4-cell stage to partially 
circumvent gastrulation defects whilst still targeting the developing CNS, although a 
high proportion still did not gastrulate.  Injected embryos were cultured until mid-
neurula stage 15 and processed for ISH.  
 
Figure 6.16.  Effect of Nek6 TALEN upon neural genes 
Xenopus laevis embryos were injected with 2ng TALEN, and controls were either uninjected or 
injected with 2ng Right TALEN only.  Embryos were cultured until stage 15 and processed for 
ISH for the pan-neural marker Sox3 (n=19), eyefield marker Rax (n=20), primary neuron 
marker N-tubulin (n=19), hindbrain marker Krox20 (n=40) and the MHB marker En2 (n=21). 
The loss of gene expression was sorted into mild and severe.  Percentages show numbers of 
embryos resembling the images shown.    
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The effects on the expression of these genes were classed as mild or severe, 
shown in Figure 6.16, which tended to correlate with how well embryos gastrulated.  
In wild type and 2ng Right TALEN only-injected controls, Sox3 expression 
demarcated the neural plate.  In TALEN-injected embryos where gastrulation 
proceeded fairly normally, Sox3 expression was patchy and in those where 
gastrulation failed completely, Sox3 expression was absent.  This suggests that 
early neural marker genes are negatively affected upon Nek6 knockout.  Nek6 
TALEN injected embryos also displayed ill-defined N-tubulin expression patterns 
pattern in some embryos, or a complete loss in others showing Nek6 is required for 
proper neurogenesis.  The neural markers Krox20 and En2 were also severely 
depleted in many TALEN-injected embryos, showing that Nek6 knockout also 
affects brain patterning and development.  Lastly, the eyefield marker Rax was also 
almost completely lost further supporting a role for Nek6 in eye development.  
These effects upon gene expression could be due to in part to gastrulation defects, 
as even though embryos were injected at the 4 cell stage, they did not gastrulate 
completely – however those that did gastrulate still displayed a loss of gene 
expression suggesting Nek6 has a separate effect on neural gene expression 
separate from its earlier effect upon the mesoderm. 
Therefore, as well as disrupting mesodermal gene expression, Nek6 knockout has a 
detrimental impact on the expression of key early neural markers, both the pan-
neural marker Sox3, as well as those specific to the eyes, hindbrain, midbrain and 
neurons. 
6.2.13 The effect of Nek6 knockout on FGF signalling  
6.2.13.1 During neurula stages, knockout of Nek6 increases MAPK signalling 
It is unknown if these effects upon mesodermal and neural genes are because they 
are also downstream targets of Nek6, or whether Nek6 knockout disrupts FGF 
signalling or other signalling pathways which cause the loss in mesodermal and 
neural gene expression.  Therefore, the effect Nek6 TALEN injection had upon the 
dpERK levels was tested at a number of stages by western blot analysis with whole 
embryos injected with 2ng TALEN at 1-cell stage and cultured to stage 11, 14 and 
17.   
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Figure 6.17 Effects of Nek6 knockout on the MAPK pathway 
Xenopus laevis embryos were injected with 2ng Nek6 TALEN and cultured to stage 11, 14 and 
17 before being processed for western blot analysis with dpERK antibody.  Left and Right 
TALEN-injected embryos (L/R) contained higher levels of active ERK than embryos injected 
with the Right TALEN only (R).  tERK was used as a loading control.   
As shown in Figure 6.17, at stage 11 there was no difference in dpERK levels 
between TALEN-injected embryos and Right TALEN controls.  However, at early 
and late neurula stage 14 and 17, TALEN-injected embryos contained higher levels 
of active ERK relative to controls.  This suggests that at neurula stages, Nek6 may 
normally repress MAPK signalling. 
6.2.13.2 Knockout of Nek6 affects the ability of iFGFR1 to induce target genes 
To investigate the effects of Nek6 TALEN upon FGF signalling further, a series of 
RT-qPCR experiments were performed using ectodermal explants.   20pg iFGFR1 
and 1ng TALEN were co-injected at the 1 cell stage. Ectodermal explants were 
taken at stage 8 and explants treated with AP20187 until stage 10.5 to coincide with 
mesoderm specification.  As positive controls, explants injected with only 20pg 
iFGFR1 were treated in the same way.  Relative to uninjected control explants, 
Xbra, MyoD and Sprouty2 were significantly upregulated by iFGFR1 induction as 
expected (Figure 6.18).  Xbra and Sprouty2 were also upregulated significantly 
when iFGFR1 was co-injected with Nek6 TALEN, however to a lesser extent to 
when iFGFR1 was expressed alone.  For Xbra, the differences between these 
conditions were significant.  Therefore, Nek6 knockout significantly negatively 
affected the ability of FGF induction by iFGFR1 to upregulate Xbra.  MyoD was 
upregulated by iFGFR1 and slightly more so in iFGFR1+Nek6 TALEN embryos, but 
there was no significant difference between MyoD levels in these two induced 
conditions. 
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Figure 6.18 Effects of Nek6 knockout on mesodermal gene expression 
Xenopus laevis embryos were injected with 20pg iFGFR1, or co-injected with 1ngTALEN + iFGFR1. Ectodermal explants were taken at stage 8, and AP20187 added 
until stage 10.5.  Ct values were normalised against those of the housekeeping gene ODC and fold expression changes normalised against uninjected explants.  Error 
bars represent SE from the mean of three biological replicates.  Asterisks represent statistical significance as measured by performing a one-way ANOVA on 
normalised Ct values.  Xbra data shown is on a different scale for ease of visualisation. 
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6.2.14 Overexpression of Nek6 
6.2.14.1 Injection of Nek6 mRNA 
Full-length Xenopus tropicalis Nek6 was obtained in a vector from Addgene.  It was 
subcloned into CS2+ and used to make sense mRNA for injection into Xenopus 
embryos.  Figure 6.19 shows the phenotype of Xenopus laevis embryos injected 
with increasing amounts of Nek6 mRNA.  At the lowest dose, only a few embryos 
displayed a noticeable phenotype which was a smaller eye than siblings and 
controls.  This was also seen at a slightly higher frequency in embryos injected with 
200pg of Nek6 mRNA.  Embryos injected with twice this dose showed more severe 
phenotypes, with some embryos failing to gastrulate.  At the highest dose tested, 
800pg, embryos with the most severe defects resembled the knockout phenotype, 
with severe gastrulation and neurulation defects, as well as anterior and posterior 
truncations in the majority of embryos.  Those that did gastrulate had under-
developed eyes and kinks in the tail. 
 
Figure 6.19 Phenotype of Xenopus embryos overexpressing Nek6 mRNA 
Xenopus laevis embryos were injected with varying amounts of Nek6 mRNA and cultured to 
stage 40.  Percentages show embryos showing a phenotype. 100pg N=23, 200pg N=20, 
400pg N=23, 800pg N=26.  800pg and 400pg injected embryos contained mild and severe 
phenotypes, as shown. 
Therefore, both overexpression and knockout of Nek6 cause similar and severe 
developmental defects, so its proper regulation must be imperative for correct 
Xenopus development. 
6.2.14.2  Nek6 mRNA partially rescues gastrulation defects caused by Nek6 TALEN 
Although both overexpression and knockout of Nek6 caused similar phenotypes, 
Nek6 mRNA was co-injected with Nek6 TALEN to see if the mRNA could rescue the 
defects associated with the TALEN embryo.  This would also be a means to assess 
the specificity of the TALEN phenotypical defects. Figure 6.20 shows embryos that 
injected with Nek6 mRNA, Nek6 TALEN, or a combination of both.  The amount of 
TALEN injected was kept at 1ng, and increasing amounts of Nek6 mRNA co-
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injected.  Representative images are shown for each condition that corresponds to 
the column graph, made after scoring embryos on their ability to gastrulate. 
 
Figure 6.20 
Xenopus laevis embryos were injected at the 1 cell stage with B-1ng Right TALEN, C-840pg 
Nek6 mRNA, D-1ng TALEN, E – 1ng TALEN+840pg Nek6 mRNA, F – 1ng TALEN + 420pg 
Nek6 mRNA and G – 1ng TALEN + 210pg Nek6 mRNA.  Representative images of each 
condition are shown above a corresponding column chart detailing percentages of embryos 
which gastrulated.  N values – A=26, B=20, C=17, D=16, E=20, F =17, G=12.  
The majority of uninjected control embryos, and control embryos injected with 1ng 
Right TALEN only gastrulated normally. Only 30% of 1ng TALEN-injected embryos 
completed gastrulation. Embryos injected with 840pg Nek6 mRNA mostly 
gastrulated, but displayed anterior truncations (65%).  Co-injection of 1ng 
TALEN:420pg mRNA resulted in 70% of embryos completing gastrulation, thus 
partially rescuing the TALEN-only phenotype.  This rescue was also seen in 1ng 
TALEN:840pg mRNA injected embryos, although it was not as penetrant with 50% 
of embryos completing gastrulation,.  Embryos injected with 1ng TALEN and 210pg 
mRNA actually gastrulated at a lower efficiency than TALEN-injected embryos, 
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(10% vs 30%), so therefore the best dosage for rescue of gastrulation is 1ng 
TALEN:420pg mRNA.  This does not produce an embryo that resembles the 
controls, as some anterior and posterior defects are still present, however they 
tended to be less severe than embryos injected with either Nek6 TALEN or Nek6 
mRNA alone.  
6.3 Using CRISPRs to characterise RNA-
seq FGF targets 
The next aim was to characterise putative novel FGF targets using CRISPR 
technology.  Three genes were picked from the RNA seq dataset to investigate 
further: Cited2, Snx10 and Zswim4.   
As discussed in previous chapters, a theme emerging from the microarray and 
RNA-seq datasets was that of a role of FGF signalling for ciliogenesis and left/right 
asymmetry.  FGF signalling has previously been implicated in ciliogenesis and the 
Nodal laterality cascade, partially through the control of Wnt signalling, although its 
exact role is unclear.  Therefore two validated iFGFR4 targets identified by RNA-
seq, previously implicated in laterality but not as yet linked with FGF signalling, were 
chosen to be characterised further.  In addition, ZSwim4 was investigated as it has 
an unknown function.  Therefore knockout of this gene could help illuminate its role 
as an FGF target during Xenopus development. 
Cited2 is a transcriptional regulator required for breaking left/right asymmetry and 
part of the nodal signalling cascade (Bamforth et al. 2004; Lopes Floro et al. 2011).  
By RNA-seq, it was found upregulated by iFGFR4 induction 2.9-fold, and was also 
significantly upregulated by iFGFR4 by RT-qPCR.  Sorting Nexin 10 (Snx10) is a 
regulator of ciliogenesis and also required for correct left/right patterning, as 
zebrafish Snx10 morphant embryos displayed randomised heart looping (Chen et 
al. 2012).  In this RNA-seq, Snx10 was found upregulated by iFGFR4 induction 2.6-
fold and was also found to be significantly upregulated by iFGFR4 by RT-qPCR.  
The third gene studied was a zinc finger protein of unknown function, ZSwim4, 
upregulated by iFGFR1 induction 4.1-fold.  These genes were not affected by 
iFGFRs in the microarray-based screen. Knockout of these genes has not been 
performed in Xenopus before or previously linked to FGF signalling to my 
knowledge, and so their function was investigated using the new CRISPR 
technology.   
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6.3.1 Design of CRISPRs  
CRISPRs were designed using the E-CRISP software.  As in Nakayama et al. 
(2013), the CRISPR target site had to satisfy the following sequence: 5’-G-n19-
nGG-3’, where the 5’ G is for T7 polymerase binding and initiation of transcription 
and the 3’ nGG is the PAM site.  Cited2 only has one exon, but a suitable site was 
found in the centre for CRISPR design. The first exon of Zswim4 was not present in 
the Xenopus tropicalis genome version used by ECrisp, and so the second coding 
exon was used.  As Snx10 consists of many very small exons, the only suitable site 
for CRISPR design was in the 5th exon.  BLAT against the Xenopus tropicalis 
genome confirmed that these target sequences were specific to the genes of 
interest.  
6.3.2 Optimisation of CRISPR/Cas9 injection conditions using 
Tyrosinase 
The Tyrosinase CRISPR from Nakayama et al. (2013) was used to optimise the 
dosage of sgRNA and Cas9 mRNA for microinjection.  Tyrosinase is commonly 
chosen for TALEN and CRISPR studies as it is required for pigment production, so 
its albino knockout phenotype is easily visualised (Ishibashi et al. 2012).  Nakayama 
et al (2013) used 2.2ng of Cas9, so this amount was injected into Xenopus tropicalis 
embryos without ill effect, and increased the degree of embryo albinism.  The 
concentration of sgRNA was then adjusted, and doses below 600pg found not to be 
toxic to embryos.  This optimisation is summarised in Figure 6.21 
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Figure 6.21 Optimising CRISPR/Cas9 injection using Tyrosinase sgRNA 
Varying amounts of Tyrosinase sgRNA and Cas9 were injected into Xenopus tropicalis 
embryos at the 1 cell stage.  Embryos were cultured to stage 40.  2.2ng of Cas9 mRNA 
could be injected without any detrimental effects to development. 500pg sgRNA/500pg 
Cas9 produced a mild mosaic phenotype in some embryos (n=35).  By increasing Cas9 
concentration to 2.2ng, a greater degree of albinism was observed in some of the embryos 
(n=29). Percentages indicate numbers of embryos resembling the representative image. 
Therefore, 500-600pg Zswim4, Snx10 and Cited2 sgRNA was co-injected with 
2.2ng Cas9 mRNA.   
6.3.3 ZSwim4 CRISPR causes head abnormalities and cyclopia 
600pg Zswim4 CRISPR was co-injected with 2.2ng Cas9 mRNA.  This CRISPR had 
a more penetrant effect than the other CRISPRs tested.  Compared to uninjected 
embryos, dorsal views of injected embryos in Figure 6.22 showed most embryos to 
have narrower heads, with more severely-affected embryos having smaller and 
cyclopic eyes, and one even had complete cyclopia.  The CRISPR also caused 
defects in organogenesis and the tail.   This suggests that ZSwim4 may be required 
for correct facial development. 
6.3.4 Sequencing shows that ZSwim4 CRISPR causes indels 
To ensure these defects occurred in embryos showing indels in Zswim4, embryos 
injected with ZSwim4 CRISPR/Cas9 showing a phenotype were collected and 
gDNA extracted from 9 individual embryos.   
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Figure 6.22 Effects of ZSwim4 CRISPR on Xenopus development 
600pg ZSwim4 and 2.2ng Cas9 mRNA were co-injected into Xenopus tropicalis embryos at 
the 1 cell stage.  N=31.  Two thirds of embryos had narrowing of the head as shown by dorsal 
views and these varied in severity with some exhibiting cyclopia. 1 embryo had total cyclopia 
(bottom).  Percentages indicate numbers of embryos resembling the representative image.  As 
well as these defects, side views of injected embryos show there were defects in the AP axis.  
Alignment of the ZSwim4 genomic CRISPR target regions against sequenced clones Zswim4-
CRISPR injected embryos is shown below.  The PAM is highlighted, around which Cas9 will 
bind to cause double stranded breaks.  Out of 22 clones sequenced, only 3 were unchanged 
from the original sequence.  A large insertion was found in 2 of the sequences (highlighted) 
and the rest had deletions 
Within the target region, the CRISPR is shown in uppercase.  All but three of the 22 
Zswim4 clones sequenced contained deletions in the genomic sequence.  Two of 
the clones contained insertions (highlighted).  These deletions are large enough to 
have a profound effect on the protein sequence to render Zswim4 non functional.  
PCR was performed using primers to amplify the genomic region around the target 
sequence.  The PCR product was T-cloned and individual clones sequenced.  
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Alignments of the sequenced clones against the genomic Xenopus tropicalis target 
sequence are shown in Figure 6.22. 
6.3.5 Snx10 and Cited2 CRISPRs cause laterality defects 
Snx10 has been previously knocked down in zebrafish and shown to cause laterality 
defects, as has a null murine Cited2 mutant (Lopes Floro et al. 2011; Chen et al. 
2012).  Therefore Xenopus tropicalis embryos injected at the 1 cell stage with 600pg 
Snx10 or Cited2 sgRNA and 2.2ng Cas9 were cultured to stage 42/43 when the 
heart and guts are in the process of looping.   
 
Figure 6.23 Effects of Cited2 and Snx10 knockout by CRISPR on development 
600pg Cited2/Snx10 sgRNA was co-injected into Xenopus tropicalis embryos at the 1 cell 
stage and cultured to stage 42 (Cited2, n=54) or stage 43 (Snx10 n=44).  Ventral views of 
CRISPR /Cas9 injected embryos showed a small number of embryos to have laterality 
defects.  Cited2 CRISPR embryos appeared normal, however a small number had either 
unlooped guts, or defective looping (compare with uninjected typical gut looping shown by 
arrow).  In Snx10 CRISPR embryos, a small number had defective gut looping compared 
to controls (typical gut looping direction shown by arrow).  In the central image, the embryo 
also had situs inversus of the developing heart (compare dotted circles showing heart 
orientation). Percentages indicate embryos resembling the representative image. 
  A small number of Cited2 CRISPR-injected embryos displayed either unlooped 
guts, or erratic gut looping suggesting laterality defects.  A small number of Snx10 
CRISPR-injected embryos also displayed laterality defects in gut looping, as well as 
one case of situs inversus of the heart.   
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6.3.6 Sequencing of Snx10 CRISPR-injected embryos 
Embryos injected with Snx10 CRISPR were processed for sequencing using the 
same methods as for the Zswim4 CRISPR.  Due to time constraints, sequencing for 
Cited2 CRISPR was not completed.  Alignments of the sequenced clones against 
the genomic Xenopus tropicalis Snx10 CRISPR target sequence are shown in 
Figure 6.24.   
 
Figure 6.24 Snx10 CRISPR alignment 
Alignments of the Snx10 genomic CRISPR target region against sequenced clones from 
Snx10 CRISPR-injected embryos.  The PAM is highlighted, around which Cas9 will bind to 
cause double stranded breaks.  None of the sequenced clones for Snx10 had a change in 
the surrounding sequence (PAM is reverse complimented, sgRNA is capitalised). 
Unfortunately, of the 27 Snx10 clones sequenced, none had deletions close to the 
PAM.  A small number of clones had point mutations quite far from the PAM, and all 
had a CA substitution.  These however do not alter the protein sequence and 
given their distance from the PAM, could be simply polymorphisms.  Therefore, the 
Snx10 CRISPR may either work at very low efficiency, reflected in the low numbers 
of phenotypically affected embryos, or the gut mutations be due to chance or off-
target effects.  
6.3.7 Dynll1 is not an FGF targeted 
Dynein light chain 1 (Dynll1) was investigated because the preliminary microarray 
showed it to be upregulated 2.6-fold by iFGFR1 and 2.3-fold by iFGFR2.   
Furthermore, RNA-seq showed Dynll1 to be 2.3-fold upregulated by iFGFR1 and 
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2.5-fold downregulated by iFGFR4 and so could be an example of a gene 
differentially regulated by FGFRs.  The function of Dynll1 was characterised through 
use of a morpholino, and found to have detrimental effects on organogenesis, and 
function of epidermal cilia, similar to that of Nek6 as embryos did not move around 
the culture dish.  However, the findings of the microarray and RNA-seq could not be 
replicated in whole embryos using iFGFRs or dnFGFRs by RT-qPCR and ISH.  The 
raw RNA-seq data was revisited, as it was hypothesised that maybe only a certain 
splice form of Dynll1 was affected by iFGFR induction, as Dynll1 was listed a 
number of times in the dataset and not always associated with a >2-fold expression 
change with either iFGFR. These two ‘classes’ of Dynll1 were found to be 
associated with different sequences.  Unfortunately a BLAST search revealed that 
the sequences of Dynll1 that were listed as upregulated in both the microarray and 
RNA-seq were not in fact Dynll1, and were instead highly similar to apolipoprotein-
C1.  As this removed any connection between Dynll1 and FGF signalling, Dynll1 
was not investigated further. 
 
6.4 Discussion 
6.4.1 FoxN4, Hmx3 and Hesx1 are negatively regulated by FGF 
signalling  
In this chapter a number of genes were analysed from the microarray dataset that 
were novel putative FGF targets down-regulated by iFGFR1 and/or iFGFR4. 
Hesx1, also known as Xanf, is a homeodomain transcription factor. It is the earliest 
known repressor present in the anterior neuroectoderm and is essential for the 
proper development of the telencephalon (Ermakova et al. 1999). These genes 
have been described in Chapter 3, as they are known to be required for anterior 
neural development and are involved in a feedback loop required for forebrain 
patterning and development.  Hesx1 was found downregulated by iFGFR1 and 
iFGFR4 by microarray, and RNA-seq results supported this finding in neuralised 
animal caps.  This could be another example of FGF promoting posterior neural 
fates by repressing telencephalic development in part mediated by Hesx1.   Hesx1 
has been functionally linked to Ras-dva, part of a positive feedback loop with AGRs, 
and Otx2 which activate FGF8, disruption of which affects forebrain development.  
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Ras-dva was found by both microarray to be downregulated by iFGFR1 and 
iFGFR2, and by RNA-seq to be downregulated by iFGFR1, however RT-qPCR in 
neuralised explants and the use of dnFGFR1 produced conflicting results (data not 
shown).  Also, knockdown of Hesx1 in Xenopus has been performed previously 
(Ermakova et al. 2007).  Therefore, these genes were not characterised functionally 
further.   
Forkhead domain transcription factor Forkhead box N4, (FoxN4) is expressed in 
progenitor cells in the developing Xenopus and chick retina and brain (Kelly et al. 
2007; Boije et al. 2013). FoxN4 has no previously reported link with FGF signalling 
but its expression domain overlaps that of FGF8 in the midbrain and hindbrain as 
well as active dpERK regions (Kelly et al. 2007).  FoxN4 was downregulated by 
iFGFR4 1.58-fold in the microarray. FoxN4 was slightly downregulated by iFGFR4 
by microarray, but this was not significant upon RT-qPCR validation.  However, 
iFGFR1 induction in whole embryos significantly downregulated FoxN4 expression 
so it may be an FGFR1 target.  Our preliminary data indicated that FoxN4 was 
repressed by Noggin and further repressed by iFGFR1 induction. Further 
experimental repeats would be required to confirm the effect of FGFR induction 
upon FoxN4. 
Hmx3, also known as Nkx5.1, has a role in regulating lateral line and inner ear 
development in zebrafish (Feng & Xu 2010).  Hmx3 is expressed in the brain, and 
previously found to be positively regulated, and to positively regulate FGF signalling 
through FGFR1 (Adamska et al. 2001).  However, in the microarray-based screen 
Hmx3 was found downregulated by iFGFR4. A negative regulation by iFGFR4 could 
therefore point to an example of differential regulation of a gene by FGFRs.  
Furthermore, in Xenopus, Hmx3 represses Hesx1 (Bayramov et al. 2004).   
Overexpression as well as inhibition of Hmx3 caused inhibition of posterior forebrain 
markers Otx2, Pax6 and Six3 in the developing Xenopus laevis forebrain due to 
aberrations in the balance between Hmx3 and Hesx1; so Hmx3 is important for 
neural development and is a good candidate for FGF regulation (Bayramov et al. 
2004). Although not tested by RT-qPCR in neuralised ectodermal explants, RNA-
seq did not show Hmx3 expression to change at all upon iFGFR1 or iFGFR4.  
Therefore on this basis it cannot be said that Hmx3 is a neural FGF target, but may 
be an FGF target in the whole embryo. 
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6.4.2 Nek6 is a novel FGF target 
The initial microarray, RNA-seq and validation of these data has revealed Nek6 to 
be positively regulated by FGF signalling in both whole embryos and neuralised 
explants. Knockout of Nek6 using a TALEN causes extreme developmental defects, 
and in whole embryos a loss of mesoderm and neural markers. In explants, Nek6 
knockout dampens the response of FGF targets to iFGFR1 induction. Therefore, as 
well as its role in the cell cycle, Nek6 is also required for Xenopus mesodermal and 
neural development, possibly through regulation of FGF signalling. 
6.4.2.1 Current knowledge about Nek6 
The 11 identified vertebrate Nek kinases are serine/threonine kinases structurally 
related to the Aspergillus nidulans never in mitosis, gene A (NIMA).  In Aspergillus, 
NIMA is essential for progression from G2 to mitosis, and is required for localisation 
of CyclinB to the nucleus (Wu et al. 1998).  Nek6 is 84% similar to Nek7, and these 
are 80% similar to Nek9.  The three Neks comprise the NIMA complex which is 
active during mitosis and involved in regulation of the mitotic spindle (Quarmby & 
Mahjoub 2005).  Dynll1 is able to bind to Nek9, increasing Nek9’s autoactivation 
potential, whilst inhibiting its ability to form a complex with Nek6 and activate it.  
However there is no evidence yet that this interaction takes place naturally in vivo 
(Regué et al. 2011).   
Research into the localisation of Nek6 using HeLa cell extracts showed it to localise 
to different microtubule-based structures during mitosis, including mitotic spindles, 
but not the spindle poles themselves (Fry et al. 2012).  HeLa cells expressing a 
kinase-dead Nek6 had more fragile mitotic spindle microtubules and less focussed 
spindle poles, which resulted in metaphase growth arrest.  On this basis, Nek6 was 
implicated in microtubule organisation and stability during mitosis (O’Regan & Fry 
2009).  Furthermore, Nek6 as part of the NIMA complex was also found to control 
centrosome separation during prophase in HeLa cell extracts (Bertran et al. 2011).   
Nek9 is activated by phosphorylation in two steps involving the cyclin-dependent 
kinase Cdk1, and the serine/threonine kinase Plk1.  Cdk1, together with CyclinB1, 
phosphorylates Nek9 at several sites during mitosis, allowing it to interact with and 
be activated by Plk1 (Bertran et al. 2011; Sdelci et al. 2011). The C-terminus of 
Nek9 then binds to and phosphorylates and activates Nek6 and Nek7 (Fry et al. 
2012). 
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As Nek6 is essential for cell division in vitro, one could hypothesise that it would be 
globally expressed throughout the Xenopus embryo. However, in situ results in 
Xenopus suggest that Nek6 is confined to discrete areas of the embryo in the 
somitic mesoderm, branchial arches and notochord and stage 40 TALEN-injected 
embryos are still alive, albeit without any recognisable features.  Overexpression of 
Nek6 also causes in some cases a failure to gastrulate and head defects (Figure 
6.19).  In vivo studies of Nek6 function are rare, although unpublished work 
referenced by Bertran et al. (2011) stated that a Nek6-/- null murine mutant was 
embryonic lethal. Automated ISH images on Xenbase report expression in the brain, 
although this was not detected here. Earlier work in mouse embryos investigating 
Nek6 and Nek7 expression suggested that Nek6 was firstly expressed in the 
trophoblast and in later embryonic stages expressed almost exclusively in the CNS 
in the ventricular and sub-ventricular zones, whereas Nek7 was expressed in the 
thalamus (Feige & Motro 2002).    
Given the cell cycle roles mentioned above, it could be predicted that Xenopus 
embryos would not survive at all post MBT, as Nek6 is required for mitotic 
progression in vitro (O’Regan & Fry 2009).  However, these Xenopus knockout data 
show embryos survive until at least stage 40 despite being very deformed, therefore 
Nek6 must have other roles in mesodermal and neural development. 
6.4.2.2 Is Nek6 a neural FGF target? 
Collectively, RNA-seq and microarray results, ISH, as well as RT-qPCR show that 
Nek6 is positively regulated by iFGFR1 induction in whole embryos and neuralised 
ectodermal explants.  However, ISH of Nek6 showed it to not be detected in the 
CNS in Xenopus in this study, although as mentioned, it has been found in the 
developing murine CNS and on ISH data on Xenbase (community submitted image) 
(Feige & Motro 2002).  RT-qPCR showed Nek6 expression to be unaffected by 
excess Noggin, perhaps counting against it being a neural FGF target, however 
other posterior neural FGF targets such as HoxB9 are also unaffected by Noggin 
(Roche et al. 2009).   
In the raw RNA-seq data, consistently low read counts (increasing from 1-2 FPKM 
to 5-7 FPKM) meant that Nek6, although being upregulated by iFGFR1 induction 5 
fold by RNA seq, did not meet filtering thresholds and therefore was not included in 
genelists.  This could mean that it is a purely mesodermal gene, and its low read 
presence is a result of mesodermal cell ‘contamination’ from taking too-large 
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ectodermal explants containing mesodermal cells reacting to FGF induction.   
Refseq data by Tan et al. (2013) includes quantified levels of Xenopus tropicalis 
genes at all developmental stages.  Betweens stages 10 and 12, Nek6 is expressed 
at very low levels - ~4 RPKM, similar to the raw RNA seq FPKMs of ~5 found here.  
As a comparison, MyoD, Cdx4 and Xbra are expressed at ~100, ~80 ~290 RPKM 
respectively (M. H. Tan et al. 2013).  In this RNA seq, Xbra expression was 
increased from only 0.2 to 2 FPKM by iFGFR1 induction, MyoD from 2.7 to 6, and 
Cdx4 from 0.1 to 0.9 – very low read counts compared to Tan and colleagues’ 
results.  This shows that known mesodermal genes expressed at a very high level in 
whole embryos are predictably expressed at very low levels in neuralised 
ectodermal explants. Nek6 levels are not similarly reduced.  Therefore, it is possible 
that Nek6 did not pass filtering conditions because it is naturally expressed at low 
levels, and not because it’s solely a mesodermal gene not normally expressed in a 
neuralised explant. 
Some of the data support a role for Nek6 in the CNS, as knockout of Nek6 using a 
TALEN targeted to the CNS reduced eye size, as well as the expression domain of 
the eyefield marker Rax.  Furthermore, ISH of embryos injected with Nek6 TALEN 
into dorsal cells at the 4-cell stage displayed reduced expression of MHB and 
hindbrain markers En2 and Krox20 as well as disrupted expression of the pan-
neural marker Sox3 and primary neuron marker N-tubulin.  Even though in some 
cases, gene disruption could have been due to the profound gastrulation defects 
caused by the TALEN, in injected embryos more able to undergo gastrulation these 
markers were still partially or totally lost.  Therefore, collectively this shows that 
knocking down Nek6 may have a role directly or indirectly in neural development as 
well as the mesoderm. 
6.4.2.3 What is Nek6’s function in development? 
ISH on embryos injected with 2ng TALEN displayed patchy loss of MyoD, Cdx4 and 
Xbra, suggesting that Nek6 normally has a positive effect on mesoderm 
development (Figure 6.15).  Maybe Nek6 targets and directly influences the 
expression of mesodermal genes, or Nek6 knockout interferes with the FGF 
signalling output at this stage, perhaps via an intermediate gene or effects on other 
pathways, such as those regulated by TGFβ (see later).  At stages where 
mesoderm induction is occurring, western blots showed that dpERK levels were 
unchanged in Nek6 TALEN-injected embryos.  Therefore these effects on 
mesodermal genes may not be due to changes in MAPK signalling output.  
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However, embryos collected at early and later neurula contained higher dpERK 
levels compared to controls.  Therefore at neurula stages, the Nek6 TALEN may 
affect the FGF signalling pathway to influence gene expression.   
To see if the presence of Nek6 TALEN affected the normal response of known FGF 
targets to FGF induction, explants co-injected with Nek6 TALEN and iFGFR1 were 
induced during the period of mesodermal gene action and the levels of Xbra, 
Sprouty2 and MyoD investigated.  For Xbra and Sprouty2, the presence of Nek6 
TALEN partially inhibited FGF-induced gene expression (Figure 6.18), and this was 
significant for Xbra.  Therefore even though this is not matched by changes in 
dpERK at these stages, Nek6 knockout seems to dampen FGF signalling (even 
though TALEN-only injections increased gene expression).  This could impair FGF-
mediated processes during mesodermal and neural development.  Further 
experiments using different genes at different timepoints would be needed to make 
this assertion more concrete. 
6.4.2.4 Interaction of Nek6 with other signalling pathways 
It is probable that Nek6’s effects on gene expression are due to it interacting with 
other pathways as well as FGF.  Network2Canvas analyses on iFGFR1 RNA seq 
data (see last chapter) identified Nek6 as being a kinase node due to its interactions 
with Sgk1;Smad4;Smurf2 and Nup98, even though Nek6 did not itself appear in the 
filtered dataset.  Sgk1 was upregulated by 5-fold by iFGFR1 and 3.5-fold by iFGFR4 
induction by this RNA-seq. In the literature, Sgk1 was identified as being 
phosphorylated by Nek6 in vitro but not  in rats in vivo, so confirming an in vivo 
interaction in Xenopus could be interesting (Lizcano et al. 2002).  Smurf2 
(upregulated 2-fold by iFGFR1 induction) is an ubiquitin protein ligase and TGFβ 
signalling effector.  In a high-throughput protein interaction screen to find novel 
TGFβ targets, an interaction between Nek6 and Smurf2 was found in mammalian 
cells using LUMIER (luminescence-based mammalian interactome mapping). This 
technology used bait –Smurf2 – fused to luciferase, which emits light when it binds 
to FLAG-tagged prey, and its interaction with Nek6-FLAG was significant (Barrios-
Rodiles et al. 2005).   However, a recent paper by Zuo et al., (2014 in press) could 
not show through co-immunoprecipitation experiments that Nek6 and Smurf2 co-
precipitate in Hep3B cells or in vivo using murine antibodies. They did find however 
that the TGFβ effector Smad4 co-precipitated with Nek6 in these conditions, and a 
luciferase assay in Hep3b cells with a Smad-reponsive reporter showed that 
reporter transcription was inhibited in the presence of Nek6, showing Nek6 to have 
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a negative effect on Smad4.  TGFβ/Smad4 downstream target genes such as 
Dapk1,p27 and p21were also inhibited by Nek6 in this paper.  Mechanistically, this 
negative interaction was shown to work in part because Nek6 sequestered Smad4 it 
in the cytoplasm (Zuo et al. 2014, in press).  To follow this up, RT-qPCR on whole 
embryos as well as animal caps treated with BMP4 protein, or expressing BMP 
antagonists/dominant negative Smads could be performed to investigate the effect 
of Nek6 TALEN on BMP signalling.  Given Nek6’s interaction with TGFβ, also 
investigating Nodal targets, such as Lefty, or activating early Nodal signalling with 
Activin could be useful in understanding Nek6’s function in early development.    
6.4.3 The use of a TALEN to investigate Nek6 
The Nek6 TALEN was 70% efficient in producing indels in Xenopus laevis and 50% 
efficient with Xenopus tropicalis, although ideally more sequencing of clones from 
more embryos would have been performed, as was done with Snx10 and ZSwim4 
CRISPR.   
Ishibashi et al. (2012) were one of the first groups to use TALENs in Xenopus.  
They also used a tyrosinase TALEN to show TALENs produced partial or full 
albinos in 90% of cases in the F0 generation. It was confirmed that these mutations 
passed to the germ line and were inherited in the F1 generation (Ishibashi et al. 
2012).  Lei et al. (2012) also investigated the targeting efficiencies of a number of 
TALENs in Xenopus tropicalis and found the highest efficiency to be 90% in the F0 
generation in terms of generating indels. On this basis, TALENs were hailed as a 
cost-effective alternative to morpholinos, and morpholinos also have varying effects 
as they knock down rather than knock out gene expression, and work temporarily 
meaning that investigating gene effects later in development is tricky (Lei et al. 
2012).    In my hands, the TALEN was more effective in Xenopus laevis than 
tropicalis, although sequencing more clones would lend more support for this.  Lei et 
al. (2012) and Suzuki et al. (2013) compared TALEN efficiencies between Xenopus 
laevis and Xenopus tropicalis with conflicting results, suggesting that it may be the 
individual TALEN responsible for this variation, rather than the frog species.  
Although TALEN mutations are long lasting and produce heritable mutations, 
Nakajima & Yaoita (2015) showed there to be low efficiencies in gene targeting the 
first few hours of development while translation of the left and right TALEN pair are 
taking place at the same time as rapid cell division.  The efficiencies of TALENs 
early after injection are important to ensure early blastula effects of gene knockout 
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are seen.   When investigating knockout of Nek6 in early stages, or targeting the 
TALEN at 8-cell to the CNS, it is important that the translation and activation of the 
TALEN is rapid and it is inherited uniformly amongst daughter cells to ensure that all 
daughter cells contain working TALEN. Nakajima and colleagues improved the 
Tyrosinase TALEN by fusing it to a gene called Deadsouth, which promotes mRNA 
translation in the oocyte.  This fusion construct was injected into Xenopus oocytes, 
which were stained with a vital dye and implanted into a host female.  When the 
oocytes were fertilised, TALEN expression was already 52% at 3 hours post 
fertilisation (hpf), rising to 99% at 8 hpf.  In contrast, for TALENs injected into 
embryos at 1-cell the indel efficiencies were 7% 4hpf, rising to 60% at 5.5 hpf and 
then slowly increased to 79% over 24 hours and maintained at 80%.  Therefore this 
could possibly increase the efficiency of the Nek6 TALEN early on, but it might be 
represent a more demanding protocol than is practicable to perform routinely in 
Xenopus. 
6.4.4 Using CRISPR to characterise FGF targets 
Three novel FGF targets – Snx10, ZSwim4 and Cited2 – were picked from the RNA 
seq dataset to characterise neural FGF targets.  All three of them produced a 
phenotype, albeit of variable efficiencies, and Zswim4 efficiently caused indels.   
ZSwim4 was found in an RNA-seq experiment to be upregulated in pregnant cow 
endometrium (Forde et al. 2012).  It is not referenced elsewhere in the literature.  An 
automated ISH image on Xenbase shows ZSwim4 to be expressed in the Xenopus 
CNS (Karpinka et al. 2014).  The ZSwim4 CRISPR caused indels at a high 
efficiency, 19/22 clones tested containing indels in the expected region next to the 
PAM.  The cyclopic narrow head phenotype of CRISPR embryos is reminiscent of 
embryos treated with the Shh inhibitor cylopamine (Dunn et al. 1995).  Therefore 
ZSwim4 could also have an effect on Shh signalling, and effects upon Shh pathway 
genes in ZSwim4 knockout embryos by ISH and RT-qPCR could be employed to 
test this hypothesis. FGF signalling has also been implicated in craniofacial 
development, as syndromes associated with defective FGF signalling such as Apert 
Syndrome include cleft palates.  Furthermore FGFR2b and FGFR2c-null mice show 
multiple skeletal and facial abnormalities  including premature fusion of the parietal 
and squamous temporal skull bones (reviewed in Nie et al. (2006).    It is Wnt 
signalling in the ANB, particularly through Lrp6 which mediates FGF signalling in 
cleft palate formation (Wang et al. 2011). 
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Sorting nexins such as Snx10 are characterised by the presence of a phox-
homology (PX) domain and they are present in all eukaryotes with 33 members 
identified in humans.  Snx proteins are involved in a range of processes including 
endocytosis, protein sorting and degradation (Cullen 2008).  In vitro, overexpression 
of Snx10 causes large vacuoles to form in the cytosol, although the functional 
relevance of this is unclear (Qin et al. 2006).  Chen et al designed a translation 
blocking morpholino against Snx10 and injected it into zebrafish embryos.  Whilst 
the morphology of the embryos was largely unchanged, the heart exhibited 
randomized or reduced looping in 30% of embryos, and bilateral or reversed spaw 
expression in the KV, suggesting that Snx10 influences left/right asymmetry.   
Closer look at the KV revealed that the cilia number, but not length was reduced in 
morphants (Chen et al. 2012).      
Based upon this, a CRISPR-mediated knockout of Snx10 in Xenopus would also be 
expected to cause laterality defects.  Although heart looping defects were not seen, 
there was one observed case of heart situs inversus where the heart leant to the left 
rather than the right (Figure 6.23).  Furthermore, a few embryos exhibited 
randomization of gut looping, another L/R regulated process.  However, this was not 
at the higher frequency found by the morpholino.  It would be interesting to see how 
the expression of nodal-related genes in Xenopus change as a response to 
Snx10/Cited2 CRISPR to further investigate the effects of these genes on early 
left/right symmetry breaking. 
Cited2 (Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal 
domain) is a transcriptional co-activator.  Cited2 has been shown to promote the 
expression of anterior neural genes, such as Otx2, and repress the eyefield marker 
Rax and the posterior neural marker HoxB9 (Yoon et al. 2011). In mouse embryos, 
null mutants of Cited2 have heart defects caused by a perturbation of left/right 
asymmetry (Lopes Floro et al. 2011).   Similar to Snx10, Cited2 has also been 
implicated in left/right asymmetry. Cited2-null mouse embryos die before birth and 
have a range of heart defects, including abnormal heart looping and left atrial 
isomerism.  As Nodal, Lefty and Pitx2 were not expressed in the lateral mesoderm 
in null mutants, this suggested that an aspect of Cited2 activity was required for 
correct left/right patterning (Weninger et al. 2005; Bamforth et al. 2004).  More 
detailed analysis of the mutant showed that although deletion of Cited2 from the 
lateral plate mesoderm did not affect laterality or Nodal expression, Cited2 present 
adjacent and posterior to the Node is required to bind to the asymmetric enhancer 
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element of Nodal, to initiate Nodal expression.  Furthermore, Cited2 was also found 
to potentiate BMP signalling, counteracting the initiation of Nodal expression.   
Therefore very early in development, Cited2 is required for the initiation of the Nodal 
cascade and its regulation via interactions with BMP.   
In this CRISPR-potentiated knockdown in Xenopus, although at a very low 
frequency, a number of Xenopus embryos here also had laterality defects – 
although no heart defects were seen, gut looping was disrupted or did not take 
place.  Sequencing the region around the PAM in these embryos would confirm this 
was due to new indels in Cited2.  More detailed analyses of Snx10 and Cited2 
CRISPR embryos earlier in development by looking at gene expression of Nodal-
regulated genes such as Coco, Lefty and Pitx1/2 could add support for Snx10 and 
Cited2 being required for left/right asymmetry in Xenopus (Schweickert et al. 2012).   
6.4.4.1 Problems with CRISPR efficiency 
 The efficiency of the two CRISPRs tested, against Snx10 and ZSwim4, were very 
different.  Guo et al. (2014) compared the efficiency of 10 CRISPRs made in their 
lab against Xenopus tropicalis genes.  In this paper they made CRISPRs against 10 
genes.  6 of these had 72-100% targeting efficiency, when seen by sequencing 
clones.  ZSwim4 therefore gives comparable rates of efficiency to this.  Four 
CRISPRs made had very low efficiencies, which were rectified by changing the 
amounts of sgRNA or remaking an alternative sgRNA.  Therefore CRISPR 
efficiencies are variable in Xenopus, and designing another sgRNA for Snx10 and 
Cited2 could improve the penetrance of their phenotype.  This unfortunately would 
not be an option for Snx10, as the only site compatible with CRISPR design was the 
one chosen in the 5th exon which in itself is not optimal.   
Increasing the efficiency of Cas9 could help increase the frequency of NHEJs.  The 
two Xenopus tropicalis CRISPR papers published at time of writing use different 
forms and dosages of Cas9.  Nakayama et al. (2013) compared bacterial Cas9, 
used in Guo et al. (2014) and a humanised form of Cas9 which is optimised for use 
in mammalian systems and has been successfully used in the zebrafish and in this 
study (Chang et al. 2013).  The ‘human’Cas9 injected at 2.2ng gave a much higher 
rate of albinism when co-injected with Tyrosinase sgRNA than bacterial Cas9.  
However, the optimal dosage of bacterial Cas9 was found to be just 300pg for Guo 
and colleagues which gave equivalent efficiencies.  Therefore it is unclear which 
Cas9 form is best to use, although the 2.2ng dosage used for this study was the 
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maximum practicable to inject into Xenopus tropicalis embryos.  A drawback to the 
CRISPR and TALEN system is that it relies on several injected mRNAs injected at 
1-cell to be rapidly translated and inherited evenly when cells divide.  Injecting the 
sgRNA with recombinant Cas9 protein could improve the efficiency of CRISPRs and 
partially get round this problem, which has been done by Gagnon et al, (2014). 
6.4.5 Dynll1 is not an FGF target 
Dynein light chain 1 (Dynll1) is a component of the Dynein motor complex and 
involved in the trafficking of molecules around the cell. In cytoplasmic dynein, two 
Dynll1 molecules interact with dynein intermediate chain, inducing dimerisation and 
organisation of the dynein complex (Regué et al. 2011).  Dynll1 was investigated 
because the preliminary microarray showed it to be upregulated 2.6-fold by iFGFR1 
and 2.3-fold by iFGFR2.   Furthermore, RNA-seq showed Dynll1 to be 2.3-fold 
upregulated by iFGFR1 and 2.5-fold downregulated by iFGFR4 and so could be an 
example of a gene differentially regulated by FGFRs.  It is also functionally linked to 
Nek6 through its interaction with Nek9 (Regué et al. 2011).  Based upon this, Dynll1 
was functionally characterised with the use of a Morpholino, and results are in 
Appendix 8.1.  However, ‘Dynll1’ was found to be misidentified in microarray and 
RNA-seq due to an errant entry on Unigene, and BLAST searches identified it as 
ApoC1.  This explained why these results could not be replicated by RT-qPCR and 
ISH using primers and morpholinos made against the actual Dynll1.  
This also happened with Zfp36L1, which was identified by RNA-seq as being 
upregulated by iFGFR1 and this was validated by RT-qPCR.  In addition to this, the 
RNA-seq found induction of iFGFR4 to cause downregulation of Zfp36L1.  
Comparison of the sequence files to ascertain whether this differential regulation of 
Zfp36L1 was down to differences in splicing showed that the iFGFR4-associated 
sequence for Zfp36L1 was not in fact Zfp36L1 as BLAST searches did not show 
alignment to a recognised gene.   
This highlights the importance of double-checking sequences of genes of interest 
before characterising them further, as there are evidently errors in Xenopus gene 
annotation. 
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6.4.6 Further work and conclusions 
In this Chapter Nek6 has been identified as a novel FGFR1 target in Xenopus.  
Nek6 knockout caused a loss of mesodermal and neuroectodermal genes. During 
neurula stages, Nek6 knockout caused an increase in dpERK levels, suggesting a 
feedback interaction with FGF signalling. Furthermore, Nek6 knockout impaired the 
ability of known FGF targets Xbra and Sprouty2 to respond to FGF induction by 
iFGFR1. Therefore Nek6 has important developmental roles during Xenopus 
development in addition to its well-documented roles in the cell cycle.  Further work 
to identify interacting pathways and Nek6 knockout effect on mesodermal and 
neural gene function could give a better understanding of its role in Xenopus 
development.  The aspect of Nek6 phenotype that would be interesting to 
investigate further in this study was the movement phenotype which is probably 
caused by defective cilia.  It would be interesting to find out if the knockout causes a 
loss of cilia, or defects such as shortening which render them unable to beat.  This 
could be done using an antibody against alpha tubulin to visualise cilia and their 
movement by live fluorescent imaging.  It would be optimal to investigate cilia 
defects in the GRP, but TALENs would have to be targeted to this structure as the 
severe phenotype would make it difficult to study. 
Characterisation of genes found in the RNA-seq dataset through knockout by 
CRISPR also produced phenotypes in novel FGF target genes Snx10 and Cited2 
which displayed laterality defects, and Zswim4 which when knocked out causes 
defects in head development.  The next steps for Snx10 and Cited2 would be to try 
and increase their efficiency, and then see what effect CRISPR mediated knockout 
of these had on other cilia and nodal related genes.  There were other genes 
implicated in cilia and left right patterning in this study, such as Atp6V0c and Ift172 
which would also be interesting to investigate by CRISPR. Lastly there are other 
examples of genes like ZSwim4 which are very scarcely mentioned in the literature, 
such as Ikzf2 and Zfp36L1 of which their developmental functions are unknown.  
Further characterisation of Zswim4 by investigation of its interaction with other 
signalling pathways, as well as other unknown targets would give a greater insight 
into the processes FGF signalling is involved with during neural development. 
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7  General Discussion 
 
7.1 Summary 
The microarray and RNA-seq based screens undertaken during this project showed 
that activation of iFGFR1-4 affected many genes during periods of early neural 
development.  These datasets showed that each iFGFR had very different signalling 
outputs, as there was little overlap between the genelists for each gene.  Therefore, 
different FGFRs must function independently and cooperate to specify and pattern 
the CNS.  As well as genes known to be involved in neural development and/or 
expressed in the developing CNS, genes involved with other signalling pathways, 
particularly Wnt signalling, as well as genes implicated in other developmental 
processes such as laterality, cell cycle and anterior CNS development were affected 
by FGF induction.  Some novel FGF targets found as a result of these screens were 
characterised further.  TALEN-mediated knockout of one of these, Nek6, affected 
the expression of several mesodermal and neural markers. In addition, loss of Nek6 
appeared to interfere with the ability of iFGFRs to affect gene expression.  CRISPR-
mediated knockout of putative FGF targets Cited2 and Snx10 lent support for these 
genes in being involved in laterality, and a CRISPR specific to ZSwim4, a gene of 
unknown function, caused cyclopia and defects in the anterior CNS.  Therefore, 
FGFRs have a range of effects that change the transcriptome and eventual 
phenotype of Xenopus embryos when induced.  
Taken as a whole, the data also confirms FGF signalling as important for neural 
induction, patterning of the developing CNS, and also neurogenesis itself.  FGFs 
have long been known to be required for posterior neural development. As well as 
Cdx and Hox genes found in the microarray screen, genes such as FoxA4, FoxB1 
and FoxD4l1.1 that have previously been implicated in posterior neural induction  
and inhibit genes associated with anterior neural development  were found 
upregulated by iFGFR1 by RNA-seq (Martynova et al. 2004; Takebayashi-Suzuki et 
al. 2011; Neilson et al. 2012).  Interestingly, iFGFR4 induction in neuralised animal 
caps was shown to negatively affect other anterior CNS genes such as Otx2, 
Hesx1, Shisa2 and Agr2, which are all part of a positive feedback loop with Fgf8 in 
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the ANB (Tereshina et al. 2014).  This suggests a role for FGFR4 in promoting a 
posterior neural fate whilst Fgf8 in the IsO and ANB regulates anterior neural 
development, which would be interesting to investigate further. Another role for 
iFGFR4 could be in eye development, as a number of genes previously implicated 
in this process were found by the RNA-seq based screen.  Gnb3, Crx and Rax were 
all downregulated, and Frs3 and Hes2 upregulated by iFGFR4 induction.  This 
suggests that although iFGFR4 behaves differently than iFGFR1 in its effects on 
MAPK signalling and development, it has distinct and important effects upon neural 
development.  There are also genes such as the novel putative iFGFR1 target, 
ZSwim4, found by RNA-seq which when knocked out produces cyclopia where 
FGFs mechanistic influence is more unclear.  Similarly, Nek6 affects mesodermal 
and neural development when knocked out but why this happens is still unclear.  
Further characterisation of these novel iFGFR1 and iFGFR4 targets will give  
greater insights into other ways FGF signalling impacts neural development. 
7.2 Further work 
7.2.1 Potential future additions to RNA-seq work 
Ideally, all iFGFRs would have been investigated in this study, and a biologically 
replicated RNA-seq experiment performed in order to fully compare and contrast 
differences in signalling output between the different iFGFRs during early neural 
development.  This may have in turn made for easier and more reliable dataset 
validation and the formation of stronger conclusions from ontological analyses.  In 
particular, it would be interesting to compare the differences between iFGFR1 VT+ 
and VT- targets, as it is unclear if what role, if any, VT- isoforms of FGFRs have in 
Xenopus development.  Furthermore, it is known that FGFR3 is expressed in the 
CNS in later neural development, but the microarray analysis suggested it 
predominantly functioned in other cellular processes during the time period 
investigated (Lea et al. 2009). Therefore, inducing iFGFRs during later periods of 
neural specification may reveal if iFGFR signalling in the CNS changes over time.  
The RNA-seq data contains information that has not been analysed in this study, 
including the many ‘Unknown’ hits, and information relating to the ‘A’ and ‘B’ forms 
of each gene, as well as any non-coding mRNAs that may have been sequenced. 
Further analyses of A and B forms of each gene, which will be more feasible when 
the laevis genome improves would be interesting, and enable a better insight into 
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gene evolution and function.  In order to analyse the 'unknown' files, the original 
sequence would have to be sourced. This proved difficult as the sequence data 
contributing to the Mayball longest cDNA library is no longer available, and the 
Mayball search engine only recognises the gene name, and not the read name 
attached to each gene. Due to time constraints, this was not investigated further 
although could yield interesting results and novel transcripts if investigated at a later 
date. As there was a high level of sequencing depth in this study, it is possible that 
miRNAs and ncRNAs are present in this data. To affirm this would require more in-
depth data processing and re-alignment of the sequencing data, and may not yield 
optimal results as the fragmentation and library preparation protocols were 
optimised for longer fragments of RNA. The protocol for finding smaller RNAs 
selects RNA fragments of only ~24 bp and makes libraries of these, which would 
exclude the longer fragments which were used for library preparation in this study 
(Harding et al. 2014; Hafner et al. 2008). Nevertheless, it could be possible to see if 
miRNAs are present in their mature form in the sequenced fragments by aligning 
them to the Xenopus tropicalis collection of known miRNAs on miRBase 
(www.mirbase.org) to see if there are any miRNAs or other short RNAs present 
before proceeding further. Lastly, there may be different splice variants of genes 
present in the data, particularly those that feature in the genelists more than once. A 
disadvantage of using a non splice-aware read mapper during sequence alignment 
means that no novel splice junctions will be found, and use of a longest cDNA 
library to align reads to may make this impossible, but further investigation into this 
dataset could give an insight into how FGF signalling might regulate splicing during 
neural development, and what functional implications this has. 
7.2.2 Characterisation of novel iFGFR signalling targets 
In this project Nek6 has been identified as a novel FGFR1 target in Xenopus. Nek6 
knockout caused a loss of mesodermal and neuroectodermal genes, and a possible 
effect upon FGF signalling itself. Therefore Nek6 has important developmental roles 
during Xenopus development in addition to its well-documented roles in the cell 
cycle. Further work to identify interacting pathways and Nek6 knockout effect on 
mesodermal and neural gene function could give a better understanding of its role in 
Xenopus development. The aspect of Nek6 phenotype that would be interesting to 
investigate further in this study was the defective movement phenotype which is 
probably caused by defective cilia. It would be interesting to find out if the knockout 
causes a loss of cilia, or defects such as shortening which render them unable to 
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beat. This could be done using an antibody against alpha tubulin to visualise cilia 
and their movement by live fluorescent imaging. It would be optimal to investigate 
cilia defects in the GRP, but TALENs would have to be targeted to this structure as 
the severe phenotype would make it difficult to study. 
Characterisation of genes found in the RNA-seq dataset through knockout by 
CRISPR also produced phenotypes in novel FGF target genes Snx10 and Cited2 
which displayed laterality defects, and Zswim4 which when knocked out causes 
defects in head development. The next steps for Snx10 and Cited2 would be to try 
and increase their efficiency, and then see what effect CRISPR mediated knockout 
of these had on other cilia and nodal related genes. There were other genes 
implicated in cilia and left right patterning in this study, such as Atp6V0c and Ift172 
which would also be interesting to investigate by CRISPR. Lastly there are other 
examples of genes like ZSwim4 which are very scarcely mentioned in the literature, 
such as Ikzf2 and Zfp36L1 of which their developmental functions are unknown. 
Further characterisation of Zswim4 by investigation of its interaction with other 
signalling pathways, as well as other unknown targets would give a greater insight 
into the processes FGF signalling is involved with during neural development. 
7.3 Can the effect of iFGFR induction in 
Xenopus be extrapolated to mammals? 
Although manipulation of FGF signalling in this study was investigated in the frog, 
the function of individual FGFRs has also been investigated in mice in several 
knockout studies. 
An FGFR1-/- mouse was made by Yamaguchi et al (1994), and was found to be 
embryonic lethal between E7.5 and E9.5, due to severe gastrulation defects and 
shortened egg cylinders.  FGFR1 mutants were generally smaller, lacked somites 
and had smaller neural folds and heads than wild type controls. This is similar to 
dnFGFR1 Xenopus phenotypes (Enrique Amaya et al. 1991).  Mesodermal cells in 
FGFR1 -/- mouse embryos accumulated in the primitive streak, and axial mesoderm 
was expanded at the expense of paraxial mesoderm (Yamaguchi et al. 1994).  
These morphological defects were found to be caused by a blockage of epidermal 
to mesenchymal transition in primitive streak cells through loss of FGFR1-mediated 
regulation of Snail1 and E-cadherin (Ciruna & Rossant 2001).  Interestingly in this 
RNA seq screen, Snail1 was found downregulated by iFGFR1 -2.8x, and E-cadherin 
219 
downregulated by iFGFR4 -1.8x, which is different from the mouse data, although 
the regulation of these genes in neuralised ectoderm versus mesoderm may be 
different. 
The phenotype of FGFR2 knockout mice is also severe, with homozygous embryos 
dying before implantation due to defects in visceral endoderm differentiation and a 
lack of growth of the inner cell mass  (Arman et al. 1998).  Conditional knockout of 
FGFR2 in radial glial cells – the primary progenitors of neurons in the dorsal 
diencephalus – is not lethal, but knockout mice display a decrease in hippocampal 
volume and have problems with learning and memory in later life (Stevens et al. 
2012).  Anatomical analysis of these knockout mice showed that FGFR2 is 
necessary for the formation of the correct number of excitatory neurons in the 
cerebral cortex and medial prefrontal cortex of the mouse brain (Stevens et al. 
2010).   
In comparison, FGFR3 knockout mice survive longer than FGFR1 and FGFR2 
knockout mice, but are characterised by skeletal defects, such as kyphosis, 
scoliosis, crooked tails and curvature of long bones and vertebras (Colvin et al. 
1996).   FGFR3 has also been shown to be required for correct brain development, 
as FGFR3 knockout mice are characterised by having a smaller forebrain 
(particularly the telencephalon), cerebral cortex and hippocampus.  These mice also 
had changes to the projections of their GABAergic neurons (Moldrich et al. 2011).  It 
would be interesting to further characterise the phenotype of the CNS in induced 
iFGFR3 Xenopus embryos, as most embryos had misshapen heads, deformed eyes 
and larger cement glands compared to controls.  The microarray and RNA seq 
based screens presented here did not reveal a role for FGFR3 in early neural 
development, possibly as the time window investigated was too early. From mid-
neurula stages there is evidence to suggest that FGFR3 is concentrated in the 
developing brain in Xenopus tropicalis (Pope et al. 2010; Lea et al. 2009).  
Therefore, if iFGFR3 was induced later in development, its effect upon neural 
development might be easier to observe. 
A major point of difference between the findings of this project in Xenopus and 
studies in mice is in the effects of disrupting FGFR4. Homozygous FGFR4 knockout 
mice consistently develop normally with only a small decrease in body weight at 
weaning found (Weinstein et al. 1998). The only detectable phenotype found in 
FGFR4 knockout mice is an arrest in muscle regeneration after injury and 
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replacement of injured muscle with fat and calcifications (Zhao et al. 2006).  This 
agrees with findings in the chick where inhibition of FGFR4 lead to arrest of muscle 
progenitor differentiation (Marics et al. 2002).  This contrasts with the severe 
developmental defects seen in Xenopus after injection of dnFGFR4a, including a 
failure of gastrulation, posterior truncations, as well as defects in telencephalon and 
eye development  (Hardcastle et al. 2000; Hongo et al. 1999). dnFGFR4 also 
drastically altered the Xenopus transcriptome in a microarray based screen 
searching for mesodermal FGF targets (Branney et al. 2009). It is important to note 
that dnFGFR4 does not specifically knock down FGFR4, and so its effects may be 
due to the partial knockdown of other FGFRs (Ueno et al. 1992; Branney et al. 
2009).  However, although this investigation induced FGFR4-mediated signalling 
instead of repressing it, iFGFR4 induction caused definite changes to the embryonic 
transcriptome and phenotype, as embryos displayed misshapen heads, in some 
cases a failure of neural tube closure, defects in eye development and a shortened 
anteroposterior axis.  This could mean that FGFR4 is only detrimental to 
development when constitutively active, or it is possible that the signalling role of 
FGFR4 is not conserved between Xenopus and mammals. 
These possible discrepancies could be an example of a limitation of using Xenopus 
in the context of understanding mammalian development and FGF signalling.  
However, data from the other FGFR mouse knockout studies seem to be more in 
keeping with what is known already about Xenopus FGF signalling.  Therefore, this 
work in Xenopus is hopefully useful for adding to knowledge about mammalian FGF 
signalling in development and disease. 
7.4 FGF misregulation in human 
development 
Understanding how FGF affects development on a molecular and anatomical scale 
is important for our understanding of a number of human developmental disorders 
which have been previously shown to centre on defective FGF signalling. 
7.4.1.1 Gain-of-function of FGFR2 causes Craniosyntosis 
Apert syndrome (AS) is characterised by craniosyntosis, which is the premature 
fusion of the coronal sutures.  In babies, this causes facial abnormalities and 
megaencephaly, and effects on other parts of the body are seen such as syndactyly 
in both upper and lower limbs (Johnson & Wilkie 2011).  Nearly 100% of people with 
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AS  carry one of two mutations on FGFR2, with 70% carrying a S252W gain-of-
function mutation (Aldridge et al. 2010; Yeh et al. 2013).  A similar craniosyntosis 
syndrome without the syndactyly phenotype – Crouzon Syndrome – is also caused 
by over-activation of FGFR2 during development, by the formation of a disulphide 
bridge between receptor monomers causing constitutive dimerisation and activation 
of the receptor (Neilson & Friesel 1995).  An AS mouse model has been made, with 
mice showing craniofacial dysmorphologies similar to humans diagnosed with AS.  
In addition to brain development being negatively impacted by defects in skull 
development, the AS FGFR2 mutation also caused aberrant brain morphologies 
independent of the skeletal defects. AS-mutant mouse brains had shorter 
rostrocaudal and longer dorsoventral axes, as well as showing severe cerebral 
asymmetry in some cases (Aldridge et al. 2010).  Another group found that AS 
mutant FGFR2 expressed in endothelial cells of the blood vessels in the brain had 
defects in their vasculature, which the authors hypothesised contribute to the 
pathophysiology of AS (Yeh et al. 2013).   Therefore a tight control of FGFR2 
expression during brain development is needed for the coordination of skull and 
brain development, and investigation into FGFR2 targets could help us to 
understand how AS-associated pathologies develop. 
7.4.1.2 FGFR3 gain-of-function in skeletal development 
FGFR3 has been associated with bone development, as it is a key regulator of 
growth and differentiation during the process of endochondral ossification (Colvin et 
al. 1996).  FGFR3 is expressed in resting and proliferating cartilage undergoing 
endochondral ossification and normally inhibits bone growth, with FGFR3 knockout 
mice displaying overgrowth of long bones due to an increase in chondrocyte 
proliferation (Colvin et al. 1996; Moldrich et al. 2011).  A gain-of-function of FGFR3 
is seen in humans with Achondroplasia.  The mechanisms underpinning how this 
links to pathology has been investigated using a mouse model.  In these AS-like 
mice, it was shown that FGFR3 inhibits chondrocyte differentiation through 
upregulation of Smurf1.  In this RNA-seq based screen, Smurf2 was found to be 
upregulated 2x by iFGFR1.  Smurf1 causes an increase in the degradation of the 
BMP receptor BMPR1, which would otherwise stimulate the differentiation of 
chondrocytes (Qi et al. 2014).  Thus, regulation of FGFR3 is important for correct 
skeletal development.  Although outside the scope of this study, it would be 
interesting to see if Xenopus embryos treated with iFGFR3 display any skeletal 
defects as tadpoles, although it would be difficult to treat embryos with AP20187 as 
they grow large enough to swim and injected iFGFR mRNA and its protein would 
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eventually degrade.  Thus a transgenesis approach may have to be employed in 
this instance.  
7.4.2 Pathologies stemming from FGF misregulation in the human 
CNS 
As can be seen from the phenotypes in Xenopus in this project, as well as in the 
mouse knockout studies described above, the disruption of FGF signalling causes 
problems with CNS development.  Investigation of the long-term effects of iFGFR 
induction upon the brain and behaviour of feeding tadpoles was outside the scope 
of this project but as referenced above, FGFR knockout mice have smaller 
hippocampi, a region associated with mental illness. Several studies in mice and 
case studies in humans have shown a possible link between FGF mis-regulation in 
the hippocampus and FGF signalling in disorders such as schizophrenia, major 
depression and bipolar disorder.   
An SNP upstream of human FGFR1 has been associated in a Genome Wide 
Association Study (GWAS) to confer a risk of developing schizophrenia (Shi et al. 
2011).  Other GWASs have identified two different SNPs upstream of FGFR2, one 
significantly associated with schizophrenia, and the other with Bipolar Disorder 
(O’Donovan et al. 2009; Wang et al. 2012).  ISH on frontal cortices and hippocampi 
of human subjects that suffered from major depression and schizophrenia found 
there to be a higher percentage of FGFR1-positive cells in these regions in their 
brains (Gaughran et al. 2006). 
Mice expressing dnFGFR1 under the control of an Otx1 promoter displayed 
reductions in total brain size, particularly in the frontal and temporal regions, 
reminiscent of brains of people diagnosed with schizophrenia.  The behaviour of 
these mice was also altered with hyperactivity and compulsive head movements 
(Shin et al. 2004).   Other dnFGFR1 mutant mice displayed deficits in prepulse 
inhibition – a lack of response to a startle stimulus after a smaller previous stimulus.  
Deficits in Prepulse inhibition is another trait shared by schizophrenia patients, 
correlating with symptom severity (Terwisscha van Scheltinga et al. 2013). A 
functional reason for these traits is thought to be an imbalance between excitatory 
glutamergic neurons and inhibitory interneurons, as well as over-activation of the 
dopamine system, imbalances of which are found in those diagnosed with 
schizophrenia and autism (Shin et al. 2004; Marín 2012).   
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Therefore as well as the severe human pathologies of FGF signalling misregulation 
in the whole body during development, recent research has shown defective FGF 
signalling in the mammalian brain could contribute to serious illness.  Therefore, the 
more that is known about FGF signalling networks during neural development, the 
more we might know about the reasons for FGF-related pathologies and potential 
therapeutic targets. 
7.5 FGF signalling, cilia and laterality in 
the CNS 
7.5.1 Consequences of defective ciliogenesis in human 
development 
In both microarray and RNA-seq datasets, a number of genes associated with 
ciliogenesis and/or laterality were identified as putative iFGFR1 or iFGFR4 targets.   
Ciliated cells are found throughout the body.  Non-motile cilia function as mechano- 
or chemosensors and detect changes in the surrounding environment.  Defects in 
non-motile cilia in humans are responsible for Polycystic Kidney Diseases in adults, 
and childhood-onset Autosomal recessive Polycystic Kidney Disease (ARPKD).  
These conditions are caused by mutations in the Polycystin1/2 or PKHD1 (reviewed 
in Badano et al. 2006).  Renal mechanosensory cilia that are immotile as a result of 
these mutations cannot maintain homeostasis of renal epithelial cells or detect renal 
flow.  It is thought this loss of environmental information causes abnormal cell 
proliferation and production of renal cysts, leading to eventual kidney failure (Nauli 
et al. 2003).   
Motile cilia include those with planar motion and are present on a cell surface in 
large numbers, often beating in an uncoordinated manner.  These are important in 
airways to waft mucus and foreign substances towards the mouth for removal, and 
in the reproductive system (Powles-Glover 2014).  Primary Ciliary Dyskinesia (PCD) 
is a condition in humans caused by ciliary dysfunction due to absence of dynein 
arms in the axoneme.  People with PCD are characterised with widening of the 
bronci (bronchiectasis), sinusitis and infertility.  When these symptoms also coincide 
with laterality defects,  it is known as Kartagener syndrome (reviewed in Badano et 
al. 2006).  Ruvbl2, found by RNA-seq to be downregulated by iFGFR1, has been 
shown to be essential for cilia motility and to interact with the zebrafish PCD protein 
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- Ruvbl2 mutant embryos contained axonemes with fewer dynein arms and embryos 
displayed kidney cysts (Zhao et al. 2013).  As previously discussed, the laterality 
organs – the GRP in Xenopus – contain cells with a single polarised rotary cilia 
responsible for leftward fluid flow thought to break left right asymmetry.  Mutations in 
Nde1, Snx10, and Ift172 found by this RNA-seq based screen have been previously 
shown to cause laterality defects, so may also have implications in human 
development and ciliopathies (Kim et al. 2011; Chen et al. 2012; Gorivodsky et al. 
2009).   
7.5.2 Wnt and Shh signalling pathways, with possible FGF input, 
are needed for cilia function 
Wnt and Shh signalling are also involved in, and require, cilia and ciliogenesis. The 
microarray and RNA-seq based screens undertaken in this project identified a 
number of components of these pathways previously implicated in cilia and/or 
laterality defects.   
Non-canonical Wnt signalling is required for planar cell polarity (PCP) signalling at 
the level of Dishevelled, which is recruited to the basal body by inversin in response 
to activated Frz (Lienkamp et al. 2012).  Both Dvl3 and Frz were downregulated by 
iFGFR1 and iFGFR2 in the microarray-based screen.  This interaction between 
inversin and Dvl3 is required for polarisation of cilia at the plasma membrane, and 
inversin mutations in mouse embryos cause laterality defects (Okada et al. 1999).  
Vangl2, upregulated by iFGFR4 in the RNA-seq based screen is also a member of 
the PCP pathway, and shown to be responsible for the polarity of the KV cilia in 
zebrafish; Xenopus Vangl2 morphants display heterotaxia as a result of PCP 
signalling disruption (Vandenberg et al. 2013; May-Simera et al. 2010).  In 
zebrafish, Vangl2 has been shown to functionally interact with Bbs8 at the basal 
body.  Mutations in Bbs8 cause Bardet–Biedl syndrome in humans – a disorder that 
has many symptoms, but often includes those of ciliopathies such as situs inversus 
and reproductive tract anomalies (May-Simera et al. 2010).   
Shh signalling is also localised to the cilium, as until Shh binds Ptch1, Ptch1 inhibits 
Smoothened by preventing its translocation to the cilium. Upon Shh binding, this 
inhibition is relieved allowing Smo to move to the tip of the cilium and signal 
(Powles-Glover 2014).  Shh, Ptch2, and Smo were listed as upregulated by iFGFR1 
and/or iFGFR2 in the microarray-based screen, and so FGF signalling could 
influence this process.  Regulation of Shh signalling is important in the context of 
225 
ciliopathies as loss of cilia changes Shh signalling, and changes to Shh signalling 
itself causes skeletal abnormalities through changes to cilia intraflagellar transport 
proteins and basal body protein complexes (Powles-Glover 2014).  Ciliary proteins 
are also required in neural tube development, and Intraflagellar transport 2 (Ift172) –
found upregulated by iFGFR4 and downregulated by iFGFR1 in this RNA-seq – was 
functionally characterised in a mouse mutagenesis screen to find targets of Shh 
signalling. Ift172 mutants had greatly reduced Ptch1 expression and as well as 
having laterality defects, embryos resembled Shh mutant embryos that lacked 
ventral neural cell types and an open neural tube (Huangfu et al. 2003).  
There is evidence to suggest that embryonic asymmetry is set up much earlier than 
the formation of cilia, as maternal ion channels and proton pumps are found 
asymmetrically located in Xenopus embryos from the 4-cell stage.  These propagate 
gradients in pH and voltage across the embryo (Vandenberg et al. 2013).  Atp6V0C, 
a component of V-ATPase and found upregulated by iFGFR1 is also implicated in 
laterality in its own right, as it is asymmetrically located in the ventral right 
blastomere at the 4-cell stage, localised to Rab11 (Vandenberg et al. 2013).  
Expression of a dominant negative Rab11, or pharmacological inhibition of Atp6V0C 
both caused consistent heterotaxia in Xenopus embryos (Vandenberg et al. 2013; 
Adams et al. 2006). 
Therefore, defects in cilia are important to understand as they are responsible for a 
variety of disorders in humans when they are non-functional.  FGF signalling may 
feed into ciliogenesis at a number of steps, firstly in being directly important for cilia 
number and length in the node as described in previous chapters, as well as 
through targets identified in this RNA-seq screen and crosstalk with other signalling 
pathways. 
7.6 FGF signalling and neural asymmetry 
As the RNA-seq screen was based upon neuralised animal cap explants, perhaps 
the laterality-related genes found in this screen are also required for neural 
asymmetry.  Laterality in the brain and CNS has been mainly studied in zebrafish 
embryos.  Nodal signalling, as well as its role in breaking symmetry in the paraxial 
mesoderm, is also transiently activated on the left-hand side of the zebrafish brain 
(Rebagliati et al. 1998).  Other Nodal pathway effectors such as Lefty1 and Pitx2 
and in the fish, Nodal-related laterality genes such as Cyclops and Oep, are 
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expressed on the left side of the brain only (Rebagliati et al. 1998; Concha et al. 
2000).  A loss of Nodal and downstream signalling leads to randomisation of the 
laterality of the pineal organ, which is normally located on the left-hand side of the 
zebrafish epithalamus (Concha et al. 2000).  In fish and amphibians, the pineal 
organ is photoreceptive and formed before the lateral eyes.  In the adult organism 
the pineal organ has endocrine roles and involved in circadian rhythm.  The 
parapineal organ of unknown function, is adjacent to the pineal organ and together 
they form the pineal complex (Halpern et al. 2005).  The pineal complex 
asymmetrically influences the gene expression and development of the adjacent 
region of the brain, the left habenular.  The habenular nuclei relay telencephalic 
input to the midbrain, and the left and right habenular nuclei project along distinct 
paths along the dorso-ventral axis (Sutherland 1982).  There are also left/right 
differences in cell morphology and packing density in the left and right epithalamus, 
as well as differences in neuron calcium responsiveness and neurotransmitters 
emitted (Gamse et al. 2003).  A loss of Cyclops or Oep expression in the 
epithalamus results in zebrafish embryos with bilaterally symmetric Nodal 
expression, and randomised orientation of the pineal and habenular complexes as a 
result (Concha et al. 2000; Gamse et al. 2003).   
FGF signalling is thought to play a role in this laterality process, as FGFR4 is known 
to be expressed in the parapineal cells.  In zebrafish FGF8 (ace) mutants, migration 
of the pineal complex to the left did not occur.  This was rescued after the addition 
of an FGF8-soaked bead to the epithalamus (Regan et al. 2009).  Ace mutants were 
also found to have fewer parapineal cells and an increase in the proportion of 
photoreceptor cell types.  Therefore, as well as influencing the Nodal cascade and 
laterality in the brain, FGFs also influence cell fate (Clanton et al. 2013). 
Neugebauer & Yost, (2014) recently found further evidence to support the 
requirement of FGF signalling for the asymmetry of the pineal complex.  Inhibition of 
FGF signalling through application of the drug SU5402 caused bilateral expression 
of Cyclops and Lefty1, and a conditional constitutively active FGFR (caFGFR) 
caused a loss of Lefty1 expression in the brain.  Interestingly, this was independent 
of the earlier Nodal cascade signalling in the lateral plate mesoderm (Neugebauer & 
Yost 2014).  FGF signalling in the zebrafish epithalamus was also found to regulate 
the transcription factors Six3 and Six7, previously found to be required for zebrafish 
brain asymmetry (Inbal et al. 2007).   Lastly, FGF signalling was found to have 
another role in the formation of a midline structure in the forebrain marked by β-
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catenin.  This is analogous to the physical midline provided by the neural tube and 
notochord in the left and right lateral plate mesoderm.  Expression of caFGFR or 
inhibition of FGF signalling through application of SU5402 caused complete loss, or 
disruption and expansion of the telencephalic midline, respectively (Neugebauer & 
Yost 2014).  
These findings suggest that genes found in this screen by RNA-seq, such as Lefty 
and other genes such as Pitx2 found in the microarray-based screen may have 
roles in Xenopus neural asymmetry as well as in the lateral plate mesoderm, and 
FGF signalling may feed into this process at a number of levels.  Although perhaps 
coincidental, the presence of FGFR4 in the pineal complex found by Regan et al. 
(2009) is also interesting, as ‘Circadian Clock System’ genes were significantly 
enriched in the iFGFR4-upregulated genelist as shown by PANTHER pathway 
analysis.  Examining the role of FGF signalling later in neural development using 
iFGFRs could confirm this, as the time window of neural development investigated 
in this project is much earlier than the developmental events described here.  There 
were other genes implicated in cilia and left right patterning in this study, such as 
Atp6V0C and Ift172 which would also be interesting to investigate by CRISPR to 
see if they produced laterality or ciliary defects. More detailed analyses of the brains 
of Snx10 and Cited2 CRISPR embryos would be useful to see if brain laterality 
defects occurred as well as the randomised gut looping that suggested problems 
with laterality in the LPM.  
Learning about laterality in the brain and the signalling processes involved is 
beneficial, as there is increasing evidence to suggest that alterations of L/R 
asymmetries in the human brain are correlated with autism, dyslexia, schizophrenia 
and depression (reviewed in Taylor et al. 2010).  For example, a recent study on 
post-mortem brains of patients with depression revealed a right-sided reduction in 
habenular volume, cell number and cell area (Ranft et al. 2010).  Therefore, the 
FGF-mediated asymmetry of the epithalamus described in the fish could have 
important implications for human mental health diagnoses and treatments. The 
more that is known about early signalling events and genes active in determining 
brain laterality, the better these pathologies and how to treat them could be 
understood.     
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7.7 Conclusions 
The microarray and RNA-seq based screens undertaken in this project revealed 
many genes to be affected by FGF signalling during early neural development.  
Further characterisation of genes discussed here by TALEN/CRISPR could give a 
greater insight into FGF’s roles in neural induction and patterning, as well other 
developmental processes occurring at the same time. It would also be interesting to 
investigate the effects of iFGFR2 and 3 in neuralised ectodermal explants as well as 
comparisons between the iFGFR1 VT- and iFGFR1 VT+ -affected transcriptome.  
Now that the depths of sequencing using the Illumina technology is known, 
biological repeats of the neuralised animal cap iFGFR induction assay using these 
other iFGFRs could be performed relatively quickly if time and resources allowed.  
These additional analyses would provide a more comprehensive view of FGF 
signalling in neural development, and further explore the differences in signalling 
output between the different FGFRs. 
Knowledge about global FGF targets and gene networks it regulates could help give 
further insights into FGF signalling and associated developmental disorders in 
humans, of which there are still gaps in the understanding of how FGF 
misregulation contributes to phenotypes.  Understanding cell signalling in 
development is also important to the understanding of cell signalling in stem cells, 
tissue regeneration and cancer.  Therefore, research into how FGF signalling 
affects these processes, directly and through interaction with other signalling 
pathways could give clues as to how these phenomena arise and can be treated. 
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8 Appendices 
 
8.1 Dynll1 
Dynein light chain 1 (Dynll1) is a component of the Dynein motor complex and 
involved in the trafficking of molecules around the cell. In cytoplasmic dynein, two 
Dynll1 molecules interact with dynein intermediate chain, inducing dimerisation and 
organisation of the dynein complex (Regué et al. 2011). Dynll1 is also known as 
LC8, but this term also covers the highly similar Dynll2.  Recently Dynll1 has been 
found to interact with myosin, cytoskeletal and motility proteins such as PAK and be 
essential for diverse processes such as nuclear transport, mitosis initiation, 
transcriptional regulation and post-synaptic density (Rapali et al. 2011) 
Dynll1 was investigated because the preliminary microarray showed it to be 
upregulated 2.6-fold by iFGFR1 and 2.3-fold by iFGFR2.   Furthermore, RNA-seq 
showed Dynll1 to be 2.3-fold upregulated by iFGFR1 and 2.5-fold downregulated by 
iFGFR4 and so could be an example of a gene differentially regulated by FGFRs. 
8.1.1 Dynll1 is expressed in regions suggesting it could be 
involved in neural development and FGF signalling 
The CDS of Dynll1 was cloned into pGEM and in-situ probe synthesized.  A range 
of Xenopus tropicalis developmental stages were collected and processed for ISH.  
Dynll1 was first visible in late gastrula embryos in a dorsal triangle above the closing 
blastopore lip (Figure 8.1A).  This corresponds to the Gastrocoel Roof Plate (GRP) 
region, which is populated with polarised cilia required for leftwards-fluid flow to 
break left/right symmetry in Xenopus (Schweickert et al. 2007).  At neurula stages 
(Figure 8.1B and C) Dynll1 is no longer visible in this region but is present in a 
punctate pattern on the epidermis.  This is most obvious in the tailbud embryo 
(Figure 8.1D), and is reminiscent of ISH experiments for cilia marker genes such as 
α-tubulin (Dubaissi & Papalopulu 2011).  As well as the epidermis, Dynll1 was also 
present in the otic vesicle, the head and CNS.  This is best shown by a cross 
section through the embryo (Figure 8.1D’) which shows Dynll1 expression in the 
neural tube.  Even though the epidermal trunk cilia are unlikely to be under FGF 
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control, the presence of Dynll1 in the CNS and close to the GRP puts it in the right 
place to feasibly be an FGF target. 
 
Figure 8.1 – Dynll1 expression during Xenopus tropicalis development 
Xenopus tropicalis embryos at various stages were processed for ISH with a probe against 
Dynll1.  A shows faint Dynll1 staining above the dorsal blastopore lip of the late gastrula 
embryo (arrowed).  In neurula stages (B and C), Dynll1 is expressed on the epidermis in a 
punctate pattern.  This is most obvious in D, a tailbud embryo, where Dynll1 is expressed on 
the trunk at places corresponding to cilia.  At the dotted line D’ the embryo was cut and the 
cross section is shown in D, which shows Dynll1, is expressed in the neural tube (arrowed). 
8.1.2 Dynll1 MO causes defects in cilia and movement of 
Xenopus embryos 
A morpholino against Dynll1 was designed with care so as to be specific to only 
Dynll1.  BLAST searches revealed a site including, and upstream of, the 
transcriptional start site that was both specific to Dynll1 only and suitable for a 
translation-blocking morpholino design.   
The morpholino was injected bilaterally at the 1-2 cell stage at a number of 
concentrations into Xenopus tropicalis and embryos cultured to stage 42.  15ng of 
control morpholino was also injected into embryos, which appeared as wild type.  At 
the time of imaging, embryos were at stage 42, when the heart and guts are looping 
(Figure 8.2, arrows).  As the dose of Dynll1 morpholino is increased, morphants 
showed a progressively diminished ability for the hearts and guts to loop, leaving 
them in an immature, tubular state.  Morphants also displayed oedema.  The CNS 
was not as drastically affected by the loss of Dynll1, although at higher 
concentrations heads appeared smaller in the dorsal-anterior most region as there 
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appeared to be less space between the eyes and the front of the head.  Embryos 
also failed to elongate posteriorly. 
 
Figure 8.2 – Phenotype of Xenopus tropicalis embryos injected with Dynll1 Morpholino 
Xenopus tropicalis embryos were injected bilaterally with varying doses of Dynll1 morpholino 
at the 1-2 cell stage.  15ng of control morpholino was also injected and showed no ill effects. 
Embryos were cultured until stage 42 and imaged on their sides, and ventrally to show gut 
looping (black closed arrow) and heart development (position shown by open arrow). 
This suggests that Dynll1 has a role in organogenesis, and antero-posterior 
development.  Further histology would be needed to see Dynll1’s effects on the 
forebrain and CNS. 
Another strong phenotype observed with these morphant embryos was that of 
movement ability– wild type and control-morpholino injected embryos ‘coasted’ 
across the culture dish, whereas morphants moved more slowly or not at all.  Cilia 
are required in this region to help the developing embryo propel itself through 
medium, and circulate surrounding nutrients and oxygen around before it can swim. 
Movies showing a defective coasting phenotype in Dynll1 morphants are shown in 
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the Accompanying Material CD in Movies 4 and 5.  15ng Dynll1 Morpholino-injected 
embryos were almost completely stationary in the culture dish (Movie 5), compared 
to uninjected controls (Movie 4).  These morphant embryos were categorised by 
their ability to coast as wild type, and to beat cellular debris away from themselves 
as a readout of epidermal cilia functionality.  Results are shown in Figure 8.3.     
 
Figure 8.3 – Effects of Dynll1 morpholino upon the ability of Xenopus tropicalis embryos to 
move.  
Xenopus tropicalis embryos were injected bilaterally at the 1-2 cell stage with varying amounts 
of Dynll1 morpholino, or 15ng of control morpholino.  Embryos were cultured until stage 30 
and scored on the basis of their ability to move through medium, and also if they could beat 
away surrounding debris.   
The most severely affected embryos were motionless and the beating action of cilia 
on cellular debris was not observed.  Embryos injected with 5ng of morpholino 
largely moved as wild type, although some were noticeably slower than others.  
Most embryos injected with 7.5ng morpholino moved slower than wild type, with 
some embryos being unable to move at all.  This movement category made up the 
majority of embryos injected with 15ng MO, with half of these unable to beat away 
cellular debris.  This suggests a role for Dynll1 in ciliogenesis. Even though the 
trunk cilia, being far from FGF expression domains are probably not under FGF 
control, the negative effects on ciliogenesis in the trunk may be found in the GRP, 
although further experiments would be required to make this assertion.   
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8.1.3 RT-qPCR validation and RNA seq raw data shows Dynll1 is 
not an FGF target 
To validate the findings of the RNA-seq and iFGFR microarray to ascertain if Dynll1 
is indeed an FGF target, RT-qPCR was performed using primers against Dynll1.  
Xenopus laevis embryos were injected bilaterally with 20pg iFGFR1, cultured at 
22°C to stage 10.5 and induced with AP20187 until stage 13, 15 or 17.  Sibling 
embryos were injected with 1ng dnFGFR1 and cultured until the same stages.   
Figure 8.4 shows that at all three stages, relative to uninjected/uninduced controls 
Dynll1 was not significantly or consistently affected by FGF induction or inhibition, 
which disagreed with the findings of the microarray.   
 
Figure 8.4  RT-qPCR shows that Dynll1 is not an FGF target 
In A, whole Xenopus laevis embryos were injected bilaterally with 20pg iFGFR1 and cultured 
until stage 10.5.  AP20187 was then added and sibling embryos cultured at 22°C until stage 
13, 15 or 17.  In B, 1ng dnFGFR1 was injected bilaterally into Xenopus laevis embryos and 
cultured until the same stages as A. Ct values were normalised against those of the 
housekeeping gene ODC and fold expression changes normalised against iFGFR1-injected 
uninduced embryos (A) or uninjected controls (B).  Error bars represent SE from the mean of 
three biological replicates 
 
The raw RNA-seq data was revisited, as it was hypothesised that maybe only a 
certain splice form of Dynll1 was affected by iFGFR induction, as Dynll1 was listed a 
number of times in the dataset and not always associated with a >2-fold expression 
change with either iFGFR. These two ‘classes’ of Dynll1 were found to be 
associated with different sequences.  Unfortunately a BLAST search revealed that 
the sequences of Dynll1 that were listed as upregulated in both the microarray and 
RNA-seq were not in fact Dynll1, and were instead highly similar to apolipoprotein-
C1.  The origins of this clone sequence was from data used in Pollet et al. (2005), 
submitted to NCBI.  The aim of this study was to perform a large semi-automated 
ISH screen of 8369 cDNA clones in Xenopus laevis embryos.  One of these clone 
sequences, cnef01 mRNA, the precursor to Apoc1, was submitted to NCBI 
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database into the Dynll1 section despite sharing no significant similarities when 
aligned by BLAST.  This ApoC1 sequence was presumably then mis-annotated as 
Dynll1 during processing of RNA-seq and microarray raw outputs.  As this removes 
any connection between Dynll1 and FGF signalling, Dynll1 was not investigated 
further. 
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Figure 8.5. Geach et al. 2014 paper
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List of Abbreviations 
ACTC1 actin, alpha, cardiac muscle 1  FLRT3 fibronectin leucine rich 
transmembrane protein 3  
AGR2 Anterior Gradient 2 FOX… forkhead box… 
ANB Anterior Neural Border FRS FGF Receptor Substrate 
APS Ammonium Persulphate FRZ… Frizzled 
AS Apert Syndrome GAB1 GRB2-associated binding protein 1 
ATP6V0C ATPase, H+ transporting, lysosomal  GAPDH glyceraldehyde-3-phosphate 
dehydrogenase 
BHLH basic helix-loop-helix GBX Gastrulation Brain Homeobox 
BMP Bone Morphogenetic Protein GDP/GTP Guanosine di/tri phosphate 
BSA Bovine Serum Albumin GFP Green Fluorescent Protein 
CAMKL1 Calmodulin kinase-like 1 GRB2 Growth factor receptor-bound 2 
C-CBL Casitas B-lineage Lymphoma GRHL… grainyhead-like 
CDH… cadherin 2, type 1, N-cadherin (neuronal) GRP Gastrocoel Roof Plate 
CDX… Caudal type homeobox GSKΒ Glycogen Synthase Kinase β 
CHMP1 charged multivesicular body protein 1A  GWAS Genome Wide Association Studies 
CIP Calf Intestinal alkaline phosphatase  HA haemagglutinin 
CITED2 Cbp/p300-interacting transactivator, with 
Glu/ Asp-rich carboxy-terminal domain 2 
HCG Human Chorionic Gonadotrophin 
CRABP2 cellular retinoic acid binding protein 2 HESX1 Hesx homeobox 1 
CRISPR clustered regularly interspaced short 
palindromic repeats 
HH Hedgehog (Drosophila) 
CYP26A1 cytochrome P450, family 26, subfamily A, 
polypeptide 1 
HMX3 H6 family homeobox 3  
DAG Diacylglycerol HOX… Homeobox 
DAVID  Database for Annotation, Visualization 
and Integrated Discovery 
HS Heparan Sulphate 
DAZAP DAZ-associated protein HSPG Heparan Sulphate Proteoglycan 
DIG Digoxygenin HTR1 5-hydroxytryptamine (serotonin) 
receptor  
DLX… Distal-less Homeobox IER2 Immediate Early Response 2 
DSB Double-stranded Break IFGFR Inducible FGFR 
DTT Dithiothreitol IFT172 Intraflaggelar Transport 172 
DUSP Dual-specificity phosphatase IG Immunoglobulin 
DYNLL1 Dynein Light Chain 1 IGF( R) Insulin-like Growth Factor 
(Receptor) 
EDTA Ethylenediaminetetraacetic acid  IP3 Inositol Triphosphate 
EGR1 early growth response 1  IRG Immunity Related Guanosine 
Triphosphatases 
EMX Empty spiracles homeobox ISH In Situ Hybridisation 
EN2 Engrailed 2 ISO Isthmic Organiser 
ENPP2 ectonucleotide 
pyrophosphatase/phosphodiesterase 2  
JNK c-Jun N-terminal kinase 
EPHA Ephrin A KEA Kinase Enrichment Analysis 
ERK Extracellular signal-Related Kinase KROX20 aka 
EGR2 
Early Growth Response 2 
ETS E26 transformation-specific KRT12 Keratin 12 
ETV ETS variant 3 KV Kupffer's Vesicle 
FGF Fibroblast Growth Factor LHX1 LIM homeobox 1 
FGFR Fibroblast Growth Factor Receptor LIN28A LIN-28 homologue A 
FGFRL1 FGFR-like 1 LMBRD2 LMBR1 domain containing 2  
FHF Fibroblast Homologous Factor   
LPAR6 Lysophosphatidic acid receptor 6  RA Retinoic Acid 
MAB(T) Maleic Acid Buffer (Tween) RAF Rapidly Accelerated Fibrosarcoma 
MAFB musculoaponeurotic fibrosarcoma 
oncogene homolog B  
RALDH Retinaldehyde dehydrogenase 2 
MAPK Mitogen Activated Protein kinase RARRES retinoic acid receptor responder 
(tazarotene induced) 1  
MBT Mid-Blastula Transition   
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MED9 Mediator 9 RAS Rat sarcoma 
MEK Mitogen Activated Protein kinase kinase RAS-DVA Ras dorso ventral anterior 
localisation 
MENF mesendoderm nuclear factor, gene 1 RAX Retina and anterior neural fold 
homeobox 
MHB Mid Hindbrain Boundary RT-QPCR Reverse Transcription Quantitative 
PCR 
MIX1 Mix paired like homeobox RVD repeat-variable diresidue 
MKP MAPK phosphatase RXR Retinoid X Receptor 
MRS Modified Ringers Solution SDS sodium dodecyl sulfate  
MYOD Myogenic differentiation SH2 Src-homology 2  
NAM Normal Amphibian Medium SHH Sonic Hedgehog 
NCAM Neural Cell Adhesion Molecule SLC12A3 solute carrier family 12 
(potassium/chloride transporter), 
member 3 
NDE1 nudE neurodevelopment protein 1  SMAD… Mothers Against Decepentaplegic 
homologue 
NEK6 NIMA-related kinase 6 SMO Smoothened 
NF Nieukwoop Faber SNP Single Nucleotide Polymorphism 
NGN.. Neurogenin SNX10 Sortin Nexin 10 
NHEJ Non homologous End Joining SOS Son of Sevenless 
NIMA Never In Mitosis A SOX… SRY (sex determining region Y)-
box 
NLS Nuclear Localisation Signal SPRED Sprouty-related, EVH1 domain-
containing protein 
NOT-B Notochord homeobox SPRY Sprouty 
OCT… Octamer transcription factor SRFP2 secreted frizzled-related protein 2 
OCT… Octamer transcription factor SSC Sodium Citrate/chloride 
ODC  ornithine decarboxylase  SUFU Suppressor of Fused Homologue 
OTX2 Orthodenticle homeobox 2 SULF… Sulphatase… 
PAM Protospacer-adjacent Motif TAE Tris-acetate-EDTA 
PANTHER Protein ANalysis THrough Evolutionary Re
lationships 
TALEN Transcription activator-like effector 
nucleases  
PAX… Paired Box 6 TEMED Tetramethylethylenediamine  
PBS(T)  Phospho Buffered Saline (Tween) TGFΒ Transforming Growth Factor β 
PCDH10 Protocadherin 10 TNNC2 troponin C type 2 (fast) 
PCP Planar Cell Polarity TSPAN1 tetraspanin 1 
PCR Polymerase Chain Reaction TUBA1A tubulin, alpha 1a 
PDX1 Pancreatic and duodenal homeobox 1 VANGL2 VANGL planar cell polarity protein 2 
PI3K Phosphatidylinositol-4,5-bisphosphate 3-
kinase 
VEG1 Vegetally localised T box 
PIP2(3) Phosphatidylinositol (3) 4,5-bisphosphate VG1 (GDF1) Growth Differention Factor 1 
PITX1 paired-like homeodomain 1 WG Wingless (Drosophila) 
PKB Protein kinase B, aka Akt WNT Wingless-type MMTV integration 
site family 
PKC Protein kinase C XBRA Xenopus Brachyury 
PLCY Phospholipase C gamma XNR Xenopus Nodal Related 
POC5 POC5 centriolar protein ZEB2 zinc finger E-box binding homeobox 
2 
PP2A protein phosphatase 2 ZFP36L1 Zinc Finger Protein 36 like 1 
PSM Presomitic mesoderm ZIC1 Zic family member 1 
PTCH2 Patched 2   
 
 
 
242 
References 
Adachi, S. et al., 2014. ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK 
pathway. Nucleic acids research, 42(15), pp.10037–49. 
Adams, D.S. et al., 2006. Early, H+-V-ATPase-dependent proton flux is necessary for consistent left-
right patterning of non-mammalian vertebrates. Development (Cambridge, England), 133(9), 
pp.1657–1671. 
Adamska, M. et al., 2001. FGFs control the patterning of the inner ear but are not able to induce the 
full ear program. Mechanisms of Development, 109(2), pp.303–313. 
Akai, J., Halley, P.A. & Storey, K.G., 2005. FGF-dependent Notch signaling maintains the spinal cord 
stem zone. Genes & development, 19(23), pp.2877–87. 
Albertson, R.C. & Yelick, P.C., 2005. Roles for fgf8 signaling in left-right patterning of the visceral 
organs and craniofacial skeleton. Developmental biology, 283(2), pp.310–21. 
Aldridge, K. et al., 2010. Brain phenotypes in two FGFR2 mouse models for Apert syndrome. 
Developmental dynamics : an official publication of the American Association of Anatomists, 
239(3), pp.987–97. 
Allen, N.P.C. et al., 2007. RASSF6 is a novel member of the RASSF family of tumor suppressors. 
Oncogene, 26(42), pp.6203–11. 
Amaya, E. et al., 1993. FGF signalling in the early specification of mesoderm in Xenopus. 
Development (Cambridge, England), 118(2), pp.477–87. 
Amaya, E., Musci, T.J. & Kirschner, M.W., 1991. Expression of a dominant negative mutant of the FGF 
receptor disrupts mesoderm formation in xenopus embryos. Cell, 66(2), pp.257–270. 
Amaya, E., Musci, T.J. & Kirschner, M.W., 1991. Expression of a dominant negative mutant of the FGF 
receptor disrupts mesoderm formation in Xenopus embryos. Cell, 66(2), pp.257–70. 
Amin, N.M. et al., 2014. RNA-seq in the tetraploid Xenopus laevis enables genome-wide insight in a 
classic developmental biology model organism. Methods, 66(3), pp.398–409. 
Aquino, J.B. et al., 2009. The retinoic acid inducible Cas-family signaling protein Nedd9 regulates 
neural crest cell migration by modulating adhesion and actin dynamics. Neuroscience, 162(4), 
pp.1106–19. 
Arima, K. et al., 2005. Global analysis of RAR-responsive genes in the Xenopus neurula using cDNA 
microarrays. Developmental Dynamics, 232(December 2004), pp.414–431. 
Arman, E. et al., 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role 
for FGF signaling in pregastrulation mammalian development. Proceedings of the National 
Academy of Sciences of the United States of America, 95(9), pp.5082–5087. 
Atkinson-Leadbeater, K. et al., 2009. FGF receptor dependent regulation of Lhx9 expression in the 
developing nervous system. Developmental dynamics : an official publication of the American 
Association of Anatomists, 238(2), pp.367–75. 
Azimzadeh, J. et al., 2009. hPOC5 is a centrin-binding protein required for assembly of full-length 
centrioles. The Journal of cell biology, 185(1), pp.101–14. 
Bachiller, D. et al., 2000. The organizer factors Chordin and Noggin are required for mouse forebrain 
development. Nature, 403(6770), pp.658–61. 
243 
Badano, J.L. et al., 2006. The ciliopathies: an emerging class of human genetic disorders. Annual 
review of genomics and human genetics, 7, pp.125–148. 
Bai, Y. et al., 2014. Ror2 receptor mediates Wnt11 ligand signaling and affects convergence and 
extension movements in zebrafish. The Journal of biological chemistry, 289(30), pp.20664–76. 
Baker, JC, Beddington, Rosa, Harland, R., 1999. Wnt signaling in Xenopus embryos inhibits bmp4 
expression and activates neural development. … & development, pp.3149–3159. 
Bamforth, S.D. et al., 2004. Cited2 controls left-right patterning and heart development through a 
Nodal-Pitx2c pathway. Nature genetics, 36(11), pp.1189–96. 
Barreto, G. et al., 2003. The function of Xenopus germ cell nuclear factor (xGCNF) in morphogenetic 
movements during neurulation. Developmental Biology, 257(2), pp.329–342. 
Barrios-Rodiles, M. et al., 2005. High-throughput mapping of a dynamic signaling network in 
mammalian cells. Science (New York, N.Y.), 307(5715), pp.1621–1625. 
Barrow, J.R., Stadler, H.S. & Capecchi, M.R., 2000. Roles of Hoxa1 and Hoxa2 in patterning the early 
hindbrain of the mouse. Development (Cambridge, England), 127(5), pp.933–44. 
Bassett, A.R. et al., 2013. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 
system. Cell reports, 4(1), pp.220–8. 
Basson, M.A. et al., 2008. Specific regions within the embryonic midbrain and cerebellum require 
different levels of FGF signaling during development. Development (Cambridge, England), 
135(5), pp.889–98. 
Basu, B. & Brueckner, M., 2009. Fibroblast “cilia growth” factor in the development of left-right 
asymmetry. Developmental cell, 16(4), pp.489–90. 
Bayramov, A. V. et al., 2004. The homeodomain-containing transcription factor X-nkx-5.1 inhibits 
expression of the homeobox gene Xanf-1 during the Xenopus laevis forebrain development. 
Mechanisms of Development, 121, pp.1425–1441. 
Belo, J.A. et al., 2000. Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse 
development. Genesis (New York, N.Y. : 2000), 26(4), pp.265–70. 
Bel-Vialar, S., Itasaki, N. & Krumlauf, R., 2002. Initiating Hox gene expression: in the early chick neural 
tube differential sensitivity to FGF and RA signaling subdivides the HoxB genes in two distinct 
groups. Development, 129(22), pp.5103–5115. 
Bénazet, J.-D. & Zeller, R., 2009. Vertebrate limb development: moving from classical morphogen 
gradients to an integrated 4-dimensional patterning system. Cold Spring Harbor perspectives in 
biology, 1(4), p.a001339. 
Bertran, M.T. et al., 2011. Nek9 is a Plk1-activated kinase that controls early centrosome separation 
through Nek6/7 and Eg5. The EMBO journal, 30(13), pp.2634–47. 
Bertrand, V. et al., 2003. Neural tissue in ascidian embryos is induced by FGF9/16/20, acting via a 
combination of maternal GATA and Ets transcription factors. Cell, 115(5), pp.615–27. 
Boije, H. et al., 2013. Forkheadbox N4 (FoxN4) triggers context-dependent differentiation in the 
developing chick retina and neural tube. Differentiation; research in biological diversity, 85(1-2), 
pp.11–9. 
Böttcher, R.T. et al., 2004. The transmembrane protein XFLRT3 forms a complex with FGF receptors 
and promotes FGF signalling. Nature cell biology, 6(1), pp.38–44. 
Böttcher, R.T. & Niehrs, C., 2005. Fibroblast growth factor signaling during early vertebrate 
development. Endocrine reviews, 26(1), pp.63–77. 
244 
Branney, P. a et al., 2009. Characterisation of the fibroblast growth factor dependent transcriptome in 
early development. PloS one, 4(3), p.e4951. 
Briscoe, J. & Novitch, B.G., 2008. Regulatory pathways linking progenitor patterning, cell fates and 
neurogenesis in the ventral neural tube. Philosophical transactions of the Royal Society of 
London. Series B, Biological sciences, 363(1489), pp.57–70. 
Broccoli, V., Boncinelli, E. & Wurst, W., 1999. The caudal limit of Otx2 expression positions the isthmic 
organizer. Nature, 401(6749), pp.164–8. 
Bundschu, K., Walter, U. & Schuh, K., 2007. Getting a first clue about SPRED functions. BioEssays, 
29(9), pp.897–907. 
Burgar, H.R. et al., 2002. Association of the signaling adaptor FRS2 with fibroblast growth factor 
receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain. The Journal 
of biological chemistry, 277(6), pp.4018–23. 
Busnadiego, O. et al., 2013. LOXL4 is induced by transforming growth factor β1 through Smad and 
JunB/Fra2 and contributes to vascular matrix remodeling. Molecular and cellular biology, 33(12), 
pp.2388–401. 
Caron, A., Xu, X. & Lin, X., 2012. Wnt/β-catenin signaling directly regulates Foxj1 expression and 
ciliogenesis in zebrafish Kupffer’s vesicle. Development (Cambridge, England), 139(3), pp.514–
24. 
Catela, C. et al., 2009. Multiple congenital malformations of Wolf-Hirschhorn syndrome are 
recapitulated in Fgfrl1 null mice. Disease models & mechanisms, 2(5-6), pp.283–94. 
Chang, N. et al., 2013. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell 
research, 23(4), pp.465–72. 
Chen, J. et al., 2006. Interaction of Pin1 with Nek6 and characterization of their expression correlation 
in Chinese hepatocellular carcinoma patients. Biochemical and biophysical research 
communications, 341(4), pp.1059–65. 
Chen, Y. et al., 2012. A SNX10/V-ATPase pathway regulates ciliogenesis in vitro and in vivo. Cell 
research, 22(2), pp.333–45. 
Chen, Y., Mohammadi, M. & Flanagan, J.G., 2009. Graded levels of FGF protein span the midbrain 
and can instruct graded induction and repression of neural mapping labels. Neuron, 62(6), 
pp.773–80. 
Cheng, J.Q. et al., 1997. Transforming activity and mitosis-related expression of the AKT2 oncogene: 
evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene, 14(23), 
pp.2793–801. 
Chi, C.L. et al., 2003. The isthmic organizer signal FGF8 is required for cell survival in the prospective 
midbrain and cerebellum. Development, 130(12), pp.2633–2644. 
Chiu, W.T. et al., 2014. Genome-wide view of TGF /Foxh1 regulation of the early mesendoderm 
program. Development, 141, pp.4537–4547. 
Cho, G.-S., Choi, S.-C. & Han, J.-K., 2013. BMP signal attenuates FGF pathway in anteroposterior 
neural patterning. Biochemical and biophysical research communications, (April). 
Chourrout, D. et al., 2006. Minimal ProtoHox cluster inferred from bilaterian and cnidarian Hox 
complements. Nature, 442(7103), pp.684–7. 
Christen, B. & Slack, J.M., 1999. Spatial response to fibroblast growth factor signalling in Xenopus 
embryos. Development (Cambridge, England), 126(1), pp.119–25. 
245 
Chung, A.-Y. et al., 2010. Neuron-specific expression of atp6v0c2 in zebrafish CNS. Developmental 
dynamics : an official publication of the American Association of Anatomists, 239(9), pp.2501–8. 
Chung, H.A. et al., 2004. Screening of FGF target genes in Xenopus by microarray: temporal 
dissection of the signalling pathway using a chemical inhibitor. Genes to cells : devoted to 
molecular & cellular mechanisms, 9(8), pp.749–61. 
Ciruna, B. & Rossant, J., 2001. FGF signaling regulates mesoderm cell fate specification and 
morphogenetic movement at the primitive streak. Developmental cell, 1(1), pp.37–49. 
Clackson, T. et al., 1998. Redesigning an FKBP-ligand interface to generate chemical dimerizers with 
novel specificity. Proceedings of the National Academy of Sciences of the United States of 
America, 95(18), pp.10437–42. 
Clanton, J.A., Hope, K.D. & Gamse, J.T., 2013. Fgf signaling governs cell fate in the zebrafish pineal 
complex. Development (Cambridge, England), 140(2), pp.323–32. 
Clarke, J.D. & Lumsden, A., 1993. Segmental repetition of neuronal phenotype sets in the chick 
embryo hindbrain. Development (Cambridge, England), 118(1), pp.151–62. 
Collart, C. et al., 2014. High-resolution analysis of gene activity during the Xenopus mid-blastula 
transition. Development (Cambridge, England), 141(1927), pp.1927–39. 
Colli, L.M. et al., 2013. Components of the canonical and non-canonical Wnt pathways are not mis-
expressed in pituitary tumors. PloS one, 8(4), p.e62424. 
Colvin, J.S. et al., 2001. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an 
essential regulator of lung mesenchyme. Development (Cambridge, England), 128(11), 
pp.2095–106. 
Colvin, J.S. et al., 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor 
receptor 3. Nat Genet, 12(4), pp.390–397. 
Concha, M.L. et al., 2000. A nodal signaling pathway regulates the laterality of neuroanatomical 
asymmetries in the zebrafish forebrain. Neuron, 28(2), pp.399–409. 
Conlon, F.L. et al., 1996. Inhibition of Xbra transcription activation causes defects in mesodermal 
patterning and reveals autoregulation of Xbra in dorsal mesoderm. Development (Cambridge, 
England), 122, pp.2427–2435. 
Cornell, R. a & Kimelman, D., 1994. Activin-mediated mesoderm induction requires FGF. Development 
(Cambridge, England), 120(2), pp.453–462. 
Del Corral, R.D. et al., 2003. Opposing FGF and Retinoid Pathways Control Ventral Neural Pattern, 
Neuronal Differentiation, and Segmentation during Body Axis Extension. Neuron, 40(1), pp.65–
79. 
Del Corral, R.D., Breitkreuz, D.N. & Storey, K.G., 2002. Onset of neuronal differentiation is regulated 
by paraxial mesoderm and requires attenuation of FGF signalling. Development, 129(7), 
pp.1681–1691. 
Cox, W.G. & Hemmati-Brivanlou, A., 1995. Caudalization of neural fate by tissue recombination and 
bFGF. Development (Cambridge, England), 121(12), pp.4349–58. 
Crossley, P.H., Martinez, S. & Martin, G.R., 1996. Midbrain development induced by FGF8 in the chick 
embryo. Nature, 380(6569), pp.66–68. 
Cullen, P.J., 2008. Endosomal sorting and signalling: an emerging role for sorting nexins. Nature 
reviews. Molecular cell biology, 9(7), pp.574–82. 
246 
Dasen, J.S., Liu, J.-P. & Jessell, T.M., 2003. Motor neuron columnar fate imposed by sequential 
phases of Hox-c activity. Nature, 425(6961), pp.926–933. 
Davidson, A.J. et al., 2003. Cdx4 Mutants Fail To Specify Blood Progenitors and Can Be Rescued By 
Multiple Hox Genes. Nature, 425(6955), pp.300–306. 
Davidson, A.J. & Zon, L.I., 2006. The caudal-related homeobox genes cdx1a and cdx4 act redundantly 
to regulate hox gene expression and the formation of putative hematopoietic stem cells during 
zebrafish embryogenesis. Developmental Biology, 292(2), pp.506–518. 
Delaune, E., Lemaire, P. & Kodjabachian, L., 2005. Neural induction in Xenopus requires early FGF 
signalling in addition to BMP inhibition. Development (Cambridge, England), 132(2), pp.299–310. 
Dessaud, E., McMahon, A.P. & Briscoe, J., 2008. Pattern formation in the vertebrate neural tube: a 
sonic hedgehog morphogen-regulated transcriptional network. Development (Cambridge, 
England), 135(15), pp.2489–503. 
Diez del Corral, R. et al., 2003. Opposing FGF and retinoid pathways control ventral neural pattern, 
neuronal differentiation, and segmentation during body axis extension. Neuron, 40(1), pp.65–79. 
Donizetti, A. et al., 2008. Differential expression of duplicated genes for prothymosin alpha during 
zebrafish development. Developmental dynamics : an official publication of the American 
Association of Anatomists, 237(4), pp.1112–8. 
Dorey, K. & Amaya, E., 2010. FGF signalling: diverse roles during early vertebrate embryogenesis. 
Development (Cambridge, England), 137(22), pp.3731–42. 
Dow, A.L. et al., 2015. Sprouty2 in the Dorsal Hippocampus Regulates Neurogenesis and Stress 
Responsiveness in Rats. Plos One, 10(3), p.e0120693. 
Duan, D.S., Werner, S. & Williams, L.T., 1992. A naturally occurring secreted form of fibroblast growth 
factor (FGF) receptor 1 binds basic FGF in preference over acidic FGF. The Journal of biological 
chemistry, 267(23), pp.16076–80. 
Dubaissi, E. & Papalopulu, N., 2011. Embryonic frog epidermis: a model for the study of cell-cell 
interactions in the development of mucociliary disease. Disease models & mechanisms, 4(2), 
pp.179–92. 
Dubrulle, J., McGrew, M.J. & Pourquié, O., 2001. FGF signaling controls somite boundary position and 
regulates segmentation clock control of spatiotemporal Hox gene activation. Cell, 106(2), 
pp.219–232. 
Dubrulle, J. & Pourquié, O., 2004. fgf8 mRNA decay establishes a gradient that couples axial 
elongation to patterning in the vertebrate embryo. Nature, 427(6973), pp.419–422. 
Dunn, M.K., Mercola, M. & Moore, D.D., 1995. Cyclopamine, a steroidal alkaloid, disrupts development 
of cranial neural crest cells in Xenopus. Developmental dynamics : an official publication of the 
American Association of Anatomists, 202(3), pp.255–270. 
Dyer, C. et al., 2014. A bi-modal function of Wnt signalling directs an FGF activity gradient to spatially 
regulate neuronal differentiation in the midbrain. Development (Cambridge, England), 141(1), 
pp.63–72. 
Eagleson, G.W. & Dempewolf, R.D., 2002. The role of the anterior neural ridge and Fgf-8 in early 
forebrain patterning and regionalization in Xenopus laevis. Comparative biochemistry and 
physiology. Part B, Biochemistry & molecular biology, 132(1), pp.179–89. 
Eblaghie, M.C. et al., 2003. Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in 
chick embryos. Current biology : CB, 13(12), pp.1009–18. 
247 
Ermakova, G. V et al., 1999. The homeobox gene, Xanf-1, can control both neural differentiation and 
patterning in the presumptive anterior neurectoderm of the Xenopus laevis embryo. 
Development (Cambridge, England), 126, pp.4513–4523. 
Ermakova, G. V et al., 2007. The homeodomain factor Xanf represses expression of genes in the 
presumptive rostral forebrain that specify more caudal brain regions. Developmental biology, 
307(2), pp.483–97. 
Esko, J.D. & Selleck, S.B., 2002. Order out of chaos: assembly of ligand binding sites in heparan 
sulfate. Annual review of biochemistry, 71, pp.435–71. 
Eswarakumar, V.P., Lax, I. & Schlessinger, J., 2005. Cellular signaling by fibroblast growth factor 
receptors. Cytokine & growth factor reviews, 16(2), pp.139–49. 
Faas, L. et al., 2013. Lin28 proteins are required for germ layer specification in Xenopus. Development 
(Cambridge, England), 986(January), pp.976–986. 
Faas, L. & Isaacs, H. V, 2009. Overlapping functions of Cdx1, Cdx2, and Cdx4 in the development of 
the amphibian Xenopus tropicalis. Developmental dynamics : an official publication of the 
American Association of Anatomists, 238(4), pp.835–52. 
Fang, H., Marikawa, Y. & Elinson, R.P., 2000. Ectopic expression of Xenopus noggin RNA induces 
complete secondary body axes in embryos of the direct developing frog Eleutherodactylus coqui. 
Development, Genes and Evolution, 210(1), pp.21–27. 
Fang, X. et al., 2005. Control of CREB-binding protein signaling by nuclear fibroblast growth factor 
receptor-1: a novel mechanism of gene regulation. The Journal of biological chemistry, 280(31), 
pp.28451–62. 
Fang, Z. & Cui, X., 2011. Design and validation issues in RNA-seq experiments. Briefings in 
Bioinformatics, 12(3), pp.280–287. 
Faux, C.H. et al., 2001. Interactions between fibroblast growth factors and Notch regulate neuronal 
differentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience, 
21(15), pp.5587–5596. 
Feige, E. & Motro, B., 2002. The related murine kinases, Nek6 and Nek7, display distinct patterns of 
expression. Mechanisms of development, 110(1-2), pp.219–23. 
Feng, Y. & Xu, Q., 2010. Pivotal role of hmx2 and hmx3 in zebrafish inner ear and lateral line 
development. Developmental biology, 339(2), pp.507–18. 
Fish, M.B. et al., 2014. Xenopus mutant reveals necessity of rax for specifying the eye field which 
otherwise forms tissue with telencephalic and diencephalic character. Developmental Biology, 
395(2), pp.317–330. 
Fisher, M.E., Isaacs, H. V & Pownall, M.E., 2002. eFGF is required for activation of XmyoD expression 
in the myogenic cell lineage of Xenopus laevis. Development (Cambridge, England), 129(6), 
pp.1307–15. 
Fletcher, R.B. & Harland, R.M., 2008. The role of FGF signaling in the establishment and maintenance 
of mesodermal gene expression in Xenopus. Developmental dynamics : an official publication of 
the American Association of Anatomists, 237(5), pp.1243–54. 
Forde, N. et al., 2012. Evidence for an early endometrial response to pregnancy in cattle: both 
dependent upon and independent of interferon tau. Physiological Genomics, 44(16), pp.799–
810. 
Freeman, S.D. et al., 2008. Extracellular regulation of developmental cell signaling by XtSulf1. 
Developmental biology, 320(2), pp.436–45. 
248 
Fry, A.M. et al., 2012. Cell cycle regulation by the NEK family of protein kinases. Journal of cell 
science, 125(Pt 19), pp.4423–33. 
Fuentealba, L.C. et al., 2007. Integrating patterning signals: Wnt/GSK3 regulates the duration of the 
BMP/Smad1 signal. Cell, 131(5), pp.980–93. 
Furdui, C.M. et al., 2006. Autophosphorylation of FGFR1 kinase is mediated by a sequential and 
precisely ordered reaction. Molecular cell, 21(5), pp.711–7. 
Fürthauer, M. et al., 2004. Fgf signalling controls the dorsoventral patterning of the zebrafish embryo. 
Development (Cambridge, England), 131(12), pp.2853–64. 
Furukawa, T. et al., 2000. rax, Hes1, and notch1 Promote the Formation of Müller Glia by Postnatal 
Retinal Progenitor Cells. Neuron, 26(2), pp.383–394. 
Gagnon, J.A. et al., 2014. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion 
and large-scale assessment of single-guide RNAs. PloS one, 9(5), p.e98186. 
Gaj, T., Gersbach, C. a. & Barbas, C.F., 2013. ZFN, TALEN, and CRISPR/Cas-based methods for 
genome engineering. Trends in Biotechnology, 31(7), pp.397–405. 
Galceran, J. et al., 1999. Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes 
& development, 13(6), pp.709–17. 
Gamse, J.T. et al., 2003. The parapineal mediates left-right asymmetry in the zebrafish diencephalon. 
Development (Cambridge, England), 130(6), pp.1059–1068. 
Ganoth, D. et al., 2001. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated 
ubiquitinylation of p27. Nature cell biology, 3(3), pp.321–4. 
Garcia-Fernàndez, J., 2005. The genesis and evolution of homeobox gene clusters. Nature reviews. 
Genetics, 6(12), pp.881–92. 
Garnett, A.T., Square, T.A. & Medeiros, D.M., 2012. BMP, Wnt and FGF signals are integrated through 
evolutionarily conserved enhancers to achieve robust expression of Pax3 and Zic genes at the 
zebrafish neural plate border. Development (Cambridge, England). 
Gaughran, F. et al., 2006. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, 
schizophrenia and bipolar disorder. Brain Research Bulletin, 70(3), pp.221–227. 
Gaunt, S.J., Drage, D. & Cockley, A., 2003. Vertebrate caudal gene expression gradients investigated 
by use of chick cdx-A/lacZ and mouse cdx-1/lacZ reporters in transgenic mouse embryos: 
evidence for an intron enhancer. Mechanisms of Development, 120(5), pp.573–586. 
Gaunt, S.J., Drage, D. & Trubshaw, R.C., 2005. cdx4/lacZ and cdx2/lacZ protein gradients formed by 
decay during gastrulation in the mouse. International Journal of Developmental Biology, 49(8), 
pp.901–908. 
Geach, T.J. et al., 2014. An essential role for LPA signalling in telencephalon development. 
Development (Cambridge, England), 141(4), pp.940–9. 
Gillespie, L.L., Chen, G. & Paterno, G.D., 1995. Cloning of a fibroblast growth factor receptor 1 splice 
variant from Xenopus embryos that lacks a protein kinase C site important for the regulation of 
receptor activity. Journal of Biological Chemistry, 270, pp.22758–22763. 
Giudetti, G. et al., 2014. Characterization of the Rx1 dependent transcriptome during early retinal 
development. Developmental dynamics : an official publication of the American Association of 
Anatomists, pp.1352–1361. 
Giudicelli, F. et al., 2003. Novel activities of Mafb underlie its dual role in hindbrain segmentation and 
regional specification. Developmental biology, 253(1), pp.150–162. 
249 
Glavic, A., Gómez-Skarmeta, J.L. & Mayor, R., 2002. The homeoprotein Xiro1 is required for midbrain-
hindbrain boundary formation. Development (Cambridge, England), 129(7), pp.1609–21. 
Goda, T., Takagi, C. & Ueno, N., 2009. Xenopus Rnd1 and Rnd3 GTP-binding proteins are expressed 
under the control of segmentation clock and required for somite formation. Developmental 
dynamics : an official publication of the American Association of Anatomists, 238(11), pp.2867–
76. 
Godsave, S.F. & Slack, J.M., 1989. Clonal analysis of mesoderm induction in Xenopus laevis. 
Developmental biology, 134(2), pp.486–90. 
Goetz, R. et al., 2007. Molecular insights into the klotho-dependent, endocrine mode of action of 
fibroblast growth factor 19 subfamily members. Molecular and cellular biology, 27(9), pp.3417–
28. 
Goetz, R. & Mohammadi, M., 2013. Exploring mechanisms of FGF signalling through the lens of 
structural biology. Nature reviews. Molecular cell biology, 14(3), pp.166–80. 
Goggolidou, P. et al., 2014. ATMIN is a transcriptional regulator of both lung morphogenesis and 
ciliogenesis. Development (Cambridge, England), 141(20), pp.3966–77. 
Goldfarb, M. et al., 2007. Fibroblast growth factor homologous factors control neuronal excitability 
through modulation of voltage-gated sodium channels. Neuron, 55(3), pp.449–63. 
Gómez, A.R. et al., 2005. Conserved cross-interactions in Drosophila and Xenopus between 
Ras/MAPK signaling and the dual-specificity phosphatase MKP3. Developmental dynamics : an 
official publication of the American Association of Anatomists, 232(3), pp.695–708. 
Gong, S.-G., 2014. Isoforms of Receptors of Fibroblast Growth Factors. Journal of cellular physiology, 
(August 2013), pp.1–28. 
Gorivodsky, M. et al., 2009. Intraflagellar transport protein 172 is essential for primary cilia formation 
and plays a vital role in patterning the mammalian brain. Developmental biology, 325(1), pp.24–
32. 
Gospodarowicz, D., 1975. PURIFICATION OF A FIBROBLAST GROWTH-FACTOR FROM BOVINE 
PITUITARY. Endocrinology, 250(7), pp.2515–20. 
Grand, E.K. et al., 2004. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 
myeloproliferative syndrome. Genes, chromosomes & cancer, 40(1), pp.78–83. 
Gross, I. et al., 2007. Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation 
and survival. Cell death and differentiation, 14(10), pp.1802–12. 
Grothe, C. et al., 2008. Expression and regulation of Sef, a novel signaling inhibitor of receptor tyrosine 
kinases-mediated signaling in the nervous system. Acta Histochemica, 110(2), pp.155–162. 
Van Grunsven, L. a et al., 2007. XSip1 neuralizing activity involves the co-repressor CtBP and occurs 
through BMP dependent and independent mechanisms. Developmental biology, 306(1), pp.34–
49. 
Grunz, H. & Tacke, L., 1989. Neural differentiation of Xenopus laevis ectoderm takes place after 
disaggregation and delayed reaggregation without inducer. Cell differentiation and development : 
the official journal of the International Society of Developmental Biologists, 28(3), pp.211–7. 
Guo, X. et al., 2014. Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis. Development 
(Cambridge, England), 141(3), pp.707–14. 
Hafner, M. et al., 2008. Identification of microRNAs and other small regulatory RNAs using cDNA 
library sequencing. Methods (San Diego, Calif.), 44(1), pp.3–12. 
250 
Halpern, M.E. et al., 2005. Lateralization of the vertebrate brain: taking the side of model systems. The 
Journal of neuroscience : the official journal of the Society for Neuroscience, 25(45), pp.10351–
10357. 
Hanafusa, H. et al., 2002. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK 
signalling pathway. Nature cell biology, 4(11), pp.850–8. 
Harada, H. et al., 1999. Localization of putative stem cells in dental epithelium and their association 
with Notch and FGF signaling. The Journal of cell biology, 147(1), pp.105–20. 
Harbers, M. & Carninci, P., 2005. Tag-based approaches for transcriptome research and genome 
annotation. Nature methods, 2(7), pp.495–502. 
Hardcastle, Z., Chalmers, A.D. & Papalopulu, N., 2000. FGF-8 stimulates neuronal differentiation 
through FGFR-4a and interferes with mesoderm induction in Xenopus embryos. Current Biology, 
10(23), pp.1511–1514. 
Harding, J.L. et al., 2014. Small RNA profiling of Xenopus embryos reveals novel miRNAs and a new 
class of small RNAs derived from intronic transposable elements Small RNA profiling of Xenopus 
embryos reveals novel miRNAs and a new class of small RNAs derived from intronic transposa. 
Genome Research, pp.96–106. 
Harvey, R.P., 1991. Widespread expression of MyoD genes in Xenopus embryos is amplified in 
presumptive muscle as a delayed response to mesoderm induction. Proceedings of the National 
Academy of Sciences of the United States of America, 88(October), pp.9198–9202. 
Hashimoto, M. et al., 2002. Fibroblast growth factor 1 regulates signaling via the glycogen synthase 
kinase-3beta pathway. Implications for neuroprotection. The Journal of biological chemistry, 
277(36), pp.32985–91. 
Hawley, S.H. et al., 1995. Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct 
neural induction. Genes & Development, 9(23), pp.2923–2935. 
Hayashi, S. et al., 2004. Expression patterns of Xenopus FGF receptor-like 1/nou-darake in early 
Xenopus development resemble those of planarian nou-darake and Xenopus FGF8. 
Developmental dynamics : an official publication of the American Association of Anatomists, 
230(4), pp.700–7. 
Hayata, T. et al., 2009. Identification of embryonic pancreatic genes using Xenopus DNA microarrays. 
Developmental dynamics : an official publication of the American Association of Anatomists, 
238(6), pp.1455–66. 
Hébert, J.M. & Fishell, G., 2008. The genetics of early telencephalon patterning: some assembly 
required. Nature reviews. Neuroscience, 9(9), pp.678–85. 
Heigwer, F., Kerr, G. & Boutros, M., 2014. E-CRISP: fast CRISPR target site identification. Nature 
methods, 11(2), pp.122–3. 
Hemmati-Brivanlou, a & Melton, D. a, 1994. Inhibition of activin receptor signaling promotes 
neuralization in Xenopus. Cell, 77(2), pp.273–81. 
Hemmati-Brivanlou, A. & Melton, D., 1997a. Vertebrate embryonic cells will become nerve cells unless 
told otherwise. Cell, 88, pp.13–17. 
Hemmati-Brivanlou, A. & Melton, D., 1997b. Vertebrate Embryonic Cells Will Become Nerve Cells 
Unless Told Otherwise. Cell, 88(1), pp.13–17. 
Hirata, H. et al., 2001. Hes1 and Hes3 regulate maintenance of the isthmic organizer and development 
of the mid/hindbrain. The EMBO journal, 20(16), pp.4454–66. 
251 
Holland, P.W.H. & Takahashi, T., 2005. The evolution of homeobox genes: Implications for the study of 
brain development. Brain research bulletin, 66(4-6), pp.484–90. 
Hollenhorst, P.C., McIntosh, L.P. & Graves, B.J., 2011. Genomic and biochemical insights into the 
specificity of ETS transcription factors. Annual review of biochemistry, 80, pp.437–71. 
Hong, S.-K. & Dawid, I.B., 2009. FGF-dependent left-right asymmetry patterning in zebrafish is 
mediated by Ier2 and Fibp1. Proceedings of the National Academy of Sciences of the United 
States of America, 106(7), pp.2230–5. 
Hongo, I., Kengaku, M. & Okamoto, H., 1999. FGF signaling and the anterior neural induction in 
Xenopus. Developmental biology, 216(2), pp.561–81. 
Hou, S. et al., 2007. The secreted serine protease xHtrA1 stimulates long-range FGF signaling in the 
early Xenopus embryo. Developmental cell, 13(2), pp.226–41. 
Houart, C., Westerfield, M. & Wilson, S.W., 1998. A small population of anterior cells patterns the 
forebrain during zebrafish gastrulation. Nature, 391(6669), pp.788–92. 
Howell, G.R. et al., 2007. Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) 
causes specific skeletal homeotic transformations. Genetics, 175(2), pp.699–707. 
Huangfu, D. et al., 2003. Hedgehog signalling in the mouse requires intraflagellar transport proteins. 
Nature, 426(6962), pp.83–7. 
Hudson, C., Darras, S., Caillol, D., Yasuo, H., Lemaire, P., 2003. A conserved role for the MEK 
signalling pathway in neural tissue specification and posteriorisation in the invertebrate chordate, 
the ascidian Ciona intestinalis. Development, 130(1), pp.147–159. 
Illes, J.C., Winterbottom, E. & Isaacs, H. V, 2009. Cloning and expression analysis of the anterior 
parahox genes, Gsh1 and Gsh2 from Xenopus tropicalis. Developmental dynamics : an official 
publication of the American Association of Anatomists, 238(1), pp.194–203. 
Inagaki, T. et al., 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile 
acid homeostasis. Cell metabolism, 2(4), pp.217–25. 
Inbal, A. et al., 2007. Six3 represses nodal activity to establish early brain asymmetry in zebrafish. 
Neuron, 55(3), pp.407–15. 
Inoue, Y. & Imamura, T., 2008. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer 
science, 99(11), pp.2107–12. 
Isaacs, H. V, Pownall, M.E. & Slack, J.M., 1994. eFGF regulates Xbra expression during Xenopus 
gastrulation. The EMBO journal, 13(19), pp.4469–81. 
Isaacs, H. V, Pownall, M.E. & Slack, J.M., 1998. Regulation of Hox gene expression and posterior 
development by the Xenopus caudal homologue Xcad3. The EMBO journal, 17(12), pp.3413–27. 
Isaacs, H. V, Tannahill, D. & Slack, J.M., 1992. Expression of a novel FGF in the Xenopus embryo. A 
new candidate inducing factor for mesoderm formation and anteroposterior specification. 
Development (Cambridge, England), 114(3), pp.711–720. 
Ishibashi, S., Cliffe, R. & Amaya, E., 2012. Highly efficient bi-allelic mutation rates using TALENs in 
Xenopus tropicalis. Biology open, 1(12), pp.1273–6. 
Itoh, K. & Sokol, S.Y., 1994. Heparan sulfate proteoglycans are required for mesoderm formation in 
Xenopus embryos. Development (Cambridge, England), 120(9), pp.2703–11. 
Itoh, N. & Ornitz, D.M., 2004. Evolution of the Fgf and Fgfr gene families. Trends in genetics : TIG, 
20(11), pp.563–9. 
252 
Itoh, N. & Ornitz, D.M., 2011. Fibroblast growth factors: From molecular evolution to roles in 
development, metabolism and disease. Journal of Biochemistry, 149(2), pp.121–130. 
Itoh, N. & Ornitz, D.M., 2008. Functional evolutionary history of the mouse Fgf gene family. 
Developmental dynamics : an official publication of the American Association of Anatomists, 
237(1), pp.18–27. 
Janssens, S. et al., 2010. Direct control of Hoxd1 and Irx3 expression by Wnt/beta-catenin signaling 
during anteroposterior patterning of the neural axis in Xenopus. The International journal of 
developmental biology, 54(10), pp.1435–42. 
Jessell, T.M., 2000. Neuronal specification in the spinal cord: inductive signals and transcriptional 
codes. Nature reviews. Genetics, 1(1), pp.20–9. 
Johnson, D. & Wilkie, A.O.M., 2011. Craniosynostosis. European Journal of Human Genetics, 19(4), 
pp.369–376. 
Kalinina, J. et al., 2012. The alternatively spliced acid box region plays a key role in FGF receptor 
autoinhibition. Structure (London, England : 1993), 20(1), pp.77–88. 
Kalkan, T. et al., 2009. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of 
transforming growth factor-beta signaling that affects neural crest formation. Molecular biology of 
the cell, 20(14), pp.3436–50. 
Karpinka, J.B. et al., 2014. Xenbase, the Xenopus model organism database; new virtualized system, 
data types and genomes. Nucleic acids research, 43(Database issue), pp.D756–63. 
Katoh, M. & Katoh, M., 2006. FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of 
WNT signaling pathway in progenitor cells. International Journal of Molecular Medicine, 17, 
pp.529–532. 
Keenan, I.D., Sharrard, R.M. & Isaacs, H. V, 2006. FGF signal transduction and the regulation of Cdx 
gene expression. Developmental biology, 299(2), pp.478–88. 
Kelly, L.E., Nekkalapudi, S. & El-Hodiri, H.M., 2007. Expression of the forkhead transcription factor 
FoxN4 in progenitor cells in the developing Xenopus laevis retina and brain. Gene expression 
patterns : GEP, 7(3), pp.233–8. 
Kennedy, M.W. et al., 2010. A co-dependent requirement of xBcl9 and Pygopus for embryonic body 
axis development in Xenopus. Developmental Dynamics, 239(October 2009), pp.271–283. 
Kessaris, N. et al., 2004. Cooperation between sonic hedgehog and fibroblast growth factor/MAPK 
signalling pathways in neocortical precursors. Development (Cambridge, England), 131(6), 
pp.1289–98. 
Kharitonenkov, A. et al., 2005. FGF-21 as a novel metabolic regulator. The Journal of clinical 
investigation, 115(6), pp.1627–35. 
Khokha, M.K. et al., 2005. Depletion of three BMP antagonists from Spemann’s organizer leads to a 
catastrophic loss of dorsal structures. Developmental cell, 8(3), pp.401–11. 
Kiecker, C. & Niehrs, C., 2001. A morphogen gradient of Wnt/{beta}-catenin signalling regulates 
anteroposterior neural patterning in Xenopus. Development, 128(21), pp.4189–4201. 
Kim, G.S. et al., 2015. Cdc6 localizes to S- and G2-phase centrosomes in a cell cycle-dependent 
manner. Biochemical and biophysical research communications, 456(3), pp.763–7. 
Kim, S. et al., 2011. Nde1-mediated inhibition of ciliogenesis affects cell cycle re-entry. Nature cell 
biology, 13(4), pp.351–60. 
253 
Kim, Y.-J. et al., 2015. Xenopus laevis FGF receptor substrate 3 (XFrs3) is important for eye 
development and mediates Pax6 expression in lens placode through its Shp2-binding sites. 
Developmental biology, 397(1), pp.129–39. 
Kimelman, D. & Kirschner, M., 1987. Synergistic induction of mesoderm by FGF and TGF-beta and the 
identification of an mRNA coding for FGF in the early Xenopus embryo. Cell, 51(5), pp.869–877. 
Klisch, T.J. et al., 2006. Mxi1 is essential for neurogenesis in Xenopus and acts by bridging the pan-
neural and proneural genes. Developmental biology, 292(2), pp.470–85. 
Ko, J.Y. et al., 2013. Inactivation of max-interacting protein 1 induces renal cilia disassembly through 
reduction in levels of intraflagellar transport 20 in polycystic kidney. The Journal of biological 
chemistry, 288(9), pp.6488–97. 
Kole, D. et al., 2014. Maintenance of multipotency in human dermal fibroblasts treated with Xenopus 
laevis egg extract requires exogenous fibroblast growth factor-2. Cellular reprogramming, 16(1), 
pp.18–28. 
Kolm, P.J. & Sive, H.L., 1995. Efficient hormone-inducible protein function in Xenopus laevis. 
Developmental biology, 171, pp.267–272. 
Kolupaeva, V. & Basilico, C., 2012. Overexpression of cyclin E/CDK2 complexes overcomes FGF-
induced cell cycle arrest in the presence of hypophosphorylated Rb proteins. Cell cycle 
(Georgetown, Tex.), 11(13), pp.2557–66. 
Kostrzewa, M. & Müller, U., 1998. Genomic structure and complete sequence of the human FGFR4 
gene. Mammalian Genome, 9(2), pp.131–135. 
Kouhara, H. et al., 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the 
Ras/MAPK signaling pathway. Cell, 89(5), pp.693–702. 
Kovalenko, D. et al., 2003. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine 
phosphorylation and subsequent ERK activation. The Journal of biological chemistry, 278(16), 
pp.14087–91. 
Kretzschmar, M., Doody, J. & Massagué, J., 1997. Opposing BMP and EGF signalling pathways 
converge on the TGF-beta family mediator Smad1. Nature, 389(6651), pp.618–22. 
Kroll, K.L. & Amaya, E., 1996. Transgenic Xenopus embryos from sperm nuclear transplantations 
reveal FGF signaling requirements during gastrulation. Development (Cambridge, England), 
122(1996), pp.3173–3183. 
Kudoh, T. et al., 2004. Combinatorial Fgf and Bmp signalling patterns the gastrula ectoderm into 
prospective neural and epidermal domains. Development (Cambridge, England), 131(15), 
pp.3581–92. 
Kudoh, T., Wilson, S.W. & Dawid, I.B., 2002. Distinct roles for Fgf, Wnt and retinoic acid in 
posteriorizing the neural ectoderm. Development (Cambridge, England), 129(18), pp.4335–46. 
Kuhns, S. et al., 2013. The microtubule affinity regulating kinase MARK4 promotes axoneme extension 
during early ciliogenesis. The Journal of cell biology, 200(4), pp.505–22. 
Kumano, G. & Smith, W.C., 2002. The nodal target gene Xmenf is a component of an FGF-
independent pathway of ventral mesoderm induction in Xenopus. Mechanisms of development, 
118(1-2), pp.45–56. 
Kuroda, H. et al., 2005. Default neural induction: neuralization of dissociated Xenopus cells is 
mediated by Ras/MAPK activation. Genes & development, 19(9), pp.1022–7. 
254 
Kwon, H.-J. & Chung, H.-M., 2003. Yin Yang 1, a vertebrate polycomb group gene, regulates antero-
posterior neural patterning. Biochemical and biophysical research communications, 306(4), 
pp.1008–13. 
Kwon, T. et al., 2014. Identifying direct targets of transcription factor Rfx2 that coordinate ciliogenesis 
and cell movement. Genomics Data, 2, pp.192–194. 
LaBonne, C. & Whitman, M., 1994. Mesoderm induction by activin requires FGF-mediated intracellular 
signals. Development (Cambridge, England), 120(2), pp.463–472. 
Ladher, R.K. et al., 2000. Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick 
development. Developmental biology, 218(2), pp.183–98. 
Lai, C.J. et al., 1995. Patterning of the neural ectoderm of Xenopus laevis by the amino-terminal 
product of hedgehog autoproteolytic cleavage. Development (Cambridge, England), 121(8), 
pp.2349–60. 
Lai, W.-T., Krishnappa, V. & Phinney, D.G., 2011. Fgf2 Inhibits Differentiation of Mesenchymal Stem 
Cells by Inducing Twist2 Spry4, Blocking Extracellular Regulated Kinase Activation and Altering 
Fgfr Expression Levels. Stem cells (Dayton, Ohio), 2, pp.1102–1111. 
Lamb, T.M. & Harland, R.M., 1995. Fibroblast growth factor is a direct neural inducer, which combined 
with noggin generates anterior-posterior neural pattern. Development (Cambridge, England), 
121(11), pp.3627–36. 
Lamborghini, J.E., 1980. Rohon-beard cells and other large neurons in Xenopus embryos originate 
during gastrulation. The Journal of comparative neurology, 189(2), pp.323–333. 
Lanctot, A.A. et al., 2013. Spatially dependent dynamic MAPK modulation by the Nde1-Lis1-Brap 
complex patterns mammalian CNS. Developmental cell, 25(3), pp.241–55. 
Lanner, F. et al., 2010. Heparan sulfation-dependent fibroblast growth factor signaling maintains 
embryonic stem cells primed for differentiation in a heterogeneous state. Stem cells (Dayton, 
Ohio), 28(2), pp.191–200. 
Lappin, T.R.J. et al., 2006. HOX genes: seductive science, mysterious mechanisms. The Ulster 
medical journal, 75(1), pp.23–31. 
Lea, R. et al., 2009. Temporal and spatial expression of FGF ligands and receptors during Xenopus 
development. Developmental dynamics : an official publication of the American Association of 
Anatomists, 238(6), pp.1467–79. 
Lee, J.Y. & Stearns, T., 2013. FOP is a centriolar satellite protein involved in ciliogenesis. PloS one, 
8(3), p.e58589. 
Lee, S.-Y. et al., 2012. The role of heterodimeric AP-1 protein comprised of JunD and c-Fos proteins in 
hematopoiesis. The Journal of biological chemistry, 287(37), pp.31342–8. 
Lei, Y. et al., 2012. Efficient targeted gene disruption in Xenopus embryos using engineered 
transcription activator-like effector nucleases (TALENs). Proceedings of the National Academy of 
Sciences, 109(43), pp.17484–17489. 
Li, C. et al., 2007. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling 
during mouse development. Development (Cambridge, England), 134(1), pp.167–76. 
Li, H. et al., 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics, 25(16), 
pp.2078–2079. 
Li, H. & Durbin, R., 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. 
Bioinformatics, 25(14), pp.1754–1760. 
255 
Li, R. et al., 2014. Isl1 and Pou4f2 form a complex to regulate target genes in developing retinal 
ganglion cells. PloS one, 9(3), p.e92105. 
Lienkamp, S., Ganner, A. & Walz, G., 2012. Inversin, Wnt signaling and primary cilia. Differentiation; 
research in biological diversity, 83(2), pp.S49–55. 
Lin, X. et al., 1999. Heparan sulfate proteoglycans are essential for FGF receptor signaling during 
Drosophila embryonic development. Development (Cambridge, England), 126(17), pp.3715–23. 
Lin, X. & Perrimon, N., 1999. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless 
signalling. Nature, 400(6741), pp.281–4. 
Linker, C. & Stern, C.D., 2004. Neural induction requires BMP inhibition only as a late step, and 
involves signals other than FGF and Wnt antagonists. Development (Cambridge, England), 
131(22), pp.5671–81. 
Liu, A. et al., 2003. FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or 
activated FGF receptors. Development (Cambridge, England), 130(25), pp.6175–85. 
Liu, J.-P., Laufer, E. & Jessell, T.M., 2001. Assigning the Positional Identity of Spinal Motor Neurons. 
Neuron, 32(6), pp.997–1012. 
Liu, X.-J. et al., 2014. Up-regulating of RASD1 and apoptosis of DU-145 human prostate cancer cells 
induced by formononetin in vitro. Asian Pacific journal of cancer prevention : APJCP, 15(6), 
pp.2835–9. 
Lizcano, J.M. et al., 2002. Molecular basis for the substrate specificity of NIMA-related kinase-6 
(NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 
protein kinase and serum- and glucocorticoid-induced protein kinase in vivo. The Journal of 
biological chemistry, 277(31), pp.27839–49. 
Lloret-Vilaspasa, F. et al., 2010. Retinoid signalling is required for information transfer from mesoderm 
to neuroectoderm during gastrulation. International Journal of Developmental Biology, 
54(December 2009), pp.599–608. 
Lombardo, A., Isaacs, H. V. & Slack, J.M.W., 1998. Expression and functions of FGF-3 in Xenopus 
development. International Journal of Developmental Biology, 42, pp.1101–1107. 
Lopes Floro, K. et al., 2011. Loss of Cited2 causes congenital heart disease by perturbing left-right 
patterning of the body axis. Human molecular genetics, 20(6), pp.1097–110. 
López-Perrote, A. et al., 2014. Structure of Yin Yang 1 oligomers that cooperate with RuvBL1-RuvBL2 
ATPases. The Journal of biological chemistry, 289(33), pp.22614–29. 
Lüders, F. et al., 2003. Slalom encodes an adenosine 3’-phosphate 5'-phosphosulfate transporter 
essential for development in Drosophila. The EMBO journal, 22(14), pp.3635–44. 
Lundin, L. et al., 2000. Selectively desulfated heparin inhibits fibroblast growth factor-induced 
mitogenicity and angiogenesis. The Journal of biological chemistry, 275(32), pp.24653–60. 
Luo, T. et al., 2007. Inca: a novel p21-activated kinase-associated protein required for cranial neural 
crest development. Development (Cambridge, England), 134(7), pp.1279–89. 
Lupo, G. et al., 2005. Dorsoventral patterning of the Xenopus eye: a collaboration of Retinoid, 
Hedgehog and FGF receptor signaling. Development (Cambridge, England), 132(7), pp.1737–
48. 
Maecker, H.T., Todd, S.C. & Levy, S., 1997. The tetraspanin superfamily: molecular facilitators. 
FASEB journal : official publication of the Federation of American Societies for Experimental 
Biology, 11(6), pp.428–42. 
256 
Majumdar, D. et al., 2011. An APPL1/Akt signaling complex regulates dendritic spine and synapse 
formation in hippocampal neurons. Molecular and cellular neurosciences, 46(3), pp.633–44. 
Makarenkova, H.P. et al., 2009. Differential interactions of FGFs with heparan sulfate control gradient 
formation and branching morphogenesis. Science signaling, 2(88), p.ra55. 
Manzanares, M. et al., 1999. The role of kreisler in segmentation during hindbrain development. 
Developmental biology, 211(2), pp.220–37. 
Marchal, L. et al., 2009. BMP inhibition initiates neural induction via FGF signaling and Zic genes. 
Proceedings of the National Academy of Sciences of the United States of America, 106(41), 
pp.17437–42. 
Marguerat, S. & Bähler, J., 2010. RNA-seq: From technology to biology. Cellular and Molecular Life 
Sciences, 67, pp.569–579. 
Marics, I. et al., 2002. FGFR4 signaling is a necessary step in limb muscle differentiation. 
Development, 129(19), pp.4559–4569. 
Marín, F. & Charnay, P., 2000. Positional regulation of Krox-20 and mafB/kr expression in the 
developing hindbrain: potentialities of prospective rhombomeres. Developmental biology, 218(2), 
pp.220–234. 
Marín, O., 2012. Interneuron dysfunction in psychiatric disorders. Nature reviews. Neuroscience, 13(2), 
pp.107–20. 
Marioni, J.C. et al., 2008. RNA-seq : An assessment of technical reproducibility and comparison with 
gene expression arrays. , pp.1509–1517. 
Martin, B.L. & Kimelman, D., 2009. Regulation of canonical Wnt signaling by Brachury is essential for 
posterior mesoderm formation. Dev. Cell, 15(1), pp.121–133. 
Martinez, S. et al., 1999. FGF8 induces formation of an ectopic isthmic organizer and isthmocerebellar 
development via a repressive effect on Otx2 expression. Development (Cambridge, England), 
126(6), pp.1189–200. 
Martinez, S., Wassef, M. & Alvarado-Mallart, R.M., 1991. Induction of a mesencephalic phenotype in 
the 2-day-old chick prosencephalon is preceded by the early expression of the homeobox gene 
en. Neuron, 6(6), pp.971–81. 
Martín-Ibáñez, R. et al., 2012. Helios transcription factor expression depends on Gsx2 and Dlx1&2 
function in developing striatal matrix neurons. Stem cells and development, 21(12), pp.2239–51. 
Martynoga, B. et al., 2005. Foxg1 is required for specification of ventral telencephalon and region-
specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Developmental 
biology, 283(1), pp.113–27. 
Martynova, N. et al., 2004. Patterning the forebrain: FoxA4a/Pintallavis and Xvent2 determine the 
posterior limit of Xanf1 expression in the neural plate. Development (Cambridge, England), 
131(10), pp.2329–38. 
Matsuda, K. & Kondoh, H., 2014. Dkk1-dependent inhibition of Wnt signaling activates Hesx1 
expression through its 5’ enhancer and directs forebrain precursor development. Genes to cells : 
devoted to molecular & cellular mechanisms, 19(5), pp.374–85. 
Maves, L., Jackman, W. & Kimmel, C.B., 2002. FGF3 and FGF8 mediate a rhombomere 4 signaling 
activity in the zebrafish hindbrain. Development (Cambridge, England), 129(16), pp.3825–3837. 
May-Simera, H.L. et al., 2010. Bbs8, together with the planar cell polarity protein Vangl2, is required to 
establish left-right asymmetry in zebrafish. Developmental biology, 345(2), pp.215–25. 
257 
McGrath, J. et al., 2003. Two populations of node monocilia initiate left-right asymmetry in the mouse. 
Cell, 114(1), pp.61–73. 
McGrew, L.L., Hoppler, S. & Moon, R.T., 1997. Wnt and FGF pathways cooperatively pattern 
anteroposterior neural ectoderm in Xenopus. Mechanisms of Development, 69(1-2), pp.105–114. 
McKay, M.M. & Morrison, D.K., 2007. Integrating signals from RTKs to ERK/MAPK. Oncogene, 
26(2007), pp.3113–3121. 
McMahon, A.P. & Moon, R.T., 1989. Ectopic expression of the proto-oncogene int-1 in Xenopus 
embryos leads to duplication of the embryonic axis. Cell, 58(6), pp.1075–84. 
McMahon, J.A. et al., 1998. Noggin-mediated antagonism of BMP signaling is required for growth and 
patterning of the neural tube and somite. Genes & development, 12(10), pp.1438–52. 
Meyers, E.N. & Martin, G.R., 1999. Differences in left-right axis pathways in mouse and chick: 
functions of FGF8 and SHH. Science (New York, N.Y.), 285(5426), pp.403–6. 
Mi, H., Muruganujan, A. & Thomas, P.D., 2013. PANTHER in 2013: modeling the evolution of gene 
function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research, 
41(Database issue), pp.D377–86. 
Miller, J.C. et al., 2011. A TALE nuclease architecture for efficient genome editing. Nature 
biotechnology, 29(2), pp.143–8. 
Min, T.H. et al., 2011. The dual regulator Sufu integrates Hedgehog and Wnt signals in the early 
Xenopus embryo. Developmental biology, 358(1), pp.262–76. 
Mitsiadis, T.A. et al., 2010. BMPs and FGFs target Notch signalling via jagged 2 to regulate tooth 
morphogenesis and cytodifferentiation. Development (Cambridge, England), 137(18), pp.3025–
35. 
Mlodzik, M. & Gehring, W.J., 1987. Expression of the caudal gene in the germ line of Drosophila: 
Formation of an RNA and protein gradient during early embryogenesis. Cell, 48(3), pp.465–478. 
Mohammadi, M. et al., 1991. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast 
growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. 
Molecular and cellular biology, 11(10), pp.5068–78. 
Mohammadi, M. et al., 1996. Identification of six novel autophosphorylation sites on fibroblast growth 
factor receptor 1 and elucidation of their importance in receptor activation and signal 
transduction. Molecular and cellular biology, 16(3), pp.977–89. 
Mohammadi, M. et al., 1997. Structures of the tyrosine kinase domain of fibroblast growth factor 
receptor in complex with inhibitors. Science (New York, N.Y.), 276(5314), pp.955–60. 
Mohammadi, M., Olsen, S.K. & Ibrahimi, O. a, 2005. Structural basis for fibroblast growth factor 
receptor activation. Cytokine & growth factor reviews, 16(2), pp.107–37. 
Moldrich, R.X. et al., 2011. Fgfr3 regulates development of the caudal telencephalon. Developmental 
Dynamics, 240(6), pp.1586–1599. 
Molina, G. et al., 2009. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands 
cardiac cell lineages. Nature chemical biology, 5(9), pp.680–7. 
Monsoro-Burq, A.-H., Fletcher, R.B. & Harland, R.M., 2003. Neural crest induction by paraxial 
mesoderm in Xenopus embryos requires FGF signals. Development, 130(>14), pp.3111–3124. 
Montavon, T. & Soshnikova, N., 2014. Hox gene regulation and timing in embryogenesis. Seminars in 
cell & developmental biology, 34C(2014), pp.76–84. 
258 
Moody, S.A., 1987. Fates of the blastomeres of the 16-cell stage Xenopus embryo. Developmental 
Biology, 119(2), pp.560–578. 
Morgan, M.J. et al., 2004. YY1 regulates the neural crest-associated slug gene in Xenopus laevis. The 
Journal of biological chemistry, 279(45), pp.46826–34. 
Morozova, O. & Marra, M. a., 2008. Applications of next-generation sequencing technologies in 
functional genomics. Genomics, 92(5), pp.255–264. 
Mukhopadhyay, M. et al., 2001. Dickkopf1 is required for embryonic head induction and limb 
morphogenesis in the mouse. Developmental cell, 1(3), pp.423–34. 
Murato, Y. et al., 2007. Two alloalleles of Xenopus laevis hairy2 gene—evolution of duplicated gene 
function from a developmental perspective. Development Genes and Evolution, 217(9), pp.665–
673. 
Murgan, S. et al., 2014. FoxA4 favours notochord formation by inhibiting contiguous mesodermal fates 
and restricts anterior neural development in Xenopus embryos. PloS one, 9(10), p.e110559. 
Nagalakshmi, U., Waern, K. & Snyder, M., 2010. RNA-seq: A method for comprehensive transcriptome 
analysis. Current Protocols in Molecular Biology, (SUPPL. 89), pp.1–13. 
Nagano, T. et al., 2006. Shisa2 promotes the maturation of somitic precursors and transition to the 
segmental fate in Xenopus embryos. Development (Cambridge, England), 133(23), pp.4643–54. 
Nagaoka, T. et al., 2014. Vangl2 regulates E-cadherin in epithelial cells. Scientific reports, 4, p.6940. 
Nakajima, K. & Yaoita, Y., 2015. Highly efficient gene knockout by injection of TALEN mRNAs into 
oocytes and host transfer in Xenopus laevis. Biology Open, 4(2), pp.180–185. 
Nakayama, T. et al., 2013. Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in 
Xenopus tropicalis. Genesis (New York, N.Y. : 2000), 51(12), pp.835–43. 
Nauli, S.M. et al., 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney 
cells. Nature genetics, 33(2), pp.129–37. 
Neilson, K.M. et al., 2012. Specific domains of FoxD4/5 activate and repress neural transcription factor 
genes to control the progression of immature neural ectoderm to differentiating neural plate. 
Developmental biology, 365(2), pp.363–75. 
Neilson, K.M. & Friesel, R.E., 1995. Constitutive activation of fibroblast growth factor receptor-2 by a 
point mutation associated with Crouzon syndrome. The Journal of biological chemistry, 270(22), 
pp.26037–26040. 
Neugebauer, J.M. et al., 2009. FGF Signaling during embryo development regulates cilia length in 
diverse epithelia. October, 458(7238), pp.651–654. 
Neugebauer, J.M. & Yost, H.J., 2014. FGF Signaling is Required for Brain Left-Right Asymmetry and 
Brain Midline Formation. Developmental biology, 1(3), pp.123–134. 
Nichane, M. et al., 2008. Hairy2-Id3 interactions play an essential role in Xenopus neural crest 
progenitor specification. Developmental biology, 322(2), pp.355–67. 
Nichane, M., Ren, X. & Bellefroid, E.J., 2010. Self-regulation of Stat3 activity coordinates cell-cycle 
progression and neural crest specification. The EMBO journal, 29(1), pp.55–67. 
Nicholson, K.M. & Anderson, N.G., 2002. The protein kinase B/Akt signalling pathway in human 
malignancy. Cellular Signalling, 14(5), pp.381–395. 
259 
Nicoli, S. et al., 2005. Regulated expression pattern of gremlin during zebrafish development. Gene 
expression patterns : GEP, 5(4), pp.539–44. 
Nie, X., Luukko, K. & Kettunen, P., 2006. FGF signalling in craniofacial development and 
developmental disorders. Oral diseases, 12(2), pp.102–11. 
Niehrs, C. & Feld, I.N., 1999. Head in the WNT the molecular nature of Spemann ’ s head organizer. , 
9525(99). 
Nieuwkoop, P. & Nigtevecht, G., 1954. Neural activation and transformation in explants of competent 
ectoderm under the influence of fragments of anterior notochord in urodeles. Journal of 
Embryology and …, 2(September), pp.175–193. 
Niswander, L. et al., 1993. FGF-4 replaces the apical ectodermal ridge and directs outgrowth and 
patterning of the limb. Cell, 75(3), pp.579–87. 
Nitta, K.R. et al., 2004. XSIP1 is essential for early neural gene expression and neural differentiation 
by suppression of BMP signaling. Developmental biology, 275(1), pp.258–67. 
Nolte, C. & Krumlauf, R., 2000. Expression of Hox Genes in the Nervous System of Vertebrates. 
Nonaka, S. et al., 1998. Randomization of left-right asymmetry due to loss of nodal cilia generating 
leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell, 95(6), pp.829–37. 
Nordström, U. et al., 2006. An early role for Wnt signaling in specifying neural patterns of Cdx and Hox 
gene expression and motor neuron subtype identity. PLoS Biology, 4(8), pp.1438–1452. 
O’Donovan, M.C. et al., 2009. Analysis of 10 independent samples provides evidence for association 
between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Molecular 
psychiatry, 14(1), pp.30–6. 
O’Regan, L. & Fry, A.M., 2009. The Nek6 and Nek7 protein kinases are required for robust mitotic 
spindle formation and cytokinesis. Molecular and cellular biology, 29(14), pp.3975–90. 
Ohta, N. & Satou, Y., 2013. Multiple signaling pathways coordinate to induce a threshold response in a 
chordate embryo. PLoS genetics, 9(10), p.e1003818. 
Oishi, I. et al., 2003. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK 
signalling pathway. Genes to cells : devoted to molecular & cellular mechanisms, 8(7), pp.645–
54. 
Okada, Y. et al., 1999. Abnormal nodal flow precedes situs inversus in iv and inv mice. Molecular cell, 
4(4), pp.459–68. 
Okada, Y. et al., 2005. Mechanism of nodal flow: a conserved symmetry breaking event in left-right 
axis determination. Cell, 121(4), pp.633–44. 
Olivera-Martinez, I. & Storey, K.G., 2007. Wnt signals provide a timing mechanism for the FGF-retinoid 
differentiation switch during vertebrate body axis extension. Development (Cambridge, England), 
134(11), pp.2125–35. 
Olsen, S.K. et al., 2006. Structural basis by which alternative splicing modulates the organizer activity 
of FGF8 in the brain. Genes & development, 20(2), pp.185–98. 
Ong, S.H. et al., 2000. FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse 
Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors. Molecular and 
Cellular Biology, 20(3), pp.979–989. 
Ornitz, D.M. et al., 1992. Heparin is required for cell-free binding of basic fibroblast growth factor to a 
soluble receptor and for mitogenesis in whole cells. Molecular and cellular biology, 12(1), 
pp.240–7. 
260 
Ornitz, D.M. & Itoh, N., 2001. Protein family review Fibroblast growth factors Gene organization and 
evolutionary history. Genome, pp.1–12. 
Osipovich, A.B. et al., 2014. Insm1 promotes endocrine cell differentiation by modulating the 
expression of a network of genes that includes Neurog3 and Ripply3. Development (Cambridge, 
England), 141(15), pp.2939–49. 
Ossipova, O. et al., 2015. Vangl2 cooperates with Rab11 and Myosin V to regulate apical constriction 
during vertebrate gastrulation. Development, 142, pp.99–107. 
Ota, S., Tonou-Fujimori, N. & Yamasu, K., 2009. The roles of the FGF signal in zebrafish embryos 
analyzed using constitutive activation and dominant-negative suppression of different FGF 
receptors. Mechanisms of development, 126(1-2), pp.1–17. 
Paek, H., Gutin, G. & Hébert, J.M., 2009. FGF signaling is strictly required to maintain early 
telencephalic precursor cell survival. Development (Cambridge, England), 136(14), pp.2457–65. 
Paterno, G.D. et al., 2000. The VT+ and VT- isoforms of the fibroblast growth factor receptor type 1 are 
differentially expressed in the presumptive mesoderm of Xenopus embryos and differ in their 
ability to mediate mesoderm formation. The Journal of biological chemistry, 275(13), pp.9581–6. 
Pellegrini, L. et al., 2000. Crystal structure of fibroblast growth factor receptor ectodomain bound to 
ligand and heparin. Nature, 407(6807), pp.1029–34. 
Peng, Y. et al., 2006. Cold-inducible RNA binding protein is required for the expression of adhesion 
molecules and embryonic cell movement in Xenopus laevis. Biochemical and biophysical 
research communications, 344(1), pp.416–24. 
Pera, E. & Ikeda, A., 2003. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation 
in neural induction. Genes & …, (310), pp.3023–3028. 
Pera, E.M. et al., 2014. Active signals, gradient formation and regional specificity in neural induction. 
Experimental cell research, 321(1), pp.25–31. 
Pézeron, G. et al., 2008. Rasl11b knock down in zebrafish suppresses one-eyed-pinhead mutant 
phenotype. PloS one, 3(1), p.e1434. 
Piccolo, S. et al., 1996. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct 
binding of chordin to BMP-4. Cell, 86(4), pp.589–98. 
Pignatelli, M. et al., 2003. The transcription factor early growth response factor-1 (EGR-1) promotes 
apoptosis of neuroblastoma cells. The Biochemical journal, 373, pp.739–746. 
Pinho, S. et al., 2011. Distinct steps of neural induction revealed by Asterix, Obelix and TrkC, genes 
induced by different signals from the organizer. PloS one, 6(4), p.e19157. 
Plotnikov, A.N. et al., 2001. Crystal structure of fibroblast growth factor 9 reveals regions implicated in 
dimerization and autoinhibition. The Journal of biological chemistry, 276(6), pp.4322–9. 
Pollet, N. et al., 2005. An atlas of differential gene expression during early Xenopus embryogenesis. 
Mechanisms of Development, 122(3), pp.365–439. 
Pope, A.P. et al., 2010. FGFR3 expression in Xenopus laevis. Gene Expression Patterns, 10(2-3), 
pp.87–92. 
Powles-Glover, N., 2014. Cilia and ciliopathies: Classic examples linking phenotype and genotype-An 
overview. Reproductive Toxicology, 48, pp.98–105. 
Pownall & Isaacs, 2010. FGF Signalling in Vertebrate Development D. S. Kessler, ed., Morgan & 
Claypool Life Sciences Publishers. 
261 
Pownall, M. et al., 2003. An inducible system for the study of FGF signalling in early amphibian 
development. Developmental Biology, 256(1), pp.90–100. 
Pownall, M.E. et al., 1996. eFGF, Xcad3 and Hox genes form a molecular pathway that establishes the 
anteroposterior axis in Xenopus. Development (Cambridge, England), 122(12), pp.3881–92. 
Pownall, M.E., Isaacs, H. V & Slack, J.M., 1998. Two phases of Hox gene regulation during early 
Xenopus development. Current biology : CB, 8(11), pp.673–6. 
Pye, D.A. et al., 2000. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is 
dependent on specific structural features: differential requirements for the modulation of FGF-1 
and FGF-2. Glycobiology, 10(11), pp.1183–1192. 
Qi, H. et al., 2014. FGFR3 induces degradation of BMP type I receptor to regulate skeletal 
development. Biochimica et Biophysica Acta - Molecular Cell Research, 1843(7), pp.1237–1247. 
Qin, B. et al., 2006. Sorting nexin 10 induces giant vacuoles in mammalian cells. The Journal of 
biological chemistry, 281(48), pp.36891–6. 
Quarmby, L.M. & Mahjoub, M.R., 2005. Caught Nek-ing: cilia and centrioles. Journal of cell science, 
118(Pt 22), pp.5161–9. 
Raffioni, S. et al., 1999. Comparison of the intracellular signaling responses by three chimeric 
fibroblast growth factor receptors in PC12 cells. Proceedings of the National Academy of 
Sciences of the United States of America, 96(June), pp.7178–7183. 
Ramsdell, a F. & Yost, H.J., 1998. Molecular mechanisms of vertebrate left-right development. Trends 
in genetics : TIG, 14(11), pp.459–65. 
Ranft, K. et al., 2010. Evidence for structural abnormalities of the human habenular complex in 
affective disorders but not in schizophrenia. Psychological medicine, 40(4), pp.557–67. 
Rapali, P. et al., 2011. DYNLL/LC8: a light chain subunit of the dynein motor complex and beyond. The 
FEBS journal, 278(17), pp.2980–96. 
Rash, B.G. & Grove, E.A., 2007. Patterning the dorsal telencephalon: a role for sonic hedgehog? The 
Journal of neuroscience : the official journal of the Society for Neuroscience, 27(43), pp.11595–
603. 
Rebagliati, M.R. et al., 1998. Zebrafish nodal-related genes are implicated in axial patterning and 
establishing left-right asymmetry. Developmental biology, 199(2), pp.261–72. 
Regan, J.C. et al., 2009. An Fgf8-dependent bistable cell migratory event establishes CNS asymmetry. 
Neuron, 61(1), pp.27–34. 
Regué, L. et al., 2011. DYNLL/LC8 protein controls signal transduction through the Nek9/Nek6 
signaling module by regulating Nek6 binding to Nek9. The Journal of biological chemistry, 
286(20), pp.18118–29. 
Reifers, F. et al., 1998. Fgf8 is mutated in zebrafish acerebellar (ace) mutants and is required for 
maintenance of midbrain-hindbrain boundary development and somitogenesis. Development 
(Cambridge, England), 125(13), pp.2381–95. 
Ren, Y. et al., 2007. Tyrosine 330 in hSef is critical for the localization and the inhibitory effect on FGF 
signaling. Biochemical and biophysical research communications, 354(3), pp.741–6. 
Reversade, B. & De Robertis, E., 2005. Regulation of ADMP and BMP2/4/7 at Opposite Embroynic 
Poles Generates a Self-Regulating Morphogenetic Field. Cell, 123(6), pp.1147–1160. 
Revest, J.-M., 2000. Fibroblast Growth Factor 9 Secretion Is Mediated by a Non-cleaved Amino-
terminal Signal Sequence. Journal of Biological Chemistry, 275(11), pp.8083–8090. 
262 
Revollo, L. et al., 2015. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and 
osteoanabolic action. Journal of bone and mineral research : the official journal of the American 
Society for Bone and Mineral Research, 30(2), pp.274–85. 
Rhinn, M. & Dollé, P., 2012. Retinoic acid signalling during development. Development (Cambridge, 
England), 139(5), pp.843–58. 
Ribisi, S. et al., 2000. Ras-mediated FGF signaling is required for the formation of posterior but not 
anterior neural tissue in Xenopus laevis. Developmental biology, 227(1), pp.183–96. 
Ritchey, E.R. et al., 2010. The pattern of expression of guanine nucleotide-binding protein beta3 in the 
retina is conserved across vertebrate species. Neuroscience, 169(3), pp.1376–91. 
Robbins, M.J. et al., 2000. Molecular cloning and characterization of two novel retinoic acid-inducible 
orphan G-protein-coupled receptors (GPRC5B and GPRC5C). Genomics, 67(1), pp.8–18. 
Robert-Moreno, À. et al., 2010. Characterization of new otic enhancers of the pou3f4 gene reveal 
distinct signaling pathway regulation and spatio-temporal patterns. PloS one, 5(12), p.e15907. 
Roche, D.D. et al., 2009. Dazap2 is required for FGF-mediated posterior neural patterning, 
independent of Wnt and Cdx function. Developmental biology, 333(1), pp.26–36. 
Rodríguez Esteban, C. et al., 1999. The novel Cer-like protein Caronte mediates the establishment of 
embryonic left-right asymmetry. Nature, 401, pp.243–251. 
Rogers, C.D., Ferzli, G.S. & Casey, E.S., 2011. The response of early neural genes to FGF signaling 
or inhibition of BMP indicate the absence of a conserved neural induction module. BMC 
developmental biology, 11, p.74. 
Ryu, M.S. et al., 2004. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding 
of cyclin B1-Cdc2 and its activity, independent of p53 expression. Experimental cell research, 
299(1), pp.159–70. 
Saka, Y., Tada, M. & Smith, J.., 2000. A screen for targets of the Xenopus T-box gene Xbra. 
Mechanisms of Development, 93(1-2), pp.27–39. 
Santiago, Y. et al., 2008. Targeted gene knockout in mammalian cells by using engineered zinc-finger 
nucleases. Proceedings of the National Academy of Sciences of the United States of America, 
105(15), pp.5809–5814. 
Sasai, Y. et al., 1995. Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning 
signals in Xenopus. Nature. 
Sasaki, A. et al., 2003. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding 
to Raf1. Nature cell biology, 5(5), pp.427–32. 
Sato, T., Araki, I. & Nakamura, H., 2001. Inductive signal and tissue responsiveness defining the 
tectum and the cerebellum. Development (Cambridge, England), 128(13), pp.2461–9. 
Sato, T., Joyner, A.L. & Nakamura, H., 2004. How does Fgf signaling from the isthmic organizer induce 
midbrain and cerebellum development? Development, growth & differentiation, 46(6), pp.487–
94. 
Schlessinger, J. et al., 2000. Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a 
Dual Role for Heparin in FGFR Binding and Dimerization. Molecular Cell, 6(3), pp.743–750. 
Schlosser, G., Koyano-Nakagawa, N. & Kintner, C., 2002. Thyroid hormone promotes neurogenesis in 
the Xenopus spinal cord. Developmental Dynamics, 225(4), pp.485–498. 
Schmid-Burgk, J.L. et al., 2013. A ligation-independent cloning technique for high-throughput assembly 
of transcription activator–like effector genes. Nature biotechnology, 31(1), pp.76–81. 
263 
Schuff, M. et al., 2006. Temporal and spatial expression patterns of FoxN genes in Xenopus laevis 
embryos. The International journal of developmental biology, 50(4), pp.429–34. 
Schulte-Merker, S. & Smith, J.C., 1995. Mesoderm formation in response to Brachyury requires FGF 
signalling. Current Biology, 5(1), pp.62–67. 
Schweickert, A. et al., 2007. Cilia-driven leftward flow determines laterality in Xenopus. Current 
biology : CB, 17(1), pp.60–6. 
Schweickert, A. et al., 2012. Linking early determinants and cilia-driven leftward flow in left-right axis 
specification of Xenopus laevis: a theoretical approach. Differentiation; research in biological 
diversity, 83(2), pp.S67–77. 
Schweickert, A. et al., 2010. The nodal inhibitor Coco is a critical target of leftward flow in Xenopus. 
Current biology : CB, 20(8), pp.738–43. 
Sdelci, S., Bertran, M.T. & Roig, J., 2011. Nek9, Nek6, Nek7 and the separation of centrosomes. Cell 
Cycle, 10, pp.3816–3817. 
Selvaraj, N., Kedage, V. & Hollenhorst, P.C., 2015. Comparison of MAPK specificity across the ETS 
transcription factor family identifies a high-affinity ERK interaction required for ERG function in 
prostate cells. Cell communication and signaling : CCS, 13(1), p.12. 
Shanmugalingam, S. et al., 2000. Ace/Fgf8 is required for forebrain commissure formation and 
patterning of the telencephalon. Development (Cambridge, England), 127(12), pp.2549–61. 
Shi, Y. et al., 2011. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nature 
genetics, 43(12), pp.1224–7. 
Shimada, T. et al., 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of 
FGF23 in phosphate and vitamin D metabolism. The Journal of clinical investigation, 113(4), 
pp.561–8. 
Shimamura, K. & Rubenstein, J.L., 1997. Inductive interactions direct early regionalization of the 
mouse forebrain. Development (Cambridge, England), 124(14), pp.2709–18. 
Shimizu, T., Bae, Y.-K. & Hibi, M., 2006. Cdx-Hox code controls competence for responding to Fgfs 
and retinoic acid in zebrafish neural tissue. Development (Cambridge, England), 133(23), 
pp.4709–19. 
Shin, D.M. et al., 2004. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex 
resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in 
mice. The Journal of neuroscience : the official journal of the Society for Neuroscience, 24(9), 
pp.2247–2258. 
Shiotsugu, J. et al., 2004. Multiple points of interaction between retinoic acid and FGF signaling during 
embryonic axis formation. Development (Cambridge, England), 131(11), pp.2653–67. 
Sirbu, I.O. et al., 2005. Shifting boundaries of retinoic acid activity control hindbrain segmental gene 
expression. Development (Cambridge, England), 132(11), pp.2611–22. 
Sivak, J.M., Petersen, L.F. & Amaya, E., 2005. FGF signal interpretation is directed by Sprouty and 
Spred proteins during mesoderm formation. Developmental cell, 8(5), pp.689–701. 
Skromne, I. et al., 2007. Repression of the hindbrain developmental program by Cdx factors is required 
for the specification of the vertebrate spinal cord. Development (Cambridge, England), 134(11), 
pp.2147–2158. 
Slack, J. et al., 1987a. Mesoderm induction in early Xenopus embryos by heparin-binding growth 
factors. Nature, 326(6109), pp.197–200. 
264 
Slack, J. et al., 1987b. Mesoderm induction in early Xenpus embryos by heparin-binding growth 
factors. Nature, pp.197–200. Available at: 
http://www.nature.com/nature/journal/v326/n6109/pdf/326197a0.pdf [Accessed December 21, 
2011]. 
Slack, J.M. et al., 1987. Mesoderm induction in early Xenopus embryos by heparin-binding growth 
factors. Nature, 326(6109), pp.197–200. 
Slack, J.M. & Forman, D., 1980. An interaction between dorsal and ventral regions of the marginal 
zone in early amphibian embryos. Journal of embryology and experimental morphology, 56, 
pp.283–299. 
Smith, W.C. & Harland, R.M., 1992. Expression cloning of noggin, a new dorsalizing factor localized to 
the Spemann organizer in Xenopus embryos. Cell, 70(5), pp.829–40. 
Sölter, M. et al., 2006. Characterization and function of the bHLH-O protein XHes2: insight into the 
mechanisms controlling retinal cell fate decision. Development (Cambridge, England), 133, 
pp.4097–4108. 
Spencer, D.M. et al., 1993. Controlling signal transduction with synthetic ligands. Science (New York, 
N.Y.), 262(5136), pp.1019–1024. 
Stachowiak, M.K. et al., 2003. Integrative Nuclear FGFR1 Signaling (INFS) as a Part of a Universal 
“Feed-Forward-And-Gate” Signaling Module That Controls Cell Growth and Differentiation. 
Journal of Cellular Biochemistry, 90(4), pp.662–691. 
Stachowiak, M.K. et al., 1996. Nuclear accumulation of fibroblast growth factor receptors is regulated 
by multiple signals in adrenal medullary cells. Molecular biology of the cell, 7(8), pp.1299–317. 
Stachowiak, M.K., Maher, P. a & Stachowiak, E.K., 2007. Integrative nuclear signaling in cell 
development--a role for FGF receptor-1. DNA and cell biology, 26(12), pp.811–826. 
Steinberg, F. et al., 2010. The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth 
factors (FGFs), and antagonizes FGF signaling in Xenopus embryos. The Journal of biological 
chemistry, 285(3), pp.2193–202. 
Stern, C.D., 2001. Initial patterning of the central nervous system: how many organizers? Nature 
reviews. Neuroscience, 2(2), pp.92–8. 
Stevens, H.E. et al., 2010. Fgfr2 is required for the development of the medial prefrontal cortex and its 
connections with limbic circuits. The Journal of neuroscience : the official journal of the Society 
for Neuroscience, 30(16), pp.5590–5602. 
Stevens, H.E. et al., 2012. Learning and memory depend on fibroblast growth factor receptor 2 
functioning in hippocampus. Biological psychiatry, 71(12), pp.1090–8. 
Streit, a et al., 2000. Initiation of neural induction by FGF signalling before gastrulation. Nature, 
406(6791), pp.74–8. 
Streit, A. et al., 1998. Chordin regulates primitive streak development and the stability of induced 
neural cells, but is not sufficient for neural induction in the chick embryo. Development 
(Cambridge, England), 125(3), pp.507–19. 
Streit, A. et al., 2000. Initiation of neural induction by FGF signalling before gastrulation. Nature, 
406(6791), pp.74–8. 
Su, Y. et al., 2008. APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP 
ubiquitin ligase. Molecular cell, 32(5), pp.652–61. 
265 
Subramanian, V., Meyer, B.I. & Gruss, P., 1995. Disruption of the murine homeobox gene Cdx1 affects 
axial skeletal identities by altering the mesodermal expression domains of Hox genes. Cell, 
83(4), pp.641–653. 
Sugimoto, K. et al., 2007. The role of XBtg2 in Xenopus neural development. Developmental 
neuroscience, 29(6), pp.468–79. 
Sun, L. et al., 1999. Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-
2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine 
Kinases. Journal of Medicinal Chemistry, 42(25), pp.5120–5130. 
Sun, Z. et al., 2006. Sp5l is a mediator of Fgf signals in anteroposterior patterning of the 
neuroectoderm in zebrafish embryo. Developmental dynamics : an official publication of the 
American Association of Anatomists, 235(11), pp.2999–3006. 
Suri, C., Haremaki, T. & Weinstein, D.C., 2005. Xema, a foxi-class gene expressed in the gastrula 
stage Xenopus ectoderm, is required for the suppression of mesendoderm. Development 
(Cambridge, England), 132(12), pp.2733–42. 
Sutherland, R.J., 1982. The dorsal diencephalic conduction system: a review of the anatomy and 
functions of the habenular complex. Neuroscience and biobehavioral reviews, 6(1), pp.1–13. 
Suzuki, K.-I.T. et al., 2013. High efficiency TALENs enable F0 functional analysis by targeted gene 
disruption in Xenopus laevis embryos. Biology open, 2(5), pp.448–52. 
Suzuki-Hirano, A., Sato, T. & Nakamura, H., 2005. Regulation of isthmic Fgf8 signal by sprouty2. 
Development (Cambridge, England), 132(2), pp.257–65. 
Takayama, H. et al., 2008. High-level expression, single-step immunoaffinity purification and 
characterization of human tetraspanin membrane protein CD81. PloS one, 3(6), p.e2314. 
Takebayashi-Suzuki, K. et al., 2011. The forkhead transcription factor FoxB1 regulates the dorsal-
ventral and anterior-posterior patterning of the ectoderm during early Xenopus embryogenesis. 
Developmental biology, 360(1), pp.11–29. 
Tan, C.M. et al., 2013. Network2Canvas: network visualization on a canvas with enrichment analysis. 
Bioinformatics (Oxford, England), 29(15), pp.1872–8. 
Tan, M.H. et al., 2013. RNA sequencing reveals a diverse and dynamic repertoire of the Xenopus 
tropicalis transcriptome over development. Genome research, 23(1), pp.201–16. 
Tanaka, H. et al., 1987. Structure of FK506, a novel immunosuppressant isolated from Streptomyces. 
Journal of the American Chemical Society, 109(16), pp.5031–5033. 
Tao, W. & Lai, E., 1992. Telencephalon-restricted expression of BF-1, a new member of the HNF-
3/fork head gene family, in the developing rat brain. Neuron, 8(5), pp.957–66. 
Taylor, R.W. et al., 2010. Making a difference together: reciprocal interactions in C. elegans and 
zebrafish asymmetric neural development. Development (Cambridge, England), 137(5), pp.681–
91. 
Tereshina, M.B. et al., 2014. Ras-dva1 small GTPase regulates telencephalon development in 
Xenopus laevis embryos by controlling Fgf8 and Agr signaling at the anterior border of the neural 
plate. Biology open, (2014), pp.1–9. 
Tereshina, M.B., Zaraisky, A.G. & Novoselov, V. V, 2006. Ras-dva, a member of novel family of small 
GTPases, is required for the anterior ectoderm patterning in the Xenopus laevis embryo. 
Development (Cambridge, England), 133(3), pp.485–94. 
Terranova, C. et al., 2015. Global Developmental Gene Programing Involves a Nuclear Form of 
Fibroblast Growth Factor Receptor-1 (FGFR1). Plos One, 10(4), p.e0123380. 
266 
Terwisscha van Scheltinga, A.F. et al., 2013. Fibroblast growth factors in neurodevelopment and 
psychopathology. The Neuroscientist : a review journal bringing neurobiology, neurology and 
psychiatry, 19(5), pp.479–94. 
Thomas, K.R. & Capecchi, M.R., 1990. Targeted disruption of the murine int-1 proto-oncogene 
resulting in severe abnormalities in midbrain and cerebellar development. Nature, 346(6287), 
pp.847–50. 
Trueb, B. et al., 2003. Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor 
preferentially expressed in skeletal tissues. The Journal of biological chemistry, 278(36), 
pp.33857–65. 
Trumpel, S., Wiedemann, L. & Krumlauf, R., 2009. Hox genes and the segmentation of the vertebrate 
hindbrain O. Pourquié, ed., Academic Press. 
Tsang, M. et al., 2002. Identification of Sef, a novel modulator of FGF signalling. Nature cell biology, 
4(February 2002), pp.165–169. 
Turner, N. & Grose, R., 2010. Fibroblast growth factor signalling: from development to cancer. Nature 
reviews. Cancer, 10(2), pp.116–29. 
Twigg, S. & Burns, H., 1998. Conserved use of a non-canonical 5′ splice site (/GA) in alternative 
splicing by fibroblast growth factor receptors 1, 2 and 3. Human molecular …, 7(4), pp.685–691. 
Ubbels, G. a et al., 1983. Evidence for a functional role of the cytoskeleton in determination of the 
dorsoventral axis in Xenopus laevis eggs. Journal of embryology and experimental morphology, 
77, pp.15–37. 
Ueno, H. et al., 1992. A Truncated Form of Fibroblast Growth Factor Receptor 1 Inhibits Signal 
Transduction by Multiple Types of Fibroblast Growth Factor Receptor *. , 267(3), pp.1470–1476. 
Umbhauer, M. et al., 1995. Mesoderm induction in Xenopus caused by activation of MAP kinase. 
Nature, 376(6535), pp.58–62. 
Umbhauer, M. et al., 2000. Signaling specificities of fibroblast growth factor receptors in early Xenopus 
embryo. Journal of cell science, 113 ( Pt 1, pp.2865–75. 
Vandenberg, L.N. et al., 2013. Rab GTPases are required for early orientation of the left-right axis in 
Xenopus. Mechanisms of development, 130(4-5), pp.254–71. 
Vassylyev, D.G. et al., 1998. Crystal structure of troponin C in complex with troponin I fragment at 2.3-
A resolution. Proceedings of the National Academy of Sciences of the United States of America, 
95(9), pp.4847–52. 
Vignali, R. et al., 2000. Xotx5b, a new member of the Otx gene family, may be involved in anterior and 
eye development in Xenopus laevis. Mechanisms of development, 96(1), pp.3–13. 
Vonica, A. & Gumbiner, B.M., 2002. Zygotic Wnt activity is required for Brachyury expression in the 
early Xenopus laevis embryo. Developmental biology, 250(1), pp.112–27. 
Wakioka, T. et al., 2001. Spred is a Sprouty-related suppressor of Ras signalling. Nature, 412(6847), 
pp.647–51. 
Walsh, S., Margolis, S.S. & Kornbluth, S., 2003. Phosphorylation of the cyclin b1 cytoplasmic retention 
sequence by mitogen-activated protein kinase and Plx. Molecular cancer research : MCR, 1(4), 
pp.280–9. 
Wang, S. et al., 2004. QSulf1, a heparan sulfate 6- -endosulfatase, inhibits fibroblast growth factor 
signaling in mesoderm O induction and angiogenesis. PNAS, 101(14), pp.4833–4838. 
267 
Wang, T. et al., 2012. FGFR2 is associated with bipolar disorder: a large-scale case-control study of 
three psychiatric disorders in the Chinese Han population. The world journal of biological 
psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 
13(8), pp.599–604. 
Wang, Y., Song, L. & Zhou, C.J., 2011. The canonical Wnt/ß-catenin signaling pathway regulates Fgf 
signaling for early facial development. Developmental Biology, 349(2), pp.250–260. 
Wang, Z., Gerstein, M. & Snyder, M., 2009. RNA-Seq: a revolutionary tool for transcriptomics. Nature 
reviews. Genetics, 10, pp.57–63. 
Webster, M.K. & Donoghue, D.J., 1997. FGFR activation in skeletal disorders: too much of a good 
thing. Trends in genetics : TIG, 13(5), pp.178–82. 
Weinstein, M. et al., 1998. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the 
murine lung. Development (Cambridge, England), 125(18), pp.3615–3623. 
Welm, B.E. et al., 2002. Inducible dimerization of FGFR1: development of a mouse model to analyze 
progressive transformation of the mammary gland. The Journal of cell biology, 157(4), pp.703–
14. 
Weninger, W.J. et al., 2005. Cited2 is required both for heart morphogenesis and establishment of the 
left-right axis in mouse development. Development (Cambridge, England), 132(6), pp.1337–
1348. 
Willardsen, M. et al., 2014. The ETS transcription factor Etv1 mediates FGF signaling to initiate 
proneural gene expression during Xenopus laevis retinal development. Mechanisms of 
development, 131, pp.57–67. 
Wills, A.E. et al., 2010. BMP antagonists and FGF signaling contribute to different domains of the 
neural plate in Xenopus. Developmental biology, 337(2), pp.335–50. 
Wilson, S.I. et al., 2000. An early requirement for FGF signalling in the acquisition of neural cell fate in 
the chick embryo. Current biology : CB, 10(8), pp.421–9. 
Winterbottom, E.F. & Pownall, M.E., 2009. Complementary expression of HSPG 6-O-endosulfatases 
and 6-O-sulfotransferase in the hindbrain of Xenopus laevis. Gene expression patterns : GEP, 
9(3), pp.166–72. 
Wolda, S., Moody, C. & Moon, R., 1993. Overlapping Expression of Xwnt-3A and Xwnt-1 in Neural 
Tissue of Xenopus laevis Embryos. Developmental biology, 155(155), pp.46–57. 
Wu, L., Osmani, S.A. & Mirabito, P.M., 1998. A role for NIMA in the nuclear localization of cyclin B in 
Aspergillus nidulans. The Journal of cell biology, 141(7), pp.1575–87. 
Xiang, M. & Li, S., 2013. Foxn4: A multi-faceted transcriptional regulator of cell fates in vertebrate 
development. Science China. Life sciences, pp.1–9. 
Xuan, S. et al., 1995. Winged helix transcription factor BF-1 is essential for the development of the 
cerebral hemispheres. Neuron, 14(6), pp.1141–1152. 
Yamagishi, M. & Okamoto, H., 2010. Competition for ligands between FGFR1 and FGFR4 regulates 
Xenopus neural development. The International journal of developmental biology, 54(1), pp.93–
104. 
Yamaguchi, T.P. et al., 1994. Fgfr-1 Is Required for Embryonic Growth and Mesodermal Patterning 
During Mouse Gastrulation. Genes and Development, 8(24), pp.3032–3044. 
Yamamoto, A. et al., 2005. Shisa promotes head formation through the inhibition of receptor protein 
maturation for the caudalizing factors, Wnt and FGF. Cell, 120(2), pp.223–35. 
268 
Yamamoto, Y., Grubisic, K. & Oelgeschläger, M., 2007. Xenopus Tetraspanin-1 regulates gastrulation 
movements and neural differentiation in the early Xenopus embryo. Differentiation; research in 
biological diversity, 75(3), pp.235–45. 
Yan, B., Neilson, K.M. & Moody, S.A., 2009. foxD5 plays a critical upstream role in regulating neural 
ectodermal fate and the onset of neural differentiation. Developmental biology, 329(1), pp.80–95. 
Yang, W. et al., 2000. Investigating protein-ligand interactions with a mutant FKBP possessing a 
designed specificity pocket. Journal of medicinal chemistry, 43(6), pp.1135–42. 
Yeh, E. et al., 2013. Novel Molecular Pathways Elicited by Mutant FGFR2 May Account for Brain 
Abnormalities in Apert Syndrome. PLoS ONE, 8(4), pp.1–7. 
Yoon, J. et al., 2011. xCITED2 Induces Neural Genes in Animal Cap Explants of Xenopus Embryos. 
Experimental neurobiology, 20(3), pp.123–9. 
Young, J.J. et al., 2014. Spalt-like 4 promotes posterior neural fates via repression of pou5f3 family 
members in Xenopus. Development (Cambridge, England), 141(8), pp.1683–93. 
Zhang, C. & Klymkowsky, M.W., 2007. The Sox axis, Nodal signaling, and germ layer specification. 
Differentiation, 75, pp.536–545. 
Zhang, X. et al., 2006. Receptor specificity of the fibroblast growth factor family. The complete 
mammalian FGF family. The Journal of biological chemistry, 281(23), pp.15694–700. 
Zhang, Y. et al., 2004. Direct cell cycle regulation by the fibroblast growth factor receptor (FGFR) 
kinase through phosphorylation-dependent release of Cks1 from FGFR substrate 2. Journal of 
Biological Chemistry, 279(53), pp.55348–55354. 
Zhao, J. et al., 2003. An SP1-like transcription factor Spr2 acts downstream of Fgf signaling to mediate 
mesoderm induction. The EMBO journal, 22(22), pp.6078–88. 
Zhao, L. et al., 2013. Reptin/Ruvbl2 is a Lrrc6/Seahorse interactor essential for cilia motility. 
Proceedings of the National Academy of Sciences of the United States of America, 110(31), 
pp.12697–702. 
Zhao, P. et al., 2006. Fgfr4 is required for effective muscle regeneration in vivo delineation of a MyoD-
Tead2-Fgfr4 transcriptional pathway. Journal of Biological Chemistry, 281(1), pp.429–438. 
Zhao, Y. et al., 2014. A novel wnt regulatory axis in endometrioid endometrial cancer. Cancer 
research, 74(18), pp.5103–17. 
Zimmerman, L.B., De Jesús-Escobar, J.M. & Harland, R.M., 1996. The Spemann organizer signal 
noggin binds and inactivates bone morphogenetic protein 4. Cell, 86(4), pp.599–606. 
Zuo, J. et al., 2014. An inhibitory role of NEK6 in TGFβ/Smad signaling pathway. BMB Reports. 
 
